<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
<!-- Created by: EDGAR Online, Inc. EDGAR Filing HTML Converter, Version: 4.63, http://www.edgar-online.com -->
<TITLE> Enzymotec Ltd. (Form: 20-F, Received: 03/03/2016 09:25:01) </TITLE>
<META NAME="TABLES" CONTENT="FIS_FORM **FIS_PART_I **FIS_IDENTITY_OF_PERSONNEL **FIS_OFFER_STATISTICS **FIS_KEY_INFORMATION **FIS_COMPANY_INFORMATION **FIS_UNRESOLVED_STAFF_COMMENTS **FIS_OPERATING_AND_FINANCIAL_REVIEW **FIS_LIQUIDITY_CAPITAL **FIS_DIRECTORS_AND_OFFICERS **FIS_NAME_AND_TITLE **FIS_COMPENSATION_TABLE **FIS_SECURITY_OWNERS **FIS_BENEFICIAL_OWNERS **FIS_FINANCIAL_DATA **FIS_LEGAL_PROCEEDINGS **FIS_LISTING **FIS_ADDITIONAL_INFORMATION **FIS_MARKET_RISK **FIS_OTHER_SECURITIES **FIS_PART_II **FIS_DEFAULTS **FIS_MATERIAL_MODIFICATIONS **FIS_CONTROL_AND_PROCEDURES **FIS_AUDIT_COMMITTEE_EXPERT **FIS_CODE_OF_ETHICS **FIS_ACCOUNTANT_FEES **FIS_EXEMPTIONS_FROM_LISTING **FIS_PURCHASES_OF_EQUITY **FIS_CHANGE_IN_ACCOUNTANT **FIS_CORPORATE_GOVERNANCE **FIS_MINE_SAFETY_DISCLOSURE **FIS_PART_III **FIS_FINANCIAL_STATEMENTS **FIS_FINANCIAL_STATEMENTS_2 **FIS_EXHIBITS **FIS_SIGNATURES **FIS_EXHIBIT_INDEX **FIS_AUDITORS_OPINION **FIS_BALANCE_SHEET **FIS_BALANCE_SHEET_2 **FIS_INCOME_STATEMENT **FIS_STOCKHOLDERS_EQUITY **FIS_CASH_FLOW **FIS_NOTES_TO_FINANCIAL_STATEMENT **FIS_OPTIONS_AGGREGATE FIS_EXHIBIT_8 FIS_EXHIBIT_12 FIS_EXHIBIT_12_2 FIS_EXHIBIT_13 FIS_EXHIBIT_15 ">
<META NAME="DETECTED PAGES" CONTENT="175">
<STYLE TYPE="text/css">
<!--
	body          { background-color: white; color: black }
	.eolNewPage   { page-break-after: always; line-height: 0; height: 0; margin: 0; padding: 0 }
	.eolLeftAlign { text-align: left; margin-left: auto; margin-right: auto }
	.eolCenter    { text-align: center }
	a:link        { color: blue }
	a:active      { color: red }
	a:visited     { color: purple }
	
	@media print
	{
		@page           { margin: 0.25in }
		body            { font-size: 10pt }
		a               { text-decoration: none }
		thead           { display: table-header-group }
		tfoot           { display: table-footer-group }
		hr.eolPageBreak { display: none }
		.eolPrint50pt   { font-size: 5pt }
		.eolPrint55pt   { font-size: 5.5pt }
		.eolPrint60pt   { font-size: 6pt }
		.eolPrint65pt   { font-size: 6.5pt }
		.eolPrint70pt   { font-size: 7pt }
		.eolPrint75pt   { font-size: 7.5pt }
		.eolPrint80pt   { font-size: 8pt }
		.eolPrint85pt   { font-size: 8.5pt }
		.eolPrint90pt   { font-size: 9pt }
		.eolPrint95pt   { font-size: 9.5pt }
	}
-->
</STYLE>
</HEAD>
<BODY>
<A NAME="eolPage1"></A>
<A NAME="FIS_TOP_OF_DOCUMENT"></A>

<A NAME="ZK1618102_HTM"></A>
<EFX_FORM>
<A NAME="FIS_FORM"></A>
<DIV>
<HR STYLE="MARGIN-TOP: -5PX; COLOR: #000000" NOSHADE SIZE="4">
<HR STYLE="MARGIN-TOP: -10PX; COLOR: #000000" NOSHADE SIZE="1">
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 14PT; FONT-WEIGHT: BOLD">
	UNITED STATES
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 14PT; FONT-WEIGHT: BOLD">
	SECURITIES AND EXCHANGE COMMISSION
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Washington, D.C. 20549
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 14PT; FONT-WEIGHT: BOLD">
	Form 20-F
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(Mark One)
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="7%" STYLE="PADDING-LEFT: 0PT; MARGIN-LEFT: 446PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: WINGDINGS">
	o
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="88%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 72PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	OR
</FONT>
</DIV>
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 72PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="7%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: WINGDINGS">
	x
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="88%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	For the fiscal year ended December 31, 2015
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	OR
</FONT>
</DIV>
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</TABLE>
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 72PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="7%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: WINGDINGS">
	o
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="88%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	For the transition period from ______ to ______
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	OR
</FONT>
</DIV>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 72PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</TABLE>
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="7%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: WINGDINGS">
	o
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="88%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	SHELL COMPANY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Date of event requiring this shell company report_______________
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Commission File Number 001-36073
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 16PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(Exact Name of Registrant as specified in its charter)
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ISRAEL
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(Jurisdiction of incorporation or organization)
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Enzymotec Ltd.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Sagi 2000 Industrial Area
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	P.O. Box 6
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Migdal Ha&#8217;Emeq 2310001, Israel
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;(Address of principal executive offices)
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Dr. Ariel Katz
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	President and Chief Executive Officer
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Enzymotec Ltd.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Sagi 2000 Industrial Area
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	P.O. Box 6
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Migdal Ha&#8217;Emeq 2310001, Israel
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	+972-74-717-7177
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	+972-74-7177-008
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(Name, telephone, email and/or facsimile number and address of company contact person)
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage2"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Securities registered or to be registered pursuant to Section 12(b) of the Act:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 72PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="47%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Title of each class
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="46%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Name of each exchange on which registered
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="47%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Ordinary Shares, par value NIS 0.01 per share
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	The NASDAQ Stock Market LLC
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="47%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Securities registered or to be registered pursuant to Section 12(g) of the Act:
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	None
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	None
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Indicate the number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of December 31, 2015:
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	22,718,335 ordinary shares,
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NIS 0.01
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	par value per share
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Yes&#160;
<FONT STYLE="DISPLAY: INLINE;" FACE="WINGDINGS">
	o
</FONT>
	&#160;&#160;&#160;
<FONT ID="TAB2" STYLE="LETTER-SPACING: 9PT">
	&#160;&#160;&#160;
</FONT>
	&#160;No
<FONT STYLE="DISPLAY: INLINE;" FACE="WINGDINGS">
	x
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Yes&#160;
<FONT STYLE="DISPLAY: INLINE;" FACE="WINGDINGS">
	o
</FONT>
	&#160;&#160;&#160;
<FONT ID="TAB2" STYLE="LETTER-SPACING: 9PT">
	&#160;&#160;&#160;
</FONT>
	&#160;No
<FONT STYLE="DISPLAY: INLINE;" FACE="WINGDINGS">
	x
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Yes&#160;
<FONT STYLE="DISPLAY: INLINE;" FACE="WINGDINGS">
	x
</FONT>
	&#160;&#160;&#160;
<FONT ID="TAB2" STYLE="LETTER-SPACING: 9PT">
	&#160;&#160;&#160;
</FONT>
	&#160;No
<FONT STYLE="DISPLAY: INLINE;" FACE="WINGDINGS">
	o
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 144PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 229.405 of this chapter), and (2) has been subject to such filing requirements for the past 90 days:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Yes&#160;
<FONT STYLE="DISPLAY: INLINE;" FACE="WINGDINGS">
	x
</FONT>
	&#160;&#160;&#160;
<FONT ID="TAB2" STYLE="LETTER-SPACING: 9PT">
	&#160;&#160;&#160;
</FONT>
	&#160;No
<FONT STYLE="DISPLAY: INLINE;" FACE="WINGDINGS">
	o
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of &#8220;accelerated filer and large accelerated filer&#8221; in Rule 12b-2 of the Exchange Act (Check one):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="13%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="20%" STYLE="TEXT-ALIGN: CENTER">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Large accelerated filer
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: WINGDINGS">
	o
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="20%" STYLE="TEXT-ALIGN: CENTER">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Accelerated filer
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: WINGDINGS">
	x
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="21%" STYLE="TEXT-ALIGN: CENTER">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Non-accelerated filer
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: WINGDINGS">
	o
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="13%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	U.S. GAAP&#160;&#160;&#160;
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: WINGDINGS">
	x
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="2%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="44%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	International Financial Reporting Standards as issued by
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the International Accounting Standards Board&#160;&#160;
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: WINGDINGS">
	o
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="2%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Other&#160;&#160;
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: WINGDINGS">
	o
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If &#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Item 17&#160;
<FONT STYLE="DISPLAY: INLINE;" FACE="WINGDINGS">
	o&#160;&#160;&#160;&#160;
</FONT>
	&#160;Item 18
<FONT STYLE="DISPLAY: INLINE;" FACE="WINGDINGS">
	o
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 144PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Yes&#160;
<FONT STYLE="DISPLAY: INLINE;" FACE="WINGDINGS">
	o
</FONT>
	&#160;&#160;
<FONT ID="TAB2" STYLE="LETTER-SPACING: 9PT">
	&#160;&#160;&#160;
</FONT>
	&#160;&#160;No
<FONT STYLE="DISPLAY: INLINE;" FACE="WINGDINGS">
	x
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage3"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 144PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	PRELIMINARY NOTES
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Introduction
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As used herein, and unless the context suggests otherwise, the terms &#8220;Enzymotec,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; and similar designations refer to Enzymotec Ltd. and its wholly-owned subsidiaries, Enzymotec USA, Inc., VAYA Pharma, Inc., Enzymotec Australia Pty Ltd. and Enzymotec Singapore PTE Ltd., and, where the context so requires, its 80%-owned subsidiary VAYA Pharma Pte Ltd., a Singapore company, or its 50%-owned joint venture, Advanced Lipids AB, a Swedish company. Additionally, the term &#8220;AL&#8221; refers to Advanced Lipids AB. In this document, references to &#8220;NIS&#8221; or &#8220;shekels&#8221; are to New Israeli Shekels, and references to &#8220;dollars&#8221; or &#8220;$&#8221; refer to U.S. dollars.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The dollar is the currency of the primary economic environment in which our operations are conducted and is our reporting currency. The majority of our sales are in dollars, the majority of our expenses are incurred in dollars and the majority of our financing has been provided in dollars. Transactions and balances originally denominated in dollars are presented at their original amounts. For non-dollar transactions, we use exchange rates in effect as of the relevant transaction dates. Non-dollar balances are translated into dollars using historical and current exchange rates for non-monetary and monetary balances, respectively. For other items in the consolidated statements of operations and comprehensive income (such as those derived from non-monetary balance sheet items such as depreciation and amortization, among others), we apply historical exchange rates. Currency transaction gains and losses are recorded in financial income (expenses), as appropriate.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The functional currency of our equity investee, AL, is the Swedish Krona, which is the currency of the primary economic environment in which the operations of AL are conducted. Currency translation adjustments are presented within other comprehensive income (loss).
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Market and Industry Data and Forecasts
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This annual report on Form 20-F (this &#8220;annual report&#8221;) includes statistical data, market data and other industry data and forecasts, which we obtained from market research, publicly available information and independent industry publications and reports that we believe to be reliable sources.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Special Note Regarding Forward-Looking Statements
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This annual report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our management&#8217;s beliefs and assumptions and on information currently available to our management. Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, financing plans, competitive position, industry environment, potential growth opportunities, potential market opportunities and the effects of competition. Forward-looking statements include all statements that are not historical facts and can be identified by terms such as &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;could,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; or similar expressions that convey uncertainty of future events or outcomes and the negatives of those terms. These statements include, but are not limited to, statements regarding:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="81%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	our ability to compete in the markets in which we sell or AL sells our products;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="81%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	our expectations regarding future growth, including our ability to develop new products;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="81%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	our ability to effectively operate through our joint ventures, including through maintaining our relationship with our Swedish partner in our AL joint venture;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	i
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage4"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="81%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	our ability to obtain raw materials and manage our raw materials inventories and related costs;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="81%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	our ability to maintain and expand relationships with our existing customers and to develop relationships with new customers;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="81%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	our ability to maintain and strengthen our reputation and the acceptance of our products;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="81%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	our expectations regarding our regulatory efforts and other regulatory initiatives with respect to our products and their raw materials;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="81%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	our expectations regarding the outcome of litigation or other legal proceedings; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="81%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	our ability to maintain adequate protection of our intellectual property.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. Forward-looking statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties, including those described in &#8220;Item 3.D. Key Information&#8212;Risk Factors.&#8221; In addition, the section of this annual report entitled &#8220;Item 4&#8211; Information on the Company&#8221; contains information obtained from independent industry sources that we have not independently verified.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;You should not put undue reliance on any forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur.
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN">
	All of the forward-looking statements included in this annual report are based on information available to us as of the date of this annual report.
</FONT>
	Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this annual report, to conform these statements to actual results or to changes in our expectations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	ii
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage5"></A>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	TABLE OF CONTENTS
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="1" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<A HREF="#ZK1618102_HTM_1">
	Part I
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
	&#160;
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 1
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_1">
	ITEM 1:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_1">
	Identity of Directors, Senior Management and Advisers
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 1
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_1">
	ITEM 2:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_1">
	Offer Statistics and Expected Timetable
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 1
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_1">
	ITEM 3:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_1">
	Key Information
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 1
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Selected Financial Data
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 1
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Risk Factors
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 5
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_2">
	ITEM&#160;4:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_2">
	Information on the Company
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 31
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	History and Development of the Company
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 31
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Business Overview
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 32
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Organizational Structure
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 49
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Property, Plants and Equipment
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 49
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_3">
	ITEM 4A:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_3">
	Unresolved Staff Comments
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 50
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_3">
	ITEM 5:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_3">
	Operating and Financial Review and Prospects
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 50
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating Results
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 51
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Liquidity and Capital Resources
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 64
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Research and Development, Patents and Licenses
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 67
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Trend Information
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 69
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Off-Balance Sheet Arrangements
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 69
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Contractual Obligations
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 70
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_4">
	ITEM 6:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_4">
	Directors, Senior Management and Employees
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 70
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Directors and Senior Management
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 70
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Compensation of Officers and Directors
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 75
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Board Practices
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 78
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Employees
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 92
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Share Ownership
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 93
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_5">
	ITEM 7:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_5">
	Major Shareholders and Related Party Transactions
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 93
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Major Shareholders
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 93
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Related Party Transactions
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 96
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_6">
	ITEM 8:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_6">
	Financial Information
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 98
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Consolidated Financial Statements and Other Financial Information
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 98
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Significant Changes
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 99
</FONT>
</TD>
</TR>
</TABLE>
<DIV>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage6"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV>
	&#160;
</DIV>
<TABLE CELLPADDING="1" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_7">
	ITEM 9:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_7">
	The Offer and Listing
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 99
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Offer and Listing Details
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 99
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Plan of Distribution
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 100
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Markets
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 100
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Selling Shareholders
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 100
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Dilution
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 100
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Expenses of the Issue
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 100
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_8">
	ITEM 10:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_8">
	Additional Information
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 100
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Share Capital
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 100
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Memorandum of Association and Articles of Association
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 100
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Material Contracts
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 105
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Exchange Controls
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 106
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Taxation
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 106
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Documents on Display
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 117
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_9">
	ITEM 11:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_9">
	Quantitative and Qualitative Disclosures about Market Risk
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 118
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_10">
	ITEM 12:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_10">
	Description of Securities Other than Equity Securities
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 120
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="1" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<A HREF="#ZK1618102_HTM_10">
	Part II
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
	&#160;
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 120
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_10">
	ITEM 13:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_10">
	Defaults, Dividend Arrearages and Delinquencies
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 120
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_10">
	ITEM 14:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_10">
	Material Modifications to the Rights of Security Holders and Use of Proceeds
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 120
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_10">
	ITEM 15:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_10">
	Controls and Procedures
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 120
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_11">
	ITEM 16:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_11">
	[Reserved]
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 121
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_11">
	ITEM 16A:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_11">
	Audit Committee Financial Expert
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 121
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_11">
	ITEM 16B:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_11">
	Code of Ethics
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 121
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_12">
	ITEM 16C:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_12">
	Principal Accountant Fees and Services
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 122
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_12">
	ITEM 16D:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_12">
	Exemptions from the Listing Standards for Audit Committees
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 122
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_12">
	ITEM 16E:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_12">
	Purchases of Equity Securities by the Company and Affiliated Purchasers
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 122
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_12">
	ITEM 16F:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_12">
	Change in Registrant&#8217;s Certifying Accountant
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 122
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_13">
	ITEM 16G:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_13">
	Corporate Governance
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 123
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_13">
	ITEM 16H
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_13">
	Mine Safety Disclosure
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 123
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
	&#160;
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
	&#160;
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
	&#160;
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<A HREF="#ZK1618102_HTM_13">
	Part III
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 123
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_13">
	ITEM 17:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_13">
	Financial Statements
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 123
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_13">
	ITEM 18:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_13">
	Financial Statements
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 123
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_13">
	ITEM 19:
</A>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="86%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<A HREF="#ZK1618102_HTM_13">
	Exhibits
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="4%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160; 123
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage7"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_PART_I>
<A NAME="FIS_PART_I"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<A NAME="ZK1618102_HTM_1">
	PART I
</A>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_IDENTITY_OF_PERSONNEL>
<A NAME="FIS_IDENTITY_OF_PERSONNEL"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 1: Identity of Directors, Senior Management and Advisers
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
</EFX_IDENTITY_OF_PERSONNEL>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_OFFER_STATISTICS>
<A NAME="FIS_OFFER_STATISTICS"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 2: Offer Statistics and Expected Timetable
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
</EFX_OFFER_STATISTICS>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_KEY_INFORMATION>
<A NAME="FIS_KEY_INFORMATION"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 3: Key Information
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	A.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Selected Financial Data
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following tables set forth our selected consolidated financial data, which is derived from our consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States of America, or U.S. GAAP. You should read the following selected consolidated financial data in conjunction with &#8220;Item 5. Operating and Financial Review and Prospects&#8221; and our consolidated financial statements and the related notes included in Item 8 of this annual report (the "Financial Statements"). The selected consolidated statements of operations data for the years ended December 31, 2013, 2014 and 2015 and the selected consolidated balance sheet data as of December 31, 2014 and 2015 are derived from our audited consolidated Financial Statements. The selected consolidated statements of operations data for the years ended December 31, 2011 and 2012 and the selected consolidated balance sheet data as of December 31, 2011, 2012 and 2013 have been derived from our previously reported audited consolidated financial statements which are not included in this annual report.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	You should read this selected financial data in conjunction with, and it is qualified in its entirety by reference to, our historical financial information and other information provided in this annual report including &#8220;Item 5. Operating and Financial Review and Prospects&#8221; and our consolidated Financial Statements and related notes. The historical results set forth below are not necessarily indicative of the results to be expected in future periods.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_2"></A>
<DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" COLSPAN="17" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December 31,
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2011
</FONT>
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2012
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	2015
</FONT>
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" COLSPAN="17" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in thousands, except share and per share data)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Consolidated statements of operations data:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	23,019
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	37,867
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	64,975
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,103
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	50,391
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cost of revenues
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,468
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	19,815
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32,110
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18,316
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	19,635
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9,551
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18,052
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32,865
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	28,787
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	30,756
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating expenses:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Research and development, net
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,860
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,611
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,947
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,986
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,149
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Selling and marketing
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,580
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,191
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,725
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8,034
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,425
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	General and administrative
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,458
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,935
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8,434
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,475
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,008
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total operating expenses
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9,898
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12,737
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,106
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,495
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	24,582
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating income (loss)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(347
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,315
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,759
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,292
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,174
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial income (expenses), net
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(416
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(539
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(531
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	499
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	471
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Income (loss) before taxes on income
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(763
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,776
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,228
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,791
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,645
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Taxes on income
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(137
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(180
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(324
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(406
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(407
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Share in profits of equity investee
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	36
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	186
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	491
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	453
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	445
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net income (loss)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(864
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,782
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,395
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,838
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,683
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Earnings (loss) per ordinary share:
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(1)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Basic
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(0.29
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.33
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.66
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.36
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.30
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Diluted
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(0.29
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.28
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.53
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.34
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.29
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Weighted average number of ordinary shares used in computing earnings (loss) per ordinary share:
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(1)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Basic
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,965,481
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,996,624
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,544,387
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,902,057
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	22,506,955
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Diluted
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,965,481
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,461,877
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9,286,456
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	23,210,573
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	23,282,865
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage8"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="17" VALIGN="TOP" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	As of December 31,
</FONT>
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%" STYLE="PADDING-BOTTOM: 2PX">
<A NAME="FIS_UNIDENTIFIED_TABLE_3"></A>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2011
</FONT>
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2012
</FONT>
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Consolidated balance sheet data:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cash and cash equivalents
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,787
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,729
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	74,430
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,315
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,987
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Current assets
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,801
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	26,649
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	107,899
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	70,343
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	84,167
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Current liabilities
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12,276
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,546
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	16,996
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8,828
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,956
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total assets
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	45,629
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	50,970
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	136,373
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	138,250
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	148,926
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total debt
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,200
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,900
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,200
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total liabilities
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18,100
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	16,789
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18,470
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9,978
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12,209
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Shareholders&#8217; equity
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	27,529
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	34,181
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	117,903
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	128,272
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	136,717
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December 31,
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in thousands)
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Supplemental financial data:
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Adjusted EBITDA
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(2)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	16,074
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,420
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,709
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Non-GAAP net income
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(2)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,786
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9,083
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8,316
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	______________
</FONT>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Basic and diluted earnings per ordinary share is computed based on the basic and diluted weighted average number of ordinary shares outstanding during each period using the two-class method for participating preferred shares for the period before our initial public offering. For additional information, see Notes 1 and 15 to our consolidated Financial Statements included elsewhere in this annual report.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Adjusted EBITDA and non-GAAP net income are non-GAAP financial measures. For definitions of these financial measures and reconciliations to our net income, see &#8220;&#8212; Non-GAAP Financial Measures&#8221; below.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage9"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Segment Data
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following tables summarize segment data for the years ended December 31, 2013, 2014 and 2015, which is derived from Note 5 to our consolidated Financial Statements included elsewhere in this annual report. The financial information included in this table under the heading &#8220;Nutrition segment&#8221; includes the results of operations of AL using the proportionate consolidation method. While under the equity method used in the presentation of our consolidated statements of operations, we recognize our share in the net results of AL as a share in profits of equity investee, under U.S. GAAP, for purposes of segment reporting, we are required to present our results of operations on the same basis provided to and utilized by management to analyze the relevant segment&#8217;s results of operations, which is achieved using the proportionate consolidation method of reporting. Under the proportionate consolidation method, we recognize our proportionate share of the gross revenues of AL and record our proportionate share of the joint venture&#8217;s costs of production in our statement of operations. For more information regarding the accounting treatment of AL in our consolidated and segment statements of operations, see &#8220;Item 5.A. Operating and Financial Review and Prospects &#8212; Operating Results &#8212; Joint venture accounting.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_4"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="18" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended&#160;December&#160;31,&#160;2013
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Nutrition
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Segment
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	VAYA
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;Pharma
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Segment
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Total&#160;Segment
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Results&#160;of
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Operations
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Elimination
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(1)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Consolidated
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Results&#160;of
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Operations
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="18" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in thousands)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	76,167
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,444
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	80,611
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(15,636
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	64,975
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cost of revenues
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(2)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	45,804
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,255
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,059
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(14,981
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32,078
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(2)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	30,363
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,189
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	33,552
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(655
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32,897
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating expenses
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(3)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,009
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,020
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	19,029
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	19,029
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Depreciation and amortization
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,415
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	136
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,551
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Adjusted EBITDA
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(5)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18,769
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2,695
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	16,074
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="18" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended&#160;December&#160;31,&#160;2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Nutrition
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Segment
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	VAYA
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;Pharma
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Segment
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Total&#160;Segment
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Results&#160;of
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Operations
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Elimination
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(1)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Consolidated
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Results&#160;of
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Operations
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="18" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in thousands)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	55,815
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,641
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	61,456
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(14,353
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,103
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cost of revenues
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(2)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	30,605
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,435
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32,040
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(13,775
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18,265
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(2)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	25,210
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,206
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	29,416
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(578
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	28,838
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating expenses
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(4)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,347
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,957
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	20,304
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(3
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	20,301
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Depreciation and amortization
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,112
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	196
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,308
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Adjusted EBITDA
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(5)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,975
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2,555
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,420
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="18" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended&#160;December&#160;31,&#160;2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Nutrition
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Segment
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	VAYA
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;Pharma
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Segment
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Total&#160;Segment
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Results&#160;of
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Operations
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Elimination
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(1)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Consolidated
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Results&#160;of
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Operations
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="18" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in thousands)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	54,163
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8,471
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	62,634
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(12,243
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	50,391
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cost of revenues
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(2)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	29,686
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,506
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	31,192
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(11,665
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	19,527
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(2)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	24,477
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,965
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	31,442
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(578
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	30,864
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating expenses
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(2)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12,704
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,356
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	23,060
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(3
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	23,057
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Depreciation and amortization
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,127
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	200
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,327
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="40%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Adjusted EBITDA
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(5)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,900
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;(3,191
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,709
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	____________________
</FONT>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Represents the change from proportionate consolidation to the equity method of accounting.
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Includes depreciation and amortization, but excludes share-based compensation expense.
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(3)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Includes depreciation and amortization, but excludes share-based compensation expense and IPO-related bonuses.
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(4)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Includes depreciation and amortization, but excludes share-based compensation expense and secondary offering expenses.
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(5)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Adjusted EBITDA is a non-GAAP financial measure. For a definition and a reconciliation of adjusted EBITDA to our net income, see &#8220;&#8212; Non-GAAP Financial Measures&#8221; below.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage10"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Non-GAAP Financial Measures
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Adjusted EBITDA and non-GAAP net income are metrics used by management to measure operating performance. Adjusted EBITDA represents net income excluding (a) financial income (expenses), net, (b) taxes on income, (c) depreciation and amortization, (d) share-based compensation expense and (e) other unusual income or expenses and after giving effect to the change from the equity method of accounting for our joint venture to the proportionate consolidation method. Non-GAAP net income represents net income excluding (i) share-based compensation expense and (ii) other unusual income or expenses.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We present adjusted EBITDA as a supplemental performance measure because we believe it facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by changes in foreign exchange rates that impact financial assets and liabilities denominated in currencies other than our functional currency (affecting financial income (expenses), net), tax positions (such as the impact on periods or companies of changes in effective tax rates) and the age and book depreciation of fixed assets (affecting relative depreciation expense). In addition, both adjusted EBITDA and non-GAAP net income exclude the non-cash impact of share-based compensation expense and a number of unusual items that we do not believe reflect the underlying performance of our business. Because adjusted EBITDA and non-GAAP net income facilitate internal comparisons of operating performance on a more consistent basis, we also use adjusted EBITDA and non-GAAP net income in measuring our performance relative to that of our competitors.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Adjusted EBITDA and non-GAAP net income are not measures of our financial performance under U.S. GAAP and should not be considered as alternatives to net income, operating income or any other performance measures derived in accordance with U.S. GAAP or as alternatives to cash flow from operating activities as measures of our profitability or liquidity. Adjusted EBITDA and non-GAAP net income have limitations as analytical tools, and you should not consider these financial measures in isolation or as a substitute for analysis of our results as reported under U.S. GAAP, because the excluded or included items may have significant effects on our operating results and financial condition. When evaluating our performance, you should consider adjusted EBITDA and non-GAAP net income alongside other financial performance measures, including cash flow metrics, net income, operating income and our other U.S. GAAP results.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following table presents a reconciliation of adjusted EBITDA to net income for each of the periods indicated:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_5"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended&#160;December&#160;31,
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in&#160;thousands)
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Reconciliation of adjusted EBITDA:
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Adjusted EBITDA
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	16,074
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,420
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,709
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Accounting for joint venture
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(655
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(575
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(575
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Depreciation and amortization
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1,551
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2,308
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2,327
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Secondary offering related expenses /IPO-related bonuses
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1,000
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(393
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN">
	&#8213;
</FONT>
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Share-based compensation expense
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1,109
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(852
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1,633
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating income
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,759
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,292
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,174
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial expenses (income), net
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	531
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(499
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(471
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Income before taxes on income
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,228
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,791
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,645
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Taxes on income
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(324
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(406
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(407
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Share in profits of equity investee
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	491
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	453
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	445
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net income
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,395
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,838
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,683
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage11"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following table presents a reconciliation of non-GAAP net income to net income for each of the periods indicated:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_6"></A>
<DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended&#160;December&#160;31,
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="3" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="9" VALIGN="BOTTOM" STYLE="TEXT-ALIGN: CENTER">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in&#160;thousands)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Reconciliation of non-GAAP net income:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Non-GAAP net income
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,786
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9,083
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8,316
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Interest expense relating to early repayment of long-term debt
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(282
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8213;
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8213;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Secondary offering related expenses /IPO-related bonuses
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1,000
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(393
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8213;
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Share-based compensation expense
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1,109
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(852
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1,633
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net income
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,395
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,838
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,683
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD ALIGN="RIGHT" STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	B.
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Capitalization and Indebtedness
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 27PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD ALIGN="RIGHT" STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	C.
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Reasons for the Offer and Use of Proceeds
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
	&#160;
</TD>
<TD VALIGN="TOP" WIDTH="95%">
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage12"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD ALIGN="RIGHT" STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	D.
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Risk Factors
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
	&#160;
</TD>
<TD VALIGN="TOP" WIDTH="95%">
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 27PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Investing in our ordinary shares involves a high degree of risk. You should carefully consider the following risk factors, in addition to the other information set forth in this
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	annual report
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	before purchasing our ordinary shares. If any of the following risks actually occurs, our business, financial condition and results of operations could suffer. In that case, the trading price of our ordinary shares would likely decline and you might lose all or part of your investment.
</FONT>
</FONT>
</DIV>
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Risks relating to our business and industry
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	A high proportion of the sales of the InFat product is to our customers who then use it in their infant formula products sold to end users in China and therefore our revenues are subject to the effects of Chinese market trends and competition from locally produced products that are not subject to import taxes.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160; &#160;&#160;In 2015, sales of InFat, the infant formula ingredient product sold by our joint venture. AL, accounted for 27.7% of our total net revenues (or 41.8% of our total segment net revenues). In 2015, we estimate that the vast majority of total InFat net revenues were attributable to sales directly or indirectly into China. Sales of InFat are spread among a number of different non-Chinese manufacturers of infant formula that primarily produce products containing InFat for Chinese infant formula brands, as well as a number of different Chinese local manufacturers of infant formula. The infant nutrition products produced by such manufacturers using InFat may be sold under the manufacturers&#8217; brand names, or may be manufactured by one or more manufacturers and then sold by third parties under the third parties&#8217; brand names.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; While we estimate that the vast majority of total InFat net revenues were attributable to sales directly or indirectly into China, InFat is not currently produced in China or another country that has a free trade arrangement with China. Chinese local manufacturers benefit from relatively high import taxes on infant formula products and ingredients imported into China. As a result, our ability to compete effectively with pricing that may be offered by producers of infant formula ingredients which are not subject to such import taxes could be limited, which could have an adverse effect on our results of operations and financial condition.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In addition, the Chinese market for infant formula has been experiencing shifts in consumer purchasing habits and has seen a
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	transition in sales channels
</FONT>
	from traditional commerce to e-commerce. We are dependent on the ability of our customers who manufacture and sell infant nutrition products in China using InFat to adapt and react to such trends. In the past, some of our customers in China have not been able to shift from traditional commerce in a timely and efficient manner in order to effectively sell their products via e-commerce channels, which has adversely affected our results of operations. If our customers are unable to effectively market products with InFat through e-commerce in addition to traditional commercial channels, our results of operations may be further adversely affected.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	We are subject to a degree of customer concentration and our customers do not enter into long-term purchase commitments with us.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	During the year ended December 31, 2015, our twelve largest customers accounted for approximately half of our revenues.&#160;&#160;Our customers generally do not enter long-term purchase commitments with us and we may therefore have limited insight into their future purchasing plans. Our largest customers may determine to lower their purchasers or cease purchasing our products completely. For example, one of our largest purchasers of krill products, which accounted for 15% of our revenues in 2013, purchased our products at significantly lower levels in 2014 and 2015. Even if a significant customer continues to purchase our products at the same or a greater level, their decision to defer purchases, even for a few weeks, could materially adversely impact our results of operations in a particular quarter.&#160;&#160;For example, some of AL&#8217;s customers in China deferred purchases from AL, which had an adverse effect on our quarterly results during 2015. The success or failure (losing market share, for example) of just a few of our customers&#8217; businesses could have a material effect on our business, financial condition and results of operations.&#160;&#160;Our business may not develop in a manner that would make us less reliant on a small number of large customers. Our results of operations may be materially adversely affected if a significant customer elects to stop purchasing our products and we are unable to find new purchasers to offset the loss of that customer.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage13"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	The demand for products based on omega-3, and, in particular, premium products such as krill oil, has declined in the past and may continue to decline. This decrease, together with a significant increase in capacity by competing manufacturers of these products, has resulted in, and may continue to cause, intense competition and price pressure, which could impair our ability to generate revenues in the krill oil market.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Krill oil accounted for 35.3% of our total net revenues (or 28.4% of our total segment net revenues) in 2015.&#160;&#160;During 2014, demand for omega-3 products and especially krill oil products significantly decreased. At the same time, krill oil suppliers increased capacity. Although consumer demand slightly improved in terms of volume during 2015, the increased capacity of these suppliers combined with the relatively lower demand for krill oil products has led to intensified competition and price pressure and erosion.&#160;&#160;We cannot provide any assurance that the demand for omega-3 products and in particular, krill oil products, which are sold at higher prices than standard omega-3 products, will improve. Such demand may also continue to decline based on consumer preferences and new information and clinical studies.&#160;&#160;Even if demand for these products increases again, such increases may not be sustainable or may not be sufficient to meet current available capacity.&#160;&#160;A further decrease in demand for krill oil-based products or further price erosion in this market due to overcapacity or other reasons will decrease our revenues and could have a material adverse impact on our business, financial condition and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Chinese regulations relating to infant formula are under re-examination, and any regulatory changes affecting the ability of our customers to market infant nutrition products containing InFat could adversely affect our revenues and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;China is continually examining and changing the regulations applicable to infant formula and nutrition, including specifically the regulations applicable to the infant formula manufacturers who purchase InFat.&#160; There are currently proposed regulations in China that aim, among other things, to improve public safety, consolidate product lines (by limiting the number of product lines and brands manufactured in any approved manufacturing facility) and regulate marketing claims.&#160; For example, there is a proposed regulation that limits the ability of persons to make claims about the benefits of sn-2 palmitate (the scientific name of the InFat product) and dictates the techniques to measure sn-2 palmitate content in infant formula, which are different from current market standards.&#160; While it remains unclear at this time whether any or all of these regulations and governmental policies will be enacted in China, if adopted, they could inhibit use by our customers of certain currently used marketing claims, which could have a materially negative effect on our revenues and results of operations.&#160; Furthermore, we cannot predict whether China will implement any further or different regulations of infant formula and nutrition which could have a materially negative effect on our revenues and results of operations.&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	We rely on AarhusKarlshamn AB, or AAK, our Swedish joint venture partner, to procure raw materials and for the manufacture of InFat.
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	While all of AAK&#8217;s claims in arbitration initiated against us by AAK were recently rejected, the arbitration has strained our relationship with AAK, and we cannot assure you that tensions and disagreements will be resolved or that the relationship will remain unchanged or will continue.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	All of the revenues from sales of our InFat product are derived from sales by AL, which is a joint venture between AAK and us. AAK provides the raw materials for and carries out most of the manufacturing processes of InFat (in a single facility owned by AAK and located in Sweden). Therefore, we depend on AAK to procure raw materials and produce InFat for AL at competitive prices. Under our joint venture agreement, we and AAK are each responsible for particular functions related to the production, marketing and sale of the final InFat product. In particular, we are responsible for research and development, business development and marketing, and AAK is responsible for the production, management of inventory, logistics relating to the sales and delivery of the InFat product and obtaining permits and licenses related to AL&#8217;s operations in Sweden.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In May 2014, AAK submitted a claim for arbitration against us to the International Chamber of Commerce, or the ICC, seeking a declaration that our disclosures in connection with our initial public offering constituted a material and intentional breach of the non-disclosure obligations related to AL contained in the joint venture agreement. AAK did not seek any remedies in connection with such alleged breach other than declaratory relief. AAK also sought a declaration with respect to an interpretation of the termination provisions of the joint venture agreement.&#160;&#160;&#160;We filed counterclaims against AAK in the arbitration with respect to operational aspects of the joint venture in which we claimed that AAK&#8217;s conduct in these respects jeopardized the value of the joint venture and that AAK&#8217;s conduct during our initial public offering was meant to jeopardize the offering.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In February 2016, the ICC tribunal issued its decision with respect to the dispute.&#160;&#160;The ICC tribunal rejected, in their entirety, AAK&#8217;s requests for declaratory relief in connection with alleged breaches by the Company of the joint venture agreement&#8217;s non-disclosure obligations.&#160;&#160;Additionally, the ICC tribunal found that the joint venture agreement should be interpreted, as we maintained, such that the parties may exit the agreement only via a buy-sell process by which one party buys out the other. The tribunal denied all relief we requested with respect to our counterclaims against AAK.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage14"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	While the operations of the joint venture generally continued in their ordinary course during the arbitration, the arbitration has strained the relationship of the Company and AAK, resulting in disagreements between the parties with respect to operational matters and the extent to which the handling of these matters serves the best interests of AL. We cannot assure you that these tensions and disagreements will be resolved now that the arbitration has concluded. AAK may also have economic or business interests or goals that are inconsistent with ours.&#160;&#160;If our relationship with AAK were to deteriorate, it could adversely affect our sales of InFat, which could have a material adverse effect on our results of operations and financial condition.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Furthermore, the term of our joint venture with AAK expires on December 31, 2019, subject to extension for additional three-year periods, unless we or AAK duly terminate the joint venture upon giving notice of termination no later than twelve months prior to the applicable expiration date. There can be no assurance that we or AAK will not terminate the agreement prior to the expiration date, or will renew the joint venture agreement or otherwise continue our relationship. We are precluded from competing with AL during the term of the relationship with AAK. If upon termination of the agreement we sell our share in AL to AAK pursuant to the buy/sell mechanism contained in the joint venture agreement, we would be subject, during the three-year period after the end of provision of services under the agreement, to non-competition obligations. Such obligations would preclude us from developing or producing InFat or competing products. Such non-competition obligations could limit our development and sales of new or existing products and could have a material adverse effect on our business, financial condition and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	A significant portion of the sales of
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	our
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	InFat product is to a single company.
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	If this company were to suffer financially, stop using InFat in all or a significant portion of the infant nutrition products sold under its brand name or use a competitor&#8217;s ingredient instead of ours, our business, financial condition and results of operations could be materially adversely affected.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In 2015, we estimate that approximately 25% of total InFat net revenues were attributable to sales in China by, and under the brand name of, Biostime International Holdings Ltd. (&#8220;Biostime&#8221;), a large Chinese pediatric nutrition company.&#160;&#160;Regulatory changes and market trends in China in recent years with respect to the production of infant formula adversely impacted some of AL&#8217;s customers, including Biostime, reducing their sales and resulting in a decrease in sales of InFat which is an ingredient in AL&#8217;s customers&#8217; infant formula.&#160;&#160;Further regulatory changes may also negatively affect our revenues and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In addition, Chinese authorities have conducted investigations and levied fines related to alleged price fixing by infant nutrition companies including Biostime and may do so in the future. To the extent that there are future investigations regarding alleged anti-competitive practices by our end customers, their reputations and results of operations could be harmed, which in turn could adversely impact our business, financial condition and results of operations.&#160;&#160;Furthermore, the percentage of our net revenues attribute to sales in China by, and under the brand name of, Biostime decreased in 2015, primarily as a result of Biostime losing market share in China. We believe this is due to greater online sales of infant nutrition products in China compared to supermarkets and health stores. If Biostime were, for any reason, to suffer further decreases in sales, cease operations or discontinue the inclusion of the InFat ingredient in all or a significant portion of the infant nutrition products sold under its brand name, or if Biostime or other Chinese pediatric nutrition companies were to use a competitor&#8217;s ingredient, this could significantly adversely affect sales of the InFat product, which could materially adversely impact our business, financial condition and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Our offering of products as &#8220;medical foods&#8221; in the United States may be challenged by regulatory authorities.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The products offered within our VAYA Pharma segment are sold under physician supervision in the United States as &#8220;medical foods&#8221; on the basis of their meeting the criteria for &#8220;medical foods&#8221; in the Federal Food, Drug, and Cosmetic Act (the &#8220;FDCA&#8221;) and FDA regulations. The term medical food is defined in the FDCA as a food which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation. See &#8220;Item 3.D. Key Information &#8212; Risk Factors &#8212; Risks related to government regulation &#8212; VAYA Pharma segment&#8221; below. Medical foods are not required to undergo premarket review or approval by the FDA.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We believe that our VAYA Pharma products meet the criteria for &#8220;medical foods&#8221; established by the FDCA, and that the labeling and marketing of our medical foods is consistent with FDA regulatory requirements. However, our offering of one or more of these products as &#8220;medical food&#8221; could be challenged by the FDA. The FDA has previously issued warning letters to other companies challenging the classification of their products as &#8220;medical food.&#8221; We believe that these letters indicate that the FDA may be applying a more narrow interpretation of what qualifies as a &#8220;medical food.&#8221; Given this enhanced focus on medical food companies, we cannot provide any assurance that we will not also receive such a letter and the FDA could take the position that one or more of our medical food products may not be lawfully sold in the United States as &#8220;medical food.&#8221; If such a challenge were to occur we could incur significant costs responding to such a claim and defending our products&#8217; status as medical foods and ultimately litigation. If we are unable to demonstrate to the FDA&#8217;s satisfaction that the product(s) meet the regulatory requirements for &#8220;medical foods,&#8221; we would need to suspend further sale and distribution of the alleged violative products in, and could be required to withdraw such product or products from the U.S. market. We could seek to re-position the products as &#8220;dietary supplements,&#8221; a distinct category of &#8220;food&#8221; under the FDCA and FDA regulations. This would require new labels, labeling and revised claims for the products, and would impose other regulatory requirements on us not applicable to &#8220;medical foods.&#8221; The United States is the principal market for the sales of the products of our VAYA Pharma segment and the cessation of such sales, even for a limited period, could have a material adverse effect on our operations, financial situation, operating results and business prospects.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage15"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV>
	&#160;
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Our product development cycle is lengthy and uncertain, and our development or commercialization efforts for our products may be unsuccessful.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We are currently working on several new products, including new uses and applications for existing products that are in various stages of development. Some of these products address new medical indications or provide new nutritional or medical benefits, while others provide different levels or concentrations of active ingredients and offer improved secondary characteristics. Research and development is a time-consuming, expensive and uncertain process that takes years to complete, with no guarantee of a favorable outcome. Because of the long and challenging product development cycle, evolving regulatory environment, changing market conditions and other factors, there is significant uncertainty as to the future development, success and commercialization of any products we may attempt to develop or commercialize. Even if our existing products prove to be successful, we may spend years and dedicate significant financial and other resources developing products that may never be commercialized. If we are unsuccessful in developing promising products, securing any necessary regulatory approvals and commercializing such products after having invested significant resources, efficiently or not at all, such failures could have a material and adverse effect on our business, financial condition and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Our inventories include sensitive compounds which may face spoilage or obsolescence.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	A considerable portion of our inventories, including a major part of the raw materials used in the production of our products, as well as final products, are comprised of compounds that are subject to relatively high levels of decomposition, contamination, oxidization and other damaging processes or events. In particular, we currently have a significant inventory of frozen krill and resin. The value of such inventories once subject to decomposition, contamination or oxidization, for example, is greatly reduced to the point that it may become worthless. We maintain our inventory in conditions suited for their specifications at storage facilities operated by us or by third party vendors; however, in light of the relative sensitivity of these materials, it is possible that our failure to timely use such inventory or a single event or a conjunction of several events will lead to a considerable reduction of the value of our inventory, which would adversely affect our financial condition and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Potential future acquisitions of companies or technologies may
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	require
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	management
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	&#8217;s time and attention
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	, may disrupt our business and may not yield the returns expected.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We may acquire or make investments in businesses, technologies or products, whether complementary or otherwise, as a means to expand our business, if appropriate opportunities arise. We cannot give assurances that we will be able to identify future suitable acquisition or investment candidates, or, if we do identify suitable candidates, that we will be able to make acquisitions or investments on reasonable terms or at all. In addition, we have no prior experience in integrating acquisitions and we could experience difficulties incorporating an acquired company&#8217;s personnel, operations, technology or product offerings into our own or in retaining and motivating key personnel from these businesses. We may also incur unanticipated liabilities as a result of such acquisitions or investments. The financing of any such acquisition or investment, or of a significant general expansion of our business, may not be readily available on favorable terms. Any significant acquisition or investment, or major expansion of our business, may require us to explore external financing sources, such as an offering of our equity or debt securities. We cannot be certain that these financing sources will be available to us or that we will be able to negotiate commercially reasonable terms for any such financing, or that our actual cash requirements for an acquisition, investment or expansion will not be greater than anticipated. In addition, any indebtedness that we may incur in such a financing may inhibit our operational freedom, while any equity securities that we may issue in connection with such a financing would dilute our shareholders. Any such difficulties could disrupt our ongoing business, distract our management and employees, increase our expenses and adversely affect our results of operations. Furthermore, we cannot provide any assurance that we will realize the anticipated benefits and/or synergies of any such acquisition or investment.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage16"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Variations in the cost of raw materials for the production of InFat may have a material adverse effect on our business, financial conditions and results of operations.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The cost and variability in price of raw materials related to the production of InFat, primarily vegetable oil and fatty acids, is a key factor in the profitability of AL and of our Nutrition segment as a whole. In 2015, the cost of raw materials comprised a majority of the costs of revenues of AL. While certain of AL&#8217;s customer contracts contain pricing formulae under which the prices of products are adjusted to reflect changes in the costs of raw materials, the adjustments do not fully insulate AL from such changes. In addition, even where InFat prices are adjusted pursuant to customer contracts which contain pricing formulae, increases in price can adversely affect sales, as the increased costs to the end-user may make such products less attractive, thereby reducing demand, and also expose AL to increased competition. Such developments could have a material adverse effect on our business, financial condition and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	We are dependent on a single facility that houses the majority of our operations, and disruptions at this facility could negatively affect our business, financial condition and operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our administrative headquarters, all of our research and development laboratories and our production plant are located in a single facility in the Sagi 2000 Industrial Area, near Migdal Ha&#8217;Emeq, Israel. The manufacture of all of the products that we sell takes place at this facility, other than the final InFat product and certain grades of our Sharp GPC product. Although the InFat product sold by AL is manufactured in Sweden, the production of the InFat enzymes, the core element for the manufacture of InFat, also takes place at our Migdal Ha&#8217;Emeq facility. Accordingly, we are highly dependent on the uninterrupted and efficient operation of this facility. If operations at this facility were to be disrupted for any reason, such as a result of equipment failures, earthquakes and other natural disasters, fires, accidents, work stoppages, power outages, acts of war or terrorism or other reasons, our business, financial condition and results of operations could be materially adversely affected. Lost sales or increased costs that we may experience due to certain disruptions may not be recoverable under our insurance policies, and longer-term business disruptions could result in a loss of customers. If this were to occur, our business, financial condition and operations could be materially negatively impacted.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	We depend on third parties to obtain raw materials, in particular krill, necessary for the production of our products.
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	If we cannot secure sufficient supply sources at competitive prices or need to utilize a greater percentage of frozen krill than we anticipate, our gross profits may be adversely affected.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;We depend on a limited number of third parties to supply krill meal, an essential raw material for the production of our krill oil, which accounted for 35.3% of our total net revenues (or 28.4% of our total segment net revenues) in 2015. Krill are small crustaceans found in oceans throughout the world. There are two primary ocean regions where krill is harvested: the Southern Ocean (Antarctic krill) and the North Pacific Ocean, mainly off the coasts of Japan and Canada (Pacific krill). We currently purchase the majority of the krill meal we use pursuant to agreements with owners of vessels that harvest Antarctic krill and process it into krill meal onboard. Though growing, there is only a limited number of vessels capable of producing krill meal onboard. In 2014, we also purchased frozen krill, which, while more expensive to process into krill meal onshore compared to krill from vessels that process krill meal onboard, is more readily obtainable.&#160;&#160;We also signed a toll processing agreement in 2014 with a toll processor for processing the frozen krill into krill meal.&#160;&#160;We do not, however, have a long-term supply agreement with any supplier of frozen krill.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; We intend to meet our krill meal needs in the future by sourcing krill meal from vessels processing krill meal onboard and from suppliers of frozen krill. While we are working on expanding our supplier base, we cannot give any assurance regarding our ability to secure sufficient supply sources of krill meal at competitive prices, in good quality and upon fair and reasonable contractual terms or successfully implement the logistical changes required. Agreements with owners of fishing vessels are mainly seasonal, as they typically relate to a specific fishing season or trip. Obtaining sufficient quantities of krill oil is also dependent on the quality of krill and respective fat content. Should prices rise or available quantities of high quality krill decrease, our business, financial condition and results of operations may be adversely affected. In addition to krill, certain raw materials used in the production of our products (such as sunflower lecithin) are of limited supply globally, and we may not be successful in obtaining a sufficient amount of these raw materials on reasonable terms or at all.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage17"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In the event that we have to increase our reliance on frozen krill, which costs more than krill that is purchased from vessels that process krill meal onboard, our gross profits may be adversely affected. Additionally, frozen krill is subject to relatively high levels of decomposition, contamination, oxidization and other damaging processes or events. It is possible that our failure to use our inventory of frozen krill on a timely basis will lead to a considerable reduction of the value of our inventory, which would adversely affect our financial condition and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	We anticipate that the markets in which we participate will become more competitive due in part to business combinations among existing competitors, the arrival of new competitors and technological developments. If we are unable to compete effectively, our financial results may suffer.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The markets in which we sell our InFat, krill oil, PS and VAYA Pharma products are becoming more competitive, and it is possible that the number of companies seeking to develop products in these markets will increase in the future. Competitors range in size from small, single product companies to large, multifaceted corporations, which have greater financial, technical, marketing and other resources than those available to us.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;Business combinations, joint ventures or mergers among our competitors that result in larger competitors with greater resources or distribution networks, or the acquisition of a competitor by a major technology, pharmaceutical or nutrition company seeking to enter the markets in which we operate, could result in increased competition and have a material adverse effect on our business, financial condition and results of operations. We currently compete directly with IOI Loders Croklaan, the producer of Betapol, in the market for sn-2 palmitate. In 2015, IOI Loders Croklaan established a joint veture with Kerry Ingredients, an Ireland-based company with considerable global marketing capabilities, as well as dry-blend capabilities (meaning the ability to provide dry powder products, such as complete infant formula). Advances by such competitors towards dry blended products, namely, products made of milk powder, may make it more difficult for our InFat products to compete effectively in the markets in which we operate. Furthermore, as Betapol is manufactured in Malaysia, which has a tax-free zone with China, the joint venture may be able to sell its products at a lower cost in China compared to our pricing for InFat. If we are unable to compete successfully with the pricing offered by this joint venture or by other competitors who create similar business combinations, our revenues and profitability may suffer.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The markets in which our InFat product is sold are becoming increasingly competitive.&#160;&#160;The InFat product is an ingredient used in the general infant nutrition products market. InFat addresses the sn-2 palmitate market, which currently holds less than 10% share of the infant formula oils market as a whole. In contrast, the majority of the oils used in the infant nutrition market are currently vegetable oil blends, with bovine milk fat also used to some extent. Despite the low market share held by InFat, we believe that if the market for sn-2 palmitate within the infant nutrition market grows, it may encourage more specialty oil producers to seek to develop and offer competitive products, increasing the level of competition that we face.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In the krill oil market, we primarily compete with Aker BioMarine AS, Neptune Technologies &amp; Bioressources Inc., Rimfrost USA, LLC (a joint venture of Avoca, Inc.) and Olympic Seafood AS.&#160;&#160;See &#8220;Item 3.D. Key Information &#8211; Risk Factors &#8211; Risks relating to our business and industry &#8211; The demand for products based on omega-3, and, in particular, premium products such as krill oil, has declined in the past and may continue to decline. This decrease, together with a significant increase in capacity by competing manufacturers of these products, has resulted in, and may continue to cause, intense competition and price pressure, which could impair our ability to generate revenues in the krill oil market". In the market for our PS product line, our principal competitors are Chemi Nutraceuticals Inc., Lipoid GmbH and Lipogen Ltd.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	While medical foods became subject to FDA regulation in the United States in 1988, the medical foods market is relatively new and our VAYA Pharma products currently face little direct competition from other medical food manufacturers. As the market develops, we could face future competition from companies seeking to enter the market, in particular, large multi-national nutrition companies, such as Abbott Laboratories, Nestl&#233; and Danone (through its clinical nutrition subsidiary, Numico N.V.), which have expressed interest in the medical foods market. Such potential competitors may have greater financial, technical, marketing and other resources than those available to us, and, accordingly, the ability to devote greater resources than we can to the development, promotion, sale and support of products. In addition, physicians may prefer to prescribe prescription drugs produced by pharmaceutical drug manufacturers rather than our medical food products and customers may prefer to use prescription drugs instead of our medical food products due to the present limited reimbursement by third-party payers. We may be unable to compete successfully against our future competitors in the medical foods market, which may result in price reductions, reduced margins and the inability to maintain market acceptance for our VAYA Pharma products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage18"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	As a result of alleged infringement on intellectual property, we may have to pay royalties with respect to sales of our krill oil products in the United States or Australia, and any infringement of intellectual property of others could also require us to pay royalties.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our commercial success depends in part on our ability to operate without infringing upon the proprietary rights of others. Beginning in October 2011, Neptune, one of our principal competitors in the krill oil products market, filed a series of complaints in the U.S. District Court for the District of Delaware alleging patent infringement by one or more of our krill oil products. In addition, in April 2013, we received a Notice of Institution of Investigation from the U.S. International Trade Commission, or ITC, regarding a similar complaint filed by Neptune in that forum.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In April 2014, we signed a final settlement and license agreement with Neptune which resulted in the termination and dismissal of the above-mentioned complaints and investigation. According to the settlement and license agreement, we made a one-time settlement payment to Neptune.&#160;&#160;In addition, we agreed, among other things, that, in the event that the outcome of an Inter Partes Review, or IPR, in the United States or a post-grant reexamination in Australia for certain agreed claims in Neptune&#8217;s patent is unfavorable to us, we will be obligated to pay royalties to Neptune with respect to sales in the United States or Australia, respectively.&#160;&#160;In the IPR, the U.S. Patent and Trademark Office, or USPTO, determined that 26 of 28 challenged claims in Neptune&#8217;s U.S. Patent No. 8,278,351 are unpatentable. We appealed the USPTO decision regarding the two remaining challenged claims on September 8, 2015. With respect to the Australian proceedings, the Australian Patent Office issued a reexamination report on September 4, 2015 finding in favor of Neptune. On November 9, 2015, we filed a further reexamination request and we are awaiting the decision of the Australian Patent Office.&#160;&#160;See &#8220;Item 8.A. Financial Information&#8212;Consolidated Financial Statements and Other Financial Information&#8212;Legal Proceedings.&#8221;
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If the appeal in the United States or the reexamination in Australia results in unfavorable outcomes to us we may be required to pay license fees or royalties to Neptune.&#160;&#160;If we are found to have infringed patents of any other third party which are determined to be valid and enforceable, we may be subject to monetary damages, including in the form of lost profits or a royalty. In the case of another third party, it may also be granted injunctive relief which would prevent us from selling the infringing products in the jurisdiction in which it has patent, a significant market for our krill oil products. In addition to any monetary damages awarded against us, in some instances we have also agreed to be financially responsible for any damages awarded against certain of our customers as a result of the purchase, importation, use, sale or offer to sell of our products if they are found to infringe certain of Neptune&#8217;s intellectual property rights and we may have to agree to similar terms. Moreover, defending against these claims has been, and defending against similar claims in the future may continue to be, time-consuming and costly, and has diverted, and may in the future divert, management&#8217;s time and attention from our business. Thus, these proceedings could materially adversely impact our business and financial results.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Unfavorable publicity or consumer perception of our products, such as krill oil, the supplements that contain them as ingredients and any similar products distributed by other companies could have a material adverse effect on our reputation, the demand for our products and our ability to generate revenues.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;We are dependent upon consumer perception of the safety and quality of our products, such as krill oil, and the supplements that contain them, as well as that of similar products distributed by other companies. Consumer perception of supplements and their ingredients can be significantly influenced by scientific research or findings, national media attention and other related publicity about product use. A product may achieve high sales due to a favorable perception among consumers, but may be unable to sustain such sales as consumer preferences change. If future scientific research or publicity questions earlier positive research or publicity about our particular products and supplements that contain them as ingredients, questions such products&#8217; effectiveness or generally disfavors the supplements industry, our sales could decrease and our results of operations and financial condition could be materially adversely affected. Additionally, whether or not accurate, adverse publicity, including in the form of published scientific research or other publicity, that associates consumption of our products, supplements containing them or any other similar products distributed by other companies with illness or other negative effects could have a material adverse effect on our reputation and the demand for our products or supplements that contain them, which could materially impede our ability to generate revenues.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage19"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	We are generally reliant upon third parties for the distribution or commercialization of our products.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Part of our strategy is to enter into and maintain arrangements with third parties that are generally exclusive with respect to a particular territory related to the marketing, sales and distribution of our products. Our revenues are dependent in part on the successful efforts of these third parties. Entering into strategic relationships can be a complex process and the interests of our distribution partners may not be or may not remain aligned with our interests. There can be no assurance that our distribution partners will market, sell and/or distribute our products successfully or choose the best means for achieving commercialization of our products. Some of our current and future distribution partners may decide to compete with us, refuse or be unable to fulfill or honor their contractual obligations to us, or reduce their commitment to, or even abandon, their relationships with us. Further, there can be no assurance that any such third-party collaboration will be on favorable terms. We may not be able to control the amount and timing of resources our distribution partners devote to our products or the efforts they expend in obtaining any requisite local approvals for our products. In addition, we may incur liabilities relating to the distribution and commercialization by our distributors of our products. While the agreements with such distributors generally include customary indemnification provisions indemnifying us for liabilities relating to the packaging of our products and their use and storage, there can be no assurance that these indemnification rights will be sufficient in amount, scope or duration to fully offset the potential liabilities associated with our distributors&#8217; handling and use of our products. Any such liabilities, individually or in the aggregate, could have a material adverse effect on our business, financial condition or results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	A growing portion of our VAYA Pharma products sales in the United States are conducted through an online pharmacy operated by a third party vendor. As this trend continues, we become increasingly reliant on that vendor. While we have a long term contract and stable relationship with that vendor, a disruption to its activities for any reason could result in difficulties distributing our VAYA Pharma products, loss of revenues and customers for a substantial period which may have a material adverse effect on our business, financial condition or results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Further, we have entered into other joint ventures in the past and may enter into other joint ventures in the future. Any current or future joint venture partner may take actions contrary to our policies or objectives, undergo a change of control, experience financial and other difficulties, or be unable or unwilling to fulfill its obligations under the joint venture, each of which may affect our financial condition or results of operations. In addition, no assurance can be given that the actions or decisions of our joint venture partner will not affect our joint venture in a way that hinders our corporate objectives or that causes material adverse effects on our business, financial condition or results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	We may not be able to
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	maintain
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	or increase market acceptance for our products.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The degree of market acceptance for our products and those of our customers depends upon a number of factors, including the receipt of regulatory approvals, the establishment and demonstration in the medical community of the clinical efficacy and safety of the products, and the establishment and demonstration of the potential advantages over competing products. Additionally, to ensure sustained and increased market acceptance for our VAYA Pharma products, we must continue to demonstrate the potential advantages over existing and new treatment methods, and we may have to expand the reimbursement of government and third-party payers. In the case of our Nutrition products, market acceptance is dependent on the acceptance of the product and appropriate distribution with large retailers, competitive pricing and the extent to which the products fulfill customer expectations and demands. There can be no assurance that consumers, physicians, patients, payers, the medical community in general, distributors or retailers will continue to accept and utilize any existing or new products that may be developed by us. Failure to achieve such market acceptance for our products could have a material adverse effect on our growth, business, financial condition or results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	We are subject to risks relating to the operation and expansion of our production or processing facilities and capabilities.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 2014, and following the 2013 expansion of our Migdal Ha&#8217;Emeq manufacturing facility, the krill meal extraction process is being performed entirely in house at our Migdal Ha&#8217;Emeq manufacturing facility.&#160;&#160;During 2015, we expanded our manufacturing facility in Israel that will result in an approximately 50% increase in its overall production capacity.&#160;&#160;In the longer term, we may build an additional production plant adjacent to our existing facility in order to further expand our production capacity. There can be no assurance that we will achieve the target capacities, cost savings and efficiencies that we anticipate.&#160;&#160;In addition, with respect to any further expansion, to the extent we determine to undertake such expansion, there can be no assurance that we will be able to obtain the requisite approvals, overcome operational challenges of implementing expansion projects, or have the necessary capital resources for the construction of this plant, or if we do, that the plant will be built or that it will satisfy demand. Conversely, there can be no assurance, even if we build an additional plant, that demand for our products will increase commensurate with the increased production capacity. Furthermore, we cannot assure you that any further projects, if implemented, will be implemented in a timely and cost-efficient manner, and that our current production will not be adversely affected by the operational challenges of implementing the expansion projects.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage20"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Our ability to obtain krill may be affected by conservation regulation or initiatives.
</FONT>
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	A substantial part of our activities in our Nutrition segment requires the use of krill. Limits on krill harvesting established by the Commission for the Conservation of Antarctic Marine Living Resources (the &#8220;Commission for Conservation&#8221;) may limit our revenue.
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	&#160;
</FONT>
	The Commission for Conservation imposes limitations and conditions regarding krill harvested in Antarctic waters. Additionally, the Commission for Conservation regulates the licensing of vessels eligible to harvest krill in these specific Antarctic Ocean areas. In the areas currently being fished for krill, the Commission for Conservation has established a combined annual catch limit of 620,000 metric tons. In 2014, approximately 300,000 metric tons were harvested. The substantial majority of harvested krill is used for aquaculture feed and fish bait while only a small portion is used for human consumption, the latter of which offers higher profit margins. The Commission for Conservation has established limits because increases in krill catches could have a negative effect on the ecosystem, including other marine life, particularly birds, seals and fish which mainly depend on krill for food. The lowering of these quotas or imposition of any other requirement or limitation affecting our ability to source krill, such as adoption of additional conservation measures, may reduce the future availability of krill and cause significant increases in its price. Any such development could harm our sales and gross profits.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Disruption to our IT system could adversely affect our reputation and have a material adverse impact on our business and results of operations.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our business operations, production facilities and research and development technologies rely on our IT system to collect, analyze and store our data, which at times may include private and confidential information of third parties. While we utilize offsite back-up storage, there can be no guarantee that such back-up storage, together with our existing onsite back-up storage, will be effective if it becomes necessary to rely on them. If our existing or future IT system does not function properly, or if the IT system proves incompatible with new technologies, we could experience interruptions in data transmissions and slow response times, preventing us from completing routine business, production or research activities.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN">
	Furthermore, despite our investments in risk prevention and contingencies, data protection, prevention of intrusions, data leaks and access control systems, we can provide no assurance that our current IT system is fully protected against third-party intrusions, viruses, hacker attacks, information or data theft or other similar threats.
</FONT>
	The risk of a security breach or disruption, particularly through cyber-attack or cyber intrusion, including by computer hackers, foreign governments and cyber terrorists, has risen as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased. Furthermore, there has been heightened legislative and regulatory focus on data security in the U.S. and abroad, including requirements for varying levels of customer notification in the event of a data breach.
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN">
	As we continue to develop our technologies, we may need to update our IT system and storage capabilities.
</FONT>
	Any such loss, disclosure or misappropriation of, or access to, customers&#8217;, employees&#8217; or business partners&#8217; information or other breach of our information security can result in legal claims or legal proceedings, including regulatory investigations and actions, may have a negative impact on our reputation, may lead to regulatory enforcement actions against us, and may materially adversely affect our business, operating results and financial condition.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN">
	Lastly,
</FONT>
	disruption or failure of our IT system due to technical reasons, natural disaster or other unanticipated catastrophic events, including power interruptions, storms, fires, floods, earthquakes, acts of war or terrorism could significantly impair our ability to deliver our products on schedule and materially and adversely affect our relationships with our partners and customers, our business, our reputation and our results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	We are not able to predict the results of clinical trials, which may prove unsuccessful or be delayed by certain factors.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We conduct clinical and pre-clinical studies to support the efficacy and safety of our products and their ingredients during their development, to extend known benefits and to uncover new benefits of our existing products and ingredients. While clinical trials are generally not required with respect to regulatory approvals for our nutrition products, we use the results of these trials to maximize the product&#8217;s reach to new customers and as a basis for establishing long-term supply agreements. Further, if in the future we seek to market products as prescription drugs, we will be required to conduct clinical trials to establish the safety and efficacy of such products. Although prior to initiating clinical trials, our compounds are tested on animals in pre-clinical trials to test their toxicity and efficacy, pre-clinical trials on animals cannot predict fully whether a proposed product will prove to be safe or effective in humans. Pre-clinical and clinical data required for regulatory approval must be developed under strict regulatory standards and may be found, on review by health regulatory authorities, to be of insufficient quality to support an application for commercialization of a product or to substantiate claims concerning a currently marketed product&#8217;s safety or effectiveness. In addition, positive results in previous clinical studies of our products may not be predictive of similar results in future clinical trials and interim results during a clinical trial do not necessarily predict final results. A number of companies in the pharmaceutical industry have suffered significant setbacks in late-stage clinical trials even after achieving promising results in early-stage development. Our clinical trials may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical trials. Moreover, clinical data may be susceptible to varying interpretations and analyses, and some companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain FDA approval for their products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	14
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage21"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Recruitment of participants in a clinical study is challenging.&#160;&#160;Identification of the appropriate study population and sites is a crucial point for success. Clinical studies with infants to test the safety and efficacy of our ingredients for infant formula are challenging since parents are frequently reluctant to permit their children to participate in trials. A number of other factors could affect the feasibility and outcome of clinical trials, including, but not limited to, study design, the size of the available study population, the eligibility criteria for participation in the clinical trials, and the availability of clinical trial sites. Prior to initiating a clinical trial, we carefully select the study population and sites with the goal of having the best chances of success and to avoid delays in study recruitment. In addition, we seek to ensure that all other study related activities, such as product supply and data capture, are ready prior to initiation in order to avoid administrative delay.&#160;&#160;Nevertheless, our clinical trials may not be successful and may be delayed or otherwise terminated prior to the end of recruitment.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Administering our product candidates to humans may produce undesirable and unexpected side effects. These side effects could interrupt, delay or halt clinical trials of our product candidates and could result in the FDA or other regulatory authorities denying approval of our product candidates for any or all targeted indications. Our ability to commercialize any new products is dependent upon the success of product development efforts and the success of clinical studies. Existing products may be the subject of post-marketing clinical trials. If these clinical trials and product development efforts fail to produce satisfactory results, or if we are unable to maintain the financial and operational capability to complete these development efforts, we may be unable to generate revenues for existing products and potential new products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	We could be subject to product liability lawsuits, which could result in costly and time-consuming litigation and significant liabilities.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The development of pharmaceutical, medical food and human nutrition products involves an inherent risk of product liability claims and associated adverse publicity. Our products may be found to be harmful, or to contain harmful substances. This exposes us to substantial risk of litigation and liability and/or may force us to discontinue production of certain products. Although we have product liability insurance for up to $10.0 million (per claim and in the aggregate per year), this coverage may not insure us against all claims made. Product liability insurance is costly and often limited in scope. There can be no assurance that we will be able to obtain or maintain insurance on reasonable terms or to otherwise protect ourselves against potential product liability claims that could impede or prevent commercialization of a material product or line of products. Furthermore, a product liability claim could damage our reputation, whether or not such claims are covered by insurance or are with or without merit. A product liability claim against us, or the withdrawal of a product from the market, could have a material adverse effect on our business or financial condition. Furthermore, product liability lawsuits, regardless of their success, would likely be time-consuming and expensive to resolve and would divert management&#8217;s time and attention, which could seriously harm our business.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	We depend on international sales, which expose us to risks associated with the business environment in those countries.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our revenues are derived from sales in multiple countries around the world, primarily through exports from Israel to distributors. In 2015 more than 40% of our sales are to customers outside the United States and approximately 3% of our sales are to customers in Israel. We anticipate that international sales will continue to account for the majority of our revenues in the foreseeable future.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our international operations and sales are subject to a number of risks, including:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	potentially longer accounts receivable collection periods and greater difficulties in their collection;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	15
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage22"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%" STYLE="PADDING-LEFT: 0PT; MARGIN-LEFT: 446PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	potential instability of local economies;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	impact of potential military or civil conflicts and other political risks;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	disruptions or delays in shipments caused by customs brokers, work stoppages or government agencies;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	potential imposition by governments of controls that prevent or restrict the transfer of funds;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	regulatory limitations imposed by foreign governments and unexpected changes in regulatory requirements, tariffs, customs, duties, tax laws and other trade barriers;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	difficulties in staffing and managing foreign operations;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	laws and business practices favoring local competition and potential preference for locally produced products;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	potentially adverse tax consequences;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	difficulties in protecting or enforcing intellectual property rights in certain foreign countries, particularly in Asia; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	fluctuations in exchange rates, described below.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If we fail to overcome the challenges that we encounter in our international sales operations, our business and results of operations could be materially adversely affected.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Our business relies on the experience and expertise of our senior management, as well as on our ability generally to retain existing, or hire additional, skilled personnel.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our success depends upon the continued service and performance of our senior management and professional experts. The loss of the services of any of these individuals could delay or prevent the continued successful implementation of our business plans, or could otherwise affect our ability to manage our company effectively and to carry out our business plan. Members of our senior management team may resign at any time and there can be no assurance that we will be able to continue to retain such individuals.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Additionally, we depend on our ability to attract and retain additional highly qualified and skilled technical, scientific, sales, managerial and finance personnel. Competition for skilled personnel is intense and the unexpected loss of an employee with a particular skill could materially adversely affect our operations until a replacement can be found and trained. If we are not able to retain our existing skilled scientific and technical personnel and attract and retain sufficiently additional skilled scientific and technical personnel, as required, for our research and development and manufacturing operations on acceptable terms, we may not be able to continue to execute our business plan on schedule. Further, any failure to effectively integrate new personnel could prevent us from successfully growing our company.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	16
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage23"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Under applicable employment laws, we may not be able to enforce covenants not to compete.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We generally enter into non-competition agreements with our employees. These agreements prohibit our employees, if they cease working for us, from competing directly with us or working for our competitors or clients for a limited period. We may be unable to enforce these agreements under the laws of the jurisdictions in which our employees work and it may be difficult for us to restrict our competitors from benefitting from the expertise our former employees or consultants developed while working for us. For example, Israeli courts have required employers seeking to enforce non-compete undertakings of a former employee to demonstrate that the competitive activities of the former employee will harm one of a limited number of material interests of the employer which have been recognized by the courts, such as the secrecy of a company&#8217;s confidential commercial information or the protection of its intellectual property. If we cannot demonstrate that such interests will be harmed, we may be unable to prevent our competitors from benefiting from the expertise of our former employees or consultants and our ability to remain competitive may be diminished.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;If we fail to manage our growth effectively, our business could be disrupted and we may not achieve our goals.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our future financial performance and ability to commercialize our products and to compete effectively will depend, in part, on our ability to manage any future growth effectively. We have made and expect to continue to make significant investments to enable our future growth through, among other things, new product innovation, clinical trials for new products, expansion of our manufacturing facility, expanding into new territories or into new business segments. It is possible that our growth and expansion plans will not flourish or that the return on those investments will be considerably delayed, thus having a material adverse effect on our business and results of operations. We must also be prepared to further increase production capabilities, expand our work force and to train, motivate and manage additional employees as the need for additional personnel arises. Our personnel, facilities, systems, procedures and controls may not be adequate to support our future operations. Any failure to manage future growth effectively could have a material adverse effect on our business and results of operations
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	We face risks in connection with securities litigation.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company and several of its current and former directors and officers have been named as defendants in a putative securities class action, as described in Note 8 to our consolidated Financial Statements included elsewhere in this annual report.&#160; The securities class action seeks unspecified damages from the Company, and we are unable to make an estimate of the likelihood that the Company might incur a financial loss as a result of the litigation or determine a range of potential loss if the plaintiffs were to prevail.&#160; However, legal expenses beyond those presently contemplated to be incurred or a settlement or adverse judgment on the merits could have a material adverse impact on the Company&#8217;s results of operations and financial condition.&#160; In addition, securities litigation, irrespective of its merits, is costly to defend and diverts management&#8217;s attention and resources, which could adversely affect our business.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Risks related to government regulation
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	We are subject to significant and increasing government regulations regarding the sale and marketing of our products.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The selling and marketing of our products are generally subject to comprehensive laws, regulations and standards enforced by various regional, national and local regulatory bodies, including the Food and Drug Administration, or FDA, the Federal Trade Commission, or FTC, and U.S. Department of Agriculture, or USDA, in the United States, the European Commission in the European Union, the Therapeutic Goods Administration, or TGA, in Australia, the Ministry of Health in China, the Health Sciences Authority, or HAS in Singapore, and the Ministry of Health in Israel and others. Compliance with the various regulatory bodies&#8217; requirements is costly and time -consuming. See &#8220;Item 4. B. Information on the Company &#8212; Business Overview &#8212; Government regulation&#8221; below. Legal and regulatory demands are increasing in a number of countries with respect to our products, and legislative bodies may repeal laws or enact new laws that would impact the sale and marketing of our products or development of new products. With respect to InFat, new regulations under consideration in China, including a requirement to register infant formula products with the CFDA and certain limitations to the number of formulas and brands that a company may manufacture, may adversely affect the infant formula industry. Additionally, regulatory authorities may change processes, regulations, and policies related to our products, which could impact product development, commercialization and business operations and require us to make changes to our products, the claims we make regarding our products or our operations. In addition, there is a lack of harmonization among the laws, regulations and standards in the principal countries in which we sell our products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	17
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage24"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Nutrition Segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Where regulatory approvals are required for our nutrition products, the process of obtaining such approvals can be costly and time -consuming and there is no guarantee of approval. Such processes therefore could delay or prevent the production and commercialization of new products. In addition, if we fail to comply with any legal or regulatory requirement, or fail to obtain any necessary regulatory approval we could be subject to various enforcement actions, including warning letters, fines, product recalls or seizures, interruption in or suspension of product manufacturing capabilities, other operating restrictions, injunctions, delays in obtaining or inability to obtain product approvals, other civil penalties and criminal sanctions. Any such enforcement action may result in significant unanticipated expenditures and may have a material adverse effect on our reputation, operations, financial situation or operating results.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The regulatory requirements we face similarly may impact our reputation, operations, financial situation or operating results. For example, legislation in the United States requires companies that manufacture or distribute dietary supplements, including certain products of our Nutrition segment, to report serious adverse events allegedly associated with their products to the FDA and maintain recordkeeping procedures for all alleged adverse events (serious and non-serious). As a result, consumers, the press or government regulators may misinterpret reports of adverse events as evidence that the ingredient or product caused the reported event, which could lead to consumer confusion, damage to our reputation, banned or recalled ingredients or products, increased insurance costs, class action litigation and a potential increase in product liability litigation, among other things.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Further, we comply with current GMP guidelines for food for human consumption and are subject to periodic self-assessment. We are subject to regular inspections with respect to our GMP compliance by the Israeli Ministry of Health. We also maintain an ISO 9001-2008 quality system certificate and a Hazard Analysis and Critical Control Points (HACCP) certificate for food safety. For more information regarding the regulations affecting our nutrition products, see &#8220;Item 4.B. Information on the Company &#8212; Business Overview &#8211; Government regulation &#8212; Nutrition segment.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	VAYA Pharma Segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The products offered by our VAYA Pharma segment are sold under physician supervision in the United States as &#8220;medical foods,&#8221; which do not require premarket approval, on the basis of their meeting the criteria for &#8220;medical foods&#8221; in the FDCA and FDA regulations. Although we believe that our VAYA Pharma products meet the criteria for &#8220;medical foods&#8221; established by the FDCA, and that the labeling and marketing of our medical foods is consistent with FDA regulatory requirements, our offering of one or more of these products as &#8220;medical food&#8221; could be challenged by the FDA, which could have a material adverse effect on the results and operations of our VAYA Pharma segment. In addition, were we to be unsuccessful in obtaining FDA approval in the United States, this could significantly adversely affect the sale of the products outside the United States. For more information regarding this risk, see &#8220;&#8212;Our offering of products as &#8220;medical foods&#8221; in the United States may be challenged by regulatory authorities.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;FDA policies and guidance are continually evolving.&#160;&#160;&#160;Medical foods and other guidance from the agency has recently been revised.&#160;&#160;It is possible we will be required to apply for and obtain certain approvals for the clinical investigation of existing or new medical food products. For example, based on recent FDA guidance, in order to initiate a human clinical trial relating to the effect(s) of a medical food on disease, a sponsor may be required to file an Investigational New Drug Application (IND) with FDA and obtain authorization from the agency prior to beginning the investigation.&#160;&#160;Furthermore, FDA has indicated that investigations of conventional foods or dietary supplements studied for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, or even to reduce the risk of disease in medically vulnerable populations (including, for instance, individuals less than 12 months of age and those with altered immune systems), are subject to the IND requirements.&#160;&#160;Changes in FDA&#8217;s policies and guidance may affect our ability to make health-related claims about our products and to market and sell medical foods.&#160;&#160;&#160;These regulatory policy changes may have a material adverse effect on our business, or cause us to incur considerable costs.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Since supply to our U.S. customers includes import into the U.S. of products or their raw materials, we are subject to and dependent on being able to import said products or raw materials into the U.S. Any restriction on our import abilities, including due to FDA or other restrictions, may have a material adverse effect on our business.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The FTC regulates certain aspects of the advertising and marketing of our products. Under the Federal Trade Commission Act, a company must be able to substantiate both the express and implied claims that are conveyed by an advertisement. It is not uncommon for the FTC to conduct an investigation of the claims that are made about products in new and emerging areas of science that involve a potentially vulnerable population such as infants and children, or that relate to conditions impacting significant portions of the population. Any adverse action by the FTC could have a negative impact on our results of operations and financial condition.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage25"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Sales in the United States of the products of our VAYA Pharma segment are significantly impacted by the reimbursement policies of government healthcare or private health insurers.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The products offered by our VAYA Pharma segment are sold in the United States on the basis of their meeting the requirements for &#8220;medical foods,&#8221; as interpreted and enforced by the FDA. Medical foods are not required to undergo premarket review or approval by the FDA, as is required for prescription drugs. However, primarily because our VAYA Pharma products are not approved as prescription drugs by the FDA, most consumers purchasing these products in the United States are currently unable to obtain reimbursement from third-party payers under government healthcare or private insurance plans, which generally do not provide reimbursement for medical foods. While we are attempting to broaden acceptance of our VAYA Pharma products as eligible for reimbursement by third-party payers, no assurance can be given that we will be successful in our efforts. We believe that, unless we are able to obtain widespread reimbursement for our VAYA Pharma products in the United States, future sales and profitability of our VAYA Pharma products may be significantly adversely impacted and we may be unable to achieve our projected sales of these products, which could have a material adverse effect on our business, financial condition and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	We could incur significant costs in complying with environmental, health and safety laws or permits or as a result of satisfying any liability or obligation imposed under such laws or permits.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We are subject to extensive environmental, health and safety laws and regulations in a number of jurisdictions, primarily Israel, governing, among other things, the use, storage, registration, handling and disposal of chemicals, waste materials and sewage; chemicals, air, water and ground contamination; air emissions and the cleanup of contaminated sites, including any contamination that results from spills due to our failure to properly dispose of chemicals, waste materials and sewage. In particular, our operations at our Migdal Ha&#8217;Emeq manufacturing facility use chemicals and produce emissions, waste materials and sewage, and accordingly require permits from various governmental authorities. These authorities conduct periodic inspections in order to review and ensure our compliance with the various regulations. Our manufacturing processes include pollutant emissions which at peak capacity approach maximum permitted levels. During 2014 and 2015, in order to meet regulatory requirements, we invested a total of approximately $0.3 million in advanced biotechnology for effluent treatment solution in our current facility, which we believe is currently sufficient for our plant&#8217;s capacity. Nevertheless, such equipment may not be completely effective or may malfunction, which could result in a violation of regulations or our need to stop operations at our manufacturing facility until we can make any necessary repairs or improvements to ensure we are compliant with regulatory requirements.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	These laws, regulations and permits could potentially require us to further dedicate significant amounts for compliance and/or remediation. Laws and regulations relating to environmental matters are often subject to change. In the event of any changes or new laws or regulations, we could be subject to new compliance measures or to penalties for activities which were previously permitted. If we fail to comply with such laws, regulations or permits, we may be subject to fines and other civil, administrative or criminal sanctions, including the revocation of permits and licenses necessary to continue our business activities. In addition, we may be required to pay damages or civil judgments in respect of third-party claims, including those relating to personal injury (including exposure to hazardous substances we use, store, handle, transport, manufacture or dispose of), property damage or contribution claims. Some environmental laws allow for strict, joint and several liability for remediation costs, regardless of comparative fault. We may be identified as a potentially responsible party under such laws. Such developments could have a material adverse effect on our business, financial condition and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Should any of our products receive FDA approval as a prescription drug, such pharmaceutical products may still not qualify for reimbursement or the terms of such reimbursement may prevent the product from being sold at a cost-effective price.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 2010, we started the process of seeking FDA approval for one of our VAYA Pharma products, Vayarol, as a prescription drug. We submitted an Investigational New Drug Application, or IND, briefing package to the FDA in April 2013. Based on comments we received from the FDA and a subsequent teleconference with FDA representatives, we believe that the FDA would require us to design a more extensive Phase 3 clinical trial. See &#8220;Item 4.B. Information on the Company &#8212; Business Overview &#8212; Government regulation &#8211; VAYA Pharma&#8221; below. There can be no assurance that this process will be successful, and we have decided to postpone further activities on Vayarol as we reconsider the costs and benefits of initiating the product. However, even if we do receive FDA approval for Vayarol, or any of our other VAYA Pharma products, as a prescription drug, consumers purchasing such products in the United States may be able to more easily obtain reimbursement from third-party payers under government healthcare or private insurance plans. However, we would then be subject to the reimbursement policies of such third-party payers and their efforts to contain or reduce the costs of health care.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	19
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage26"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition, certain U.S. federal and state laws currently apply to the pricing and reporting of price information for prescription drugs. There also have been, and we expect that there will continue to be, a number of U.S. federal and state proposals to further increase government control over pricing and profitability of prescription drugs. Moreover, the emphasis on managed health care in the United States has increased and will continue to increase the pressure on the pricing of pharmaceuticals. Third-party payers are increasingly challenging the prices charged for medical products. To the extent that we succeed in obtaining FDA prescription drug approval for any of our products, there can be no assurance that such product will qualify for reimbursement from third-party payers, or if it does, whether the terms of such reimbursement will be considered cost-effective or will be sufficient to allow the sale of these products by us on a competitive basis.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Risks related to our intellectual property
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	We may not be able to protect our proprietary technology or prevent its unauthorized use by third parties.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our ability to obtain and maintain patent protection and trade secret protection for our intellectual property and proprietary technologies, our products and their uses is important to our commercial success. We rely on a combination of patent, copyright, trademark and trade secret laws, non-disclosure and confidentiality agreements, licenses, assignments of invention agreements and other restrictions on disclosure and use to protect our intellectual property rights. We have been granted over 100 patents in more than a dozen countries and have applications for approximately 70 additional patents pending worldwide.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Patents that claim specific molecules or active ingredients are generally considered to be the strongest form of intellectual property protection for products that are new molecules. However, as the main ingredients of our products are derived from nature, those types of claims are generally not available for our products. Instead, our issued patents and pending patent applications cover specifically selected narrow compositions, proprietary processes used in the manufacture of certain products, or specific uses for certain products. Accordingly, other parties may compete with us, for example, by independently developing or obtaining similar or competing technologies, designing around our patents and/or marketing competing products that do not claim our patented uses.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Furthermore, there can be no assurance that patent applications relating to our products, processes or technologies will result in patents being issued, or that any patents that have been issued will be adequate to protect our intellectual property or that we will enjoy patent protection for any significant period of time. Additionally, any issued patents may be challenged by third parties, and patents that we hold may be found by a judicial authority to be invalid or unenforceable. If any of our composition-of-matter patents or pending applications was to be subject to a successful challenge or failed to issue, our business and competitive advantage could be significantly affected. Other parties may independently develop similar or competing technology or design around any patents that may be issued to or held by us. Our current patents will expire or they may otherwise cease to provide meaningful competitive advantage, and we may be unable to adequately develop new technologies and obtain future patent protection to preserve our competitive advantage or avoid adverse effects on our business.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition to seeking patents for some of our proprietary technologies, processes and products, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information in attempting to develop and maintain a competitive position. However, trade secret protection is risky and uncertain and the disclosure or independent development of our proprietary technology could have a material adverse impact on our business and results of operations. Any party with whom we have executed non-disclosure and/or non-use agreements may breach those agreements and disclose our proprietary technology, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and a favorable outcome is not guaranteed. In addition, if any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent such third party, or those to whom they communicate such technology or information, from using that technology or information to compete with us.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We cannot be certain that the steps that we have taken will prevent the misappropriation or other violation of our confidential information and other intellectual property, particularly in foreign countries, such as China, in which laws may not protect our proprietary rights as fully as in the United States and other developed economies. Moreover, if we lose any key personnel, we may not be able to prevent the unauthorized disclosure or use of our technical knowledge or other trade secrets by those former employees. If we are unable to maintain the security of our proprietary technology, this could materially adversely affect our competitive advantage, business and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	20
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage27"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	We may become subject to litigation regarding intellectual property rights.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our commercial success depends in part on our ability to operate without infringing upon the proprietary rights of others. In recent years, there has been significant litigation in the United States and abroad involving patents and other intellectual property rights in the industries in which we operate. As discussed above, we were previously involved in legal proceedings in the United States concerning our krill oil products with Neptune, one of our principal competitors in the krill oil market which resulted in a final settlement and license agreement.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We may also, in the future, be a party to litigation to determine the scope and validity of our own intellectual property, which, if resolved adversely to us, could invalidate or render unenforceable our intellectual property or generally preclude us from restraining competitors from commercializing products using technology developed by us. In addition, because patent applications can take many years until the patents issue, there may be applications now pending of which we are unaware, which may later result in issued patents that our products may infringe. If any of our products infringe a valid and enforceable patent, or if we wish to avoid potential intellectual property litigation or alleged infringement, we may not be able to sell applicable products unless and until we can obtain a license, which we may not be able to obtain on commercially reasonable terms, if at all. Alternatively, we could be forced to pay substantial royalties or redesign a product to avoid infringement. A successful claim of infringement against us, or our failure or inability to develop non-infringing technology or license the infringed technology, on acceptable terms and on a timely basis, if at all, could materially adversely affect our business and results of operations. These outcomes could also directly and indirectly benefit our competitors, including, for example, by obtaining judgments against or payments from us, reputational harm to us and our products, and/or gaining market share from us. Furthermore, litigation to establish or challenge the validity of patents, to defend against infringement, enforceability or invalidity claims or to assert infringement, invalidity or enforceability claims against others, if required, regardless of its success, would likely be time-consuming and expensive to resolve and would divert management&#8217;s time and attention, which could seriously harm our business.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition to our existing agreements related to the Neptune litigation (see &#8220;Item 8. A. Financial Information &#8212; Consolidated Financial Statements and Other Financial Information &#8212; Legal Proceedings&#8221;) we may in the future agree to be financially responsible for any damages awarded against certain of our customers, and in some cases the cost of defense for such customers, as a result of the purchase, importation, use, sale or offer to sell of our products that a third party claims infringes its intellectual property rights. If any of the products at issue are found to infringe the valid and enforceable intellectual property right of such third party, the payment of such damages could have a materially adverse impact on our financial results and business.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	It is possible that the products currently marketed or under development by us may in the future be found to infringe patents issued or licensed to others or otherwise violate the intellectual property rights of others. Likewise, it is possible that other parties may independently develop similar technologies, duplicate our technologies or, with respect to patents that are issued to us, or rights licensed to us, design around the patented aspects of the technologies. Third parties may also obtain patents that we may need to license from them in order to conduct our business.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Changes in U.S. or foreign patent law could diminish the value of patents in general, thereby impairing our ability to protect our products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Obtaining and enforcing patents involves technological and legal complexity, and is costly, time -consuming, and inherently uncertain. Patent policy also continues to evolve in the United States and many foreign jurisdictions and the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. For example, the U.S. Supreme Court has ruled on several patent cases in recent years, including narrowing the scope of patent protection available in certain circumstances or weakening the rights or remedies of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Furthermore, decisions by the U.S. Congress, the federal courts, and the U.S. Patent and Trademark Office or comparable authorities in foreign jurisdictions could change the laws and regulations governing patents in unpredictable ways that may weaken or undermine our ability to obtain new patents or to enforce our existing patents and patents we might obtain in the future.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage28"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	We may not be able to protect our intellectual property rights throughout the world.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Filing, prosecuting, maintaining and defending patents on each of our products in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States are less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Also, it may not be possible to effectively enforce intellectual property rights in some foreign countries at all or to the same extent as in the United States and other countries. Consequently, we are unable to prevent third parties from using our inventions in all countries, or from selling or importing products made using our inventions in the jurisdictions in which we do not have (or are unable to effectively enforce) patent protection. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop, market or otherwise commercialize their own products, and we may be unable to prevent those competitors from importing those infringing products into territories where we have patent protection but enforcement is not as strong as in the United States. These products may compete with our products and our patents and other intellectual property rights may not be effective or sufficient to prevent them from competing in those jurisdictions. Moreover, competitors or others in the chain of commerce may raise legal challenges against our intellectual property rights or may infringe upon our intellectual property rights, including through means that may be difficult to prevent or detect.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions, including China, a significant market for InFat and other products. The legal systems of certain countries, including China, have not historically favored the enforcement of patents or other intellectual property rights, which could hinder us from preventing the infringement of our patents or other intellectual property rights in those countries and result in substantial risks to us.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Furthermore, proceedings to enforce our patent rights in the United States or foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing, and could provoke third parties to assert patent infringement or other claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights in the United States and around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license from third parties.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Risks related to our ordinary shares
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	The market price of our ordinary shares may be subject to fluctuation, regardless of our operating results and financial condition. As a result, our shareholders could lose all or part of their investment.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;The stock market in general, and the market price of our ordinary shares, have been and will be subject to fluctuation, whether due to, or irrespective of, our operating results and financial condition. During the year ended December, 31 2015, our share price ranged from $5.38 to $10.83, and since our initial public offering in September 2013, has been as high as $35.12. The market price of our ordinary shares on the NASDAQ Global Select Market may fluctuate as a result of a number of factors, some of which are beyond our control, including, but not limited to:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	actual or anticipated variations in our and our competitors&#8217; results of operations and financial condition;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	market acceptance of our products and the effect of changing consumer preferences, including in China, on our sales;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the mix of products that we sell and related services that we provide;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	changes in earnings estimates or recommendations by securities analysts, if they continue to cover our ordinary shares;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	22
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage29"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the results of operations of AL and our relationship with AAK following the recent decision of the arbitral tribunal;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	development of technological innovations or new competitive products by others;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	outcome of litigation in which we may be involved from time to time;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	announcements of technological innovations or new products by us;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	publication of the results of pre-clinical or clinical trials for any of our products or products under development;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	failure by us to achieve a publicly announced milestone;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	delays between our expenditures to develop and market new or enhanced products and the generation of sales from those products;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	developments concerning intellectual property rights, including our involvement in litigation;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	regulatory developments and the decisions of regulatory authorities as to the marketing of our current products or the approval or rejection of new or modified products;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	changes in the amounts that we spend to develop, acquire or license new products, technologies or businesses;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	changes in our expenditures to promote our products;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	our sale or proposed sale, or the sale by our significant shareholders, of our ordinary shares or other securities in the future;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	changes in key personnel;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	success or failure of research and development projects of us or our competitors;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the trading volume of our ordinary shares; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	general economic and market conditions and other factors, including factors unrelated to our operating performance.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	23
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage30"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	These factors and any corresponding price fluctuations may materially and adversely affect the market price of our ordinary shares and result in substantial losses being incurred by our investors. In the past, following periods of market volatility, public company shareholders have often instituted securities class action litigation. Lawsuits brought against us by shareholders, such as the shareholder class action suits against us, some of our past and present directors and certain of our executive officers, could cause us to incur costs defending the lawsuits and divert the resources and attention of our management from the operation of our business.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	If equity research analysts do not continue to publish research or reports about our business or if they issue unfavorable commentary or downgrade our ordinary shares, the price of our ordinary shares could decline.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The trading market for our ordinary shares will rely in part on the research and reports that equity research analysts publish about us and our business. We do not have control over these analysts and we do not have commitments from them to write research reports about us. The price of our ordinary shares could decline if one or more equity research analysts downgrade(s) our ordinary shares or if those analysts issue other unfavorable commentary or cease publishing reports about us or our business.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Future sales of our ordinary shares could reduce the market price of our ordinary shares.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If our existing shareholders, particularly our largest shareholders, our directors, their affiliates, or our executive officers, sell a substantial number of our ordinary shares in the public market, the market price of our ordinary shares could decrease significantly. As of February 29, 2016, the holders of 4,623,232 ordinary shares were entitled to require that we register their shares under the Securities Act for resale into the public markets. All shares sold pursuant to an offering covered by such registration statement will be freely transferable. See &#8220;Item 7.B. Major Shareholders and Related Party Transactions&#8212;Related Party Transactions&#8212;Investors&#8217; Rights Agreement.&#8221; Sales by us or our shareholders of a substantial number of ordinary shares in the public market, or the perception that these sales might&#160;&#160;occur, could cause the market price of our ordinary shares to decline or could impair our ability to raise capital through a future sale of, or pay for acquisitions using, our equity securities.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;In addition to these registration rights, as of December 31, 2015, 1,672,684 ordinary shares were subject to outstanding awards granted to directors, officers, employees, and other service providers under our equity incentive plans, including 987,568 ordinary shares issuable under currently exercisable share options. On December 30, 2013, we filed a registration statement on Form S-8 registering up to 2,424,948 ordinary shares issuable under our 2003 Plan and our 2013 Plan. Additionally, on March 18, 2015, we filed a registration statement on Form S-8 registering an additional 880,946 shares issuable under our 2013 Plan. As of December 31, 2015, 1,805,160 shares remained available for issuance under our equity incentive plans, which amount includes 1,672,684 ordinary shares subject to outstanding awards. Shares included in such registration statements may be freely sold in the public market upon issuance, except for shares held by affiliates who have certain restrictions on their ability to sell.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	We have never paid cash or non-cash dividends on our share capital, and we do not anticipate paying any cash or non-cash dividends in the foreseeable future.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have never declared or paid cash or non-cash dividends on our share capital, nor do we anticipate paying any cash or non-cash dividends on our share capital in the foreseeable future. We currently intend to retain all available funds and any future earnings to fund the development and growth of our business. As a result, capital appreciation, if any, of our ordinary shares will be investors&#8217; sole source of gain for the foreseeable future. In addition, Israeli law limits our ability to declare and pay dividends, and may subject our dividends to Israeli withholding taxes and our payment of dividends (out of tax-exempt income) may subject us to certain Israeli taxes, to which we would not otherwise be subject (see &#8220;Item 8.A. Financial Information &#8212; Consolidated Financial Statements and Other Financial Information &#8212; Dividend policy, &#8221; &#8220;Item 10.B. Additional Information &#8212; Memorandum of Association and Articles of Association&#8212;Dividend and liquidation rights&#8221; and &#8220;Item 10.E. Additional Information &#8212; Taxation &#8212; Israeli tax considerations and government programs&#8221;).
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	24
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage31"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	As a foreign private issuer, we are permitted to follow certain home country corporate governance practices instead of otherwise applicable SEC and NASDAQ requirements, which may result in less protection than is accorded to investors under rules applicable to domestic U.S. issuers.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As a foreign private issuer, we are permitted to, and do, follow certain home country corporate governance practices instead of those otherwise required under the Listing Rules of the NASDAQ Stock Market for domestic U.S. issuers. For instance, we follow home country practice in Israel with regard to the quorum requirement for shareholder meetings. As permitted under the Israeli Companies Law, our articles of association provide that the quorum for any meeting of shareholders shall be the presence of at least two shareholders present in person, by proxy or by a voting instrument, who hold at least 25% of the voting power of our shares instead of 33 1/3% of the issued share capital requirement. These quorum requirements for the meeting of our shareholders are lower than is customary for domestic issuers. We may in the future elect to follow home country practices in Israel with regard to other matters, including the formation of compensation, nominating and corporate governance committees, separate executive sessions of independent directors and non-management directors and the requirement to obtain shareholder approval for certain dilutive events (such as for the establishment or amendment of certain equity-based compensation plans, issuances that will result in a change of control of the company, certain transactions other than a public offering involving issuances of a 20% or more interest in the company and certain acquisitions of the stock or assets of another company). Our adoption of home country governance practices as opposed to the requirements that would otherwise apply to a domestic issuer listed on the NASDAQ Global Select Market may provide less protection to you than what is accorded to investors under the NASDAQ rules applicable to domestic issuers.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	As a foreign private issuer, we are not subject to the provisions of Regulation FD or U.S. proxy rules and are exempt from filing certain Exchange Act reports.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As a foreign private issuer, we are exempt from the rules and regulations under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file annual and current reports and Financial Statements with the Securities and Exchange Commission ("SEC") as frequently or as promptly as U.S. domestic companies whose securities are registered under the Exchange Act, we are permitted to disclose limited compensation information for our executive officers on an individual basis in accordance with home country law and we are generally exempt from filing quarterly reports with the SEC under the Exchange Act.&#160;&#160;&#160;Moreover, we are not required to comply with Regulation FD, which restricts the selective disclosure of material nonpublic information to, among others, broker-dealers and holders of a company&#8217;s securities under circumstances in which it is reasonably foreseeable that the holder will trade in the company&#8217;s securities on the basis of the information.&#160;&#160;These exemptions reduce the frequency and scope of information and protections to which you may otherwise have been eligible in relation to a U.S. domestic issuer.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; We would lose our foreign private issuer status if (a) a majority of our outstanding voting securities were either directly or indirectly owned of record by residents of the United States and (b)(i) a majority of our executive officers or directors were United States citizens or residents, (ii) more than 50 percent of our assets were located in the United States or (iii) our business were administered principally in the United States. Although we have elected to comply with certain U.S. regulatory provisions, our loss of foreign private issuer status would make such provisions mandatory. The regulatory and compliance costs to us under U.S. securities laws as a U.S. domestic issuer may be significantly higher. If we are not a foreign private issuer, we will be required to file periodic reports and registration statements on U.S. domestic issuer forms with the SEC, which are more detailed and extensive than the forms available to a foreign private issuer. We may also be required to modify certain of our policies to comply with accepted governance practices associated with U.S. domestic issuers. Such conversion and modifications will involve additional costs. In addition, we may lose our ability to rely upon exemptions from certain corporate governance requirements on U.S. stock exchanges that are available to foreign private issuers.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	&#160;
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	We are an &#8220;emerging growth company&#8221; and the reduced disclosure requirements applicable to emerging growth companies may make our ordinary shares less attractive to investors.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We are an &#8220;emerging growth company,&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and we take advantage of certain exemptions from various requirements that are applicable to other public companies that are not &#8220;emerging growth companies.&#8221; Most of such requirements relate to disclosures that we would only be required to make if we cease to be a foreign private issuer in the future. Nevertheless, as a foreign private issuer that is an emerging growth company, we will not be required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 for up to five fiscal years after the date of our initial public offering.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We will remain an emerging growth company until the earliest of: (a) the last day of our fiscal year during which we have total annual gross revenues of at least $1.0 billion; (b) December 31, 2018, the last day of our fiscal year following the fifth anniversary of the closing of our initial public offering; (c) the date on which we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt; or (d) the date on which we are deemed to be a &#8220;large accelerated filer&#8221; under the Exchange Act. When we are no longer deemed to be an emerging growth company, we will not be entitled to the exemptions provided in the JOBS Act discussed above. Investors may find our ordinary shares less attractive as a result of our reliance on exemptions under the JOBS Act, which may contribute to a less active trading market for our ordinary shares and volatility in our share price.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	25
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage32"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	If we are unable to satisfy the requirements of Section 404 of the Sarbanes-Oxley Act of 2002, or if our internal controls over financial reporting are not effective, investors may lose confidence in the accuracy and the completeness of our financial reports, the reliability of our financial statements may be questioned and our share price may suffer.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; We are required to comply with the internal control, evaluation and certification requirements of Section 404 of the Sarbanes-Oxley Act of&#160;2002 (the "Sarbanes-Oxley Act") of this annual report, including the requirement to furnish a report by management on the effectiveness of our internal control over financial reporting. Additionally, pursuant to Section 404(b) of the Sarbanes-Oxley Act, unless we lose our status as an &#8220;emerging growth company&#8221; under the JOBS Act prior to the end of the fiscal year in which the fifth anniversary of our IPO occurred, we will not be required to obtain an auditor attestation under Section 404 of the Sarbanes-Oxley Act until the year ended December 31, 2018.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; To maintain the effectiveness of our disclosure controls and procedures and our internal control over financial reporting, we expect that we will need to continue enhancing existing, and implement new, financial reporting and management systems, procedures and controls to manage our business effectively and support our growth in the future. The process of evaluating our internal control over financial reporting requires an investment of substantial time and resources, including by our Chief Financial Officer and other members of our senior management. The determination and any remedial actions required could divert internal resources and could result in us incurring additional costs that we did not anticipate, including the hiring of outside consultants.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Irrespective of compliance with Section 404, any failure of our internal control over financial reporting could have a material adverse effect on our stated results of operations and harm our reputation. If we are unable to implement any of the required changes to our internal control over financial reporting effectively or efficiently, it could adversely affect our operations, financial reporting and/or results of operations and could result in an adverse opinion on internal controls from our independent auditors. Further, if our internal control over financial reporting is not effective, the reliability of our financial statements may be questioned and our share price may suffer.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Our U.S. shareholders may suffer adverse tax consequences if we are characterized as a passive foreign investment company.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Generally, if for any taxable year 75% or more of our gross income is passive income, or at least 50% of the average quarterly value of our assets (which may be determined in part by the market value of our ordinary shares, which is subject to change) are held for the production of, or produce, passive income, we would be characterized as a passive foreign investment company, or PFIC, for U.S. federal income tax purposes. Based on our gross income and gross assets, we do not believe that we were classified as a PFIC for the taxable year ended December 31, 2015. There can be no assurance that we will not be considered a PFIC for 2016 or any future taxable year.&#160;&#160;PFIC status is determined as of the end of the taxable year and depends on a number of factors, including the value of a corporation&#8217;s assets and the amount and type of its gross income. Furthermore, because the value of our gross assets is likely to be determined in large part by reference to our market capitalization, a decline in the value of our ordinary shares may result in our becoming a PFIC. If we are characterized as a PFIC, our U.S. shareholders may suffer adverse tax consequences, including having gains realized on the sale of our ordinary shares treated as ordinary income, rather than a capital gain, the loss of the preferential rate applicable to dividends received on our ordinary shares by individuals who are U.S. Holders (as defined in &#8220;Item 10.E. Additional Information &#8212; Taxation &#8212; U.S. federal income tax consequences&#8221;), and having interest charges apply to distributions by us and the proceeds of share sales. Certain elections exist that may alleviate some of the adverse consequences of PFIC status and would result in an alternative treatment (such as mark-to-market treatment) of our ordinary shares; however, we do not intend to provide the information necessary for U.S. holders to make qualified electing fund elections if we are classified as a PFIC. See &#8220;Item 10.E. Additional Information &#8212; Taxation &#8212; Passive foreign investment company consequences.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	26
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage33"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	We have incurred and could continue to incur increased costs as a result of operating as a public company, and our management has been and may continue to be required to devote substantial time to new compliance initiatives.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We completed our initial public offering in 2013 and, as a public company whose ordinary shares are listed in the United States, we have incurred and will continue to incur significant accounting, legal and other expenses, including costs associated with our reporting requirements under the U.S. Securities Exchange Act of 1934, as amended, or the Exchange Act. We could also incur additional costs associated with corporate governance requirements, including requirements under Section 404 and other provisions of the Sarbanes-Oxley Act, as well as rules implemented by the SEC and the NASDAQ Global Select Market, and provisions of Israeli corporate law applicable to public companies. Laws and regulations affecting public companies also make it more difficult or costly for us to obtain certain types of insurance, such as director and officer liability insurance. These rules and regulations could continue to increase our legal and financial compliance costs and make some activities more time-consuming and costly.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Changes in the laws and regulations affecting public companies will result in increased costs to us as we respond to their requirements. These laws and regulations could make it more difficult or more costly for us to obtain certain types of insurance, including director and officer liability insurance, and we may be forced to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive officers. We cannot predict or estimate the amount or timing of additional costs we may incur in order to comply with such requirements.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Risks primarily related to our operations in Israel
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Our headquarters, manufacturing and other significant operations are located in Israel and, therefore, our results may be adversely affected by political, economic and military instability in Israel.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our headquarters, manufacturing and principal research and development facilities are located in northern Israel. In addition, the majority of our key employees, officers and directors are residents of Israel. Accordingly, political, economic and military conditions in Israel may directly affect our business. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its neighboring countries. Any hostilities involving Israel or the interruption or curtailment of trade between Israel and its trading partners could adversely affect our operations and results of operations. In addition, our operations may be adversely affected by the call-up of certain of our employees, including members of our senior management, to active military service in the case of such hostilities.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	During the Second Lebanon War of 2006, between Israel and Hezbollah, a militant Islamic movement, rockets were fired from Lebanon into Israel causing casualties and major disruption of economic activities in northern Israel. An escalation in tension and violence between Israel and the militant Hamas movement (which controls the Gaza Strip) and other Palestinian Arab groups, culminated with Israel&#8217;s military campaign in Gaza in December 2008 and again in November 2012 and in July and August 2014 in an endeavor to prevent continued rocket attacks against Israel&#8217;s southern towns. It is unclear whether any negotiations that may occur between Israel and the Palestinian Authority will result in an agreement. In addition, Israel faces threats from more distant neighbors, in particular, Iran, an ally of Hezbollah and Hamas, and the militant group known as the Islamic State of Iraq and Syria.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our commercial insurance does not cover losses that may occur as a result of an event associated with the security situation in the Middle East. Although the Israeli government is currently committed to covering the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, we cannot assure you that this government coverage will be maintained, or if maintained, will be sufficient to compensate us fully for damages incurred. Any losses or damages incurred by us could have a material adverse effect on our business. Any armed conflict involving Israel could adversely affect our operations and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Further, our operations could be disrupted by the obligations of personnel to perform military service. As of December 31, 2015, we had 136 employees based in Israel, some of whom may be called upon to perform up to 54 days in each three year period (and in the case of officers, up to 84 days in each three year period) of military reserve duty until they reach the age of 40 (and in some cases, depending on their specific military profession up to 45 or even 49 years of age) and, in certain emergency circumstances, may be called to immediate and unlimited active duty. The number of our employees that were called to military reserve duty in the last three years was 12, none of which were members of management. Our operations could be disrupted by the absence of a significant number of employees related to military service, which could materially adversely affect our business and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	27
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage34"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Several countries, principally in the Middle East, restrict doing business with Israel and Israeli companies, and additional countries may impose restrictions on doing business with Israel and Israeli companies whether as a result of hostilities in the region or otherwise. In addition, there have been increased efforts by activists to cause companies and consumers to boycott Israeli goods based on Israeli government policies. Such actions, particularly if they become more widespread, may adversely impact our ability to sell our products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Exchange rate fluctuations between the dollar and the Israeli shekel, the Euro and other non-U.S. currencies may negatively affect our earnings.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The dollar is our functional and reporting currency. Although most of our revenues and a portion of our expenses are denominated in dollars, a significant portion of our cost of revenues and operating expenses is incurred in Israeli shekels. As a result, we are exposed to the risks that the shekel may appreciate relative to the dollar, or, if the shekel instead devalues relative to the dollar, that the inflation rate in Israel may exceed such rate of devaluation of the shekel, or that the timing of such devaluation may lag behind inflation in Israel. In any such event, the dollar cost of our operations in Israel would increase and our dollar-denominated results of operations would be adversely affected. We cannot predict any future trends in the rate of inflation in Israel or the rate of devaluation (if any) of the shekel against the dollar. For example, the rate of devaluation of the dollar against the shekel was approximately 7.0% in 2013, which was compounded by inflation in Israel at a rate of approximately 1.8%, respectively. This had the effect of increasing the dollar cost of our operations in Israel. While the dollar appreciated relative to the shekel by 12.0% in 2014 and 0.3% in 2015, eclipsing the 0.2% and 1.0% rate of deflation in Israel in 2014 and 2015, respectively, there is no guarantee that the prior trend of dollar devaluation relative to the shekel will not return in the future. If the dollar cost of our operations in Israel increases, our dollar-measured results of operations will be adversely affected. Our operations also could be adversely affected if we are unable to effectively hedge against currency fluctuations in the future.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Although most of our revenues and a portion of our expenses are denominated in dollars, we do have substantial revenues and certain expenses that are denominated in other currencies apart from the dollar and the shekel, particularly the euro. Therefore, our operating results and cash flows are also subject to fluctuations due to changes in the relative values of the dollar and these foreign currencies. These fluctuations could negatively affect our operating results and could cause our revenues and net income or loss to vary from quarter to quarter. Furthermore, to the extent that we increase our revenues in certain countries, such as several countries in the Asia Pacific region, where our sales are denominated in dollars, a strengthening of the dollar versus other currencies could make our products less competitive in those foreign markets and collection of receivables more difficult.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;We engage in currency hedging activities. These measures, however, may not adequately protect us from material adverse effects due to the impact of inflation in Israel or from fluctuations in the relative values of the dollar and foreign currencies in which we transact business, and may result in a financial loss. For further information, see &#8220;Item 11. Quantitative and Qualitative Disclosures About Market Risk&#8221; elsewhere in this annual report.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	We may become subject to claims for remuneration or royalties for assigned service invention rights by our employees, which could result in litigation and adversely affect our business.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;We enter into assignment of invention agreements with our employees pursuant to which such individuals agree to assign to us all rights to any inventions created in the scope of their employment or engagement with us. A significant portion of our intellectual property has been developed by our employees in the course of their employment for us. Under the Israeli Patent Law, 5727-1967, or the Patent Law, inventions conceived by an employee during the scope of his or her employment with a company are regarded as &#8220;service inventions,&#8221; which belong to the employer, absent a specific agreement between the employee and employer giving the employee service invention rights. The Patent Law also provides that if there is no such agreement between an employer and an employee, the Israeli Compensation and Royalties Committee, or the Committee, a body constituted under the Patent Law, shall determine whether the employee is entitled to remuneration for his or her inventions. Recent decisions by the Committee (which have been upheld by the Israeli Supreme Court on appeal) have created uncertainty in this area, as it held that employees may be entitled to remuneration for their service inventions despite having specifically waived any such rights. However, a decision by the Committee in 2015 held that such right can be waived by the employee. The Committee further held that an explicit reference to the waived right is not necessary in every circumstance in order for the employee&#8217;s waiver of such right to be valid. Such waiver can be formalized in writing or orally or be implied by the actions of the parties in accordance with the rules of interpretation of Israeli contract law.&#160;Although our employees have agreed to assign to us service invention rights, we may face claims demanding remuneration in consideration for assigned inventions. As a consequence of such claims, we could be required to pay additional remuneration or royalties to our current and/or former employees, or be forced to litigate such claims, which could negatively affect our business.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	28
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage35"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	The government tax benefits that we currently receive require us to meet several conditions and may be terminated or reduced in the future.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Some of our operations in Israel, referred to as &#8220;Approved Enterprises&#8221; and &#8220;Benefited Enterprises,&#8221; carry certain tax benefits under the Law for the Encouragement of Capital Investments, 5719-1959, or the Investment Law. Based on an evaluation of the relevant factors under the Investment Law, including the level of non-Israeli investment in our company, we have determined that our effective tax rate to be paid with respect to all of our Israeli operations under these benefits programs is 0%, based on the available level of benefits under the law. Substantially all of our income before taxes can be attributed to these programs. If we do not meet the requirements for maintaining these benefits, they may be reduced or cancelled and the relevant operations would be subject to Israeli corporate tax at the standard rate, which was 26.5% for 2014 and 2015 and is 25% starting in 2016.
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	&#160;
</FONT>
	In addition to being subject to the standard corporate tax rate, we would be required to refund any tax benefits that we have already received, as adjusted by the Israeli consumer price index, plus interest and penalties thereon. Even if we continue to meet the relevant requirements, the tax benefits that our current &#8220;Approved Enterprise&#8221; and &#8220;Benefited Enterprises&#8221; receive may not be continued in the future at their current levels or at all. If these tax benefits were reduced or eliminated, the amount of taxes that we pay would likely increase, as all of our operations would consequently be subject to corporate tax at the standard rate, which could adversely affect our results of operations. Additionally, if we increase our activities outside of Israel, for example, by way of acquisitions, our increased activities may not be eligible for inclusion in Israeli tax benefit programs. See &#8220;Item 10.E. Additional Information &#8212; Taxation &#8212; Tax benefits under the Law for the Encouragement of Capital Investments, 5719-1959&#8221; for additional information concerning these tax benefits.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	We received Israeli government grants for certain research and development activities. The terms of those grants require us to satisfy specified conditions and to pay penalties in addition to repayment of the grants upon certain events.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our research and development efforts were and are financed in part through grants from the Office of the Chief Scientist in the Israeli Ministry of Economy and Industry, or OCS.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Even following full repayment of any OCS grants, we must nevertheless continue to comply with the requirements of the Israeli Law for the Encouragement of Industrial Research and Development, 1984, and related regulations, or the Research Law. When a company develops know-how, technology or products using OCS grants, the terms of these grants and the Research Law restrict the transfer outside of Israel of such know-how, and the manufacturing or manufacturing rights of such products, technologies or know-how, without the prior approval of the OCS. Therefore, if aspects of our technologies are deemed to have been developed with OCS funding, the discretionary approval of an OCS committee would be required for any transfer to third parties outside of Israel of know-how or manufacturing or manufacturing rights related to those aspects of such technologies. We may not receive those approvals. Furthermore, the OCS may impose certain conditions on any arrangement under which it permits us to transfer technology or development out of Israel.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The transfer of OCS-supported technology or know-how outside of Israel may involve the payment of significant penalties and other amounts, depending upon the value of the transferred technology or know-how, the amount of OCS support, the time of completion of the OCS-supported research project and other factors. These restrictions and requirements for payment may impair our ability to sell our technology assets outside of Israel or to outsource or transfer development or manufacturing activities with respect to any product or technology outside of Israel. Furthermore, the consideration available to our shareholders in a transaction involving the transfer outside of Israel of technology or know-how developed with OCS funding (such as a merger or similar transaction) may be reduced by any amounts that we are required to pay to the OCS.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Provisions of Israeli law and our amended articles of association may delay, prevent or otherwise impede a merger with, or an acquisition of, us, even when the terms of such a transaction are favorable to us and our shareholders.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Israeli corporate law regulates mergers, requires tender offers for acquisitions of shares above specified thresholds, requires special approvals for transactions involving directors, officers or significant shareholders and regulates other matters that may be relevant to such types of transactions. For example, a tender offer for all of a company&#8217;s issued and outstanding shares can only be completed if the acquirer receives positive responses from the holders of at least 95% of the issued share capital. Completion of the tender offer also requires approval of a majority of the offerees that do not have a personal interest in the tender offer, unless at least 98% of the company&#8217;s outstanding shares are tendered. Furthermore, the shareholders, including those who indicated their acceptance of the tender offer (unless the acquirer stipulated in its tender offer that a shareholder that accepts the offer may not seek appraisal rights), may, at any time within six months following the completion of the tender offer, petition an Israeli court to alter the consideration for the acquisition. See &#8220;Item 10.B. Additional Information &#8212; Memorandum of Association and Articles of Association&#8212; Acquisitions under Israeli law&#8221; for additional information.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	29
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage36"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our amended articles of association provide that our directors (other than external directors) are elected on a staggered basis, such that a potential acquirer cannot readily replace our entire board of directors at a single annual general shareholder meeting. This could prevent a potential acquirer from receiving board approval for an acquisition proposal that our board of directors opposes.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Furthermore, Israeli tax considerations may make potential transactions unappealing to us or to our shareholders whose country of residence does not have a tax treaty with Israel exempting such shareholders from Israeli tax. For example, Israeli tax law does not recognize tax-free share exchanges to the same extent as U.S. tax law. With respect to mergers, Israeli tax law allows for tax deferral in certain circumstances but makes the deferral contingent on the fulfillment of a number of conditions, including, in some cases, a holding period of two years from the date of the transaction during which sales and dispositions of shares of the participating companies are subject to certain restrictions. Moreover, with respect to certain share swap transactions, the tax deferral is limited in time, and when such time expires, the tax becomes payable even if no disposition of the shares has occurred. These provisions could delay, prevent or impede an acquisition of us or our merger with another company, even if such an acquisition or merger would be beneficial to us or to our shareholders.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	It may be difficult to enforce a judgment of a U.S. court against us, our officers and directors or the Israeli experts named in this annual report in Israel or the United States, to assert U.S. securities laws claims in Israel or to serve process on our officers and directors and these experts.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We are incorporated in Israel. All but one of our executive officers, all the Israeli experts and all but three of our directors listed in this annual report reside outside of the United States, and most of our assets and most of the assets of these persons are located outside of the United States. Therefore, a judgment obtained against us, or any of these persons, including a judgment based on the civil liability provisions of the U.S. federal securities laws, may not be collectible in the United States and may not be enforced by an Israeli court. It also may be difficult to effect service of process on these persons in the United States or to assert U.S. securities law claims in original actions instituted in Israel. Israeli courts may refuse to hear a claim based on an alleged violation of U.S. securities laws reasoning that Israel is not the most appropriate forum in which to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proven as a fact by expert witnesses, which can be a time -consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There is little binding case law in Israel that addresses the matters described above. As a result of the difficulty associated with enforcing a judgment against us in Israel, it may not be possible to collect any damages awarded by either a U.S. or foreign court.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	The rights and responsibilities of our shareholders are governed by Israeli law, which differs in some material respects from the rights and responsibilities of shareholders of U.S. companies.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;The rights and responsibilities of the holders of our ordinary shares are governed by our amended articles of association and by Israeli law. These rights and responsibilities differ in some material respects from the rights and responsibilities of shareholders in U.S.-based corporations. In particular, a shareholder of an Israeli company has a duty to act in good faith and in a customary manner in exercising its rights and performing its obligations towards the company and other shareholders, and to refrain from abusing its power in the company, including, among other things, in voting at a general meeting of shareholders on matters such as amendments to a company&#8217;s articles of association, increases in a company&#8217;s authorized share capital, mergers and acquisitions and related party transactions requiring shareholder approval. In addition, a shareholder who is aware that it possesses the power to determine the outcome of a shareholder vote or to appoint or prevent the appointment of a director or executive officer in the company has a duty of fairness toward the company. There is limited case law available to assist us in understanding the nature of this duty or the implications of these provisions. These provisions may be interpreted to impose additional obligations and liabilities on holders of our ordinary shares that are not typically imposed on shareholders of U.S. corporations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	30
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage37"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_KEY_INFORMATION>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_COMPANY_INFORMATION>
<A NAME="FIS_COMPANY_INFORMATION"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 4: Information on
<A NAME="ZK1618102_HTM_2">
	the Company
</A>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	A.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	History and Development of the Company
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Our History
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Enzymotec Ltd. is a profitable nutritional ingredients and medical foods company. Our proprietary technologies, research expertise, and clinical validation process enable us to develop differentiated solutions across a variety of products. Our innovative and diverse product suite addresses the entire human life-cycle, from infancy to old age, and is comprised of novel key ingredients in products ranging from infant formula to nutritional supplements, as well as branded medical foods, sold only under a doctor&#8217;s supervision. We market our product portfolio to established global consumer companies and physicians and target large and growing consumer health and wellness markets. Our strategic partnerships, state-of-the-art good manufacturing practice (&#8220;GMP&#8221;)-compliant manufacturing facility, and global sales and marketing infrastructure enable us to develop, manufacture and market our comprehensive product solutions to our customers globally.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our clinically-validated products include bio-functional lipid-based compounds designed to address dietary needs, medical disorders and common diseases. Lipids represent a major structural component of all life and are essential for cell structure and important biological functions, including energy storage and cell signaling. Our proprietary technologies enable us to identify appropriate lipid-modifying enzymes and then improve the activity of these enzymes to enhance their efficiency, stability and recyclability, as well as to enable their use in organic media. These enhanced enzymes are then utilized to restructure lipids found in natural sources including krill, fish, vegetable sources and bovine milk. We transform the lipids from these raw materials into lipids that are familiar to the human body but cannot be extracted efficiently or in sufficient yield, are not provided in sufficient amounts through normal dietary intake or cannot otherwise be manufactured. For example, our leading infant formula ingredient product, InFat, is produced through modifying the molecular structure of vegetable oils to create an ingredient that more closely resembles a key component of human breast milk that is known to facilitate healthy infant development. Similarly, Vayarin, one of our branded medical foods, utilizes the same technologies to create a safe and stimulant-free solution for the dietary management of certain lipid imbalances associated with attention deficit hyperactivity disorder (&#8220;ADHD&#8221;) in children. Our expertise also allows us to produce lipid ingredients that have beneficial secondary characteristics, such as extended shelf life, nutrient absorption and improved scent or taste profile. We leverage our technology platform to develop new products, improve our existing leading product portfolio and create new product categories.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We were founded in 1998, launched our first product in 2003 and since then have designed, developed and launched 14 additional products, generating sales in over 30 countries. Our net revenues, adjusted EBITDA and net income for the year ended December 31, 2015 were $50.4 million, $10.7 million and $6.7 million, respectively. For further discussion on the important events in the development of our business, see &#8220;Item 5. Operating and Financial Review and Prospects&#8212;Company overview.&#8221; For a further description of the seasonality of the company&#8217;s main business, see &#8220;Item 5.A. Operating and Financial Review and Prospects&#8212;Operating Results&#8212;Seasonality.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In September 2013, we
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
	listed our shares on the Nasdaq Global Select Market. We are a company limited by shares organized under the laws of the State of Israel. We are registered with the Israeli Registrar of Companies. Our registration number is 51-260924-9. Our principal executive offices are located at Sagi 2000 Industrial Area P.O. Box 6, Migdal Ha&#8217;Emeq 2310001, Israel, and our telephone number is +972-74-717-7177. Our website address is www.enyzmotec.com. Information contained on, or that can be accessed through, our website does not constitute a part of this annual report and is not incorporated by reference herein. We have included our website address in this annual report solely for informational purposes. Our agent for service of process in the United States is Enzymotec USA, Inc., and its telephone number is +1 (973) 912-9400.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Principal Capital Expenditures
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The majority of our investment activities have historically been related to the construction and expansion of our manufacturing facilities and the purchase of manufacturing equipment and components for our production lines. Capital expenditures for purchase of property, plant and equipment and intangible assets were $4.9 million, $6.4 million and $2.9 million in the years ended December 31, 2013, 2014 and 2015, respectively. Capital expenditures for purchase of property, plant and equipment for the year ended December 31, 2013 were primarily related to our manufacturing facility expansion project, which is enabling us to extract krill oil from krill meal ourselves using technologically advanced equipment and proprietary processes. Capital expenditures for purchase of property, plant and equipment and intangible assets for the year ended December 31, 2014 were primarily related to the completion of our manufacturing facility expansion project as well as to our capacity increase project in our current facility and to payment of a license fee in connection with the settlement of claims by Neptune Technologies &amp; Bioresources Inc. Capital expenditures for purchase of property, plant and equipment for the year ended December 31, 2015 were primarily related to our capacity increase project in our current facility.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	31
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage38"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have leased additional space next to our existing facility in northern Israel for purposes of constructing an additional manufacturing facility.&#160;&#160;In the event that we determine to construct a new manufacturing facility, capital expenditures would increase significantly, but we currently do not have any plans to do so.&#160;&#160;The timing and amount of the capital expenditures associated with this project, if we do undertake it, is uncertain.&#160;&#160;We may also seek to employ our capital to acquire complementary businesses or technologies. For further description regarding the status of our Israeli real estate, please see &#8220;Item 4.D. Information on the Company &#8212; Property, Plants and Equipment &#8212; Property and infrastructure.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	B.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Business Overview
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160; We have two reportable segments, our Nutrition segment and our VAYA Pharma segment, both of which offer a variety of products that leverage our lipid-related expertise. Our Nutrition and VAYA Pharma segments represented 83.2% and 16.8% of net revenues in the year ended December 31, 2015, respectively. For a geographic breakdown of our revenues, see &#8220;Item 5.A. Operating Results&#8212;Components of statements of operations&#8212;Net revenues by geographical region.&#8221;
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Nutrition.
</FONT>
	Our Nutrition segment develops and manufactures nutritional ingredient products based on lipids, such as phospholipids, which form the structural basis of cell membranes and are easily recognized, incorporated and used by the body. Our customer base for this segment includes leading infant formula and nutritional supplement companies such as Biostime and International Vitamin Corporation, or IVC. Our two best-selling nutritional ingredient products are InFat, a clinically-proven fat ingredient for infant formula, and krill oil.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our premium infant formula ingredient products seek to more closely resemble the composition and properties of human breast milk fat, which is considered the &#8220;gold standard&#8221; in infant nutrition because of both its short and long term health and developmental benefits, to facilitate healthy infant development. Peer reviewed clinical studies demonstrate that our leading formula ingredient product, InFat, provides unique benefits such as stronger bones, improved intestinal flora and reduced crying, in addition to reduced constipation, improved calcium absorption and more efficient energy intake. As a result, we believe InFat is the most significant development to infant formula ingredients since docosahexaenoic acid, or DHA, and arachidonic acid, or ARA, were introduced to the market almost 15 years ago. The next generation of our infant formula ingredient products targets additional attributes of key lipids found in human breast milk such as improved brain development. InFat has been achieving rapid penetration in the Chinese and other Asian markets, and we believe that we have significant opportunities in other developing markets and developed markets such as North America and Europe. InFat is sold and marketed through AL, our joint venture with AarhusKarlshamn AB, or AAK, a Sweden-based, global producer of specialty oils.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our krill oil products, which provide the benefits of omega-3 fatty acids, have significantly improved bioavailability over competing products in the market. We use our technological and manufacturing know-how to provide additional secondary benefits such as improved scent, taste and shelf life. Our other products in this segment are targeted at improving brain health and providing benefits in memory, learning abilities and concentration. In addition, we add value to our customers through product customization, clinical validation, regulatory expertise and quality control. We believe there are significant growth opportunities in other geographic markets beyond our core markets in the United States and Australia, and also intend to capitalize on consumer trends towards supplementing their diets with premium health and wellness products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	VAYA Pharma
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	.
</FONT>
	VAYA Pharma, develops, manufactures and sells branded, under physician supervision-only medical foods for the dietary management of patients with certain medical conditions or diseases having special, medically determined nutrient requirements. Although medical foods must be proven to be safe and effective as demonstrated in human clinical studies, they do not require the same expensive and time-consuming regulatory approval process typical of prescription drugs. Our U.S. medical foods business generated its first revenues in 2011 and currently consists of three branded products, all based on our proprietary lipid-based technologies, which address the dietary management of the following conditions: hypertriglyceridemia (Vayarol); lipid imbalances associated with ADHD in children (Vayarin); and lipid imbalances associated with early memory impairment (Vayacog). Our products are designed to provide a safe, cost-effective, first-line dietary therapy. We are currently funding additional clinical studies for two of our medical food products, to reach an expanded consumer market and to support additional marketing claims. In addition to our existing products, we have several other products to address additional indications in the development phase. We currently market VAYA Pharma products in the United States through sales representatives based in large metropolitan areas of twenty three states, as well as in Singapore, in Israel through Teva and in Ukraine through Dexcel Pharma.&#160;&#160;We have plans to expand in the United States as well as in other international markets.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage39"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Our technology
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our technology and research and development platform supports product development for both of our reportable segments by leveraging our core scientific expertise in lipid and enzymatic technologies. Our research and development activities are directed towards developing bio-functional lipid ingredients and final products. In order to achieve this goal, we have developed and continue to develop and utilize sophisticated proprietary technologies and know-how that enable us to extract lipids from natural sources, separate and analyze lipid molecules and use enzymes to synthesize lipid molecules known to the body. We have established a proprietary toolset that allows us to efficiently convert the lipids that we obtain from natural sources into those that have unique structural and functional characteristics.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our technology encompasses distinct but interrelated domains, each of which comprises part of our product development cycle:
</FONT>
</DIV>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	enzyme processes;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	lipid modification;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<DIV>
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	clinical effects of nutritional products;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	lipid analysis; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	process technology and development.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In connection with enzyme processes, we have developed a technological platform that modifies crude enzymes which improves their activity and enables their utilization in synthesis in organic media, such as oils and organic solvents, with enhanced efficiency, stability and recyclability.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Using that enzymatic technology platform, we modify lipids found in natural sources such as krill, fish, soybeans, sunflowers, bovine milk and other sources in order to synthesize lipids that mimic the composition and properties of other lipids have a beneficial nutritional value and are natural to the human body. For instance, our PS product line involves the synthesis of phosphatidylserine, or PS, a component of brain membranes and brain function, and the InFat product is a sn-2 palmitate oil product which more closely resembles the composition and properties of human breast milk fat.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our synthesis of lipids is predicated on our expertise in lipid analysis. This expertise enables us to analyze and map the structure of lipid molecules, which also assists us in separating and quantifying different lipid classes within various compounds. We also utilize our lipid analysis expertise for conducting biochemical analysis for the purpose of supporting regulatory applications, designing and conducting preclinical and clinical trials and for the quantification of other elements found in lipids, such as antioxidants, minor contaminants and other minor components.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We leverage the data and information gained from our enzyme process, lipid modification and lipid analysis technologies in order to extract, purify and synthesize modified lipid fractions, which we then use to formulate and produce our products. Our process and engineering know-how includes an emphasis on developing cost effective processes, and focuses on quality, repeatability and safety. Our process know-how relates to the entire production process, from sourcing raw materials and designing technical specifications for use by our suppliers in developing, improving and incorporating various production technologies, such as extraction, filtration, drying, oxidation control and fermentation.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	33
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage40"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Our products
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Nutrition segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our Nutrition segment sells lipid compositions and bioactive ingredients as ingredients for infant formula, adult nutrition products and dietary supplements, which we tailor to the special needs of the nutrition industry. These ingredients are sold by us to three types of customers: (i) companies that manufacture the end-product themselves; (ii) companies that outsource manufacturing of the end product; and (iii) outsourced manufacturers of the end product.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_7"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="18%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	InFat
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="18%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Soy-PS
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="18%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	K&#8226;REAL, our
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	krill oil
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	PS Line of
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Products
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="14%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	GPC Line of
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Products
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="18%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226; A clinically-proven fat ingredient for infant formula that more closely resembles the composition and properties of human breast milk fat.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226; Offered by AL.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="18%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226; A nutritional ingredient to improve cognitive and mental performance.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="18%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226; Pure K&#8226;REAL
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226; High Potency K&#8226;REAL
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226; Custom made K&#8226;REAL
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="15%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226; Sharp PS
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226; Sharp PS SILVER
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226; Sharp PS GOLD
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226; Sharp PS GREEN
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="14%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226; Sharp GPC
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226; Sharp GPC ACTIVE
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	InFat
</FONT>
	&#8212; InFat is a clinically-tested lipid ingredient for infant formula that enables infant formulas to more closely resemble the composition and properties of human breast milk fat. The product was originally developed by us and its initial sales, from 2004 to 2006, were made directly by us. In 2007, we entered into a joint venture with AAK relating to the production, marketing, sale and distribution of InFat. As a result, all sales of the product are now made through AL, the joint venture company. See &#8220;&#8212; Joint Venture with AAK&#8221; below.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Human breast milk is considered the optimum nutrition for infants, as it provides the perfect balanced diet to meet the needs of the growing child. Accordingly, the ultimate goal for every infant formula producer is to offer a product as similar as possible in its functional and nutritional benefits to human breast milk. The special fat structure in human breast milk, which is known as sn-2 palmitate, is found in all women and offers clinically proven benefits for infant development. Through the use of our proprietary technologies, we have developed an enzymatic process to restructure vegetable oils into a sn-2 palmitate enriched fat, the InFat ingredient for infant formula, which more closely resembles the fat composition and properties of human breast milk fat.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our published peer reviewed clinical studies demonstrate that formula containing InFat provides infants with unique benefits, such as stronger bones, improved intestinal flora and reduced crying, in addition to reduced constipation, improved calcium absorption and more efficient energy intake.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The InFat ingredient sold by AL is customized according to customers&#8217; requirements, ranging from a concentrate form of InFat to complete blends of InFat with various additional vegetable oils for use by infant nutrition manufacturers.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Soy-PS
</FONT>
	&#8212; Our Soy-PS product is a lipid ingredient. Our Soy-PS formulation is derived from soybean lecithin and is designed to improve cognitive and mental performance.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Krill Oil
</FONT>
	&#160;&#160;&#8212; We are a leading manufacturer of krill oil, a premium omega-3 bound to phospholipids. Our product, K&#8226;REAL, previously known as Krill Oil+, which was first commercialized in 2006, is manufactured by us according to rigorous quality and freshness standards. Krill oil offers advantages over competing products, such as fish oil, due to the bio-availability of krill oil and the ease with which the omega-3 fatty acids are absorbed into the bloodstream. Our krill oil also offers the additional benefits of increased shelf life and improved scent and taste profiles as compared with competitor products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We offer the following krill oil products:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Pure K&#8226;REAL, characterized by its purity, freshness, high stability and low viscosity;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	High Potency K&#8226;REAL, which contains enriched levels of omega-3 fatty acids, without dilution of the level of phospholipids found in pure krill oil; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Custom made K&#8226;REAL, suited for specific customer needs, including different grades of K&#8226;REAL, more cost-effective K&#8226;REAL through the reduction of phospholipid levels, and the inclusion of higher levels of certain ingredients as compared to our other K&#8226;REAL products.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	34
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage41"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	K&#8226;REAL is processed only from Antarctic krill, which we source from vessels and facilities approved for food handling and storage by the appropriate national food safety authorities. These vessels and facilities are also approved by members of the Commission for the Conservation of Antarctic Marine Living Resources, an international commission with responsibility for the conservation of Antarctic marine ecosystems. We have conducted comprehensive safety evaluations of K&#8226;REAL krill ingredients and have determined them to be &#8220;Generally Recognized as Safe&#8221; (GRAS) for certain conventional food and medical food uses. We notified the FDA of our GRAS determinations and the FDA issued a &#8220;no questions&#8221; response letter advising us that the FDA accepts our conclusion that our K&#8226;REAL krill ingredients are GRAS. Further, as of 2015, the Novel Food status of K-REAL krill oil has been expanded to cover additional grades of the product.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	PS line of products
</FONT>
	&#160;&#160;&#8212; This consists of a range of food supplements, containing Phosphatidylserine, or PS, a phospholipid component of cell membranes and a building block of the human brain. Research has indicated that PS has a role in the proper signal processing and cell-to-cell communication functions of nerve cells. These products are sold by us as a powder (generally for use in tablets, capsules and functional foods) and as a liquid or dispersion (generally for use in soft gels). This line of products includes the following:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Sharp PS
</FONT>
	&#160;&#160;&#8212; Is a soybean-derived PS brain nutrient, introduced in 2003. It is a nutritional supplement for adults, intended to improve cognitive capabilities, such as memory. Sharp PS is also shown to benefit other populations, such as young persons, by improving memory, learning abilities and concentration.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Sharp PS SILVER
</FONT>
	&#8212; Is a patent protected blend of two different active ingredients, PS and omega-3, derived from soybean and fish oils, introduced in 2008. It is intended to improve mental and cognitive abilities.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Sharp PS GOLD
</FONT>
	&#8212; This patented compound nutrient, introduced in 2006, offers high potency PS together with targeted deliveries of DHA to the brain. It mimics human PS found in the brain. Two versions of this product are available, one derived from fish oil and the other from krill oil. Clinical trials have shown that Sharp PS GOLD is effective in improving memory in elderly persons suffering from age-associated memory decline.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Sharp PS GREEN
</FONT>
	&#8212; Is a soy-free PS food supplement, derived from sunflowers, introduced in 2010, aimed at the large and growing market of health conscious and environmentally-concerned consumers who demand clean, pure, soy allergen-free and non-GMO (genetically modified organisms) ingredients. Sharp PS GREEN is also offered in a special gummy-bears application intended for children under out trade name SharpKidz.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	GPC line of products
</FONT>
	&#8212; Consist of a range of food supplements, containing L-Alpha Glycerylphosphorylcholine, or alpha GPC, a natural choline compound found in the brain. Alpha GPC is the simplest phospholipid, and a key metabolite in choline metabolism signaling. In addition, alpha GPC serves as an organic osmolyte and assists in proper kidney function and may play a role in sperm motility. Alpha GPC is naturally occurring in certain foods, such as milk, eggs and meat, in low amounts. Alpha GPC is sold in the United States as a dietary supplement and in Europe and South America as a drug for patients suffering from dementia related to Alzheimer&#8217;s disease or cerebrovascular conditions, such as strokes.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our GPC products are sold by us as a powder (generally for use in tablets and capsules) and as a liquid (generally for use in soft gels and drops).
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	35
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage42"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	This line of products includes the following:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Sharp GPC
</FONT>
	&#8212; This product, derived from soybeans and introduced in 2011, is used for improving cognitive functions for different age populations. It is also suitable for use by aging persons facing the deterioration of their cognitive functioning. Sharp GPC is available in various forms, including a powder (with 99% maximum purity) and a liquid (with 85% maximum purity) for different applications.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Sharp GPC ACTIVE
</FONT>
	&#160;&#160;&#8212; This product, derived from soybeans and introduced in 2011, is an alpha-GPC-based complex (comprised of 45% alpha-GPC), which has the known beneficial value of GPC on human health, especially on cognitive function and additional important biological activity, resulting from the presence of other naturally occurring, lecithin-derived compounds. Sharp GPC ACTIVE is a naturally-sweet, water-based platform, which is compatible with a wide range of nutrients and does not require special preservatives.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We also have a nutritional ingredient product, InCog, which is an innovative lipid composition for cognitive functioning.&#160;&#160;InCog has been approved as a Novel Food in Europe and its further development is ongoing. We plan to launch pre-clinical studies in connection with InCog during 2016 for the purpose of evaluating its efficacy.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We are currently selling Omega-PC, which is an extract from cold-water wild fish containing omega-3 fatty acids bound to both phospholipids and triglycerides. The nutritional benefits of fish and fish oil are widely accepted due to the presence of DHA and eicosapentaenoic acid (EPA) fatty acids. However, current fish oil products contain DHA and EPA attached to triglycerides, whereas up to 30% of the DHA and EPA found in cold-water fish are bound to phospholipids. Thus, Omega-PC imitates a natural way to consume omega-3. Clinical evidence demonstrates that DHA and EPA bound to phospholipids are absorbed better than DHA and EPA bound to triglycerides. Our Omega-PC aims to provide the benefits of DHA and EPA along with the improved absorption of omega-3.&#160;&#160;We are currently considering whether or not we will continue to offer this product in the future.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 2014, we also began production and sale of Pro&#8226;krill, our first product that is for uses other than human consumption. Pro&#8226;krill is an enriched protein preparation left after the krill oil is extracted, which we are able to access now that we perform krill oil extraction in-house.&#160;&#160;It has a unique composition of amino acids making it a very good source of protein for aqua culture.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Clinical Validation
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	InFat.
</FONT>
	From August 2010 to October 2012, we conducted several comparative trials to assess the benefits of InFat compared to standard vegetable fat. The trials divided a sample pool of infants into either two or three groups. In both cases, one group was provided a diet with InFat, while a second group was provided a diet with a control fat, consisting of either standard infant formula or standard vegetable fat. In certain trials, a group given human breast milk served as a reference point. The P values represent a measure of statistical significance, with P&lt;0.05 considered statistically significant.
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The first trial, which included 36 term infants (eight of which were in the control group, 14 of which were given InFat and 14 of which were breast fed), showed that breast-fed infants and infants who were given a diet with InFat rather than the control fat for six weeks had higher counts of Lactobacilli and Bifidobacteria bacteria (P&lt;0.01), suggesting that InFat promotes a healthy intestinal micro flora and might enhance infants&#8217; gut health and immunity. Additionally, the Lactobacillus counts between the infants fed InFat and the breast-fed infants were comparable (P&gt;0.05). The results of this trial were presented at the Federation of American Societies for Experimental Biology (FASEB) Conference (United States, July 2011) and the International Conference on Nutrition and Growth (Paris, March 2012) and published in the
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Journal of Pediatric Gastroenterology and Nutrition
</FONT>
	(&#8220;JPGN&#8221;) in 2013. These results support the growing understanding that the composition of the intestinal microbiota is influenced by factors in the milk diet of the young infant.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The second trial, which included 83 term infants (28 of which were in the control group, 30 of which were given InFat and 25 of which were breast fed), revealed that at 12 weeks of life term infants who were provided the InFat-enriched formula instead of the control formula had higher bone strength parameters (tested by a non-invasive ultrasound bone sonometry device measuring the speed of sound (&#8220;SOS&#8221;) along the bone) (P&lt;0.05) and were comparable to breast-fed infants (P&gt;0.05). The results indicate that the InFat formula increases infants&#8217; bone strength. These results were published in
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Calcified Tissue International
</FONT>
	in 2012. A second outcome of this clinical trial revealed that feeding term infants formula with InFat for the 12 weeks after birth lowered the daily crying duration in comparison to feeding with control formula (P&lt;0.05) and the control formula group infants cried for a longer duration in comparison to the breastfed group (P&lt;0.3). These results were published in
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Prostaglandins, Leukotrienes and Essential Fatty Acids
</FONT>
	in 2013 and in BMC Pediatrics in 2014. Importantly, further analysis of the diurnal crying pattern revealed that feeding term infants formula with InFat for the 12 weeks after birth decreased the percentage of infants who cried, especially in the afternoon and evening hours (P&lt;0.05), and also the daily crying duration (P&lt;0.05), compared to infants fed a standard formula. These results were published in BMC Pediatrics in 2014. The results of this trial were also presented at the European Society for Paediatric Gastroenterology Hepatology and Nutrition (&#8220;ESPGHAN&#8221;) Conference (Italy 2011) and the International Society for the Study of Fatty Acids and Lipids (&#8220;ISSFAL&#8221;) Congress (Vancouver, May 2012).
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	36
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage43"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In July 2011, we completed a comparative, open label 12-week trial, comparing the development of 75 Chinese infants divided into two groups (34 of which were given InFat and 41 of which were breast fed). During the trial, the first group was provided with a diet including InFat and the second group served as a reference and was given breast milk. The final results of the trial showed that InFat formula was not statistically significantly different from human breast milk in terms of body growth and infant well-being (P&gt;0.05), highlighting the comparability of InFat lipids compared to those found in human breast milk. Though the two groups differed in crying duration, stool frequency and consistency, both were similar in prevention of hard stools.&#160;&#160;The manuscript was submitted for publication.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In October 2012, we completed the clinical phase of a comparative, randomized, double-blinded, multi-center, 24-week trial, to compare the development of 171 Chinese full term infants, enrolled at five Chinese FDA-approved medical centers in different cities in China, divided into three groups (the control group was fed with infant formula with prebiotics and regular vegetable oils fat (n=57), the InFat group was fed infant formula with the same level of prebiotics and InFat as the fat (n=57), and a breastfed group (n=57)). The purpose of the study was to assess the efficacy of infant formula with high percentage of palmitic acid at the sn-2 position (InFat) as compared to standard vegetable oil based infant formula on general gastrointestinal tolerance and fat excretion, reducing calcium soaps formation and stool hardness in Chinese formula-fed term infants on top of prebiotics, a common bioactive ingredient in infant formula, which was shown to promote nutrient absorption, benefit stool consistency and reduce crying. Results showed that at six weeks postnatal, the amount of free fatty acids excreted in stool was lower in the sn-2 palmitate and breast milk groups compared to the control group, and most of the fatty acids excreted were in the form of soaps. Importantly, these effects were observed although both InFat and the vegetable oil formula contained prebiotics. These results were presented at the Nutrition &amp; Growth conference in Barcelona in January 2014 and at the ESPGHAN conference in Jerusalem in June 2014 and published in JPGN in 2015. These results were published in a book published by Nova Publisher in 2014. A second outcome of this clinical trial revealed that feeding term infants formula with InFat for the 12 weeks after birth lowered the daily crying duration in comparison to feeding with control formula (P&lt;0.05). The control formula group had higher daily crying duration also in comparison to the breastfed group (P&lt;0.01). A further analysis of the diurnal crying pattern revealed that feeding term infants formula with InFat for the 12 weeks after birth decreased the percentage of infants who cried, especially in the morning and evening hours (P&lt;0.05) compared to infants fed a standard formula. The percentage of infants who cried in the control group was higher in the control group also compared to the breastfed group (P&lt;0.05). There was no difference between the percentage of crying infants at week 12 between infants fed with formula containing InFat and breastfed infants. These results were published in a book by Nova Publisher in 2014 and presented at the ESPGHAN conference in Jerusalem in June 2014. An additional outcome of this study was that feeding term infants formula with InFat for the 12 weeks after birth increased the daily sleeping duration in comparison to feeding with control formula (P&lt;0.05), although both groups&#8217; sleeping time was in the range of accepted norm of sleeping for this age. The last two outcomes related to crying and sleep were submitted for publication.&#160;&#160;The publication is currently under evaluation by journal reviewers.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	37
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage44"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Krill Oil.
</FONT>
	In December 2011, we completed a comparative, double-blind, placebo controlled randomized crossover, three phase clinical trial, to compare the absorption of omega-3 fatty acids in both red blood cells and plasma after consumption of krill oil, fish oil or placebo by 24 healthy adult participants. During the trial, each group went through three four-week phases in which they were provided with one of the following three supplements: three grams of our krill oil supplement (K-REAL), three grams of fish oil and three grams of placebo. Between each phase there was an eight-week wash out period before the next supplement was provided. The final results of the trial showed significantly higher levels of absorption of EPA, the sum of EPA and DHA as determined by the omega-3 index, and omega-3 fatty acids in both the plasma and red blood cells when provided krill oil in contrast to either fish oil or the placebo (P&lt;0.05). These results indicate that krill oil has a positive and superior efficacy of the absorption of EPA and omega-3 fatty acids in both the red blood cells and the plasma when compared to fish oil supplements. In addition, the participants completed a questionnaire on status of memory, mood and concentration at the end of each treatment phase. Based on the results of these questionnaires, krill oil treatment was found to improve memory, mood and ability to concentrate compared with fish oil or control treatments. These results were published in
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Lipids in Health and Disease 2013
</FONT>
	.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In April 2012, we completed a comparative, single-blind crossover, four-week clinical trial consisting of 20 healthy adults, to compare omega-3 fatty acid absorption after the intake of high potency krill oil and the intake of pure krill oil. During the trial, the group was provided with 1.5 grams of our high potency krill oil (K-REAL). Omega-3 fatty acid absorption was then compared to the levels measured when the same group of adults was provided with twice the amount of pure krill oil as given in a previous trial. The results of the trial showed that both supplements had a similar absorption of omega-3 fatty acids, despite the fact that during the trial the participants provided with high potency krill oil were only given half the quantity of supplementation compared to the previous trial. These results enable us to market to our customers' high potency krill oil that allows for the reduction of krill oil consumption by half while retaining the benefits of taking a full dose of pure krill oil. These results were published in
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Lipids in Health and Disease
</FONT>
	in
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;
</FONT>
	2015.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Sharp PS.
</FONT>
	In March 2008, we completed a single center, open-label, 12-week clinical trial, to observe the effects of Sharp PS on cognitive functions in elderly volunteers with subjective memory complaints. During the trial, the volunteers were provided with 300 mg/day of soy-PS. The final results of the trial, in which 26 subjects completed the study, demonstrated statistical significance on improving memory recognition, memory recall, executive function and mental flexibility (P&lt;0.05). The results indicate that the daily intake of soy-PS, as found in Sharp PS, has a high efficacy on cognitive function, including memory parameters, executive function, and mental flexibility. These results were published in
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Clinical Interventions in Aging
</FONT>
	in 2013.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Sharp PS Gold.
</FONT>
	In November 2007, we completed an open-label, six week pilot study, to observe the effects of Sharp PS Gold on cognitive functions in eight elderly volunteers with subjective memory complaints. During the trial, the volunteers were provided with 300 mg/day of PS and 37.5 mg/day of EPA and DHA. The final results of the trial showed positive effects on cognitive function, specifically on memory recall and the ability to store, hold and retrieve information (P&lt;0.05). These results indicate that the daily intake of PS bound to DHA and EPA, which is found in the Sharp PS Gold, over a six-week period, has a positive impact on cognitive functions, including long-term memory processes. These results were published in
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Clinical Interventions in Aging
</FONT>
	in 2010.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Cognitex.
</FONT>
	In April 2009, we completed an open-label, 12-week clinical trial that observed the effects of Cognitex on cognitive functions in twenty-six elderly volunteers with subjective memory complaints. Cognitex, a premium product manufactured by one of our customers, is a formulation of Sharp PS Gold, glycerylphosphorylcholine (&#8220;GPC&#8221;) and other ingredients. During the trial, the volunteers were provided with Cognitex three times a day. The final results of the trial showed positive effects on cognitive function, with significant improvement in memory abilities, attention, visual learning, and daily activities commencing within the first two weeks of the trial (P&lt;0.05). Such improvement was sustained without further improvement over the course of the study, with the exception of the activities of daily living measure, which demonstrated an additional statistically significant improvement following the ten additional weeks (P&lt;0.05). These results indicate that the daily intake of Cognitex has a positive significant effect on cognitive functions, commencing within the first two weeks of its intake, including improvement in memory abilities, attention, visual learning, and daily activities. These results were published in the
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Journal of Dietary Supplements
</FONT>
	in 2011.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ID="FTR" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	38
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage45"></A>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	VAYA Pharma segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our VAYA Pharma segment is dedicated to the discovery, development, manufacture and marketing of innovative clinically-tested, effective and safe lipid-based medical foods for the cardiovascular and neurological markets, as well as for the pharmaceutical drug markets. Our VAYA Pharma segment currently offers the following products:
</FONT>
<BR>
</DIV>
<DIV>
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_8"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="25%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Vayarin
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="25%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Vayacog
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Vayarol
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="25%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For clinical dietary management of certain lipid imbalances associated with ADHD.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="25%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For clinical dietary management of certain lipid imbalances associated with early memory impairment.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="34%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For the clinical dietary management of patients with high triglyceride levels, (particularly those at risk for an increase in blood concentrations of low density lipoprotein cholesterol (LDL-C) upon omega-3 administration).
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In the United States, each of three products currently offered by our VAYA Pharma segment is sold as a &#8220;medical food,&#8221; available only under the supervision of a physician (either by prescription or acquired directly from a physician in the context of the physician patient-relationship), meeting the criteria for medical foods enumerated by the FDA. See &#8220;&#8212; Government regulation&#8221; below.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Below is a brief description of each of this segment&#8217;s current products:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Vayarin
</FONT>
	&#8212; Vayarin is an orally administered medical food for the clinical dietary management of certain lipid imbalances associated with attention deficit-hyperactivity disorder, or ADHD. It is used under the supervision of physicians. Vayarin is aimed at children and pre-adolescents with ADHD, children who are reluctant to start drug therapy or are intolerant to stimulant therapy, or children with a more pronounced hyperactive-impulsive behavior, as well as mood and behavior dysregulation. Vayarin contains Lipirinen, a proprietary composition containing EPA-enriched PS omega-3, which is derived from krill. Vayarin was first introduced in Israel in 2010 and in the United States in 2011.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Vayacog
</FONT>
	&#8212; Vayacog is an orally administered medical food for the clinical dietary management of certain lipid imbalances associated with early memory impairment. It is used under the supervision of physicians. Vayacog is aimed at people with subjective memory impairment, those suffering from normal age-associated memory decline and people with mild cognitive impairment (MCI). Vayacog contains Lipicogen, a proprietary composition containing DHA-enriched PS omega-3, derived from both fish and soybean. Vayacog was first marketed in 2011.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Vayarol
</FONT>
	&#8212; Vayarol was initially introduced as a dietary supplement in the United States in 2007 and as a medical food in 2011. In the United States, it is now an orally administered medical food for the clinical dietary management of hypertriglyceridemia. It is used under physician supervision. Outside the United States, Vayarol targets those suffering from hypertriglyceridemia, individuals who are reluctant to start drug therapy for this condition, or those with borderline to moderate mixed hyperlipidemia. In the latter case, it is administered to patients with mild elevation of LDL cholesterol or who are intolerant to statins and other medications. Vayarol contains Lipirolen, a proprietary composition containing phytosterol esters of omega-3, which is derived from fish oil and soybean.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	While our current focus is to expand our three current products, we also have a number of VAYA products in various stages of development.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Clinical Validation
</FONT>
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	VAYA Pharma&#8217;s clinical studies have been focused on three therapeutic segments: ADHD, early memory impairment, and hyperlipidemia. Efficacy was evaluated using validated outcome measures, including tools assessed by professional clinicians, raters, and health providers. These studies also monitored safety and tolerability. In the below-described clinical studies, P&lt;0.05 was considered statistically significant. In light of the positive results of the Vayarol clinical trials, we have been in discussions with the FDA regarding the development of Vayarol as a full prescription drug for hypertriglyceridemia. For more information regarding the FDA approval process of Vayarol, see &#8220;&#8212; Government regulations.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	39
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage46"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Vayarol.
</FONT>
	We completed a comparative, semi-randomized, multiple phase, crossover clinical trial, to test the effects of Vayarol on the lipid profiles of 21 mildly overweight, hypercholesterolemic subjects. The trial included four phases of 29 days each, in which the participants&#8217; diets were identical except for the differing supplemental treatment oil provided in each phase, which consisted of Vayarol (early formulation), control olive oil, fish oil and commercial phytosterols. Following each phase, the participants had a 28-day wash out period before being provided with a different treatment. The final results of the trial showed that Vayarol was safe and well-tolerated by the trial participants and that the administration of Vayarol resulted in lower fasting and postprandial triglyceride levels as compared to any other tested treatments, including fish oil (P=0.025 and 0.0001, respectively). In addition, Vayarol administration resulted in substantial reduction of ApoB levels and total/HDL cholesterol ratio in comparison with fish oil administration (P&lt;0.05). These results were published in the
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	American Journal of Clinical Nutrition
</FONT>
	in 2006 and
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Lipids in Health and Disease
</FONT>
	in 2007.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We also completed a comparative, randomized double-blinded, placebo controlled, multi-centered 12-week clinical trial, to observe the effects of Vayarol on lipid profiles and other coronary heart disease risk factors in 91 mixed hyperlipidemic subjects, who had both elevated low-density lipoprotein triglycerides and elevated cholesterol (&#8220;LDL-C&#8221;), divided into two groups. During the trial, one group (46 subjects) was provided with Vayarol and the second (45 subjects) was provided with a placebo. The final results of the trial, which were received in December 2008, showed that Vayarol was found to be safe and well-tolerated by the trial participants and that the Vayarol group had reduced levels of triglycerides by 19% (P=0.025), without experiencing LDL-C elevation. Vayarol was also shown to significantly reduce inflammation, as measured by a decrease in C-reactive protein (P=0.0), and reduce diastolic blood pressure by 7% (P=0.036). We believe these results indicate that the daily intake of Vayarol is beneficial for the dietary management of hypertriglyceridemia. The study results were published in
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Cardiovascular Drug Therapy
</FONT>
	in 2010.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Vayarin.
</FONT>
	We completed a comparative, double-blinded, randomized placebo controlled 12-week clinical trial, to compare the effects of Vayarin on ADHD symptoms in 83 inattentive children to an omega-3 supplement or a placebo. During the trial, one group (29 subjects) was provided with Vayarin (an early formulation), the second (28 subjects) was provided with fish oil supplements offered as a competing market product and the third (26 subjects) was given a placebo. The Test of Variables of Attention (TOVA), a well-established, computer-based assessment of executive functions, in particular inattention, was used to measure efficacy. The final results of the trial showed that Vayarin was safe and well-tolerated and also demonstrated that it had a significant effect on children&#8217;s executive function (P&lt;0.05). Specifically, the findings indicated that it had a significant effect on children&#8217;s attention performance, demonstrated by superior results in the total TOVA score as compared to those observed in the groups who were provided with either fish oil or a placebo. The findings further suggest that providing inattentive children with high EPA/DHA phosphatidylserine preparation can affect visual, sustained attention performance. We believe these results indicate that Vayarin might have superior efficacy over other competing fish oil supplements. These results were published in the
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	American Journal of Clinical Nutrition
</FONT>
	in 2008.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We also completed a comparative, double-blinded, randomized, placebo controlled 15-week clinical trial, followed by a 15-week open-label extension, to observe the effects of Vayarin on ADHD symptoms in 200 children with ADHD. During the trial, one group (137 subjects) was provided with Vayarin and the second group (63 subjects) was provided with a placebo. The primary efficacy measure of the study was the Conners&#8217; Teacher Rating Scale Revised Long-Hebrew Version (CRS-T) which is a questionnaire answered by a child&#8217;s teacher to assess symptoms of ADHD. Other assessments included the Conners&#8217; Parent Rating Scale Revised Long-Hebrew Version (CRS-P), which is answered by the child&#8217;s parent and additionally, quality of life was assessed by the Child Health Questionnaire (CHQ) which assesses physical and psychosocial concepts related to the child&#8217;s well-being. The final results of the trial, which were received in 2009, showed that while there was no significant difference between the Vayarin and control groups in any of the CRS-T subscales, a significant reduction was observed in one ADHD symptom as well as a trend of reduction in other ADHD symptoms and significant improvement on quality of life was also shown. Further, we observed a significant reduction in certain ADHD symptoms on both the CRS-T and CRS-P subscales in a subgroup of children (78 subjects) with a more pronounced hyperactive/impulsive behavior in combination with mood and behavioral dysregulation. In addition, Vayarin was found to be safe and well-tolerated by the trial participants. We believe these results, though they require a follow-up study for confirmation, indicate that Vayarin is an effective and safe new approach for the clinical dietary management of ADHD. These results were presented at the annual meeting of the American Academy of Child &amp; Adolescent Psychiatry (AACAP) in 2010 and 2011 and published in
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	European Psychiatry
</FONT>
	in 2011 and 2013.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	40
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage47"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Vayacog.
</FONT>
	We completed a comparative, double-blinded, randomized placebo controlled 15-week clinical trial, followed by a 15-week open-label extension, to observe the effects of Vayacog on cognitive abilities in 157 elderly persons with memory complaints, divided into two groups. During the trial, one group of participants (79 subjects) received Vayacog and the second group (78 subjects) received a placebo. The purpose of the trial was to evaluate the efficacy and safety of Vayacog in improving the cognitive function of non-demented elderly with memory complaints. The final results of the trial showed that Vayacog had a significant effect, compared to placebo, on improving short-term memory (P&lt;0.05) as well as being safe and well-tolerated by the trial participants. In addition, subgroup analysis suggests that participants with relatively good cognitive performance at the beginning of the study (78 subjects) were more likely to respond to Vayacog. These results indicate that the daily intake of Vayacog can serve as an effective and safe new approach for the clinical dietary management of early memory impairment. The study results were presented in the International Conference on Alzheimer&#8217;s Disease (ICAD, 2010) and in Alzheimer&#8217;s Disease International conference (ADI, 2010) and published in
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Dementia and Geriatric Cognitive Disorders
</FONT>
	in 2010 and 2014, and in
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	BMC Neurology
</FONT>
	in 2011
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Marketing, sales and distribution
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Nutrition segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We sell our nutrition products to manufacturers of branded products in different markets around the world. Those manufacturers then incorporate them into their own products and sell them to end customers.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Sales and distribution of the InFat product are carried out by AL. In most of our markets sales are conducted directly by AL. See &#8220;&#8212; Joint Venture with AAK&#8221; below. Additionally, AL sells through distributors and agents in Korea, New Zealand, Australia and, along with direct sales to certain brands, China.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The marketing, sales and distribution of our Soy-PS product is carried out by local distributors.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We sell our krill, PS and GPC products to companies that manufacture and market dietary supplements, to food companies that combine our bioactive ingredients in functional food applications, and to distributors of these products. In North America, the marketing, sales and distribution of these products are carried out through our wholly-owned U.S. subsidiary, Enzymotec USA, Inc. Outside North America, we perform the primary marketing and sales roles, while the distribution and marketing support of these products is generally carried out by our local sales offices and local distributors and agents.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	VAYA Pharma segment
</FONT>
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In the United States, which accounted for the vast majority of our VAYA Pharma sales in 2015, the marketing and sales of these products are carried out directly by the dedicated sales personnel of our wholly-owned U.S. subsidiary, VAYA Pharma Inc. The majority of our VAYA Pharma products are distributed by pharmaceutical wholesalers and the remaining products are sold through our on-line pharmacy directly to end users. We currently market our VAYA products in the United States through sales representatives based in large metropolitan areas of twenty three states and plan to expand our marketing efforts, including by hiring additional sales representatives in the United States.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The products offered by our VAYA Pharma segment are sold in the United States on the basis of their meeting the criteria for medical foods, as enumerated by the FDA. Medical foods are not required to undergo premarket review or approval by the FDA. However, primarily because our VAYA Pharma products are not approved as prescription drugs by the FDA, most consumers purchasing these products in the United States are currently unable to obtain reimbursement from third-party payers under government healthcare or private insurance plans, which generally do not provide reimbursement for medical foods. We are attempting to broaden acceptance of our VAYA Pharma products as eligible for reimbursement by third-party payers.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Outside the United States, marketing and distribution of the VAYA Pharma products is carried out either by license partners, generally pharmaceutical companies under exclusive license agreements or directly by us. In Singapore, we have recently established VAYA Pharma PTE Ltd. together with our local partner. The entity&#8217;s business model is similar to our U.S. subsidiary subject to the local regulations in Singapore.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	41
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage48"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Our customers and partners
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We sell our nutrition products to manufacturers of branded products in different markets around the world. For example, we have developed relationships with infant formula manufacturers who partner with us in bringing our ingredients for infant formula to the end-user market. With respect to our other Nutrition products, we target customers that have a significant presence in the vitamin and mineral supplement, or VMS, industry within their geographic markets. In our VAYA Pharma segment, the majority of our products are marketed directly to physicians by our dedicated sales personnel, but we have also partnered with pharmaceutical companies to provide our products outside of the United States and Singapore.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Nutrition segment
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	AL, our Swedish joint venture which is 50% owned by us and 50% owned by AAK, seeks to position InFat as a strategic ingredient that enables its customers to strengthen their premium brands of infant formula. We believe that this strategy will help create long-term relationships and customer commitments to InFat.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	AL is currently party to strategic agreements with two leading providers of infant nutrition products to the Chinese market.
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	&#160;
</FONT>
	Of these two agreements, we consider the agreement with Biostime to be material to our results of operations because we estimate that approximately 25% of total InFat net revenues in 2015 were attributable to sales by, and under the brand name of, Biostime. The agreement contains multi-year minimum purchase undertakings by Biostime and minimum supply guarantees by AL, subject to an agreed pricing formula. We have also entered into agreements with these two customers to collaborate on research activities related to infant nutrition products, including working with the customers to upgrade their infant nutrition products. We believe that these collaborative research activities provide additional value to our customers. We do not derive any revenues from these collaborative research activities and they are not material to our business.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	AL also seeks to target new infant formula manufacturers and brands to incorporate the InFat products into their products.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Sn-2 palmitate has been incorporated in infant formula products by companies such as Danone, Nestl&#233; and Heinz. AL is a major supplier of the sn-2 palmitate in the market.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The other customers in our Nutrition segment include leading VMS manufacturers and retailers. We target customers with well-developed marketing and distribution infrastructure, strong relationships with and knowledge of their end-customers, awareness of global industry trends and scientific expertise in our fields, such as IVC.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We are currently seeking to establish strategic relationships with customers that market and sell their products to mass market retailers (such as Wal-Mart and Costco). We are also working with leading nutrition companies to combine our ingredients into their products and present our ingredients in new applications, such as gummy bears, liquid formulations and tablets.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	VAYA Pharma segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In the United States and in Singapore, the marketing and sales of our VAYA Pharma products are carried out directly by the dedicated sales personnel of VAYA Pharma Inc. in the US and of VAYA Pharma PTE Ltd. in Singapore, and the majority of products are distributed by pharmaceutical wholesalers with the remaining portion sold to physicians and on-line directly to end users. Outside of the United States and Singapore, where we are not developing our own specialized marketing and sales staff of medical representatives, we seek to partner with leading providers of pharmaceuticals and other health products in specific geographic markets by licensing our VAYA Pharma brands, often on an exclusive basis, in order to leverage our partners&#8217; market presence and distribution capabilities. To date, we have partnered with several partners internationally, including Teva Pharmaceuticals in Israel, Atlantis Ilac in Turkey, Daewon Pharmaceutical in South Korea and Dexcel Pharma in Ukraine. We do not currently derive material revenues from these arrangements.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Sourcing, manufacture and production
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The principal raw materials used by us in the manufacture of our products consist of krill biomass, fish biomass, lecithins and oils derived from fish and certain plants (primarily soybean, canola and sunflower), amino acids, as well as various enzymes.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Krill oil, unlike fish oil, is extracted from its crude biomass in a delicate process, as many of its nutrients are extremely sensitive to heat. Primarily, the krill used by us is harvested in the cold waters of the Southern Ocean and sold to us pursuant to agreements between us and the owners of fishing vessels. Once harvested, the krill is processed into krill meal aboard the trawler, a process that must be carried out within a short time after capture, primarily in order to prevent the enzymes in the krill from causing a rapid breakdown of the valuable nutrients in the krill. We estimate that only a few vessels have the capability to process raw krill into krill meal. We also purchase krill meal from several agents and also purchase frozen krill.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	42
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage49"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Agreements with such owners of fishing vessels are mainly seasonal, as they typically relate to a specific fishing season or trip. Obtaining sufficient quantities of krill oil is also dependant on the quality of krill and respective fat content. Therefore, assuring krill sourcing is challenging.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Until the first quarter of 2014, the first stage of processing krill meal into crude krill oil was carried out for us by a dedicated contract manufacturer in India.&#160;&#160;&#160;In 2013, we expanded our Migdal Ha&#8217;Emeq manufacturing facility and in the first quarter of 2014 we started to perform the first stage of the extraction process, turning krill meal into crude krill oil, ourselves using technologically advanced equipment and our proprietary processes. The crude krill oil is then processed through purification using our proprietary Multi Stage Oil, or MSO, extraction process, which ensures that the krill oil&#8217;s natural attributes remain intact for at least two years (its stated shelf life), without diluting efficacy or potency, to produce our K&#8226;REAL products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Most of the fish and plant lecithins and oils and the amino acids used by us in the manufacture of our products are generally readily available and sold by multiple suppliers.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The enzymes used by us in connection with the manufacture of the InFat product and our Sharp PS line of products are each purchased from single suppliers. However, in both instances, we maintain a substantial inventory which would enable us sufficient time to find an alternative source, should our current supplier be unable to supply sufficient quantities.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	With the exception of the manufacture of certain grades of our Sharp GPC product and the final InFat product, all of our products are manufactured at our plant in Migdal Ha&#8217;Emeq, Israel. See &#8220;Item 4.D. Information on the Company &#8212; Property, Plants and Equipment &#8212; Property and infrastructure&#8221; below. In addition, the enzymes used for the manufacture of the InFat product go through a special process, known as immobilization, carried out by us at our Migdal Ha&#8217;Emeq plant. We then ship those enzymes to AAK, where they are used as the core element for the production of InFat through the restructuring of the vegetable oils procured by AAK. InFat production currently takes place in the dedicated production facility built and owned by AAK in Karlshamn, Sweden, which has a fully automated production line equipped with the technology to ensure full product consistency. See &#8220;&#8212; Joint Venture with AAK&#8221; below.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The capsulation and packaging of our VAYA Pharma products, which are currently the only products sold by us in final form for use by the end user, is carried out by third-party contractors.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Joint Venture with AAK
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	AL is a joint venture we established with AarhusKarlshamn AB, a Swedish company also known as AAK, regarding the production, marketing, sale and distribution of our InFat product, which is sold to the infant nutrition industry for use in infant formula. AAK is one of the world&#8217;s leading manufacturers of specialty vegetable oils and fats. Pursuant to the joint venture agreement, we supply the enzymes used in the manufacture of InFat, and AAK manufactures the final InFat product. The profit of AL is allocated between us and AAK on a 50:50 basis. AL's profit under the joint venture agreement represents the difference between revenues from sales by AL and the overall direct production costs (excluding depreciation) of the joint venture partners. Each partner is responsible for funding its expenses associated with its role in the joint venture. For a discussion of the accounting treatment of AL&#8217;s results of operations, see &#8220;Item 5.A. Operating and Financial Review and Prospects &#8212; Operating Results&#8212; Joint venture accounting.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Supply and production arrangements.
</FONT>
	We have agreed to supply exclusively to AAK the enzymes used in the production of InFat. These enzymes represent our proprietary patented production technology for the InFat product. AAK has the sole responsibility over the purchase and procurement of other raw materials, namely the fats, for the InFat product, and is responsible for its production which takes place in a designated facility built by AAK for the joint venture. AAK has agreed to supply exclusively to the joint venture the InFat products produced by it. We do not have a supply agreement with AL. Subject to extension related to the buy/sell mechanism discussed below, both supply agreements terminate upon the termination of the joint venture.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	43
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage50"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Joint venture responsibilities.
</FONT>
	We are responsible for research and development, as well as business development (including penetration of new markets) and marketing activities on behalf of the joint venture while drawing on AAK&#8217;s expertise. We are also responsible for regulatory matters related to the joint venture. We license the InFat trade name to the joint venture.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	AAK is responsible for capital expenditures in respect of increased production capacity; the management of inventory and warehousing; logistics relating to the actual sales and delivery of the product; collection of trade receivables from customers of AL; obtaining permits and licenses related to AL&#8217;s operations in Sweden; and procuring product liability insurance.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have an ongoing disagreement with AAK over certain operational matters, including responsibility for certain functions related to sales of the joint venture&#8217;s products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Joint venture management.
</FONT>
	All decisions of AL require mutual consent of us and AAK. AL has a board of directors consisting of four members, two of whom are appointed by AAK and two of whom are appointed by us. Members of the board serve until they are removed by the joint venture partner responsible for appointing them or until they resign. From among the four board members a chairman is chosen to serve for a period of two years. The right to appoint the chairman alternates every two years between AAK and us. All actions taken by the board must be taken unanimously by the board members present at a meeting. In addition to the board of directors of AL, the day-to-day management of AL is the responsibility of a committee comprised of two members, a Managing Director and a Technical Director, one appointed by us and the other appointed by AAK. Members of this committee may not serve concurrently as board members but serve until they are removed by the joint venture partner who appointed them or until they resign. The Managing Director has the power and authority to make all decisions concerning the day-to-day affairs of AL but must discuss and deliberate with the Technical Director prior to taking action. The position of Managing Director is for a period of two years and the right to appoint the Managing Director alternates between AAK and us. Furthermore, the right to appoint the Managing Director belongs to the party not appointing the chairman of the board of directors in that particular year.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Restrictions related to the joint venture.
</FONT>
	The joint venture agreement includes restrictions on the ability of both joint venture parties to transfer their shares in AL, non-disclosure obligations and non-competition obligations, both during the term of the joint venture and after termination of the agreement and the parties&#8217; obligations thereunder. In the event of the sale of AL pursuant to the buy/sell mechanism discussed below, the party that sells its share in AL will be subject, during the three-year period after the end of provision of services under the joint venture agreement, to non-competition obligations. Pursuant to these obligations, the selling party may not, among other restrictions, develop or sell InFat or products that directly compete with InFat, excluding those competing products that the selling party developed and sold prior to the non-competition period.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Liability for breach of agreement.
</FONT>
	If either we or AAK fails to perform any of our respective obligations under the joint venture agreement, such partner shall be deemed to have breached the joint venture agreement and shall have 90 days from receipt of notice from the other party specifying the breach to cure such breach. If, after the expiration of that period, the breach is not corrected, then the partner in breach shall be liable to the other partner for all direct and foreseeable damages caused to it or to AL by the breach, in addition to any other remedy the other partner is entitled to pursuant to the joint venture agreement. In no event shall either partner be liable for special, incidental or consequential damages.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Dispute resolution.
</FONT>
	If a dispute arises related to the joint venture, we are first required to attempt to resolve the dispute through friendly consultations between us and AAK. If these consultations do not lead to a resolution within 30 days the dispute is referred to our chairman and the chairman of AAK to continue negotiations. If, after an additional 30 days, the dispute is still not resolved, either party may submit the matter to arbitration in accordance with the terms of the agreement.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Termination.
</FONT>
	The joint venture agreement&#8217;s initial term runs until December 31, 2016. Thereafter, the agreement will be automatically extended for consecutive periods of three years, unless terminated by notice of either party at least 12 months prior to a term&#8217;s expiration. Additionally, the agreement may be terminated in customary circumstances, such as in the case of intentional material breach of the agreement or if a partner becomes controlled by a competitor of AL. Following our arbitration process with AAK regarding the interpretation of the termination provision of the joint venture agreement, the arbitration tribunal found that the joint venture agreement should be interpreted such that the only exit the parties have from the agreement is via a buy-sell process. The joint venture agreement provides the mechanism of such buy-sell process. Specifically, in the event that one party notifies the other party of its intent to terminate the agreement (other than in the case of an intentional, material breach that causes grave and serious damage), either party may notify the other of its intent to buy the other party&#8217;s shares in AL by making an unconditional, irrevocable offer to purchase the other party&#8217;s shares. The agreement also provides for a counteroffer mechanism, such that the party who is willing to pay the highest price for AL will be entitled to purchase the other party&#8217;s shares in AL. Additionally, in cases of an intentional material breach of the agreement causing grave and serious damage (subject to a 90-day cure period), the non-breaching party has the right to purchase the shares of the breaching party for no consideration and to continue the business of AL post termination.&#160;&#160;This includes extending the supply obligations (or any other obligations) of the breaching party necessary to conduct the business of AL post-termination for a period of three years.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	44
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage51"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Following the lapse of December 31, 2015, and as neither party has issued a notice of termination of the joint venture agreement the joint venture agreement has been automatically extended until December 31, 2019 in accordance with its terms.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Dispute with AAK.
</FONT>
	In May 2014, AAK submitted a request for arbitration against us seeking certain declaratory relief with respect to the joint venture agreement.&#160;&#160;We filed counterclaims against AAK with respect to certain disputed operational issues which we raised and for AAK&#8217;s conduct during our initial public offering.&#160;&#160;In February 2016, the ICC tribunal rejected, in their entirety, AAK's requests for declaratory relief and denied all relief we requested with respect to our counterclaims against AAK. See &#8220;Item 3.D. Key Information &#8212; Risk Factors &#8212; Risks relating to our business and Industry &#8212; We rely on AarhusKarlshamn AB, or AAK, our Swedish joint venture partner, to procure raw materials and for the manufacture of InFat. While all of AAK&#8217;s claims in arbitration initiated against us by AAK were recently rejected, the arbitration has strained our relationship with AAK, and we cannot assure you that tensions and disagreements will be resolved or that the relationship will remain unchanged or will continue.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Competition
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The level of competition we face varies from product to product. However, we believe that the number of companies seeking to develop products in the markets in which we compete will increase. Competitors range in size from small, single product companies to large, multifaceted corporations, which may have greater financial, technical, marketing and other resources than those available to us. Many of these competitors or potential competitors may have greater name recognition and broader product lines than we do.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Nutrition
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	With respect to the InFat product, we currently compete with one other company offering an sn-2 palmitate product, IOI Loders Croklaan, a Malaysian company, which offers a product under the Betapol brand name. IOI Loders Croklaan recently teamed with Kerry Group to further develop and market the nutrition lipid Betapol business. We expect that others may seek to enter the sn-2 palmitate market, especially in China. Further, InFat competes with other products in the general infant nutritional product market. The majority of market participants are currently using various vegetable oil blends, although bovine milk fat is also used to some extent. Accordingly, our main challenge in this market is to enlarge InFat&#8217;s market share by convincing customers to use InFat instead of lower-cost regular vegetable oil. We believe that as the sn-2 palmitate market share grows, it will encourage more specialty oil producers to endeavor to develop and offer competitive products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	With respect to our krill products, krill oil suppliers have increased capacity due to strong market growth in 2013 and the general decline in the krill oil market in 2014 and 2015 resulted in intensified competition.&#160;&#160;Our three principal competitors in the krill oil market are: Aker BioMarine AS (which recently merged with Aker Seafoods Holding AS), a Norwegian company; Neptune Technologies &amp; Bioressources Inc., a Canadian company; and Rimfrost USA, LLC, a joint venture of Avoca, Inc. and Olympic Seafood AS. In the PS market, our principal competitors are Chemi Nutraceuticals Inc., Lipoid GmbH and Lipogen Ltd.&#160;&#160;We expect that competition will remain intense with significant manufacturing capacity available among our competitors.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	VAYA Pharma
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our VAYA Pharma products currently face little direct competition in the medical foods market. However, even though we are positioning ourselves as a first line therapy, the present major growth challenge, principally in the United States, which constitutes our largest market for medical foods products, is that physicians may prefer to prescribe prescription drugs produced by pharmaceutical drug manufacturers rather than our medical food products. Further, potential customers may prefer to use prescription drugs instead of our medical foods products, as they may be deterred from purchasing our products due to the present lack of reimbursement from third party payers. The prescriptions likely to be prescribed by physicians and used by patients include drugs produced by large, well-established pharmaceutical companies as well as specialty pharmaceutical sales and marketing companies and specialized cardiovascular disease, or CVD, biopharmaceutical companies. For our Vayarol product, the principal prescription drugs with which we compete include Lovaza, marketed by GlaxoSmithKline plc, Niaspan marketed by AbbVie (formerly Abbott Laboratories), and Vascepa marketed by Amarin Corporation plc; for our Vayarin product, Strattera produced by Eli Lilly &amp; Co., Intuniv (guanfacine) produced by Shire plc, and generic products, such as Ritalin. We believe there are not presently any drugs that address the indication addressed by Vayacog in the market.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	45
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage52"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our VAYA Pharma products currently face little direct competition from other medical foods manufacturers, as we believe that there are high barriers to entry in the medical foods market. While they do not currently market medical foods that compete with our products, we are aware that large multi-national nutrition companies, such as Abbott Laboratories, Nestl&#233; and Danone (through its clinical nutrition subsidiary, Numico N.V.) have expressed interest in the medical food market. Such potential competitors may have greater financial, technical, marketing and other resources than those available to us and, accordingly, the ability to devote greater resources than we can to the development, promotion, sale and support of products. However, even if such companies do enter the medical food market, we would not view them as significant competitors to the extent that their medical foods products address different indications than our medical foods products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Government regulation
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Nutrition Segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The selling and marketing of our nutrition products are generally subject to comprehensive laws, regulations and standards enforced by various regional, national and local regulatory bodies, including the FDA in the United States, the European Commission in the European Union, the Therapeutic Goods Administration (the &#8220;TGA&#8221;) in Australia, the Ministry of Health in China, the Ministry of Health in Israel and others.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In the United States, two regulatory pathways exist for dietary ingredients, one for ingredients marketed in food and the other for dietary ingredients marketed in nutritional supplements. Dietary ingredients that were marketed in nutritional supplements prior to October 1994 are not subject to premarket authorization requirements. All other dietary ingredients must undergo a &#8220;premarket notification&#8221; process. This process requires the manufacturer to detail the quality and safety of the ingredient and file such information with the FDA at least 85 days prior to placing the ingredient on the market as a dietary supplement.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Food ingredients must be determined to be safe prior to being added to foods. The following categories of food ingredients are considered to be safe by the FDA:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a food additive that has received pre-market approval from the FDA;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	an ingredient that is generally recognized, among qualified experts, as having been adequately shown to be safe under the conditions of its intended use (referred to as generally recognized as safe, or &#8220;GRAS&#8221;); or
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	an ingredient that was determined to be safe for use in food prior to September 6, 1958 (a list of these substances that are GRAS are published by the FDA in the Federal Register).
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For an ingredient to be considered GRAS, the manufacturer of the ingredient must provide information on the quality and safety of the ingredient for its intended use as well as the results of relevant clinical studies. Such information is reviewed by qualified experts who determine whether the ingredient has been adequately shown to be GRAS. Additionally, such information may be voluntarily submitted to the FDA for review. If the FDA is satisfied with the determination of the new ingredient as GRAS, it will issue an Agency Response Letter advising that the agency has no questions regarding the safety conclusions of the ingredient.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have conducted comprehensive safety evaluations of our InFat, Sharp PS, Sharp PS Gold, Sharp PS Green and krill oil ingredients, which were found to be GRAS following a review by qualified experts. We have voluntarily notified the FDA of our GRAS determinations and received a &#8220;no questions&#8221; response letter from the FDA advising us that the FDA accepts our conclusions that these ingredients are GRAS. A GRAS notification to the FDA on omega PC as GRAS for use in a variety of food products has been submitted to the FDA. During the FDA's evaluation process, we decided to withdraw that notice and resubmit at a later stage. In addition, we obtained regulatory approvals for our ingredients in main markets such as Europe, China and Australia as well as other countries in Asia and America.
</FONT>
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	46
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage53"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The selling and marketing of our nutrition products are generally subject to comprehensive laws, regulations and standards enforced by various regional, national and local regulatory bodies, including the FDA in the United States, the European Commission in the European Union, the TGA in Australia, the Ministry of Health in China and the Ministry of Health in Israel.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	VAYA Pharma segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Medical foods
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In the United States, the products currently offered by our VAYA Pharma segment are sold as medical foods, consistent with the statutory and FDA regulatory criteria for &#8220;medical foods.&#8221; The products are available only under the supervision of a physician (acquired on prescription or directly from a physician). The term &#8220;medical food,&#8221; as defined in the Orphan Drug Amendments of 1988 to the FDCA, is a food &#8220;which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.&#8221; The FDA has issued regulations detailing the agency&#8217;s interpretation of the characteristics of food products that qualify as &#8220;medical foods." Accordingly, under FDA regulations, a food qualifies as a &#8220;medical food&#8221; only if:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	it is specially formulated and processed (as opposed to a naturally occurring foodstuff used in its natural state), for the partial or exclusive feeding of a patient by means of oral intake or enteral feeding by tube;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	it is intended for the dietary management of a patient who, because of therapeutic or chronic medical needs, has limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foodstuffs or certain nutrients, or who has other special medically determined nutrient requirements, the dietary management of which cannot be achieved by modification of the normal diet alone;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	it provides nutritional support specifically modified for the management of the unique nutrient needs that result from the specific disease or condition, as determined by medical evaluation;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	it is intended to be used under medical supervision; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	it is intended only for a patient receiving active and ongoing medical supervision wherein the patient requires medical care on a recurring basis for, among other things, instructions on the use of the medical food.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The FDA has issued warning letters to other medical food companies challenging the classification of their products as &#8220;medical food.&#8221; We believe that these letters indicate that the FDA may be applying a more narrow interpretation of what qualifies as a &#8220;medical food.&#8221; Given this enhanced focus on medical food companies, we cannot provide any assurance that we will not also receive such a letter and the FDA could take the position that one or more of our medical foods products may not be lawfully sold in the United States as &#8220;medical food.&#8221; If such a challenge were to occur we could incur significant costs associated with responding and defending our products&#8217; status as medical foods and ultimately litigation. If we are not able to demonstrate to the FDA&#8217;s satisfaction that the product(s) meet the regulatory requirements for &#8220;medical foods,&#8221; we may be forced to suspend sale and distribution of such product(s) in the U.S. market or attempt to reposition the product(s) as a supplement.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Outside the United States, the question of whether our VAYA Pharma products are categorized as prescription products, and the extent to which they can be purchased without medical supervision, depends upon national, regional and local laws and regulations, as well as the sales and marketing strategy adopted by our local license partners following discussions with us. For example, in Israel these products are sold over the counter, without a prescription, whereas in South Korea, one of our products, Vayarol, will be sold and marketed, subject to approval, as a prescription drug.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage54"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Prescription drugs
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In the United States, the FDA regulates drugs under the FDCA, and implementing regulations. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, local and foreign statutes and regulations requires the expenditure of substantial time and financial resources. Failure to comply with the applicable U.S. requirements at any time during the product development process, approval process or after approval, may subject an applicant to a variety of administrative or judicial sanctions, such as the FDA&#8217;s refusal to approve pending New Drug Applications or NDAs, withdrawal of an approval, imposition of a clinical hold, issuance of warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement or civil or criminal penalties.
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The process required by the FDA before a drug may be marketed in the United States generally involves the following:
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	completion of preclinical laboratory tests, animal studies and formulation studies in compliance with the FDA&#8217;s good laboratory practice, or GLP, regulations;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	submission to the FDA of an investigational new drug application, or IND, which must become effective before human clinical trials may begin;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	approval by an independent institutional review board, or IRB, at each clinical site before each trial may be initiated;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	performance of adequate and well-controlled human clinical trials in accordance with good clinical practices, or GCP, to establish the safety and efficacy of the proposed drug or biological product for each indication;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	submission to the FDA of an NDA;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	satisfactory completion of an FDA advisory committee review, if applicable;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	satisfactory completion of an FDA inspection of the manufacturing facility or facilities at which the product is produced to assess compliance with cGMP, and to assure that the facilities, methods and controls are adequate to preserve the drug&#8217;s identity, strength, quality and purity; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	FDA review and approval of the NDA.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In the future, we may use our R&amp;D platform to seek to penetrate the prescription pharmaceuticals market. In 2010, we commenced the process of seeking FDA approval for Vayarol as a prescription drug for the reduction of triglyceride levels in patients with hypertriglyceridemia. We submitted an Investigational New Drug Application, or IND, briefing package to the FDA in April 2013. Based on comments we received from the FDA and a subsequent teleconference with FDA representatives, we believe that the FDA would require us to design a more extensive Phase 3 clinical trial.&#160;&#160;In light of the FDA&#8217;s expanded requirements for the investigational program and the crowded market for hypertriglyceridemia treatments, we have decided to hold further activities with respect to Vayarol and are evaluating our next steps, reconsidering the costs and benefits of initiation of such project with one of our other products for a different indication with greater commercial opportunity.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	48
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage55"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Environmental matters
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We are subject to extensive environmental, health and safety laws and regulations in a number of jurisdictions, primarily Israel, governing, among other things: the use, storage, registration, handling and disposal of chemicals, waste materials and sewage; chemicals, air, water and ground contamination; air emissions and the cleanup of contaminated sites, including any contamination that results from spills due to our failure to properly dispose of chemicals, waste materials and sewage. Our operations at our Migdal Ha&#8217;Emeq manufacturing facility use chemicals and produce waste materials and sewage. Our activities require permits from various governmental authorities including, local municipal authorities, the Ministry of Environmental Protection, the Ministry of Health and the Ministry of Agriculture and Rural Development. The Ministry of Environmental Protection, the Ministry of Health, the Ministry of Agriculture and Rural Development, local authorities and the municipal water and sewage company conduct periodic inspections in order to review and ensure our compliance with the various regulations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	These laws, regulations and permits could potentially require the expenditure by us of significant amounts for compliance and/or remediation. If we fail to comply with such laws, regulations or permits, we may be subject to fines and other civil, administrative or criminal sanctions, including the revocation of permits and licenses necessary to continue our business activities. In addition, we may be required to pay damages or civil judgments in respect of third-party claims, including those relating to personal injury (including exposure to hazardous substances we use, store, handle, transport, manufacture or dispose of), property damage or contribution claims. Some environmental laws allow for strict, joint and several liability for remediation costs, regardless of comparative fault. We may be identified as a potentially responsible party under such laws. Such developments could have a material adverse effect on our business, financial condition and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Furthermore, our customers are showing greater interest in the environmental impact of our products, the manner in which they are produced, and the sustainable approach towards the sourcing of our raw materials. Any natural resources used as raw materials are sensitive to such claims. For example, the Commission for the Conservation of Antarctic Marine Living Resources has established limits on krill harvesting, which provides the raw material for our krill oil products, because increases in krill harvesting could have a negative effect on the ecosystem, including other marine life, particularly birds, seals and fish which mainly depend on krill for food. While we attempt to work with our suppliers in complying with and obtaining sustainable accreditation (from our krill suppliers), a shift in focus among customers and other third parties toward sustainable products may affect our ability to effectively compete.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition, laws and regulations relating to environmental matters are often subject to change. In the event of any changes or new laws or regulations, we could be subject to new compliance measures or to penalties for activities which were previously permitted. For instance, new Israeli regulations were promulgated in 2012 relating to the discharge of sewage by plants into the sewer system. These regulations establish new and potentially significant fines for discharging forbidden or irregular sewage into the sewage system.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	C.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Organizational Structure
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The legal name of our company is Enzymotec Ltd. and we are organized under the laws of the State of Israel. We have four wholly-owned subsidiaries: Enzymotec USA, Inc. and VAYA Pharma, Inc., both incorporated in the United States, Enzymotec Australia Pty Ltd. incorporated in Australia and Enzymotec Singapore PTE Ltd., incorporated in Singapore.
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	&#160;
</FONT>
	We also hold 50% of our joint venture in Advanced Lipids AB, a Swedish company and we own 80% of VAYA Pharma PTE Ltd., a Singapore company.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	D.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Property, Plants and Equipment
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Property and infrastructure
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our principal executive and administrative offices, research and development laboratories and production plant are in the Sagi 2000 Industrial Area, near Migdal Ha&#8217;Emeq, Israel. These facilities are built on a plot of approximately 107,600 square feet, leased in 2007 from the Israel Land Administration pursuant to a 98 -year lease (expiring in May 2105) for approximately $136,000, with additional related payments of approximately $314,000 to the Israeli Ministry of Economy and Industry and the Israeli Tax Authority. Currently, these facilities consist of approximately 70,000 square feet of built space.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	49
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage56"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our production plant is located in a building currently comprising four floors, each of approximately 6,000 square feet. The production process is fully automated. The equipment installed at the production plant includes reactors, solid &#8212; liquid separation systems, distillation systems, a deodorization system, drying, blending and packaging systems as well as a pilot plant dedicated to research and experiments.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition, in 2013, we completed construction of an approximately 7,500 square feet extension to our production plant. This extension has enhanced our production capabilities and is equipped to enable us to extract crude krill oil ourselves from krill meal using new and technologically advanced equipment and proprietary processes.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our plant utilities infrastructure (including, among other items, a steam boiler, cooling and chilled water systems and a water purification system) are designed to support 100% expansion of production beyond our capacity.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In October 2011, we exercised an option for a long-term (98-year) lease for an adjoining plot of approximately 107,600 square feet from the Israel Land Administration for approximately $60,000, with additional related payments of approximately $370,000 to the Israeli Ministry of Economy and Industry, upon which we may build an additional manufacturing facility. This plot is held pursuant to, and for the remainder of the term of, the lease of the plot upon which our current facilities are built. Pursuant to our lease agreement, we are obligated to complete certain construction projects by August 2016. We were recently approached by the Israel Land Administration notifying us of the steps they are taking towards terminating the lease agreement concerning the adjoining plot. We intend to enter into negotiations with the Israel Land Administration to modify the terms of our lease or to extend the period to complete these projects but we cannot assure that the Israel Land Administration will agree to modify the lease or extend the completion period.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Office space is also leased by our two U.S. subsidiaries, in Morristown, New Jersey (approximately 300 square feet) and Baltimore, Maryland (approximately 3,000 square feet), by our Chinese representative office (approximately 1,000 square feet) in Shanghai, and by our Singapore subsidiary VAYA Pharma PTE LTD (approximately 100 square feet). All our facilities are fully utilized.
</FONT>
</DIV>
</EFX_COMPANY_INFORMATION>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNRESOLVED_STAFF_COMMENTS>
<A NAME="FIS_UNRESOLVED_STAFF_COMMENTS"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 4A: Unresolved Staff Com
<A NAME="ZK1618102_HTM_3">
	ments
</A>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
</EFX_UNRESOLVED_STAFF_COMMENTS>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_OPERATING_AND_FINANCIAL_REVIEW>
<A NAME="FIS_OPERATING_AND_FINANCIAL_REVIEW"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 5: Operating and Financial Review and Prospects
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;Company overview
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We are a leading global supplier of specialty lipid-based products and solutions. We develop, manufacture and market innovative bio-functional lipid ingredients, as well as final products, based on sophisticated proprietary processes and technologies. We deliver our products and solutions through the following two reportable segments:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Nutrition segment
</FONT>
	. This segment develops and manufactures nutritional ingredients for infant formula and dietary supplements. These ingredients include InFat, a proprietary, clinically-proven infant formula fat ingredient that more closely resembles human breast milk fat to facilitate healthy infant development and premium phosopholipid-based bioactive ingredients for nutritional supplements. Our best-selling nutritional ingredient for dietary supplements is krill oil, which provides the benefits of omega-3 fatty acids. Our other nutritional ingredients for dietary supplements are targeted at improving brain health and providing benefits in memory, learning abilities and concentration.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	VAYA Pharma segment
</FONT>
	. This segment develops, manufactures and sells branded lipid-based medical foods for the dietary management of medical disorders and common diseases. This is a research-based, specialty pharmaceutical segment, which currently offers medical food products for the cardiovascular and neurological markets. Our VAYA Pharma products are currently the only products sold by us for use by end users.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	50
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage57"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following are the key milestones in our business and financial development:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We were founded in 1998.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 2003, we initiated sales of our nutritional ingredients for dietary supplements, our first products offered for sale.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 2004, we generated our first revenues from InFat.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 2007, we entered into a joint venture arrangement with our Swedish joint venture partner, AarhusKarlshamn AB, or AAK, a global producer of specialty vegetable fats and established our Swedish joint venture, Advanced Lipids AB or AL. Our InFat product is now offered exclusively through our joint venture.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 2008, we initiated Enzymotec USA, Inc.&#8217;s operations in the United States.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 2009, we completed the building of our headquarters and manufacturing facility in Migdal Ha&#8217;Emeq, Israel, where we produce many of our products. This facility significantly increased our manufacturing capacity and streamlined our operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 2011, we initiated sales of our VAYA Pharma products in the United States.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 2013, we completed our manufacturing facility expansion project, which has enabled us to move the entire krill oil extraction process, which we previously outsourced, in-house. We also completed our initial public offering and listing on the NASDAQ Global Select Market.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 2014, we began extracting krill oil in house and we established Enzymotec Australia PTY Ltd. in Australia and VAYA Pharma PTE Ltd. in Singapore to expand our in house sales and marketing capabilities.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
<DIV>
	&#160;
</DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" COLSPAN="3" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	A.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="97%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Operating Results
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Components of our statements of operations
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;Net revenues
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Revenues are recorded net of reserves for returns (primarily related to rights granted to distributors of VAYA Pharma products which have been negligible to date), and net of cash discounts and distribution fees.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;Nutrition segment
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;We sell many of our Nutrition products, including our krill oil, to companies that manufacture and market dietary supplements and to distributors of these ingredients and products. Sales of our InFat product are made through AL to companies that provide balanced infant nutrition products, primarily in China. For an explanation of our commercial arrangement with our joint venture and how we account for our joint venture, see &#8220;&#8212; Joint venture accounting&#8221; below.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	VAYA Pharma segment
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We sell our VAYA Pharma products in the United States as medical food through wholesalers of pharmaceutical products. In 2015 we generated initial revenues from, and expect a growing portion of our VAYA Pharma products sales in the United States to be through, an online pharmacy which is operated by a third-party vendor. Outside of the United States, we sell our VAYA Pharma products to pharmaceutical companies in various countries. We rely upon those pharmaceutical companies not only to distribute our products, but also to execute substantially all selling and marketing activities related to our VAYA Pharma products in those countries. Under U.S. law, distributors of medical food have the right to return unused products. Accordingly, we recognize revenues from the sale of VAYA Pharma products in the United States net of provisions for returns that can be reasonably estimated, cash discounts and distribution fees to wholesalers.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	51
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage58"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;Net revenues by geographical region
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following table presents net revenues by geographic breakdown of customers in dollars and as a percentage of net revenues for the periods indicated. This data refers to the location of the customer to whom we directly sell and does not take into consideration the location of the end-user (to the extent it is different).
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_9"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="23" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended&#160;December&#160;31,
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="7" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="7" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Net
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Revenues
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Percentage
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Net
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Revenues
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Percentage
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Net
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Revenues
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Percentage
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="23" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in thousands)
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Geographical region
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	North America
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	35,458
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	55
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	25,810
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	55
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	29,635
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	59
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Europe
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,382
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	15
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,395
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	22
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,071
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	20
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Australia &amp; New Zealand
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,811
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	17
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,388
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,188
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Asia
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,735
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,019
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	15
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,173
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	14
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Israel
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	589
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,491
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,324
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	64,975
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	100
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,103
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	100
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	50,391
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	100
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Many of the sales made by our European, Australian and New Zealand customers are made into Asia and we believe that approximately 30% of our net revenues are derived from end customers in Asia.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;Costs of revenues and gross profit
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our costs of revenues consist of costs of raw materials, as well as labor, utility and maintenance costs associated with the operation of our manufacturing facility, depreciation and shipping and handling. We allocate depreciation of our manufacturing facility, which is used by each of our segments, to each segment on the basis of actual use. The key driver of cost of revenues is the level of production, as increased output requires additional raw materials and labor.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our gross profit is influenced by a number of factors. The most important of these is the cost of raw materials. The main factors influencing the cost of revenues and gross profit of each of our segments are set forth below.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Nutrition
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit of our Nutrition segment is primarily a function of the cost of raw materials, which comprised the majority of the costs of revenues in the year ended December 31, 2015. With respect to our InFat product, the cost of raw materials comprised a majority of the costs of revenues in 2015. While certain InFat customer contracts contain pricing formulae under which the prices of products are adjusted to reflect changes in the costs of raw materials, the adjustments do not fully insulate AL from such changes. In addition, even where InFat prices are adjusted pursuant to customer contracts that contain pricing formulae, increases in price can adversely affect sales and also expose AL to increased competition. AL&#8217;s gross profit is also influenced by the mix of products sold, as the InFat products with the higher levels of concentration of our proprietary sn-2 palmitate component carry higher profit margins than the other InFat blends that we offer.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	52
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage59"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Further, a material portion of our costs of revenues for our nutritional ingredients is comprised of the costs of sourcing raw krill meal and extracting krill oil from the meal. We currently purchase the majority of the krill meal we use pursuant to agreements with the owners of vessels that harvest Antarctic krill and process the freshly caught krill into krill meal onboard. Pursuant to these agreements, the price we pay for krill meal is adjusted in accordance with the fat content of the harvested krill.&#160;&#160;In addition, during 2014 we purchased frozen krill and entered into a toll processing agreement with a third party to process krill meal from the frozen krill. We intend to meet our krill meal needs in the future by sourcing krill meal both from vessels that process krill meal onboard and from suppliers of frozen krill.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Prior to 2014, our costs related to our krill products also included payments to an Indian manufacturer for processing krill meal and extracting krill oil, which resulted in lower gross profits. In addition, our gross profit is affected by the quality of the krill meal we source, meaning the level of oils found in the krill meal, as higher quality krill meal results in greater yield and less processing.&#160;&#160;During 2013, we expanded our Migdal Ha&#8217;Emeq manufacturing facility and equipped it to enable us to extract krill oil ourselves using technologically advanced equipment and processes. In the first quarter of 2014 we moved the entire krill oil extraction process in-house. This has helped us to save all processing costs, which were approximately $1.6 million in the year ended December 31, 2013, which had previously been paid to our Indian manufacturer. In addition, moving the extraction process in house has enabled us to sell many of the marketable byproducts of the krill oil extraction process that we previously could not sell due to Indian export restrictions, thereby further increasing revenues and gross profit.&#160;&#160;The extraction process at our new facility is also more efficient than it had been at our outsourced manufacturer due to our use of new technologies. Accordingly, we believe that this move has positively impacted the gross profit of our Nutrition segment.&#160;&#160;However, the frozen krill we purchased in 2014 is still held by us in inventory and we would need to use it in the near to medium term in order to avoid obsolescence.&#160;&#160;In general, purchasing frozen krill and processing it into krill meal is significantly more costly than purchasing krill meal that was processed onboard fishing vessels. Accordingly, oil produced from frozen krill has significantly lower gross margins than the krill oil produced from krill meal processed from freshly caught krill, and to the extent we utilize our inventory of frozen krill we may negatively impact the gross margins of our Nutrition segment.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	VAYA Pharma
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The gross profit of VAYA Pharma is influenced primarily by the sale prices of its products. The gross profit from sales of VAYA Pharma products in the United States and Singapore is higher than the gross profit from sales in other markets due to the fact that we perform sales and marketing of VAYA Pharma products in the United States and Singapore through our dedicated sales staff, and accordingly charge higher sales prices to our wholesale distributors than to distributors in other countries who perform sales and marketing functions for us. The costs of revenues are primarily comprised of costs of production, which accounted for approximately 75% of costs of revenues in 2015 and 2014, respectively, and encapsulation, packaging and bottling of these products, which accounted for substantially the entire balance of the segment&#8217;s costs of revenues in 2015 and 2014, respectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Operating expenses
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Research and development expenses
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Research and development expenses consist primarily of salaries and other employee benefits of our research and development personnel, costs of clinical trials and laboratory expenses, which include materials and depreciation of laboratory equipment. Research and development expenses are presented net of grants received from Israel&#8217;s OCS. For additional information regarding these grants, see &#8220;Item 5.B. Operating and Financial Review and Prospects &#8212; Liquidity and Capital Resources &#8212; Government Grants.&#8221; We charge all research and development expenses to operations as they are incurred. We expect research and development expenses to increase in absolute terms as we continue to conduct clinical trials this year to reinforce the science as well as develop new indications of our products.&#160;&#160;In 2014, we initiated a study for Vayarin for adults with ADHD, a long-term study for Vayacog for patients with mild cognitive impairment, and a study for a product for children with Autism Spectrum Disorder. We also commenced in 2015 an investigator initiated clinical trial of Vayarin in managing ADHD in children with epilepsy. These studies continued during 2015 and are scheduled to continue through 2016.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	53
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage60"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;Selling and marketing expenses
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Selling and marketing expenses consist primarily of salaries and other employee benefits of our sales and marketing personnel, global marketing expenses and sales commissions. The majority of our selling and marketing expenses are generated by our VAYA Pharma segment, which maintains a dedicated sales and marketing staff in the United States and Singapore consisting of medical representatives. As part of our growth strategy, we intend to increase our dedicated U.S. VAYA Pharma sales and marketing staff and therefore expect selling and marketing expenses to increase in absolute terms and as a percentage of our consolidated net revenues.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;General and administrative expenses
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	General and administrative expenses consist primarily of salaries and other employee benefits for our managerial and administrative personnel, together with associated overhead costs. Other significant general and administrative costs include insurance costs and costs of operating as a public company, including professional fees for accounting and legal services. If our sales grow, we expect our general and administrative expenses to increase in absolute terms, but to decrease as a percentage of our consolidated net revenues.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Financial income (expenses), net
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial income (expenses), net consist of interest income accrued on our bank deposits and marketable securities, changes in the fair value of foreign currency forward transactions which are not qualified as hedge transactions, foreign currency gains and losses and interest paid in respect of our long-term liabilities under our September 2009 bank financing agreement which was repaid in full in January 2014. For more information regarding these facilities, please see &#8220;Item 5.B. Operating and Financial Review and Prospects &#8212; Liquidity and Capital Resources.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Currency exchange rates
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As our functional currency for all of our operations other than AL is the dollar, any movements in the currencies of other countries in which we operate can have an impact on our operating results. While the majority of our sales are in dollars and most of our expenses are in dollars, we do have exposure to the Euro and NIS. In addition, the functional currency of AL, is the Swedish Krona, and therefore the results of operations of our Nutrition segment, as reported in Note 5 to our consolidated Financial Statements included elsewhere in this annual report, are also influenced by fluctuations of the dollar against the Swedish Krona. For a discussion of our efforts to reduce our exposure to exchange rate fluctuations, see &#8220;Item 11. Quantitative and Qualitative Disclosures about Market Risk.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Taxes on income
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The standard corporate tax rate in Israel was reduced to 25% starting in 2016. For the 2014 and 2015 tax years, it was 26.5%, and for the 2013 tax year, it was 25%.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As discussed in greater detail below under &#8220;Item 10.E. Additional Information &#8212; Taxation &#8212; Israeli tax considerations and government programs,&#8221; we have received various tax benefits under the Investment Law. Under the Investment Law, our effective tax rate to be paid with respect to our Israeli taxable income under these benefits programs is 0%. The majority of the benefits we receive under the Investment Law are pursuant to programs that are scheduled to expire in 2022.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Investment Law and other Israeli legislation, we are entitled to certain additional tax benefits, including accelerated depreciation and amortization rates for tax purposes on certain assets, deduction of public offering expenses in three equal annual installments and amortization of other intangible property rights for tax purposes.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our non-Israeli subsidiaries are taxed according to the tax laws in their respective jurisdictions of organization. We estimate our effective tax rate for the coming years based on the planned future financial results of our current business in existing and new markets and the key factors affecting our tax liability.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	54
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage61"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Share in profits of equity investee
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;Under U.S. GAAP, we are required to account for the results of operations of AL, using the equity method, meaning that we recognize our share in the net results of AL as a share in profits of equity investee. See &#8220;&#8212; Joint venture accounting&#8221; below.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Joint venture accounting
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have a joint venture arrangement with AAK, for which we and AAK are responsible for particular functions related to the production, marketing and sale of the final InFat product. We and AAK jointly own 50% each of Advanced Lipids (AL), which serves as a distributor for the joint venture arrangement.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Our role
</FONT>
	. We manufacture enzymes that we supply to AAK, which then produces the final InFat product at its dedicated facility in Sweden using those enzymes together with other raw materials that AAK is responsible for sourcing. We are responsible for research and development, as well as business development (including penetration of new markets) and marketing activities. We are also responsible for funding our operating expenses associated with our role in the joint venture, including the manufacturing of enzymes.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	AAK&#8217;s role
</FONT>
	. AAK is responsible for the production of the final InFat product at its dedicated facility in Sweden which includes, among others, sourcing of raw materials, labor and other costs of production, including freight and logistics, as well as for capital expenditures for increased capacity, inventory storage and management, receivables collection and product liability insurance. Once it has produced the final InFat product, AAK sells it to AL, which, in turn, sells the product to three types of customers: (i) companies that manufacture the end product themselves; (ii) companies that outsource manufacturing of the end product; and (iii) outsourced manufacturers of the end product. AAK is also responsible for funding its operating expenses associated with its role in the joint venture.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Accounting for the arrangement
</FONT>
	. We recognize two sources of income from the JV arrangement.&#160;&#160;First, we recognize revenue for the enzymes sold by us to AAK upon the sale of the final InFat product by AL to its customers. The price that we charge AAK is set forth in the JV Agreement and is our direct production costs plus an agreed-upon margin defined in the JV Agreement.&#160;&#160;For any enzymes supplied to AAK that are not yet sold to an end customer of AL, the amount remains in our inventory as title is not transferred prior to the sale to the end customer and is not recognized as revenue.&#160;&#160;Second, we also record our share of AL profits under the equity method of accounting within the line item &#8220;share in profits of equity investees.&#8221; The AL profits that are shared between us and AAK are the profits that AL earns for its distribution activity.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For purposes of segment reporting, which requires presentation on the same basis provided to and utilized by the chief operating decision maker (CODM) to analyze the relevant segment&#8217;s results of operations, we account for the arrangement with AAK and the results of operations of AL using the proportionate consolidation method.&#160;&#160;Under the proportionate consolidation method, we recognize our proportionate share (50%) of the revenues of AL and record our proportionate share (50%) of the overall joint venture&#8217;s costs of production and other operating expenses in our income statement.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Since our consolidated U.S. GAAP results represent our investment in AL under the equity method, our consolidated U.S. GAAP results of operations reflect lower revenues and a higher gross profit margin than our results of operations accounted for on a proportionate consolidation basis, as shown for purposes of segment reporting.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	55
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage62"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Comparison of year-to-year results of operations
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following table sets forth certain consolidated statement of income data as a percentage of total net revenues for the years indicated. All items are included in, or derived from, our consolidated statements of operations. The year-to-year comparison of financial results is not necessarily indicative of future results.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_10"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	100.0
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	100.0
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	100.0
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cost of revenues
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	49.4
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	38.9
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	39.0
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	50.6
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	61.1
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	61.0
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating expenses
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Research and development, net
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9.2
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12.7
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12.2
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Selling and marketing
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10.4
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	17.1
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	22.7
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	General and administrative
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13.0
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	15.9
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13.9
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total operating expenses
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32.5
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	45.7
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	48.8
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating income
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18.1
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	15.4
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12.2
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial income (expense), net
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(0.8
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1.1
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1.0
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Income before taxes on income
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	17.3
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	16.5
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13.2
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Taxes on income
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(0.5
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(0.9
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(0.8
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Share in profits of equity investee
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.8
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1.0
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.9
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net income
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	17.5
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	16.6
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13.3
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December 31, 2015, compared with year ended December 31, 2014
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total net revenues increased by $3.3 million, or 7.0%, to $50.4 million in the year ended December 31, 2015 from $47.1 million in the year ended December 31, 2014. The increase is driven mainly from increase in revenues of the VAYA Pharma segment. For further discussion, see the analysis of segment reporting below.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	Nutrition segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues of our Nutrition segment in the year ended December 31, 2015 were $54.1 million, representing a decrease of 3.0% from net revenues of $55.8 million in the year ended December 31, 2014. The change was primarily due to: (i) a decrease of $1.5 million in InFat sales, resulting primarily from the Chinese infant formula market undergoing a shift in how infant formula is sold. Historically, local brands, where a majority of AL customers are positioned, were sold primarily through supermarkets and health stores.&#160;&#160;Increasingly, sales are migrating to an e-commerce platform, thereby inviting increased competition and affecting the market share of AL customers, (ii) a decrease of $1.4 million in the sales of krill products, driven primarily by a reduction in the average selling price resulting from decreased demand and overcapacity partially offset by increased volume of sales and (iii) an increase of $1.3 million in the volume of sales of our PS line of products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	VAYA Pharma segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues for our VAYA Pharma segment in the year ended December 31, 2015 were $8.5 million, representing an increase of 50.2% over net revenues of $5.6 million in the year ended December 31, 2014. The increase in net revenues reflected increased volume of sales as we continued penetrating the U.S. market and increased volume of sales in Singapore.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	56
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage63"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cost of revenues and gross profit
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;The following table presents net revenues, cost of revenues and gross profit in dollars and as a percentage of net revenues for the years indicated, and the percentage change in such amounts year-over-year:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_11"></A>
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="5" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended&#160;December&#160;31,
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="5" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Change &#160;in
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	As&#160;a&#160;percentage&#160;of net
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	revenues&#160;for&#160;the&#160;year&#160;ended
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	December&#160;31,
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	dollars
</FONT>
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	percentage
</FONT>
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="22" VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	($ in thousands)
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,103
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	50,391
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,288
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7.0
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cost of revenues
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18,316
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	19,635
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,319
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7.2
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	38.9
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	39.0
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	28,787
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	30,756
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,969
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6.8
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	61.1
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	61.0
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit increased by $2.0 million, or 6.8%, to $30.8 million in the year ended December 31, 2015, from $28.8 million in the year ended December 31, 2014. The increase in absolute gross profit relates primarily to our increased volume of sales in the year ended December 31, 2015, compared to the year ended December 31, 2014.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit margin decreased eight basis points to 61.0% for the year ended December 31, 2015 from 61.1% for the year ended December 31, 2014.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	Nutrition segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit of our Nutrition segment in the year ended December 31, 2015 decreased by $0.7 million to $24.5 million from $25.2 million in the year ended December 31, 2014. Gross profit margin remained relatively the same, and was 45.19% in the year ended December 31, 2015 compared to 45.17% in the year ended December 31, 2014. The decrease in absolute gross profit was due to the decrease in the sales of our Nutrition products. Gross profit margin remained relatively the same, as improvements in our production efficiency were substantially offset by the reduction of selling prices of our krill oil products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	VAYA Pharma segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;Gross profit for our VAYA Pharma segment in the year ended December 31, 2015 increased by $2.8 million to $7.0 million from $4.2 million in the year ended December 31, 2014, due to increased volume of sales. Gross profit margin increased to 82.2% in the year ended December 31, 2015 from 74.6% in the year ended December 31, 2014, primarily due to increased volume of sales in the United States and Singapore, where our gross margins on sales of VAYA Pharma products are higher than in other markets.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating expenses
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following table presents the types of operating expenses in dollars and as a percentage of net revenues for the years indicated, and the percentage change in such amounts year-over-year:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_12"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="25%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="18%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	December&#160;31,&#160;2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="19%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year-over-year
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	change
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="18%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	December&#160;31,&#160;2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="25%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	($&#160;in
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	thousands)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Percentage
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	of&#160;total&#160;net
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	revenues
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	($&#160;in
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	thousands)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(Percentage)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	($&#160;in
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	thousands)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Percentage
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	of&#160;total&#160;net
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	revenues
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="25%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Research and development, net
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,986
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12.7
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	163
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2.7
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,149
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12.2
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="25%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Selling and marketing
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8,034
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	17.1
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,391
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	42.2
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,425
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	22.7
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="25%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	General and administrative
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,475
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	15.9
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(467
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(6.2
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,008
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13.9
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="25%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total operating expenses
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,495
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	45.7
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,087
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	14.4
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	24,582
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	48.8
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	57
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage64"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Research and development expenses slightly increased by $163,000, to $6.1 million in the year ended December 31, 2015, from $6.0 million in the year ended December 31, 2014. As a percentage of net revenues, our research and development expenses decreased to 12.2% in the year ended December 31, 2015 from 12.7% in the year ended December 31, 2014. The increase in absolute amounts primarily reflected an increase of $0.6 million related to expenses in respect of VAYA Pharma clinical trials, partially offset by a decrease of $0.4 million in regulatory activities. The decrease in research and development expenses as a percentage of net revenues reflected the increase in net revenues partially offset by the increase in research and development expenses as an absolute amount. Grants from the OCS decreased by $19,000, or 13.1%, to $126,000 in the year ended December 31, 2015, from $145,000 in the year ended December 31, 2014.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Selling and marketing expenses increased by $3.4 million, or 42.2%, to $11.4 million in the year ended December 31, 2015, from $8.0 million in the year ended December 31, 2014. As a percentage of net revenues our selling and marketing expenses increased to 22.7% in the year ended December 31, 2015 from 17.1% in the year ended December 31, 2014. The increase in selling and marketing expenses both as an absolute amount and as a percentage of net revenues reflected primarily an increase of $1.8 million in headcount and share-based compensation, due primarily to the addition of sales personnel for the VAYA Pharma segment in the United States and an increase of $1.3 million in marketing activities (primarily marketing activities related to the marketing of VAYA Pharma products).
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	General and administrative expenses decreased by $0.5 million, or 6.2%, to $7.0 million in the year ended December 31, 2015, from $7.5 million in the year ended December 31, 2014. As a percentage of net revenues, our general and administrative expenses decreased to 13.9% in the year ended December 31, 2015 from 15.9% in the year ended December 31, 2014. The decrease in general and administrative expenses as an absolute amount was due to a decrease in legal expenses of $0.5 million (mainly related to a decrease in Neptune patent litigation costs offset by an increase in litigation costs related to the arbitration with AAK).&#160;&#160;The decrease was also due to a decrease of $0.2 million in expenses relating to being a public company (mainly reflecting our February 2014 secondary offering) and a decrease of $0.2 million in allowance for doubtful accounts, partially offset by an increase in headcount and share-based compensation expenses of $0.4 million.&#160;&#160;&#160;The decrease in general and administrative expenses as a percentage of net revenues reflected the decrease in the absolute amount of general and administrative expenses and the increase in net revenues.&#160;&#160;We believe that general and administrative expenses will decrease in 2016 as a result of the anticipated reduction in legal fees resulting from the completion of the arbitration with AAK.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial income (expenses), net
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following table presents our financial income, net, in dollars and as a percentage of net revenues for the years indicated, and the percentage change in such amounts year-over-year:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_13"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended&#160;December
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	31,&#160;2014
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year-over-year
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	change
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended&#160;December&#160;31,
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="11" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in thousands)
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial income, net
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	499
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(28
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	471
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Percentage of total net revenues
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1.1
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1.0
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial income for the year ended December 31, 2015 was $471,000, compared to financial income of $499,000 for the year ended December 31, 2014. The decrease was primarily due to foreign currency exchange differences of $0.6 million, partially offset by an increase of $0.3 million in interest received and accrued on our bank deposits and marketable securities and by an increase in gain in respect of derivatives of $0.3 million.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	58
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage65"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December 31, 2014, compared with year ended December 31, 2013
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total net revenues decreased by $17.9 million, or 27.5%, to $47.1 million in the year ended December 31, 2014 from $65.0 million in the year ended December 31, 2013. The decrease was due to a decrease in sales of our Nutrition segment partially offset by an increase of $1.2 million in sales of our VAYA Pharma segment.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	Nutrition segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues of our Nutrition segment in the year ended December 31, 2014 were $55.8 million, representing a decrease of 26.7% from net revenues of $76.2 million in the year ended December 31, 2013. The change was primarily due to: (i) a decrease of $15.8 million in the volume of sales of krill products, representing a decrease of 45.2% in the sales of these products from the year ended December 31, 2013, driven primarily by decreased sales in the United States and in Australia. Approximately $8.4 million of the decrease in sales of krill products was from one customer in the United States that had not placed orders with us since the second quarter of-2014. In addition, approximately $5.7 million of the decrease in sales of krill products was from our distributor in Australia, as a result of the decreased demand for krill and omega-3 products in the Australian market, (ii) a decrease of $4.6 million in InFat sales, resulting primarily from the Chinese infant formula market undergoing a shift in how infant formula is sold. Historically, local brands, where a majority of AL customers are positioned, were sold primarily through supermarkets and health stores.&#160;&#160;Increasingly, sales are migrating to an e-commerce platform, thereby inviting increased competition and affecting the market share of AL customers. In addition, new Chinese regulation which became effective in 2014 required both domestic and foreign infant formula companies, including some of AL&#8217;s customers, to make certain changes to their supply and production chain.&#160;&#160;This had a short term effect on the sales of AL&#8217;s customers and correspondingly on InFat which is an ingredient in some of AL&#8217;s customer&#8217;s infant formula.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	VAYA Pharma segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues for our VAYA Pharma segment in the year ended December 31, 2014 were $5.6 million, representing an increase of 26.9% over net revenues of $4.4 million in the year ended December 31, 2013. The increase in net revenues reflected increased volume of sales as we continued penetrating the U.S. market.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cost of revenues and gross profit
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;The following table presents net revenues, cost of revenues and gross profit in dollars and as a percentage of net revenues for the years indicated, and the percentage change in such amounts year-over-year:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_14"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended&#160;December&#160;31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Change &#160;in
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	As&#160;a&#160;percentage&#160;of net
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	revenues&#160;for&#160;the&#160;year&#160;ended
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	December&#160;31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	dollars
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	percentage
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="22" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in thousands)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	64,975
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,103
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(17,872
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(27.5
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cost of revenues
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32,110
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18,316
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(13,794
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(43.0
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)%&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	49.4
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	38.9
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32,865
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	28,787
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(4,078
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(12.4
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	50.6
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	61.1
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	59
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage66"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit decreased by $4.1 million, or 12.4%, to $28.8 million in the year ended December 31, 2014, from $32.9 million in the year ended December 31, 2013. The decrease in absolute gross profit relates primarily to our decreased volume of sales in the year ended December 31, 2014, compared to the year ended December 31, 2013.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit margin increased to 61.1% for the year ended December 31, 2014 from 50.6% for the year ended December 31, 2013. Approximately 680 basis points of the increase in gross profit margin were due to the operation of our new extraction facility and other improvements in production efficiency.&#160;&#160;Approximately 370 basis points of the increase in gross profit margin resulted from changes in the mix of products sold, as net revenues in the year ended December 31, 2014 reflected an increase in the volume of sales of InFat (as a percentage of consolidated sales) and an increase in sales of VAYA Pharma products, which carry a higher gross margin than some of our other products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	Nutrition segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit of our Nutrition segment in the year ended December 31, 2014 decreased by $5.2 million to $25.2 million from $30.4 million in the year ended December 31, 2013, and gross profit margin increased to 45.2% in the year ended December 31, 2014 from 39.9% in the year ended December 31, 2013. The decrease in absolute gross profit was due to lower volume of sales of our Nutrition products. The increase in gross profit margin was due primarily to improvements in production efficiency as well as to a higher volume of sales of InFat in the year ended December 31, 2014 in relation to other Nutrition products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	VAYA Pharma segment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;Gross profit for our VAYA Pharma segment in the year ended December 31, 2014 increased by $1.0 million to $4.2 million from $3.2 million in the year ended December 31, 2013, due to increased volume of sales. Gross profit margin increased to 74.6% in the year ended December 31, 2014 from 71.8% in the year ended December 31, 2013, primarily due to increased volume of sales in the United States, where our gross margins on sales of VAYA Pharma products are higher than in other markets.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating expenses
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following table presents the types of operating expenses in dollars and as a percentage of net revenues for the years indicated, and the percentage change in such amounts year-over-year:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_15"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	December&#160;31,&#160;2013
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year-over-year
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	change
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	December&#160;31,&#160;2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	($&#160;in
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	thousands)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Percentage
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	of&#160;total&#160;net
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	revenues
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	($&#160;in
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	thousands)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(Percentage)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	($&#160;in
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	thousands)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Percentage
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	of&#160;total&#160;net
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	revenues
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Research and development, net
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,947
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9.2
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	39
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.7
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,986
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12.7
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Selling and marketing
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,725
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10.4
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,309
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	19.5
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8,034
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	17.1
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	General and administrative
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8,434
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13.0
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(959
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(11.4
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,475
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	15.9
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total operating expenses
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,106
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32.5
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	389
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1.8
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,495
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	45.7
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Research and development expenses slightly increased by $39,000, to $6.0 million in the year ended December 31, 2014, from $5.9 million in the year ended December 31, 2013. As a percentage of net revenues, our research and development expenses increased to 12.7% in the year ended December 31, 2014 from 9.2% in the year ended December 31, 2013. The increase in absolute amounts reflected an increase of $0.3 million in expenses related to clinical trials partially offset by a decrease of $0.2 million in laboratory expenses. The increase in research and development expenses as a percentage of net revenues reflected the overall decrease in net revenues. Grants from the OCS decreased by $52,000, or 26.4%, to $0.1 million in the year ended December 31, 2014, from $0.2 million in the year ended December 31, 2013.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	60
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage67"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Selling and marketing expenses increased by $1.3 million, or 19.5%, to $8.0 million in the year ended December 31, 2014, from $6.7 million in the year ended December 31, 2013. As a percentage of net revenues our selling and marketing expenses increased to 17.1% in the year ended December 31, 2014 from 10.4% in the year ended December 31, 2013. The increase in selling and marketing expenses both as an absolute amount and as a percentage of net revenues reflected primarily an increase of $0.6 million in salaries, due primarily to the addition of sales personnel for the VAYA Pharma segment in the United States and an increase of $0.2 million in marketing activities (primarily marketing activities related to the marketing of VAYA Pharma products) and also due to an increase in license amortization expenses of $0.4 million related to the settlement and license agreement signed with Neptune Technologies &amp; Bioresources Inc. and Acasti Pharma Inc. Sales and marketing expenses as a percentage of net revenues was also impacted by the overall decrease in net revenues.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	General and administrative expenses decreased by $1.0 million, or 11.4%, to $7.5 million in the year ended December 31, 2014, from $8.4 million in the year ended December 31, 2013. As a percentage of net revenues, our general and administrative expenses increased to 15.9% in the year ended December 31, 2014 from 13.0% in the year ended December 31, 2013. The decrease in general and administrative expenses as an absolute amount was due to a decrease in litigation expenses of $1.0 million (mainly related to a decrease in Neptune patent litigation offset by an increase in litigation costs related to the arbitration with AAK and the class action.&#160;&#160;The decrease was also due to a decrease of $1.0 million in salaries (mainly related to the bonuses granted to certain of our employees in connection with our initial public offering, or IPO, in October 2013 that were recorded in the fourth quarter of 2013), as well as a decrease in share-based compensation expenses of $0.4 million (primarily as a result of the acceleration of vesting of options in the fourth quarter of 2013 related to the IPO). This was partially offset by expenses of $0.4 million related to the secondary offering we conducted in February 2014, other expenses of $0.7 million relating to being a public company and an increase of $0.2 million in allowance for doubtful accounts.&#160;&#160;The increase in general and administrative expenses as a percentage of net revenues reflected the overall decrease in net revenues, partially offset by the decrease in the absolute amount of general and administrative expenses.&#160;&#160;We anticipate that general and administrative expenses may increase in 2015 as a result of legal costs relating to the arbitration with AAK.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial income (expenses), net
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following table presents our financial income (expenses), net, in dollars and as a percentage of net revenues for the years indicated, and the percentage change in such amounts year-over-year:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_16"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended&#160;December
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	31,&#160;2013
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year-over-year
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	change
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year&#160;ended&#160;December&#160;31,
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in thousands)
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial income (expenses), net
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(531
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,030
</FONT>
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	499
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Percentage of total net revenues
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(0.8
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)%
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1.1
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial income for the year ended December 31, 2014 was $0.5 million, compared to financial expenses of $0.5 million for the year ended December 31, 2013, primarily due to decrease in financial expenses of $0.5 million related to the long-term loans that were repaid in January 2014, interest received and accrued on our bank deposits and marketable securities of $0.3 million and foreign currency exchange differences of $0.3 million, partially offset by a decrease in gain in respect of derivatives of $0.1 million.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Seasonality
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our revenues generally are not affected by seasonality.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	61
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage68"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Critical accounting estimates and assumptions
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;We have prepared our consolidated financial statements and related disclosures in conformity with U.S. GAAP. This has required us to make estimates based on our judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates. See &#8220;Item 3.D. Key Information&#8212;Risk factors&#8221; for a discussion of the possible risks which may affect these estimates. Note 1 to our consolidated Financial Statements contained elsewhere in this annual report describes the significant accounting policies and principles that are used to prepare our consolidated financial statements.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;We have identified several critical accounting estimates that required us to use assumptions about matters that were uncertain at the time of our estimates. Had we used different assumptions, the amounts we recorded could have been significantly different. Additionally, if we had used different assumptions or had different conditions existed, our financial condition or results of operations could have been materially different. The critical accounting policies that were impacted by the estimates, assumptions, and judgments used in the preparation of our consolidated financial statements are discussed below.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Revenue recognition
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We recognize revenues from sales of products to customers, including distributors, when persuasive evidence of a sale arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is reasonably assured. We recognize revenues related to AL from sales to AAK only upon sales by AL to its customers. Revenues are recorded net of reserves for returns and net of cash discounts and distribution fees.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We provide a right of return to U.S. distributors upon expiration of the medical food products sold in the VAYA Pharma segment, in compliance with applicable regulations. The majority of our product returns are the result of product dating. Accordingly, we record a reserve for estimated sales returns based on historical experience with actual returns, as well as specific factors, such as levels of inventory in the distribution channel, product dating and expiration. Returns to date have been inconsequential. Revenues from product sales are also recorded net of cash discounts and distribution fees, which can be reasonably estimated.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;Share-based compensation
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under U.S. GAAP, we account for employee share-based compensation awards classified as equity awards in accordance with the provisions of Accounting Standards Codification ("ASC") No. 718, &#8220;Compensation &#8212; Stock Based Compensation,&#8221; which requires us to measure the cost of options based on the fair value of the award on the grant date. We also apply ASC No. 718, &#8220;Compensation &#8212; Stock Based Compensation&#8221; and ASC No. 505-50, &#8220;Equity Based Payments to Non-Employees&#8221; with respect to options issued to consultants and other non-employees.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We selected the binomial option pricing model as the most appropriate method for determining the estimated fair value of our share-based compensation awards. The fair value of share-based compensation awards is recognized as an expense over the requisite service period, which is usually the vesting period, net of estimated forfeitures. We estimate forfeitures based on historical experience and anticipated future conditions. We recognize compensation cost for an award with service conditions that has a graded vesting schedule using the straight-line method based on the multiple-option award approach.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	When options are granted as consideration for services provided by consultants and other non-employees, the grant is accounted for based on the fair value of the consideration received or the fair value of the options issued, whichever is more reliably measurable. The fair value of the options granted is measured on a final basis at the end of the service period and is recognized over the service period using the straight-line method.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	62
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage69"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Option valuations
</FONT>
	. The determination of the grant date fair value of options using an option pricing model is affected by estimates and assumptions regarding a number of complex and subjective variables. The key variables are as follows:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 18PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Fair Value of our Ordinary Shares
</FONT>
	. Prior to our initial public offering, due to the absence of a public market for our ordinary shares, the fair value of our ordinary shares for purposes of determining the exercise price for award grants was determined in good faith by our management and approved by our board of directors. In connection with preparing our financial statements, our management considered the fair value of our ordinary shares based on a number of objective and subjective factors consistent with the methodologies outlined in the American Institute of Certified Public Accountants Practice Aid, Valuation of Privately-Held-Company Equity Securities Issued as Compensation, referred to as the AICPA Practice Aid. The fair value of our ordinary shares is now determined based on the trading price on the NASDAQ Global Select Market.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 18PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Volatility
</FONT>
	. The expected share price volatility was based on the historical equity volatility of the ordinary shares of publicly traded comparable companies with a trading history as long as the contractual term.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 18PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Risk-Free Interest Rate
</FONT>
	. The annual risk-free interest rate was based on the interest curve for U.S. government bonds for periods corresponding to the life term of the option on the grant date.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 18PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Contractual Term
</FONT>
	. The contractual term is 10 years. This was then adjusted based on data regarding our historical post-vesting exit rates. Pre-vesting exit rates were reflected in an adjustment to the number of options recognized in expenses.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 18PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Early Exercise Multiple
</FONT>
	. The early exercise multiple was based on the early exercise multiple data of publicly traded comparable companies with a trading history as long as the contractual term.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 18PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Dividend Yield
</FONT>
	. We have never declared or paid any cash dividends and do not presently plan to pay cash dividends in the foreseeable future. Consequently, we used an expected dividend yield of zero.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If any of the assumptions used changes significantly, share-based compensation awards for future awards may differ materially compared with the awards granted previously.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Research and development expenses
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Research and development expenses are charged to income as incurred. Participation from government departments and from research foundations for development of approved projects is recognized as a reduction of expense as the related costs are incurred. The main components of the research and development expenses are salaries and related expenses, laboratory, clinical research and regulatory related expenses.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Taxes on income
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Deferred income taxes are determined by the asset and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the tax rates expected to be in effect at the time when these differences reverse. Valuation allowances in respect of the deferred tax assets are provided when it is more likely than not that all or a portion of the deferred income tax assets will not be realized. See Note 10g to our consolidated Financial Statements contained elsewhere in this annual report for additional information regarding the composition of the deferred taxes.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;We assess our valuation allowance considering different indicators, including profitability of the different entities around the world and the ability to utilize the deferred tax assets in subsequent years.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;Tax benefits recognized in our consolidated financial statements are those that our management deems at least more likely than not to be sustained, based on technical merits. The amount of benefits recorded for these tax benefits is measured as the largest benefit our management deems more likely than not to be sustained.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	63
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage70"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Contingencies
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Certain conditions may exist as of the date of our financial statements, which may result in a loss to us but which will only be resolved when one or more future events occur or fail to occur. We assess such contingent liabilities and estimated legal fees, if any, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against us, or unasserted claims that may result in such proceedings, we evaluate the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We apply the guidance in ASC Topic 450-20- 25 issued by the Financial Accounting Standards Board ("FASB") when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability is recorded as accrued expenses in our financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material are disclosed. Loss contingencies considered to be remote are generally not disclosed unless they involve guarantees, in which case the guarantees are disclosed.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Impairment of long-lived assets
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We test long-lived assets (including intangible assets) for impairment whenever events or circumstances present an indication of impairment. If the sum of expected future cash flows (undiscounted and without interest charges) of the assets is less than the carrying amount of such assets, an impairment loss would be recognized. The assets would be written down to their estimated fair values, calculated based on the present value of expected future cash flows (discounted cash flows), or some other fair value measure. As of December 31, 2015, 2014 and 2013, we did not recognize an impairment loss for its long-lived assets.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	New and Revised Financial Accounting Standards
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;
</FONT>
	The JOBS Act permits emerging growth companies such as us to delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have irrevocably elected not to avail ourselves of this and, therefore, we are subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Recently Issued Accounting Pronouncements
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;See Note 1 to our consolidated Financial Statements included elsewhere in this annual report.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<EFX_LIQUIDITY_CAPITAL>
<A NAME="FIS_LIQUIDITY_CAPITAL"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	B.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Liquidity and Capital Resources
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
	A summary of our statement of cash flows for the years ended December 31, 2013, 2014 and 2015 is as follows:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_17"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in thousands)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net income
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,395
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,838
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,683
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Depreciation and amortization
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,551
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,308
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,327
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Change in inventories
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2,584
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(9,629
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(243
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Change in accounts receivable
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(6,965
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,304
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(881)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Change in accounts payable and accruals
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,052
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(3,868)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,300
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net cash provided by operating activities
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,390
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,965
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,198
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net cash used in investing activities
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(5,025
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(63,558
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(62
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net cash provided by (used in) financing activities
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	69,336
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2,522)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	536
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net increase (decrease) in cash and cash equivalents
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	71,701
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(64,115)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,672
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Balance of cash and cash equivalents at end of year
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	74,430
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,315
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,987
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	64
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage71"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cash flows provided by operating activities
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;Cash flows from operating activities consist primarily of net income adjusted for certain non-cash items. Adjustments to net income for non-cash items include depreciation and amortization and share-based compensation expense. In addition, operating cash flows are impacted by changes in operating assets and liabilities, which include inventories, accounts receivable and other assets and accounts payable.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;We generated $11.2 million in cash from operating activities in the year ended December 31, 2015, while in the year ended December 31, 2014, we generated $2.0 million from operating activities. Cash from operating activities in the year ended December 31, 2015 was due primarily to our achieving net income of $6.7 million, a decrease of $2.3 million in accounts payable and accruals as well as $2.3 million in depreciation and amortization and $1.6 million in share-based compensation expense. This was partially offset by an increase in accounts receivable of $0.9 million,
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	&#160;
</FONT>
	share of profits of equity investee of $0.4 million, increase in non-current assets of $0.3 million and increase in inventories of $0.2 million. Cash from operating activities in the year ended December 31, 2014 was due primarily to our achieving net income of $7.8 million and to a decrease of $5.3 million in accounts receivable due to the decreased sales, as well as $2.3 million in depreciation and amortization and $0.9 million in share-based compensation expense. This was partially offset by an increase of $9.6 million in inventories reflecting our strategy of building inventories from certain single source suppliers to partially manage supply risk as well as a result of the decreased sales, share of profits of equity investee of $0.5 million and a decrease of $3.9 million in accounts payable due to the decreased activity in the fourth quarter of 2014 compared to the activity in the fourth quarter of 2013. Cash from operating activities in the year ended December 31, 2013 was due primarily to our achieving net income of $11.4 million and to an increase of $3.1 million in accounts payable reflecting primarily increased purchases of raw materials due to increased activity, as well as $1.6 million in depreciation and amortization and $1.1 million in share-based compensation expense. This was partially offset by an increase of $2.6 million in inventories reflecting our increased activity as well as our strategy of building inventories from certain single source suppliers to partially manage supply risk and an increase of $7.0 million in accounts receivable due to increased sales.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Working capital
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our working capital, which we define as accounts receivable plus inventory less accounts payable, decreased from $29.3 million at December 31, 2014 to $28.2 million at December 31, 2015 due to an increase in accounts payable of $2.1 million, partially offset by an increase in accounts receivable of $0.8 million and an increase in inventories of $0.2 million. Working capital as a percentage of net revenues decreased from 62.2% at December 31, 2014 to 55.9% at December 31, 2015, mainly reflecting a decrease in our inventories conversion period as well as a decrease in our receivables conversion period.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Working capital increased from $20.7 million at December 31, 2013 to $29.3 million at December 31, 2014 due to an increase in inventory of $9.6 million and a decrease in accounts payable of $4.0 million, partially offset by a decrease in accounts receivables of $5.0 million. Working capital as a percentage of net revenues increased from 31.8% at December 31, 2013 to 62.2% at December 31, 2014, mainly reflecting increases in our inventories conversion period as a result of our strategy of building inventories from certain single source suppliers to partially manage supply risk as well as a result of the decreased sales.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cash flows used in investing activities
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We invested the substantial portion of the cash proceeds of our initial public offering of ordinary shares into bank deposits and marketable securities in the year ended December 31, 2014.&#160;&#160;Otherwise, the majority of our investment activities have historically been related to the construction and expansion of our manufacturing facilities and the purchase of manufacturing equipment and components for our production lines.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	65
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage72"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cash flows used in investing activities in the year ended December 31, 2015 amounted to $0.1 million which reflected primarily our investment of $9.4 million in bank deposits and marketable securities, purchase of property, plant and equipment and intangible assets of $2.9 million (mainly related to the expansion of our manufacturing facility), partially offset by $9.3 million in proceeds from the sale of marketable securities and a decrease of $3.0 million in bank deposits.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cash flows used in investing activities in the year ended December 31, 2014 amounted to $63.6 million which reflected primarily our investment of $62.5 million, mostly comprised of proceeds from our initial public offering, in bank deposits and marketable securities, purchase of property, plant and equipment and intangible assets of $6.4 million (mainly related to the construction and expansion of our manufacturing facility and the one-time
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	&#160;
</FONT>
	settlement payment to Neptune), partially offset by $5.3 million in proceeds from the sale of marketable securities.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We expect cash used in investing activities to increase significantly when and if we will commence the construction on our new manufacturing facility. While we anticipate that construction of this new facility will require significant capital expenditures, we have not yet started construction of the facility or even entered into contracts relating to the construction and therefore it would not be completed, if we do undertake it, before 2017. The timing and amount of the capital expenditures associated with this project, if we do undertake it, is uncertain.&#160;&#160;In addition, cash used in investing activities would increase to the extent that we acquire complementary businesses or assets.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cash flows provided by (used in) financing activities
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cash provided by financing activities in the year ended December 31, 2015 amounted to $0.5 million that represents the proceeds from exercises of options by employees.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cash used in financing activities in the year ended December 31, 2014 amounted to $2.5 million, which reflects primarily a repayment in full of $4.2 million of our long-term loan, partially offset by proceeds from exercises of options by employees of $1.8 million.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We generated $69.3 million in cash from financing activities in the year ended December 31, 2013, which reflects primarily $62.8 million of net proceeds from our IPO and $8.2 million received in an investment in our preferred shares and warrants, partially offset by a repayment of $1.0 million in short-term loans under our working capital credit facility and repayment of $0.7 million under our long-term loan.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Capital resources
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have traditionally funded our operations with a combination of cash generated from operating activities, third-party debt consisting mainly of long-term and short-term bank credit facilities, as well as cash generated through the sale of equity securities.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As of December 31, 2013, we had $4.2 million in outstanding principal amount under a long-term credit facility. On January 31, 2014, we repaid this amount in full and, as a result, we accrued $150,000 in early repayment fees.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We believe that, based on our current business plan, our cash, cash equivalents and short-term bank deposits on hand and cash from operations, we will be able to meet our capital expenditure and working capital requirements, and liquidity needs for at least the next twelve months. We may require additional capital in the future, and therefore may engage in debt or equity financings to meet our longer term liquidity and future growth objectives.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	66
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage73"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	C.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Research and Development, Patents and Licenses
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Research and development
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We believe that our leading position as a developer and manufacturer of innovative bioactive ingredients is due in part to our expertise in lipids and enzymes accompanied by our policy of shared research and development resources across our organization and leveraging the significant cross benefits.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We maintain an ongoing program of research and development, or R&amp;D, to substantiate our clinical evidence and to enlarge our technological platform and process capabilities in relation to, among other things, lipid chemistry, enzymatic technology and lipid analysis. The primary aim of our R&amp;D program is to develop improved and more affordable products. We therefore focus on the enhancement of our existing product lines in order to reinforce our competitive strengths and expand the scope of our existing products into new indications. We have a pipeline of several products, including new uses and applications for existing products, in various stages of development. Some of these products address new medical indications or provide new dietary or medical benefits, while others provide different levels/concentrations of active ingredients and offer improved secondary characteristics. In addition to further substantiating the value and efficacy of our existing products, our R&amp;D program also focuses on the development of additional lipid-based products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As all of our products are derived from our expertise in lipids biochemistry and our capabilities in analyzing lipid structure, composition and performance, much of our R&amp;D is not divided based on segment or product line. Rather, more general R&amp;D is conducted and only after particular R&amp;D is seen to relate to the development of a new product or the enhancement of an existing product does that R&amp;D become associated with a specific product line or segment. We believe that this helps us leverage shared R&amp;D resources across our organization.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have several new nutritional ingredient products for infant formula under development planned to launch within the next few years.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We invest a significant amount of our resources in R&amp;D as we believe that superior technology is key to maintaining a leading market position. Our R&amp;D expenses were $5.9 million, $6.0 million and $6.1 million in the years ended December 31, 2013, 2014 and 2015, respectively, representing 9.2%, 12.7% and 12.2% of net revenues, respectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We may use our R&amp;D platform to seek to penetrate the prescription pharmaceuticals market. For more information regarding our prescription pharmaceuticals, see &#8220;Item 4.B. Information on the Company &#8212; Business Overview &#8212; Government regulation &#8212; VAYA Pharma &#8212; Prescription drugs.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	InCog is a marine-based lipid composition for use in infant nutrition products that is intended to mimic certain characteristics of human breast milk. Pre-clinical trials of InCog have shown encouraging results, and we are currently considering its position and engaging in additional pre-clinical trials for the purpose of evaluating its efficacy. This ingredient is approved as GRAS by the FDA for marketing in the United States for the general population. We are currently in the process of applying for GRAS certification for infants. We are also in the process of preparing a submission for registration in China and Europe.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We anticipate that InCog will generate incremental revenues, but we do not expect it to be material to our results of operations in the near term.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We currently have several products in our VAYA Pharma segment in various stages of development. These include compositions based on phosphatidylserine (PS) and other lipids known to support cognitive, behavioral and metabolic human functions. We are developing and evaluating these products for the treatment of various cognitive, behavioral, mood or metabolic disorders. None of these products is expected to be individually material to our business in the near term.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Clinical Trials
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We generally conduct clinical and pre-clinical studies to support the efficacy and safety of our products and their ingredients and to extend and validate their benefits for human health. Pre-clinical studies allow us to substantiate the safety of our products and obtain preliminarily indications of their pharmacological profile and mechanism of the action. Through January 31, 2016, we had conducted 12 pre-clinical studies, according to the principles of Good Laboratory Practices (GLP) and completed 15 clinical studies, according to the principles of Good Clinical Practices (GCP). As a result, we have developed significant experience in planning, designing, executing, analyzing and publishing clinical studies.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	67
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage74"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 2014, we initiated a number of clinical trials, including a clinical trial for a product on managing Autism Spectrum Disorder symptoms, a clinical trial on Vayarin for adults with Attention Deficit Hyperactivity Disorder and a clinical trial on long term efficacy of Vayacog in mild cognitive impairment. These studies continued during 2015 and are scheduled to continue through 2016. In 2014, we also finalized the clinical phase of a clinical study of Vayarol for reducing triglyceride levels in patients with hypertriglyceridemia.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our R&amp;D team manages our clinical studies and is deeply involved with project planning, trial design, execution, outcome analyses and manuscript submission. During the design, execution and publication of our studies, our R&amp;D team consults with key opinion leaders in the relevant field of research to optimize both design and execution, as well as to strengthen the scientific and academic level of the investigational plan. Our clinical studies have been conducted in collaboration with leading medical and research centers in countries such as Israel, Canada, China and the Netherlands including Meir Medical Center, Israel; Sourasky Medical Center, Israel; Sheba Medical Center, Israel; and McGill University, Canada. For information regarding the clinical validation of our various products, see &#8220;Item 4.B. Information on the Company &#8212; Business Overview &#8212; Our products &#8212; Nutrition segment &#8212; Clinical validation&#8221; and &#8220;Item 4.B. Information on the Company &#8212; Business Overview &#8212; Our products &#8212; VAYA Pharma segment &#8212; Clinical validation.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Intellectual property
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our proprietary technology is important to the development, manufacture and sale of our products, and we seek to protect such technology and other intellectual property through a combination of patents, copyrights, trademarks, trade secrets, non-disclosure and confidentiality agreements, licenses, assignments of invention and other contractual arrangements with our employees, consultants, partners, suppliers, customers and others. We rely on our research and development program, clinical trials, production techniques and marketing and distribution programs to advance our products.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As of January 31, 2016, we had been granted approximately 100 patents and had applications for approximately 70 additional patents pending worldwide. Our principal granted patents relate to our technologies arising out of novel formulations, their beneficial uses and processes for the manufacturing thereof, rather than claiming specific molecules or active ingredients.
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	InFat
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	.
</FONT>
	The patent portfolio for the InFat products includes issued patents and pending applications directed to formulations, manufacturing process and methods of use. Our current and potential customers for InFat include major global nutrition companies with worldwide operations. The majority of manufacturers of infant formula containing InFat are located in Europe, New Zealand and Australia, where we have issued patents. In China, which is our largest end user market for InFat products, we have one issued patent covering a formulation and a process related to InFat and another issued patent covering a use related to InFat. In addition, we have pending applications covering additional uses. In Europe, we have three issued patents: one claiming a formulation which expires in 2024, and two claiming uses of InFat which expire in 2028 and 2031 and are currently under opposition proceedings. We also have other applications related to InFat in Europe. In each of New Zealand and Australia, we have issued patents claiming a manufacturing process for InFat, which expire in 2020 and 2018, respectively. In addition, we have two issued patents in Australia which cover uses related to InFat and expire in 2028 and 2031, and two issued patents in New Zealand which cover uses related to InFat and expire in 2031. While the United States is not currently a major market for InFat, we do believe it presents a growth opportunity for InFat. In the United States, we have one issued patent claiming a manufacturing process, which expires in 2017, and four issued patents claiming methods of use, which expire in 2026, 2027 and 2031. We also have five pending U.S. applications covering particular compositions and uses related to the InFat products. We also have issued patents related to these products in Israel, Mexico, South Korea, India, Canada, Hong Kong, Singapore and Russia, and patent applications pending in various countries around the world.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	PS Products
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	.
</FONT>
	The patent portfolio for our PS products (including Sharp PS) includes patents and patent applications directed to formulations, manufacturing processes, and methods of use. In each of the United States and Europe, the two largest markets for our PS products, we own one issued patent covering a formulation related to Sharp PS, which expires in the United States in 2026 and in Europe in 2024. We also have issued counterparts to that patent in Australia, Canada, Japan Hong Kong, Israel and South Korea. In addition, during 2015 we filed an international application under the Patent Cooperation Treaty (&#8220;PCT&#8221;) with the International Bureau of the World Intellectual Property Organization (&#8220;WIPO&#8221;) to cover certain PS compositions and processes.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	68
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage75"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Krill Oil Products
</FONT>
	. During 2015, we filed three international applications under the PCT with the International Bureau of WIPO relating to intellectual property relevant to krill oil formulations, manufacturing processes and methods of use.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	VAYA Products
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	.
</FONT>
	The patent portfolio for our various VAYA products (including Vayarol, Vayacog and Vayarin) includes patents and patent applications directed to formulations and methods of use. The United States is currently the largest market for our VAYA products. We have four issued patents in the United States covering formulations or methods of use related to Vayarin, of which three of these patents also cover formulations or uses of Vayacog. None of these patents expires before 2024. We also have two issued U.S. patents covering composition and method of use related to Vayacog, which expire in 2030, and two issued patents covering a formulation of Vayarol and a use related to Vayarol, which expire in 2024 and in 2026, respectively. One or more patents related to one or more of our VAYA products have also been issued in each of Australia, Canada, China, Europe, Hong Kong, India, Israel, Japan, Mexico, New Zealand, the Philippines, Russia and South Korea.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have an exclusive license under a family of third party patents related to a process for the enzymatic production of PS, Vayarin and Vayacog including issued patents in the United States, Europe, China and Japan, each expiring in 2016. Under that license, we have the right to enforce the licensed patents against third party infringers. Royalties payable under that license are not material to our results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	While our policy is to obtain patents by application, license or otherwise, to maintain trade secrets and to seek to operate without infringing on the intellectual property rights of third parties, technologies related to our business have been rapidly developing in recent years. Loss or invalidation of certain of our patents, or a finding of unenforceability or limited scope of certain of our intellectual property, could have a material adverse effect on us. See &#8220;Item 8.A. Financial Information &#8212; Consolidated Financial Statements and Other Financial Information &#8212; Legal Proceedings&#8221; below.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition to patent protection, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information in attempting to develop and maintain our competitive position.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We also rely on protection available under trademark laws. We currently hold registered trademarks in various jurisdictions for the mark &#8220;MSO&#8221; and certain other key product names, including &#8220;InFat,&#8221; &#8220;K&#8226;REAL,&#8221; &#8220;Sharp PS,&#8221; &#8220;Vayarol,&#8221; &#8220;Vayacog&#8221; and &#8220;Vayarin.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We believe that, while our patents provide us with a competitive advantage, our success depends primarily on our marketing, business development, know-how and ongoing research and development efforts. Accordingly, we believe that the expiration of any of our patents, or the failure of any of our patent applications to result in issued patents, would have no more than a short-term adverse effect on our business or financial position. Nevertheless, we are continuously working to generate a new cluster of patents to reinforce our intellectual property position and protect the competitive edge we are creating in the market. In any event, there can be no assurance that our patents or other intellectual property rights will afford us a meaningful competitive advantage.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	D.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Trend Information
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;Other than as disclosed elsewhere in this annual report, we are not aware of any trends, uncertainties, demands, commitments or events for the period from January 1, 2015 to December 31, 2015 that are reasonable likely to have a material adverse effect on our net revenues, income, profitability, liquidity or capital resources, or that caused the disclosed financial information to be not necessarily indicative of future operating results or financial condition.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	E.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Off-Balance Sheet Arrangements
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;Except for standard operating leases, we do not engage in any off-balance sheet arrangements, such as the use of unconsolidated subsidiaries, structured finance, special purpose entities or variable interest entities.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	69
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage76"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_18"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	F.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Contractual Obligations
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our future contractual cash obligations as of December 31, 2015 in excess of one year are summarized in the following table:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="80%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Total&#160;
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(1)
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Less&#160;than&#160;1
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	year
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	1&#160;&#8211;&#160;3&#160;years
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	3&#160;&#8211;&#160;5&#160;years
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	More&#160;than&#160;5
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	years
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="18" VALIGN="BOTTOM" WIDTH="58%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in thousands)
</FONT>
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating lease obligations
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,620
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	802
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	708
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	110
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Excludes future projected royalty payments of approximately 3%-5% of revenues derived from research and development projects that were funded in part by grants received from the OCS.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition, in 2014 we have entered into a 10-year toll manufacturing agreement with respect to one of our products. Under the terms of the agreement, we have committed for minimum purchasing through the entire term of the agreement. In the event that we fail to meet our minimum purchase requirements or otherwise terminate the agreement, we will be required to pay a termination payment which is based on a fixed amount of up to $500,000 reduced by the amount actually purchased before termination.
</FONT>
</DIV>
</DIV>
</EFX_LIQUIDITY_CAPITAL>
</EFX_OPERATING_AND_FINANCIAL_REVIEW>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<EFX_DIRECTORS_AND_OFFICERS>
<A NAME="FIS_DIRECTORS_AND_OFFICERS"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 6: Directors, Senior M
<A NAME="ZK1618102_HTM_4">
	ana
</A>
	gement and Employees
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_NAME_AND_TITLE>
<A NAME="FIS_NAME_AND_TITLE"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	A.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Directors and Senior Management
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following table sets forth information for our executive officers and directors as of the date of this annual report. Unless otherwise stated, the address for our directors and executive officers is c/o Enzymotec Ltd., Sagi 2000 Industrial Area, P.O. Box 6, Migdal Ha&#8217;Emeq 2310001, Israel.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="3" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Name
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="6%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Age
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="51%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Position(s)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Executive officers
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Ariel Katz
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	57
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	President and Chief Executive Officer
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Oren Bryan
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	41
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Vice President and Chief Financial Officer
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gai Ben-Dror
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Vice President &#8211; Process Development
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Shachar Carmi
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	51
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Vice President &#8211; Nutrition Division
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Robert Crim
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	58
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	President and CEO VAYA Pharma USA
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Itay Dromi
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	51
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Vice President &#8211; Human Resources and Information Systems
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Yariv Gratz
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(6)
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	51
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Vice President &#8211; Operations
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Yael Richter
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	41
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Vice President &#8211; Research and Development
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Directors
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Steve Dubin
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(3)(4)
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	62
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Chairman of the Board
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Nir Belzer
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(2)(4)
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	53
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Director
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Tamar Howson
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(4)
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	67
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Director
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Holger Liepmann
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(4)
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	64
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Director
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Dov Pekelman
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(1)(4)
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	75
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Director
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Yossi Peled
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(4)
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	68
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Director
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Michal Silverberg
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(1)(2)(4)(5)
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	39
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Director
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Joseph Tenne
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(1)(2)(3)(4)(5)
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	60
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Director
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="26%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Imanuel (Mani) Wasserman
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(3)(4)
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	49
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="51%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Director
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV>
<HR STYLE="COLOR: BLACK" ALIGN="LEFT" NOSHADE SIZE="1" WIDTH="15%">
</DIV>
</DIV>
</DIV>
</EFX_NAME_AND_TITLE>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Member of our audit committee.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	70
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage77"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Member of our compensation committee.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(3)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Member of our nominating and governance committee.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(4)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Independent director under the rules of the NASDAQ Stock Market.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(5)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	External director under the Israeli Companies Law. See &#8220;&#8212; Board Practices &#8212; External directors.&#8221;
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(6)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Mr. Gratz informed us in January 2016 that he would resign from his position at the Company effective March 3, 2016.
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV>
<DIV>
	&#160;
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Our executive officers
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Dr. Ariel Katz
</FONT>
	has served as our President and Chief Executive Officer since joining us in 2000. He has also served as the head of our VAYA Pharma segment from January 2012 to August 2014. Prior to joining Enzymotec, Dr. Katz held various positions with the Dead Sea Bromine Group of Israel Chemicals Ltd. over a period of 14 years, including senior positions in research and development, plant management, marketing and business development. Dr. Katz holds a bachelor&#8217;s degree in chemistry and a master&#8217;s degree in economic management both from Ben-Gurion University of the Negev, Beer Sheva, Israel, and a PhD in engineering in the field of artificial intelligence from Exeter University, UK. Dr. Katz was a guest lecturer in the Biotechnology Department of the Technion &#8212; Israel Institute of Technology, Haifa, Israel from 2003 to 2010.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Oren Bryan
</FONT>
	has served as our Vice President and Chief Financial Officer since June 2008. Prior to joining Enzymotec, he served as Chief Financial Officer of MIND C.T.I. Ltd., a global provider of real-time, product-based mediation, billing and customer care solutions for voice, data, video and content service from 2006 to 2008 and Controller of MIND C.T.I. Ltd. from 2005 to 2006. Before working at MIND C.T.I. Ltd., Mr. Bryan served as Controller of both Dor Chemicals Ltd. from 2001 to 2005 and a private software company from 2000 to 2001. Between 1997 and 2000, he was an accountant with Kost, Forer, Gabbay and Kasierer, a member of Ernst &amp; Young Global. Mr. Bryan is a certified public accountant and holds a B.A. in economics and accounting from Haifa University, Israel.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	71
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage78"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Gai Ben-Dror
</FONT>
	has served as our Vice President &#8212; Process Development and previously as our Director of Process Development since joining Enzymotec in December 2001. As Director of Process Development, he was responsible for the development and commercialization of all of our products and for the building of our technological and analytical teams. Prior to joining us, Mr. Ben-Dror was a plant and pilot engineer in the Dead Sea Bromine Group of Israel Chemicals Ltd. from 1996 to 2000. Prior to that he worked as a research team leader at Sense-IT Ltd., a hardware development company, and as a project manager at Chimtec Ltd., a water treatment engineering company. He holds a B.Sc. in chemical engineering and an M.B.A. from Ben-Gurion University of the Negev, Beer Sheva, Israel.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Shachar Carmi
</FONT>
	has served as our Vice President &#8211; Sales, Nutrition Division since July 2014 and became our Vice President Nutrition Division in February 2015. Prior to joining Enzymotec, from 2009 to June 2014, he served as Vice President &#8211; Sales and Marketing at Biobee Sde Eliyahu, a leading producer of bumble bees for natural pollination and beneficial insects used in agriculture as an alternative to chemical pesticides. From 2007 to 2009, he served as Product Manager at Hazera Genetics, a leading breeder and supplier of vegetable seeds. Prior to that, he held positions at Milestone Agriculture, Inc. and Click Software. Mr. Carmi received his B.Sc. in Industrial Engineering from Tel Aviv University.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Robert Crim
</FONT>
	has served as President and CEO of Vaya Pharma USA since August 2014. Mr. Crim has over 15 years of experience in the global clinical nutrition and medical foods area. Prior to joining Vaya Pharma, from 2010 to 2014, Mr. Crim was an independent consultant focusing on medical nutrition and healthcare clients. From 2004 to 2010, he held positions of increasing responsibility at Danone/Numico, including General Manager of the SHS business and Regional Vice President &#8211; North America and Global Business Development as well as serving on the Executive Committee of the Medical Nutrition Division. Prior to that, Mr. Crim held positions at Abbott, including Vice President &#8211; Consumer Nutritionals where he was responsible for the Ensure and Glucerna businesses. Mr. Crim has also held positions at Johnson &amp; Johnson and Procter and Gamble. He received his M.B.A. from University of Michigan and his B.A. from Harvard University.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Itay Dromi
</FONT>
	has served as our Vice President &#8211; Human Resources since July 2014. Mr. Dromi has over 20 years of global experience in human resources and organizational management. Prior to joining Enzymotec, Mr. Dromi served from 2010 to 2014 in multiple senior human resources positions at Teva Pharmaceutical, Ltd, including as Vice President &#8211; Human Resources TGO Asia Region and as Vice President &#8211; Human Resources of the Chemical Division. Mr. Dromi previously held human resources positions at Ultrashape and Delta Galil Industries. Mr. Dromi received his M.B.A from Bar Ilan University and an M.A. in Public Administration from the University of Haifa.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Yariv Gratz
</FONT>
	has served as our Vice President &#8211; Operations since June 2014. Prior to joining Enzymotec, Mr. Gratz served from 2010 to 2014 as Director of Operations at Nilit Ltd. where he was responsible for managing manufacturing facilities in Israel and China including global engineering and projects department and the industrial engineering unit, overseeing a total of 650 employees. Prior to this position, he served as Vice President &#8211; Operations for MIS &#8211; Israel. From 1992 to 2010, he held positions at Sanmina SCI, EIL &#8211; Electrochemical Industries and Gadot Bio Chem. Mr. Gratz received his M.B.A. from Herriot Watt and B.Sc. in Chemical Engineering from The Technion &#8211; Israel Institute of Technology.&#160;&#160;Mr. Gratz informed us in January 2016 that he would resign from his position at the Company effective March 3, 2016.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Yael Richter
</FONT>
	has served as our Vice President &#8211; Research and Development since October 2015. Previously, she served as our Director of Research and Development and as the head of VAYA Pharma&#8217;s research and development team since joining Enzymotec in May 2006. She was also responsible for building VAYA Pharma&#8217;s medical affairs team, supporting all the scientific communication and education activities. She holds a bachelor&#8217;s degree in Chemistry from the Hebrew University and a PhD in chemistry from Bar-Ilan University, Israel, where she specialized in medicinal chemistry.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Our directors
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Steve Dubin
</FONT>
	has served as Chairman of our board of directors since January 2014 and served as Vice Chairman before that following his appointment as a director in April 2013. Since November 2011, Mr. Dubin has been a Principal in SDA Ventures LLC, a firm primarily focused on assisting emerging growth and middle-market companies, primarily in the health &amp; wellness and nutritional products markets, on matters including corporate development, business acquisition, customer relations, growth strategies and corporate finance. In connection with SDA Ventures, Mr. Dubin acts as an Operating Professional to Paine &amp; Partners, LLC, a global private equity investment firm located in New York, Chicago, and San Francisco, for the purpose of identifying and executing investment opportunities in the global human and animal food and nutritional products industries. From 2006 until its acquisition by Royal DSM N.V. in February 2011, Mr. Dubin served as Chief Executive Officer and a member of the board of directors of Martek Biosciences Corporation. He later served as President of DSM&#8217;s Nutritional Lipids Division from February 2011 through October 2011 and as a Senior Advisor to DSM Nutritional Products from November 2011 through October 2012. After joining Martek in 1992 and serving in various management positions, including Chief Financial Officer, Treasurer, Secretary, General Counsel and Senior Vice President, Business Development, he served as President of Martek from 2003 to 2006. From 2000 to 2003, Mr. Dubin co-founded and co-managed a Maryland-based, angel-investing club and was &#8220;Of Counsel&#8221; to Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., a U.S. law firm, during part of 2001 and 2002. Mr. Dubin currently serves as a member of the board of two privately held companies, NeurExpand Brain Center LLC, formerly
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	&#160;
</FONT>
	The Brain Center, LLC (which has ceased its operations as of 2015)&#160;&#160;and Alcresta, Inc. During 2011 and 2012, he was a member of the board of directors of Scerene Healthcare, Inc. From March 2013 through March 2014, Mr. Dubin was a director of MyCell Technologies and its subsidiary Oceans Omega LLC. Mr. Dubin holds a bachelor&#8217;s degree in accounting from the University of Maryland and a Juris Doctor degree from the National Law Center at George Washington University. He is a certified public accountant and a member of the Maryland Bar.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	72
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage79"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Nir Belzer
</FONT>
<FONT STYLE="FONT-STYLE: NORMAL; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	has served as a director of Enzymotec since January 2007. Mr. Belzer is a co-founder of Aquagro Fund L.P., one of Israel&#8217;s first funds to focus on clean technologies, and has served as its Managing Partner since 2007. In addition, he is a co-founder of the Millennium Materials Technologies funds, which was previously a major shareholder of ours, and has served as Managing Partner of Millennium Materials Technologies funds since 1998. Mr. Belzer has 20 years of extensive experience in venture capital management, including fund management in Israel&#8217;s IDB Group. From 1995 to 1997, Mr. Belzer worked in the Israeli high tech industry, at Globes, a leading Israeli financial newspaper, as a Marketing Manager, and at Israel Aerospace Industries Ltd., as an avionics engineer for the Lavi project. Mr. Belzer was appointed as a director pursuant to Millennium Materials Technologies&#8217; appointment rights under our articles of association in effect prior to our initial public offering. He holds a bachelor&#8217;s degree in mathematics, computer science and avionics and an M.B.A. from Tel Aviv University. Mr. Belzer was re-elected as director&#160;in 2015.
</FONT>
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Tamar Howson
</FONT>
	has served as a director of Enzymotec since July 2015. Ms. Howson has served as a corporate business development and strategy consultant to biopharmaceutical companies since 2011. From 2009 to 2011, she worked for JSB-Partners, a transaction advisory firm, providing business development support to life sciences companies. From 2007 to 2008, Ms. Howson served as Executive Vice President, Corporate Business Development at Lexicon Pharmaceuticals.
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	&#160;
</FONT>
	From 2001 to 2007, Ms. Howson held the position of Senior Vice President, Corporate and Business Development at Bristol-Myers Squibb. Ms. Howson currently serves on the Board of Directors of publicly traded Organovo, Inc. (NYSE: ONVO), OXiGENE, Inc. (NASD: OXGN) and Cynapsus (TSE: CTH), Inc. In the past, Ms. Howson served as a director of Actavis plc, Idenix Pharmaceuticals Inc., Warner Chilcott plc, Soligenix, Inc. and Cardax, Inc., all of which are publicly traded. In addition, Ms. Howson serves as a director of the International Partnership for Microbicides, a non-profit product development partnership. She has also served on the boards of Aradigm, S*BIO, Ariad Pharmaceuticals, SkyePharma, NPS Pharma, Targacept and HBA. Ms. Howson holds a bachelor&#8217;s degree in Chemical Engineering from the Technion, Israel, an M.S. from the City University of New York and an M.B.A. from Columbia University.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Holger Liepmann
</FONT>
	&#160;has served as a director of Enzymotec since February 2015. He served in various positions with Abbott Laboratories from 1986 until his retirement in 2011.&#160;&#160;From 2006 to 2011, Mr. Liepmann served as executive vice president, Nutritional Products of Abbott Laboratories.&#160;&#160;&#160;In this capacity he was responsible for all aspects of Abbott Laboratories&#8217; global nutritional business, including R&amp;D, manufacturing, supply chain and commercial operations, and reported to Abbott&#8217;s CEO.&#160;&#160;&#160;Previously, he served as executive vice president, Pharmaceutical Products Group, senior vice president, Abbott International, the commercial operations for Abbott's international pharmaceutical business, and vice president Japan Operations. He enjoyed an international career with postings in Japan, Spain, Puerto Rico, Germany and the United States. Prior to joining Abbott, Mr. Liepmann worked for Bayer AG in a variety of capacities between 1975 and 1986, both in the US and in Germany. Mr. Liepmann earned a bachelor&#8217;s degree from Dartmouth College and a master&#8217;s degree in business administration from Stanford University. He currently sits on the boards of Altan Pharma Ltd., which he co-founded, and Desert Research Institute Foundation and SmartTots, two non-governmental organizations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Prof. Dov Pekelman
</FONT>
	has served as a director of Enzymotec since October 2010. In addition, Professor Pekelman currently serves as the Chairman of the special committee of the board of directors of Taro Pharmaceuticals Industries Ltd. (NYSE: TARO), as well as Chairman of Atera Networks Ltd.. Prof. Pekelman serves on the board of directors of the Interdisciplinary Center (IDC), Herzliya, Israel and is Chairman of the IDC Corporation, the center&#8217;s economic arm. From 1985 to 2008, Professor Pekelman served as a senior consultant to Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and also founded and ran a leading, Israeli-based management-consulting firm, P.O.C. Ltd. Previously, he served on the board of directors of several industrial corporations, including Koor Industries Ltd. (TASE: KOR), and was also a member of the advisory committee of the Bank of Israel. He holds bachelor&#8217;s degree from the Technion &#8212; Israel Institute of Technology, Haifa, Israel and a doctorate from the University of Chicago.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	73
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage80"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Yossi Peled
</FONT>
	has served as a director of Enzymotec since June 2001. From June 2009 to October 2011, Mr. Peled was the Chairman of our board of directors. In addition, he has served as the Chief Executive Officer of Galam Ltd. since 1987 and from 1977 until 1984. Mr. Peled is a member of the board of directors of a number of companies within the Galam Group, including Eurosweet GmbH (of which he is Chairman) and Galam Invest Ltd. From 2001 to 2003, Mr. Peled served as the Chairman of the board of directors of Lehavot Fire Protection Ltd., Israel&#8217;s leading fire protection equipment manufacturer. Previously, he held various managerial roles in Kibbutz Maanit and HaKibbutz HaArtzi, the national kibbutz organization in Israel, which represents more than 250 kibbutzim. Mr. Peled studied business administration at the Ruppin Academic Center, Israel, and executive business management at &#8220;Lahav&#8221; of the Faculty of Management Tel Aviv University.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Michal Silverberg
</FONT>
	has served as a director of Enzymotec since September 2013. In 2014 Ms. Silverberg became a Senior Director for TVI (Takeda Ventures Inc). Since 2007, Ms. Silverberg has worked in various positions in Novo Nordisk&#160;&#160;A/S, a global healthcare company headquartered in Denmark with shares listed on the Copenhagen and New York Stock Exchanges. Since 2010, she has served as Senior Director, New Product Commercialization &amp; Business Development for the BioPharm unit. Prior to joining Novo Nordisk, Ms. Silverberg held various positions in a biotech company, an investment group and the Office of the Chief Scientist of Israel (Technological Incubators). Ms. Silverberg holds a B.A. in Economics and Business Management from Haifa University, Israel, an M.B.A. from Tel Aviv University, and an M.A. in Biotechnology from Columbia University.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Joseph Tenne
</FONT>
	has served as a director of Enzymotec since September 2013. Mr. Tenne is the Vice President of Finance of Itamar Medical Ltd. (TASE: ITMR), an Israeli company engaged in the medical devices business. From March 2005 until April 2013, Mr. Tenne served as the Chief Financial Officer of Ormat Technologies, Inc. (NYSE: ORA), which is engaged in the geothermal and recovered energy business. From January 2006 until April 2013, Mr. Tenne also served as the Chief Financial Officer of Ormat Industries Ltd., an Israeli holding company which was listed on the Tel Aviv Stock Exchange and was the parent company of Ormat Technologies, Inc. From 2003 to 2005, Mr. Tenne was the Chief Financial Officer of Treofan Germany GmbH &amp; Co. KG, a German company, which is engaged in the development, production and marketing of oriented polypropylene films, which are mainly used in the food packaging industry. From 1997 until 2003, Mr. Tenne was a partner in Kesselman &amp; Kesselman, Certified Public Accountants in Israel and a member of PricewaterhouseCoopers International Limited (PwC Israel). Mr. Tenne serves as a director of AudioCodes Ltd. (NASD/TASE: AUDC) and Ratio Oil Exploration (Finance) Ltd. (TASE: RATI.L), both Israeli companies, and an external director of Orbotech Ltd. (NASD: ORBK) and MIND C.T.I. Ltd. (NASD: MNDO), also Israeli companies. Mr. Tenne holds a B.A. in Accounting and Economics and an M.B.A. from Tel Aviv University. Mr. Tenne is also a Certified Public Accountant in Israel.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Dr. Imanuel (Mani) Wasserman
</FONT>
<FONT STYLE="FONT-STYLE: NORMAL; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	has served as a director of Enzymotec since October 2011. Dr. Wasserman is a co-founder of Beresheit General Partner Ltd., the general partner of Manof I funds, a NIS 2 billion Israeli fund, and has served as its managing partner since its inception in 2009. Previously, he was a co-founder and managing director of Magna Capital Ltd., an Israeli strategy and M&amp;A consulting firm, from 2000 to 2009. In addition, Dr. Wasserman worked as a lawyer, from 1992 to 1994 and from 1997 to 1999, with Zellermayer Pelossof and Co., an Israeli law firm. From 1995 to 1996, he was a foreign lawyer at Fried, Frank, Harris, Shriver and Jacobson, a U.S. law firm. Dr. Wasserman is the chairman of Zohar Dalia, an Israeli manufacturer of cleaning products and raw materials. He currently serves as a director for the following companies: Beresheit General Partner Ltd., Galam Ltd., Cargal Ltd., Plasto-sac Ltd. (TASE: PLST), Controp Ltd., Aeronautics Ltd. and Liberty Properties Ltd. Dr. Wasserman holds a bachelor&#8217;s degree in industrial engineering, an LLB, an LLM and a doctorate in law, all from Tel Aviv University. Dr. Wasserman was appointed as a director pursuant to Galam&#8217;s appointment rights under our articles of association in effect prior to our initial public offering.&#160;&#160;Mr. Wasserman was re-elected as director&#160;in 2015.
</FONT>
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Arrangements concerning election of directors; family relationships
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our current board of directors consists of nine directors. Pursuant to our articles of association in effect prior to our initial public offering, certain of our shareholders had rights to appoint members of our board of directors. See &#8220;&#8212; Directors and Senior Management.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	74
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage81"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	All rights to appoint directors and observers terminated upon the closing of the initial public offering, although currently-serving directors that were appointed pursuant to such rights will continue to serve pursuant to their appointment until the annual meeting of shareholders at which the term of their class of director expires.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We are not a party to, and are not aware of, any voting agreements among our shareholders. In addition, there are no family relationships among our executive officers and directors.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	B.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Compensation of Officers and Directors
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Compensation of executive officers and directors
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The aggregate compensation paid and share-based compensation and other payments expensed by us and our subsidiaries to our directors and executive officers with respect to the year ended December 31, 2015 was $3.0 million. This amount includes approximately $0.2 million set aside or accrued to provide pension, severance, retirement or similar benefits or expenses, but does not include business travel, relocation, professional and business association dues and expenses reimbursed to office holders, and other benefits commonly reimbursed or paid by companies in our industry. As of December 31, 2015, options to purchase 991,224 ordinary shares granted to our current directors and executive officers were outstanding under our equity incentive plans at a weighted average exercise price of $5.62 per share. In addition, as of December 31, 2015, 193,995 restricted share units and 117,028 restricted shares were granted to our current directors and executive officers of which 17,944 restricted share units and 39,032 restricted shares were vested. We do not have any written agreements with any director providing for benefits upon the termination of such director&#8217;s relationship with our company or our subsidiaries.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As of December 31, 2015, 132,476 ordinary shares remained available for grant under our share incentive plans.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<EFX_COMPENSATION_TABLE>
<A NAME="FIS_COMPENSATION_TABLE"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Summary Compensation Table
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The table below reflects the compensation paid to or earned by our five most highly compensated office holders during or with respect to the year ended December 31, 2015.&#160;&#160;All amounts reported in the table are in terms of cost to the Company, as recognized in our financial statements for the year ended December 31, 2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Name and Position
</FONT>
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Salary Cost
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(1)
</FONT>
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Bonus
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(2)
</FONT>
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Share-Based Compensation
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(3)
</FONT>
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	All Other Compensation
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(4)
</FONT>
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Directors&#8217; Fees
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Total
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="22" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in thousands)
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(5)
</FONT>
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Steve Dubin
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Chairman of the Board
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
	&#160;
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
	&#160;
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	412
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
	&#160;
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	120
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	532
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Ariel Katz
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	President and CEO
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	277
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	90
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	103
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	40
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	510
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Rob Crim
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	President and CEO of Vaya Pharma USA
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	214
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	83
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	83
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	398
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Oren Bryan
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Vice President and CFO
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	172
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	55
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	62
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	20
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	309
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Gai Ben Dror
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Vice President &#8211; Process Development
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	152
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	39
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	41
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	27
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	259
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_COMPENSATION_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 18PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1)
</FONT>
</DIV>
</TD>
<TD>
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Represents the office holder&#8217;s gross salary plus payment of mandatory social benefits made by the Company on behalf of such office holder. Such benefits may include, to the extent applicable to the office holder, payments, contributions and/or allocations for savings funds (e.g., Managers&#8217; Life Insurance Policy), education funds (referred to in Hebrew as &#8220;keren hishtalmut&#8221;), pension, severance, and risk insurance (e.g., life, or work disability insurance), health insurance convalescence pay and social security payments.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" ID="LIST" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 18PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2)
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Represents the amount recognized in our financial statements with respect to the year ended December 31, 2015 for bonuses to such office holder. The bonus for Ariel Katz is subject to approval by our shareholders.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 18PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(3)
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Represents grant date fair value computed in accordance with accounting guidance for equity-based compensation.&#160;&#160;For a discussion of the assumptions used in reaching this valuation, see Note 9 of the notes to our consolidated Financial Statements included elsewhere in this annual report.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 18PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(4)
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Represents other benefits provided to such office holder, which include (i) car expenses, including lease costs, gas and maintenance, provided to the office holder, (ii) unused vacation accruals and redemption, and (iii) accruals for severance pay.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 18PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(5)
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Some of the amounts were translated from NIS into dollars using the average exchange rate during the year ended December 31, 2015 of NIS 3.884 = $ 1.00, based on the daily representative rate of exchange between the NIS and the dollar reported by the Bank of Israel.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	75
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage82"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Employment agreements with executive officers; consulting and directorship services provided by directors
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have entered into written employment agreements with all of our executive officers. These agreements contain provisions standard for a company in our industry regarding non-competition, confidentiality of information and assignment of inventions. See &#8220;Item 3.D. Key Information &#8212; Risk factors &#8212; Risks relating to our business and industry &#8212; Under applicable employment laws, we may not be able to enforce covenants not to compete&#8221; for a further description of the enforceability of non-competition clauses. These agreements do not provide for benefits upon the termination of these executives&#8217; respective employment with us, other than payment of salary and benefits during the required notice period for termination of these agreements, which varies under these individual agreements. See &#8220;Item 6.D. Directors, Senior Management and Employees &#8212; Employees &#8212;Agreements and arrangements with, and compensation of, directors and executive officers&#8221; for additional information.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We receive consulting and directorship services from certain of our directors. The amounts payable pursuant to these arrangements have been approved by our board of directors and shareholders.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Equity incentive plans
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following are our equity incentive plans:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2003 Israeli Share Option Plan with 2012 U.S. Addendum
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In November 2003, we adopted our 2003 Israeli Share Option Plan and in June 2012, we adopted the 2012 U.S. Addendum to this plan. This plan, including the 2012 U.S. Addendum, is referred to as the 2003 Plan. The 2003 Plan permits the grant of options to purchase our ordinary shares to the employees, officers, directors and service providers of our company and our subsidiaries (to whom we refer as permitted grantees). The 2003 Plan was terminated on August 21, 2013, although option awards outstanding as of that date will continue in full force in accordance with the terms under which they were granted. There were 2,000,560 options outstanding under the 2003 Plan at the time it was terminated.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The 2003 Plan is administered by our board of directors, which determined, subject to Israeli law, the grantees of awards and the terms and provisions of the grant, including, the number of shares, exercise prices, vesting schedules, acceleration of vesting and the other matters necessary in the administration of the 2003 Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The 2003 Plan provides for the grant by us of awards under various tax regimes including, without limitation, pursuant to Sections 102 and 3(i) of the Israeli Income Tax Ordinance, to which we refer as the Ordinance, and Section 422 of the U.S. Internal Revenue Code of 1986, as amended, to which we refer as the Code. The Israeli Tax Authority, to which we refer as the ITA, approved the 2003 Plan, as required by applicable law.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Section 102 of the Ordinance allows employees, directors and officers, who are not controlling shareholders and who are Israeli residents, to receive favorable tax treatment for compensation in the form of shares or options. Section 102 of the Ordinance includes two alternatives for tax treatment involving the issuance of options or shares to a trustee for the benefit of the grantees and also includes an additional alternative for the issuance of options or shares directly to the grantee. Section 102(b)(2) of the Ordinance, the most favorable tax treatment for grantees, permits the issuance to a trustee under the &#8220;capital gains track.&#8221; In order to comply with the terms of the capital gains track, all options granted under a specific plan and subject to the provisions of Section 102 of the Ordinance, as well as the shares issued upon exercise of such options and other shares received subsequently following any realization of rights with respect to such options, such as share dividends and share splits, must be registered in the name of a trustee selected by the board of directors and held in trust for the benefit of the relevant employee, director or officer. The trustee may not release these options or shares to the holders thereof before the second anniversary of the registration of the options in the name of the trustee. However, under this track, we are not allowed to deduct an expense with respect to the issuance of the options or shares.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	76
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage83"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The 2003 Plan provides that options granted to our employees, directors and officers who are not controlling shareholders and who are considered Israeli residents are intended to qualify for special tax treatment under the &#8220;capital gains track&#8221; provisions of Section 102(b)(2) of the Ordinance. Our Israeli non-employee service providers and controlling shareholders may only be granted options under Section 3(i) of the Ordinance, which does not provide for similar tax benefits.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Options granted under the 2003 Plan to U.S. residents may qualify as &#8220;incentive stock options&#8221; within the meaning of Section 422 of the Code, or may be non-qualified. The exercise price for &#8220;incentive stock options&#8221; must not be less than the fair market value on the date on which an option is granted, or 110% of the fair market value if the option holder holds more than 10% of our share capital.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Options awarded under the 2003 Plan, generally vest over a four-year period from the effective date of grant, 25% on each anniversary of the date of grant. Any option not exercised within ten years from the grant date or within three months from termination of employment (and in certain cases, according to a resolution of the board of directors) will expire, unless extended by the board of directors. All option agreements for outstanding options include provisions for accelerated vesting upon the occurrence of certain events, including the completion of our initial public offering, or in the event of change in control, as defined. Pursuant to these provisions, 50% of every grantee&#8217;s unvested outstanding options under the 2003 Plan will vest immediately and the vesting of the remaining 50% will be accelerated to the earlier of: (i) one year from the date of closing of such initial public offering or event of change in control, subject to the grantee continuing to serve in the capacity of a permitted grantee under the plan; or (ii) in the event of change in control, the date upon which the grantee&#8217;s services are terminated, other than in the event of termination for cause.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013 Omnibus Equity Incentive Plan
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In August 2013, we adopted our 2013 Omnibus Equity Incentive Plan, which we refer to as the 2013 Plan, and which was approved by our shareholders on September 2, 2013. The 2013 Plan provides for the grant of options, restricted shares, restricted share units and other share-based awards to our company&#8217;s and our subsidiaries&#8217; respective directors, employees, officers, consultants, advisors and to any other person whose services are considered valuable to us or any of our affiliates. Following the approval of the 2013 Plan by the Israeli tax authorities, we will only grant options or other equity incentive awards under the 2013 Plan, although previously-granted options and awards will continue to be governed by our 2003 Plan. The number of shares reserved under the plan is automatically increased annually on January 1 of each year by a number of ordinary shares equal to the lowest of (i) 2% of our outstanding shares; (ii) a number of shares determined by our board of directors, if so determined prior to January 1 of the year on which the increase will occur; and (iii) 1,360,000 shares.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The 2013 Plan is administered by our board of directors or by a committee designated by the board of directors, which shall determine, subject to Israeli law, the grantees of awards and the terms of the grant, including, exercise prices, vesting schedules, acceleration of vesting and the other matters necessary in the administration of the 2013 Plan. The 2013 Plan enables us to issue awards under various tax regimes including, without limitation, pursuant to Sections 102 and 3(i) of the Ordinance, and as &#8220;incentive stock options&#8221; under Section 422 of the Code and nonqualified stock options, as discussed under &#8220;2003 Israeli Share Option Plan with 2012 U.S. Addendum&#8221; above.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We currently intend to grant options under the 2013 Plan only to our employees, directors and officers who are not controlling shareholders and are considered Israeli residents, under the capital gains track of Section 102(b)2 of the Ordinance.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Awards under the 2013 Plan may be granted until September 2, 2023, ten years from the date on which the 2013 Plan was approved by our shareholders.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Options granted under the 2013 Plan generally vest over four years commencing on the date of grant such that 25% vest on the first anniversary of the date of grant and an additional 6.25% vest at the end of each subsequent three-month period thereafter for 36 months. Options, other than certain incentive share options, that are not exercised within ten years from the grant date expire, unless otherwise determined by our board of directors or its designated committee, as applicable. Incentive share options granted to a person holding more than 10% of our voting power will expire within five years from the date of the grant. In the event of termination of employment or services for reasons of disability or death, or retirement, the grantee, or in the case of death, his or her legal successor, may exercise options that have vested prior to termination within a period of one year from the date of disability or death, or within three months following retirement. If we terminate a grantee&#8217;s employment or service for cause, all of the grantee&#8217;s vested and unvested options will expire on the date of termination. If a grantee&#8217;s employment or service is terminated for any other reason, the grantee may exercise his or her vested options within 90 days of the date of termination. Any expired or unvested options return to the pool for reissuance.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	77
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage84"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In the event of a merger or consolidation of our company, or a sale of all, or substantially all, of our shares or assets or other transaction having a similar effect on us, then without the consent of the option holder, our board of directors or its designated committee, as applicable, may but is not required to (i) cause any outstanding award to be assumed or an equivalent award to be substituted by such successor corporation or (ii) in case the successor corporation refuses to assume or substitute the award (a) provide the grantee with the option to exercise the award as to all or part of the shares or (b) cancel the options against payment in cash in an amount determined by the board of directors or the committee as fair in the circumstances. Notwithstanding the foregoing, our board of directors or its designated committee may upon such event amend or terminate the terms of any award, including conferring the right to purchase any other security or asset that the board of directors shall deem, in good faith, appropriate.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Restricted share awards are ordinary shares that are awarded to a participant subject to the satisfaction of the terms and conditions established by the board of directors or a committee designated by the board of directors. Until such time as the applicable restrictions lapse, restricted shares are subject to forfeiture and may not be sold, assigned, pledged or otherwise disposed of by the participant who holds those shares. Generally, if a grantee&#8217;s employment or service is terminated for any reason prior to the expiration of the time when the restrictions lapse, shares that are still restricted will be forfeited.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;The following table presents certain data for our 2003 Plan and 2013 Plan as at December 31, 2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<EFX_UNIDENTIFIED_TABLE>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="10%" STYLE="PADDING-BOTTOM: 2PX">
<A NAME="FIS_UNIDENTIFIED_TABLE_19"></A>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Grants&#160;of
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	restricted&#160;shares
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="4" VALIGN="BOTTOM" WIDTH="20%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Grants&#160;of
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	restricted&#160;shares units (RSU)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="8" VALIGN="BOTTOM" WIDTH="32%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Grants&#160;of&#160;share&#160;options
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Plan
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Shares
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	available&#160;for
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	future&#160;grants
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Number&#160;of
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	vested
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	shares
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Number
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	of&#160;unvested
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	shares
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Number
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	of&#160;vested
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	RSUs
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Number
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	of&#160;unvested
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	RSUs
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Aggregate&#160;number
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	exercised
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Aggregate&#160;number
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	outstanding
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Weighted
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	average
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	exercise&#160;price&#160;of
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	outstanding
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	options
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="10%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2003 Plan
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,169,067
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	860,124
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2.81
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="10%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2013 Plan
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	132,476
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1)&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	87,584
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	77,996
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	60,344
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	333,274
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	812,560
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="TEXT-ALIGN: RIGHT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11.17
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	______________________
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="2%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="97%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As of January 1, 2016, the reserved pool under the 2013 Plan increased to 586,843 shares pursuant to the provisions of the 2013 Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Between January 1, 2016 and February 29, 2016, we granted additional 378,309 options and 189,177 restricted share units to our employees and officers.
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	C.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Board Practices
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Board of Directors
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law, the management of our business is vested in our board of directors. Our board of directors may exercise all powers and may take all actions that are not specifically granted to our shareholders or to management. Our executive officers are responsible for our day-to-day management and have individual responsibilities established by our board of directors. Our Chief Executive Officer is appointed by, and serves at the discretion of, our board of directors, subject to the employment agreement that we have entered into with him. All other executive officers are also appointed by our board of directors, and are subject to the terms of any applicable employment agreements that we may enter into with them.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	78
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage85"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We comply with the rule of the NASDAQ Stock Market that a majority of our directors be independent. Our board of directors has determined that all of our directors are independent under such rules. The definition of independent director under NASDAQ rules and external director under the Israeli Companies Law overlap to a significant degree such that we would generally expect the two directors serving as external directors to satisfy the requirements to be independent under NASDAQ rules. The definition of external director under the Israeli Companies Law includes a set of statutory criteria that must be satisfied, including criteria whose aim is to ensure that there is no factor that would impair the ability of the external director to exercise independent judgment. The definition of independent director under NASDAQ rules specifies similar, although less stringent, requirements in addition to the requirement that the board consider any factor which would impair the ability of the independent director to exercise independent judgment. In addition, both external directors and independent directors serve for a period of three years; external directors pursuant to the requirements of the Israeli Companies Law and independent directors pursuant to the staggered board provisions of our articles of association. However, external directors must be elected by a special majority of shareholders while independent directors may be elected by an ordinary majority. See &#8220;&#8212; External directors&#8221; for a description of the requirements under the Israeli Companies Law for a director to serve as an external director.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under our articles of association, our board of directors must consist of at least seven and not more than 11 directors, including at least two external directors required to be appointed under the Israeli Companies Law. At any time, the minimum number of directors (other than external directors) may not fall below five. Our board of directors currently consists of nine directors, including our two external directors. Other than our external directors, for whom special election requirements apply under the Israeli Companies Law, as detailed below, our directors are divided into three classes with staggered three-year terms. Each class of directors consists, as nearly as possible, of one-third of the total number of directors constituting the entire board of directors (other than the external directors). At each annual general meeting of our shareholders, the election or re-election of directors following the expiration of the term of office of the directors of that class of directors, will be for a term of office that expires on the third annual general meeting following such election or re-election, such that each year the term of office of only one class of directors will expire. Each director will hold office until the annual general meeting of our shareholders for the year in which his or her term expires, unless they are removed by a vote of 65% of the voting power of our shareholders at a general meeting of our shareholders or upon the occurrence of certain events, in accordance with the Israeli Companies Law and our articles of association.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;Our directors are divided among the three classes as follows:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the Class I directors are Holger Liepmann and Yossi Peled, and their terms will expire at the annual general meeting of shareholders to be held in 2017;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the Class II directors are Nir Belzer, Tamar Howson and Immanuel (Mani) Wasserman, and their terms will expire at the annual general meeting of shareholders to be held in 2018; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the Class III directors are Steve Dubin and Dov Pekelman, and their terms will expire at the annual general meeting of shareholders to be held in 2016.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition, our articles of association allow our board of directors to appoint directors to fill vacancies on our board of directors, for a term of office equal to the remaining period of the term of office of the director(s) whose office(s) have been vacated. External directors are elected for an initial term of three years and may be elected for additional three-year terms under the circumstances described below. External directors may be removed from office only under the limited circumstances set forth in the Israeli Companies Law. See &#8220;&#8212; External directors&#8221; below.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	79
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage86"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law and our articles of association, nominations for directors may be made by any shareholder holding at least 1% of our outstanding voting power. However, any such shareholder may make such a nomination only if a written notice of such shareholder&#8217;s intent to make such nomination has been given to our Secretary (or, if we have no Secretary, our Chief Executive Officer). Any such notice must include certain information, including, among other things, a description of all arrangements between the nominating shareholder and the proposed director nominee(s) and any other person pursuant to which the nomination(s) are to be made by the nominating shareholder, the consent of the proposed director nominee(s) to serve as our director(s) if elected and a declaration signed by the nominee(s) declaring that there is no limitation under the Israeli Companies Law preventing their election, and that all of the information that is required under the Israeli Companies Law to be provided to us in connection with such election has been provided.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law, our board of directors must determine the minimum number of directors who are required to have accounting and financial expertise. See &#8220;&#8212; External directors.&#8221; In determining the number of directors required to have such expertise, our board of directors must consider, among other things, the type and size of the company and the scope and complexity of its operations. Our board of directors has determined that the minimum number of directors of our company who are required to have accounting and financial expertise is one.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	External directors
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law, we are required to include at least two members who qualify as external directors. Joseph Tenne and Michal Silverberg currently serve as our external directors.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The provisions of the Israeli Companies Law set forth special approval requirements for the election of external directors. External directors must be elected by a majority vote of the shares present and voting at a shareholders meeting, provided that either:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	such majority includes at least a majority of the shares held by all shareholders who are non-controlling shareholders and do not have a personal interest in the election of the external director (other than a personal interest not deriving from a relationship with a controlling shareholder) that are voted at the meeting, excluding abstentions, to which we refer as a disinterested majority; or
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the total number of shares voted by non-controlling shareholders and by shareholders who do not have a personal interest in the election of the external director against the election of the external director does not exceed two percent (2%) of the aggregate voting rights in the company.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The term &#8220;controlling shareholder&#8221; is defined in the Israeli Companies Law as a shareholder with the ability to direct the activities of the company, other than by virtue of being an office holder. A shareholder is presumed to be a controlling shareholder if the shareholder holds 50% or more of the voting rights in a company or has the right to appoint the majority of the directors of the company or its general manager. With respect to certain matters, a controlling shareholder is deemed to include a shareholder that holds 25% or more of the voting rights in a public company if no other shareholder holds more than 50% of the voting rights in the company, but excludes a shareholder whose power derives solely from his or her position as a director of the company or from any other position with the company.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our two external directors serve on the Board for fixed three-year periods. Under the Israeli Companies law, the initial term of an external director is three years. Thereafter, an external director may be reelected by shareholders to serve in that capacity for up to two additional three-year terms, provided that either:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(i)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	his or her service for each such additional term is recommended by one or more shareholders holding at least 1% of the company&#8217;s voting rights and is approved at a shareholders meeting by a disinterested majority, where the total number of shares held by non-controlling, disinterested shareholders voting for such reelection exceeds 2% of the aggregate voting rights in the company, subject to additional restrictions set forth in the Israeli Companies Law with respect to the affiliations of the external director nominee; or
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(ii)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	his or her service for each such additional term is recommended by the board of directors and is approved at a shareholders meeting by the same majority required for the initial election of an external director (as described above).
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	80
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage87"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The term of office for external directors for Israeli companies traded on certain foreign stock exchanges, including the NASDAQ Global Select Market, may be extended indefinitely in increments of additional three-year terms, in each case provided that the audit committee and the board of directors of the company confirm that, in light of the external director&#8217;s expertise and special contribution to the work of the board of directors and its committees, the reelection for such additional period(s) is beneficial to the company, and provided that the external director is reelected subject to the same shareholder vote requirements (as described above). Prior to the approval of the reelection of the external director at a general shareholders meeting, the company&#8217;s shareholders must be informed of the term previously served by him or her and of the reasons why the board of directors and audit committee recommended the extension of his or her term.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	External directors may be removed from office by a special general meeting of shareholders called by the board of directors, which approves such dismissal by the same shareholder vote percentage required for their election or by a court, in each case, only under limited circumstances, including ceasing to meet the statutory qualifications for appointment, or violating their duty of loyalty to the company. If an external directorship becomes vacant and there are fewer than two external directors on the board of directors at the time, then the board of directors is required under the Israeli Companies Law to call a shareholders&#8217; meeting as soon as practicable to appoint a replacement external director.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Each committee of the board of directors that exercises the powers of the board of directors must include at least one external director, except that the audit committee and the compensation committee must include all external directors then serving on the board of directors, and an external director must serve as the chairperson thereof. Under the Israeli Companies Law, external directors of a company are prohibited from receiving, directly or indirectly, any compensation from the company other than for their services as external directors pursuant to the Israeli Companies Law and the regulations promulgated thereunder. Compensation of an external director is determined prior to his or her appointment and may not be changed during his or her term subject to certain exceptions.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Israeli Companies Law provides that a person is not qualified to be appointed as an external director if (i) the person is a relative of a controlling shareholder of the company, or (ii) if that person or his or her relative, partner, employer, another person to whom he or she was directly or indirectly subordinate, or any entity under the person&#8217;s control, has or had, during the two years preceding the date of appointment as an external director: (a) any affiliation or other disqualifying relationship with the company, with any person or entity controlling the company or a relative of such person, or with any entity controlled by or under common control with the company; or (b) in the case of a company with no shareholder holding 25% or more of its voting rights, had at the date of appointment as an external director, any affiliation or other disqualifying relationship with a person then serving as chairman of the board or chief executive officer, a holder of 5% or more of the issued share capital or voting power in the company or the most senior financial officer.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The term relative is defined in the Israeli Companies Law as a spouse, sibling, parent, grandparent or descendant; spouse&#8217;s sibling, parent or descendant; and the spouse of each of the foregoing persons.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law, the term affiliation and the similar types of disqualifying relationships include (subject to certain exceptions):
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	an employment relationship;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a business or professional relationship even if not maintained on a regular basis (excluding insignificant relationships);
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	control; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	service as an office holder, excluding service as a director in a private company prior to the initial public offering of its shares if such director was appointed as a director of the private company in order to serve as an external director following the initial public offering.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	81
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage88"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The term &#8220;office holder&#8221; is defined in the Israeli Companies Law as a general manager, chief business manager, deputy general manager, vice general manager, any other person assuming the responsibilities of any of these positions regardless of that person&#8217;s title, a director and any other manager directly subordinate to the general manager.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition, no person may serve as an external director if that person&#8217;s position or professional or other activities create, or may create, a conflict of interest with that person&#8217;s responsibilities as a director or otherwise interfere with that person&#8217;s ability to serve as an external director or if the person is an employee of the Israel Securities Authority or of an Israeli stock exchange. A person may furthermore not continue to serve as an external director if he or she received direct or indirect compensation from the company including amounts paid pursuant to indemnification or exculpation contracts or commitments and insurance coverage for his or her service as an external director, other than as permitted by the Israeli Companies Law and the regulations promulgated thereunder.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Following the termination of an external director&#8217;s service on a board of directors, such former external director and his or her spouse and children may not be provided a direct or indirect benefit by the company, its controlling shareholder or any entity under its controlling shareholder&#8217;s control. This includes engagement as an office holder of the company or a company controlled by its controlling shareholder or employment by, or provision of services to, any such company for consideration, either directly or indirectly, including through a corporation controlled by the former external director. This restriction extends for a period of two years with regard to the former external director and his or her spouse or child and for one year with respect to other relatives of the former external director.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If at the time at which an external director is appointed all members of the board of directors who are not controlling shareholders or relatives of controlling shareholders of the company are of the same gender, the external director to be appointed must be of the other gender. A director of one company may not be appointed as an external director of another company if a director of the other company is acting as an external director of the first company at such time.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	According to the Israeli Companies Law and the regulations promulgated thereunder, a person may be appointed as an external director only if he or she has professional qualifications or if he or she has accounting and financial expertise (each, as defined below); provided that, at least one of the external directors must be determined by our board of directors to have accounting and financial expertise. However, if at least one of our other directors (i) meets the independence requirements under the Exchange Act; (ii) meets the standards of the NASDAQ rules for membership on the audit committee; and (iii) has accounting and financial expertise as defined under Israeli Companies Law, then neither of our external directors is required to possess accounting and financial expertise as long as each possesses the requisite professional qualifications.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	A director with accounting and financial expertise is a director who, due to his or her education, experience and skills, possesses an expertise in, and an understanding of, financial and accounting matters and financial statements, such that he or she is able to understand the financial statements of the company and initiate a discussion about the presentation of financial data. A director is deemed to have professional qualifications if he or she has any of (i) an academic degree in economics, business management, accounting, law or public administration; (ii) an academic degree or has completed another form of higher education in the primary field of business of the company or in a field which is relevant to his/her position in the company; or (iii) at least five years of experience serving in one of the following capacities, or at least five years of cumulative experience serving in two or more of the following capacities: (a) a senior business management position in a company with a significant volume of business; (b) a senior position in the company&#8217;s primary field of business; or (c) a senior position in public administration or service. The board of directors is charged with determining whether a director possesses financial and accounting expertise or professional qualifications.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our board of directors has determined that Joseph Tenne has accounting and financial expertise and possesses professional qualifications as required under the Israeli Companies Law.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	82
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage89"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Audit Committee
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our audit committee consists of Dov Pekelman, along with our two external directors, Joseph Tenne and Michal Silverberg. Joseph Tenne serves as the chairman of the audit committee.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Companies Law Requirements
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law, we are required to have an audit committee comprised of at least three directors, including all of the external directors and one of whom must serve as chairman of the committee. The audit committee may not include the chairman of the board, a controlling shareholder of the company, a relative of a controlling shareholder, a director employed by or providing services on a regular basis to the company, to a controlling shareholder or to an entity controlled by a controlling shareholder or a director who derives most of his or her income from a controlling shareholder.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition, under the Israeli Companies Law, the audit committee of a publicly traded company must consist of a majority of unaffiliated directors. In general, an &#8220;unaffiliated director&#8221; under the Israeli Companies Law is defined as either an external director or as a director who meets the following criteria:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	he or she meets the qualifications for being appointed as an external director, except for (i) the requirement that the director be an Israeli resident (which does not apply to companies such as ours whose securities have been offered outside of Israel or are listed outside of Israel); and (ii) the requirement for accounting and financial expertise or professional qualifications; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	he or she has not served as a director of the company for a period exceeding nine consecutive years. For this purpose, a break of less than two years in the service shall not be deemed to interrupt the continuation of the service.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	NASDAQ Listing Requirements
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the NASDAQ rules, we are required to maintain an audit committee consisting of at least three independent directors, each of whom is financially literate and one of whom has accounting or related financial management expertise.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Each of the members of our audit committee is an independent director in accordance with Rule 10A-3(b)(1) under the Exchange Act and satisfies the independent director requirements under the NASDAQ rules.&#160;&#160;All members of our audit committee meet the requirements for financial literacy under the NASDAQ rules. Our board of directors has determined that Joseph Tenne meets the requirements of an audit committee financial expert as defined by the SEC rules.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Audit Committee Role
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our board of directors has adopted an audit committee charter that sets forth the responsibilities of the audit committee consistent with the rules and regulations of the SEC and the NASDAQ rules, as well as the requirements for such committee under the Israeli Companies Law, including the following:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	oversight of our independent registered public accounting firm and recommending the engagement, compensation or termination of engagement of our independent registered public accounting firm to the board of directors in accordance with Israeli law;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	recommending the engagement or termination of the person filling the office of our internal auditor; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	recommending the terms of audit and non-audit services provided by the independent registered public accounting firm for pre-approval by our board of directors.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	83
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage90"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our audit committee provides assistance to our board of directors in fulfilling its legal and fiduciary obligations in matters involving our accounting, auditing, financial reporting, internal control and legal compliance functions by pre-approving the services performed by our independent accountants and reviewing their reports regarding our accounting practices and systems of internal control over financial reporting. Our audit committee also oversees the audit efforts of our independent accountants and takes those actions that it deems necessary to satisfy itself that the accountants are independent of management.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law, our audit committee is responsible for:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(i)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	determining whether there are deficiencies in the business management practices of our company, including in consultation with our internal auditor or the independent auditor, and making recommendations to the board of directors to improve such practices;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(ii)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	determining whether to approve certain related party transactions (including transactions in which an office holder has a personal interest and whether any such transaction is extraordinary or material under Israeli Companies Law) (see &#8220;&#8212; Approval of related party transactions under Israeli law&#8221;);
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(iii)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	establishing the approval process (including, potentially, the approval of the audit committee) for certain transactions with a controlling shareholder or in which a controlling shareholder has a personal interest;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(iv)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	where the board of directors approves the working plan of the internal auditor, examining such work plan before its submission to the board of directors and proposing amendments thereto;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(v)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	examining our internal controls and internal auditor&#8217;s performance, including whether the internal auditor has sufficient resources and tools to dispose of its responsibilities;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(vi)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	examining the scope of our independent auditor&#8217;s work and compensation and submitting a recommendation with respect thereto to our board of directors or shareholders, depending on which of them is considering the appointment of our auditor; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(vii)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	establishing procedures for the handling of employees&#8217; complaints as to the management of our business and the protection to be provided to such employees.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our audit committee may not approve any actions requiring its approval (see &#8220;&#8212; Approval of related party transactions under Israeli law&#8221;), unless at the time of the approval a majority of the committee&#8217;s members are present, which majority consists of unaffiliated directors including at least one external director.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Compensation Committee and Compensation Policy
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our compensation committee consists of Joseph Tenne, chairman, and Michal Silverberg and Nir Belzer, each of whom is independent under NASDAQ rules.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law, the board of directors of a public company must appoint a compensation committee. The compensation committee must be comprised of at least three directors, including all of the external directors, who must constitute a majority of the members of, and include the chairperson of, the compensation committee. However, subject to certain exceptions, Israeli companies whose securities are traded on stock exchanges such as the NASDAQ Global Select Market, and who do not have a controlling shareholder, do not have to meet this majority requirement; provided, however, that the compensation committee meets other Israeli Companies Law composition requirements, as well as the requirements of the jurisdiction where the company&#8217;s securities are traded. Each compensation committee member who is not an external director must be a director whose compensation does not exceed an amount that may be paid to an external director. The compensation committee is subject to the same Israeli Companies Law restrictions as the audit committee as to who may not be a member of the compensation committee.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	84
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage91"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The duties of the compensation committee include the recommendation to the company&#8217;s board of directors of a policy regarding the terms of engagement of office holders, to which we refer as a compensation policy. That policy must be adopted by the company&#8217;s board of directors, after considering the recommendations of the compensation committee, and will need to be brought for approval by the company&#8217;s shareholders, which approval requires what we refer to as a Special Majority Approval for Compensation. A Special Majority Approval for Compensation requires shareholder approval by a majority vote of the shares present and voting at a meeting of shareholders called for such purpose, provided that either: (a) such majority includes at least a majority of the shares held by all shareholders who are not controlling shareholders and do not have a personal interest in such compensation arrangement; or (b) the total number of shares of non-controlling shareholders and shareholders who do not have a personal interest in the compensation arrangement and who vote against the arrangement does not exceed 2% of the company&#8217;s aggregate voting rights.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have adopted a compensation policy which serves as the basis for decisions concerning the financial terms of employment or engagement of office holders, including exculpation, insurance, indemnification or any monetary payment or obligation of payment or other benefit in respect of employment or engagement. The compensation policy must relate to certain factors, including advancement of the company&#8217;s objectives, the company&#8217;s business plan and its long-term strategy, and creation of appropriate incentives for office holders. It must also consider, among other things, the company&#8217;s risk management, size and the nature of its operations. The compensation policy must furthermore consider the following additional factors:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the knowledge, skills, expertise and accomplishments of the relevant office holder;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the office holder&#8217;s roles and responsibilities and prior compensation agreements with him or her;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the relationship between the terms offered and the average compensation of the other employees of the company, including those employed through manpower companies;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the impact of disparities in salary upon work relationships in the company;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the possibility of reducing variable compensation at the discretion of the board of directors; and the possibility of setting a limit on the exercise value of non-cash variable equity-based compensation; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	as to severance compensation, the period of service of the office holder, the terms of his or her compensation during such service period, the company&#8217;s performance during that period of service, the person&#8217;s contribution towards the company&#8217;s achievement of its goals and the maximization of its profits, and the circumstances under which the person is leaving the company.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 27PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The compensation policy must also include the following principles:
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the link between variable compensation and long-term performance and measurable criteria;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the relationship between variable and fixed compensation, and the ceiling for the value of variable compensation;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the conditions under which an office holder would be required to repay compensation paid to him or her if it was later shown that the data upon which such compensation was based was inaccurate and was required to be restated in the company&#8217;s financial statements;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the minimum holding or vesting period for variable, equity-based compensation; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	maximum limits for severance compensation.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	85
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage92"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The compensation committee is responsible for (a) recommending the compensation policy to a company&#8217;s board of directors for its approval (and subsequent approval by its shareholders) and (b) duties related to the compensation policy and to the compensation of a company&#8217;s office holders as well as functions previously fulfilled by a company&#8217;s audit committee with respect to matters related to approval of the terms of engagement of office holders, including:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	recommending whether a compensation policy should continue in effect, if the then-current policy has a term of greater than three (3) years (approval of either a new compensation policy or the continuation of an existing compensation policy must in any case occur every three years);
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	recommending to the board of directors periodic updates to the compensation policy;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	assessing implementation of the compensation policy;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	approving compensation terms of executive officers, directors and employees that require approval of the compensation committee;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	determining whether the compensation terms of a chief executive officer nominee, which were determined pursuant to the compensation policy, will be exempt from approval of the shareholders because such approval would harm the ability to engage with such nominee; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	determining, subject to the approval of the board and under special circumstances, override a determination of the company&#8217;s shareholders regarding certain compensation related issues.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Compensation Committee Role
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our board of directors has adopted a compensation committee charter setting forth the responsibilities of the compensation committee, which include:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the responsibilities set forth in the compensation policy;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	reviewing and approving the granting of options and other incentive awards to the extent such authority is delegated by our board of directors; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	reviewing, evaluating and making recommendations regarding the compensation and benefits for our non-employee directors.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	86
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage93"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Nominating and Governance Committee
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our nominating and governance committee consists of Imanuel (Mani) Wasserman, chairman, Steve Dubin and Joseph Tenne. Our board of directors has adopted a nominating and governance committee charter that sets forth the responsibilities of the nominating and governance committee, which include:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	overseeing and assisting our board in reviewing and recommending nominees for election as directors;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	assessing the performance of the members of our board; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	establishing and maintaining effective corporate governance policies and practices, including, but not limited to, developing and recommending to our board a set of corporate governance guidelines applicable to our company.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Internal Auditor
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law, the board of directors of an Israeli public company must appoint an internal auditor recommended by the audit committee. An internal auditor may not be:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a person (or a relative of a person) who holds 5% or more of the company&#8217;s outstanding shares or voting rights;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a person (or a relative of a person) who has the power to appoint a director or the general manager of the company;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	an office holder (including a director) of the company (or a relative thereof); or
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a member of the company&#8217;s independent accounting firm, or anyone on its behalf.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The role of the internal auditor is to examine, among other things, our compliance with applicable law and orderly business procedures. The audit committee is required to oversee the activities and to assess the performance of the internal auditor as well as to review the internal auditor&#8217;s work plan.&#160;&#160;Our internal auditor is an employee of the Israeli member firm of KPMG and not functioning as an employee or officer of the company.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Approval of related party transactions under Israeli law
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Fiduciary duties of directors and executive officers
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Israeli Companies Law codifies the fiduciary duties that office holders owe to a company. Each person listed in the table under &#8220;&#8212;Directors and Senior Management&#8221; is an office holder under the Israeli Companies Law.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	An office holder&#8217;s fiduciary duties consist of a duty of care and a duty of loyalty. The duty of care requires an office holder to act with the level of care with which a reasonable office holder in the same position would have acted under the same circumstances. The duty of loyalty requires that an office holder act in good faith and in the best interests of the company.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	87
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage94"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The duty of care includes a duty to use reasonable means to obtain:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	information on the advisability of a given action brought for his or her approval or performed by virtue of his or her position; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	all other important information pertaining to any such action.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The duty of loyalty includes a duty to:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	refrain from any conflict of interest between the performance of his or her duties to the company and his or her other duties or personal affairs;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	refrain from any activity that is competitive with the company;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	refrain from exploiting any business opportunity of the company to receive a personal gain for himself or herself or others; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	disclose to the company any information or documents relating to the company&#8217;s affairs which the office holder received as a result of his or her position as an office holder.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.55PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Disclosure of personal interests of an office holder and approval of certain transactions
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Israeli Companies Law requires that an office holder promptly disclose to the board of directors any personal interest that he or she may be aware of and all related material information or documents concerning any existing or proposed transaction with the company. An interested office holder&#8217;s disclosure must be made promptly and in any event no later than the first meeting of the board of directors at which the transaction is considered. A personal interest includes an interest of any person in an act or transaction of a company, including a personal interest of such person&#8217;s relative or of a corporate body in which such person or a relative of such person is a 5% or greater shareholder, director or general manager or in which he or she has the right to appoint at least one director or the general manager, but excluding a personal interest stemming from one&#8217;s ownership of shares in the company. A personal interest furthermore includes the personal interest of a person for whom the office holder holds a voting proxy or the personal interest of the office holder with respect to his or her vote on behalf of a person for whom he or she holds a proxy even if such shareholder has no personal interest in the matter. An office holder is not, however, obliged to disclose a personal interest if it derives solely from the personal interest of his or her relative in a transaction that is not considered an extraordinary transaction. Under the Israeli Companies Law, an extraordinary transaction is defined as any of the following:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a transaction other than in the ordinary course of business;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a transaction that is not on market terms; or
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a transaction that may have a material impact on a company&#8217;s profitability, assets or liabilities.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If it is determined that an office holder has a personal interest in a transaction which is not an extraordinary transaction, approval by the board of directors is required for the transaction, unless the company&#8217;s articles of association provide for a different method of approval. Further, so long as an office holder has disclosed his or her personal interest in a transaction, the board of directors may approve an action by the office holder that would otherwise be deemed a breach of his or her duty of loyalty. However, a company may not approve a transaction or action that is not in the best interests of the company or that is not performed by the office holder in good faith. An extraordinary transaction in which an office holder has a personal interest requires approval first by the company&#8217;s audit committee and subsequently by the board of directors. The compensation of, or an undertaking to indemnify or insure, an office holder who is not a director requires approval first by the company&#8217;s compensation committee, then by the company&#8217;s board of directors. If such compensation arrangement or an undertaking to indemnify or insure is inconsistent with the company&#8217;s stated compensation policy or if the office holder is the chief executive officer (apart from a number of specific exceptions), then such arrangement is further subject to a Special Majority Approval for Compensation.&#160;&#160;Arrangements regarding the compensation, indemnification or insurance of a director require the approval of the compensation committee, board of directors and shareholders by ordinary majority, in that order, and under certain circumstances, a Special Majority Approval for Compensation.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	88
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage95"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Generally, a person who has a personal interest in a matter which is considered at a meeting of the board of directors or the audit committee may not be present at such a meeting or vote on that matter unless the chairman of the relevant committee or board of directors (as applicable) determines that he or she should be present in order to present the transaction that is subject to approval. If a majority of the members of the audit committee or the board of directors (as applicable) has a personal interest in the approval of a transaction, then all directors may participate in discussions of the audit committee or the board of directors (as applicable) on such transaction and the voting on approval thereof, but shareholder approval is also required for such transaction.
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.55PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Disclosure of personal interests of controlling shareholders and approval of certain transactions
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Pursuant to Israeli law, the disclosure requirements regarding personal interests that apply to directors and executive officers also apply to a controlling shareholder of a public company. In the context of a transaction involving a shareholder of the company, a controlling shareholder also includes a shareholder who holds 25% or more of the voting rights in the company if no other shareholder holds more than 50% of the voting rights in the company. For this purpose, the holdings of all shareholders who have a personal interest in the same transaction will be aggregated. The approval of the audit committee or the compensation committee, the board of directors and the shareholders of the company, in that order is required for (a) extraordinary transactions with a controlling shareholder or in which a controlling shareholder has a personal interest, (b) the engagement with a controlling shareholder or his or her relative, directly or indirectly, including through a company under the control of the controlling shareholder, for the provision of services to the company, (c) the terms of engagement and compensation of a controlling shareholder or his or her relative who is an office holder or (d) the employment of a controlling shareholder or his or her relative by the company, other than as an office holder. In addition, the shareholder approval requires one of the following, which we refer to as a Special Majority:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;&#160;&#160;&#160;&#160;&#160;&#160;at least a majority of the shares held by all shareholders who do not have a personal interest in the transaction and who are present and voting at the meeting approves the transaction, excluding abstentions; or
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;&#160;&#160;&#160;&#160;&#160;&#160;the shares voted against the transaction by shareholders who have no personal interest in the transaction and who are present and voting at the meeting do not exceed 2% of the voting rights in the company.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	To the extent that any such transaction with a controlling shareholder is for a period extending beyond three years, approval is required once every three years, unless, with respect to certain transactions, the audit committee determines that the duration of the transaction is reasonable given the circumstances related thereto.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Arrangements regarding the compensation, indemnification or insurance of a controlling shareholder in his or her capacity as an office holder require the approval of the compensation committee, board of directors and shareholders by a Special Majority, in that order, and the terms thereof may not be inconsistent with the company&#8217;s stated compensation policy.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Pursuant to regulations promulgated under the Israeli Companies Law, certain transactions with a controlling shareholder or his or her relative, or with directors, that would otherwise require approval of a company&#8217;s shareholders may be exempt from shareholder approval upon certain determinations of the audit committee and board of directors. Under these regulations, a shareholder holding at least 1% of the issued share capital of the company may require, within 14 days of the publication of such determinations, that despite such determinations by the audit committee and the board of directors, such transaction will require shareholder approval under the same majority requirements that would otherwise apply to such transactions.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	89
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage96"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Shareholder duties
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Pursuant to the Israeli Companies Law, a shareholder has a duty to act in good faith and in a customary manner toward the company and other shareholders and to refrain from abusing his or her power in a company, including, among other things, in voting at a general meeting and at shareholder class meetings with respect to the following matters:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	an amendment to the company&#8217;s articles of association;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	an increase of the company&#8217;s authorized share capital;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a merger; or
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the approval of related party transactions and acts of office holders that require shareholder approval.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	A shareholder also has a general duty to refrain from discriminating against other shareholders.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition, certain shareholders have a duty of fairness toward the company. These shareholders include any controlling shareholder, any shareholder who knows that he or she has the power to determine the outcome of a shareholder vote and any shareholder who has the power to appoint or to prevent the appointment of an office holder of the company or other power towards the company. The Israeli Companies Law does not define the substance of the duty of fairness, except to state that the remedies generally available upon a breach of contract will also apply in the event of a breach of the duty to act with fairness.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Exculpation, insurance and indemnification of directors and officers
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law, a company may not exculpate an office holder from liability for a breach of the duty of loyalty. An Israeli company may exculpate an office holder in advance from liability to the company, in whole or in part, for damages caused to the company as a result of a breach of duty of care but only if a provision authorizing such exculpation is included in its articles of association. Our articles of association include such a provision. A company may not exculpate in advance a director from liability arising out of a prohibited dividend or distribution to shareholders.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law, a company may indemnify an office holder in respect of the following liabilities and expenses incurred for acts performed by him or her as an office holder, either pursuant to an undertaking made in advance of an event or following an event, provided its articles of association include a provision authorizing such indemnification:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	financial liability imposed on him or her in favor of another person pursuant to a judgment, including a settlement or arbitrator&#8217;s award approved by a court. However, if an undertaking to indemnify an office holder with respect to such liability is provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based on the company&#8217;s activities when the undertaking to indemnify is given, and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances, and such undertaking shall detail the abovementioned foreseen events and amount or criteria;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	reasonable litigation expenses, including attorneys&#8217; fees, incurred by the office holder (1) as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (i) no indictment was filed against such office holder as a result of such investigation or proceeding; and (ii) no financial liability was imposed upon him or her as a substitute for the criminal proceeding as a result of such investigation or proceeding or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; and (2) in connection with a monetary sanction; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	reasonable litigation expenses, including attorneys&#8217; fees, incurred by the office holder or imposed by a court in proceedings instituted against him or her by the company, on its behalf, or by a third party, or in connection with criminal proceedings in which the office holder was acquitted, or as a result of a conviction for an offense that does not require proof of criminal intent.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	90
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage97"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law, a company may insure an office holder against the following liabilities incurred for acts performed by him or her as an office holder if and to the extent provided in the company&#8217;s articles of association:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a breach of the duty of loyalty to the company, provided that the office holder acted in good faith and had a reasonable basis to believe that the act would not harm the company;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a breach of duty of care to the company or to a third party, to the extent such a breach arises out of the negligent conduct of the office holder; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a financial liability imposed on the office holder in favor of a third party.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law, a company may not indemnify, exculpate or insure an office holder against any of the following:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a breach of the duty of loyalty, except for indemnification and insurance for a breach of the duty of loyalty to the company to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not harm the company;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a breach of duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	an act or omission committed with intent to derive illegal personal benefit; or
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a fine or forfeit levied against the office holder.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law, exculpation, indemnification and insurance of office holders in a public company must be approved by the compensation committee and the board of directors and, with respect to certain office holders or under certain circumstances, also by the shareholders. See &#8220;&#8212; Approval of related party transactions under Israeli law.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our articles of association permit us to exculpate, indemnify and insure our office holders to the fullest extent permitted or to be permitted by the Israeli Companies Law.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition, we have entered into agreements with each of our directors and executive officers exculpating them from liability to us for damages caused to us as a result of a breach of duty of care and undertaking to indemnify them, in each case, to the fullest extent permitted by our articles of association and Israeli law.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The maximum indemnification amount set forth in such agreements is limited to an amount the higher of (x) 25% of our total shareholders&#8217; equity based on our most recently published financial statements prior to the time that indemnification is paid; or (y) $25 million; provided, however, that in relation to indemnification claimed in connection with a public offering of our securities, the amount, if higher, shall be equal to the aggregate proceeds raised by us and/or selling shareholders. The maximum amount set forth in such agreements is in addition to any amount paid (if paid) under insurance and/or by a third-party pursuant to an indemnification arrangement.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have obtained directors and officers liability insurance for the benefit of our office holders and intend to continue to maintain such coverage and pay all premiums thereunder to the fullest extent permitted by the Israeli Companies Law.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	91
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage98"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV>
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_20"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	D.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Employees
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The total number of our full-time employees and the distribution of our employees (i) geographically; and (ii) according to main area of activity, as of the end of each of the last three years, are set forth in the following two tables, respectively:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Number&#160;of&#160;full-time&#160;employees&#160;by&#160;region&#160;as&#160;of&#160;December&#160;31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Region
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Israel
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	126
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	136
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	136
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	United States
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	30
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	31
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	48
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	China
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Singapore
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Germany
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Australia
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	158
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	170
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	195
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Number&#160;of&#160;full-time&#160;employees&#160;by
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	area&#160;of&#160;activity&#160;as&#160;of&#160;December&#160;31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Area&#160;of&#160;Activity
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Management and administrative
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	26
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	28
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	31
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Research and development
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	29
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	34
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	27
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operations and manufacture
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	49
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	52
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	51
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Sales and marketing
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	43
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	45
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	75
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Quality
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	158
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	170
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	195
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	During the periods covered by the above tables, we did not employ a significant number of temporary employees.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Israeli labor laws govern the length of the workday, minimum wages for employees, procedures for hiring and dismissing employees, determination of severance pay, annual leave, sick days, advance notice of termination, payments to the National Insurance Institute, and other conditions of employment and include equal opportunity and anti-discrimination laws. While none of our employees is party to any collective bargaining agreements, certain provisions of the collective bargaining agreements between the Histadrut (General Federation of Labor in Israel) and the Coordination Bureau of Economic Organizations (including the Industrialists&#8217; Associations) are applicable to our employees in Israel by order of the Israeli Ministry of Economy and Industry. These provisions primarily concern pension fund benefits for all employees, insurance for work-related accidents, recuperation pay and travel expenses. We generally provide our employees with benefits and working conditions beyond the required minimums.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have never experienced any employment-related work stoppages or actions and believe our relationships with our employees are good.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	92
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage99"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	E.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Share Ownership
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For information regarding the share ownership of our directors and executive officers, please refer to &#8220;Item 6.B. Directors, Senior Management and Employees&#8212;Compensation&#8212;Option plans&#8221; and &#8220;Item 7.A. Major Shareholders and Related Party Transactions&#8212;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Major Shareholders.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	Our directors and executive officers
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	held
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	, in the aggregate, as of February 29
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	,
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	2016, options exercisable for 991,224 ordinary shares, which have a weighted average exercise price of $5.62 per share and have expiration dates generally ten years after the grant date of the option.&#160;&#160;In addition, as of February 29
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	,
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	2016, our directors and executive officers held, in the aggregate, 193,995 restricted share units and 117,028
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	&#160;
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	restricted shares.
</FONT>
</FONT>
</DIV>
</EFX_DIRECTORS_AND_OFFICERS>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<EFX_SECURITY_OWNERS>
<A NAME="FIS_SECURITY_OWNERS"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 7: Major S
<A NAME="ZK1618102_HTM_5">
	ha
</A>
	reholders and Related Party Transactions
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	A.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Major Shareholders
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;The following table sets forth information with respect to the beneficial ownership of our ordinary shares as of February 29, 2016:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	each person or entity known by us to own beneficially more than 5% of our outstanding ordinary shares;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	each of our executive officers and directors individually; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	all of our executive officers and directors as a group.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The beneficial ownership of our ordinary shares is determined in accordance with the rules of the SEC and generally includes any shares over which a person exercises sole or shared voting or investment power, or the right to receive the economic benefit of ownership. For purposes of the table below, we deem ordinary shares issuable pursuant to options that are currently exercisable or exercisable within 60 days of February 29, 2016 to be outstanding and to be beneficially owned by the person holding the options for the purposes of computing the percentage ownership of that person, but we do not treat them as outstanding for the purpose of computing the percentage ownership of any other person. The percentage of ordinary shares beneficially owned is based on 22,748,358 ordinary shares outstanding as of February 29, 2016.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	93
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage100"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;All of our shareholders, including the shareholders listed below, have the same voting rights attached to their ordinary shares. See &#8220;Item 10.B. Memorandum and Articles of Association&#8212;Voting rights and conversion.&#8221; None of our principal shareholders or our directors and executive officers have different or special voting rights with respect to their ordinary shares. Unless otherwise noted below, each shareholder&#8217;s address is c/o Enzymotec Ltd., Sagi 2000 Industrial Area, P.O. Box 6, Migdal Ha&#8217;Emeq 2310001, Israel.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_BENEFICIAL_OWNERS>
<A NAME="FIS_BENEFICIAL_OWNERS"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Shares Beneficially Owned
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Name of Beneficial Owner
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Number
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Percent
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Principal Shareholders
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Galam Ltd.
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(1)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,623,232
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	20.3
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Paulson &amp; Co. Inc.
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(2)
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,238,275
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18.6
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Visium Balanced Master Fund, Ltd.
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(3)
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,200,000
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9.7
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Tiger Partners Trading LLC
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(4)
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,162,845
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5.1
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Directors and officers
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Steve Dubin
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Nir Belzer
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(5)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	224,677
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1.0
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Tamar Howson
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Holger Liepmann
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Dov Pekelman
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Yossi Peled
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Michal Silverberg
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Joseph Tenne
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Imanuel (Mani) Wasserman
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Ariel Katz
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(6)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	462,146
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2.0
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Oren Bryan
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gai Ben-Dror
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Yael Richter
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Shahar Carmi
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Robert Crim
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Itay Dromi
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Yariv Gratz
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	All directors and executive officers as a group (17 persons)
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(7)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,254,205
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5.4
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;____________
</FONT>
</DIV>
</EFX_BENEFICIAL_OWNERS>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Less than 1% of our outstanding ordinary shares.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	94
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage101"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1)
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Based on a Schedule 13G filed&#160;&#160;on February 12, 2015 by Galam Ltd., includes 3,318,856 ordinary shares held by Galam Management and Marketing Agricultural Cooperative Society Ltd. (&#8220;Galam M&amp;M&#8221;) and 1,304,376 ordinary shares held by Galam Ltd., its wholly-owned subsidiary. The management boards of the two entities are comprised of the same people and hold voting and dispositive power over the shares held by the two entities. As such, the members of the boards may be deemed to be the beneficial owners of those shares. There are 13 members of the management boards, two of which, Imanuel (Mani) Wasserman and Yossi Peled, are also members of our board of directors. A majority of the shares of Galam M&amp;M are held by Ochmanit the Economic Union for Ma&#8217;anit Agricultural Cooperative Society Ltd. (&#8220;Ochmanit&#8221;). Ochmanit is wholly-owned by Kibbutz Ma&#8217;anit and its members with 51% of the voting rights held by Kibbutz Ma&#8217;anit. A majority of the members of the management boards of Galam M&amp;M and Galam Ltd. are appointed by Ochmanit, in part based on candidates nominated by a vote of the members of Kibbutz Ma&#8217;anit.&#160;&#160;Established in 1935, Kibbutz Ma&#8217;anit is a communal society, referred to in Hebrew as a &#8220;kibbutz,&#8221; with approximately 180 members located near Pardes-Hanna between Tel Aviv and Haifa. The Kibbutz is engaged in a number of economic activities, including agriculture and industrial operations, and holds its assets on a communal basis. No members of Kibbutz Ma&#8217;anit are employed by us. The address of this shareholder is Kibbutz Ma&#8217;anit, 3785500, Israel.
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Based on a Schedule 13G/A filed on February 17, 2015 by Paulson &amp; Co. Inc., includes 4,238,275 ordinary shares held by Paulson &amp; Co. Inc. (&#8220;Paulson&#8221;), an investment advisor that is registered under Section 203 of the Investment Advisers Act of 1940.&#160;&#160;In its role as investment advisor, or manager, Paulson possesses voting and/or investment power over our shares that are owned by various onshore and offshore investment funds and separate managed accounts (the &#8220;Funds&#8221;).&#160;&#160;All securities reported above are owned by the Funds.&#160;&#160;The address of this shareholder is 1251 Avenue of the Americas, New York, NY 10020.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(3)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Based on a Schedule 13G/A filed on February 12, 2016 by Visium Balanced Master Fund, Ltd., includes 2,200,000 ordinary shares held by Visium Balanced Master Fund, Ltd., a Cayman Islands corporation (&#8220;VBMF&#8221;). Visium Asset Management, LP, a Delaware limited partnership (&#8220;VAM&#8221;) is an investment manager of the pooled assets of VBMF and as such may be deemed to beneficially own the ordinary shares beneficially owned by VBMF.&#160;&#160;JG Asset, LLC, a Delaware limited liability company (&#8220;JG Asset&#8221;), is the General Partner of VAM and as such may be deemed to beneficially own the ordinary shares beneficially owned by VAM.&#160;&#160;Jacob Gottlieb, a natural person, is the Managing Member of JG Asset and as such may be deemed to beneficially own the ordinary shares beneficially owned by JG Asset. This shareholder&#8217;s principal business office is c/o Visium Asset Management, LP, 888 Seventh Avenue, New York, NY 10019.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(4)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;Based on a Schedule 13G filed on December 4, 2015 by Tiger Partners Trading LLC, a Delaware limited liability company, Tiger Partners, L.P., a Delaware limited partnership, Tiger Partners GP, L.L.C., a Delaware limited liability company, Tiger Management L.L.C., a Delaware limited liability company, The Julian H. Robertson, Jr. Revocable Trust, which is formed under Delaware law, and Julian H. Robertson, Jr., a natural person, includes 1,162,845 shares held by Tiger Partners Trading LLC.&#160;&#160;The address of this shareholder is 101 Park Avenue New York, NY 10178.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	95
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage102"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(5)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Consists of 8,000 shares held by Mr. Belzer in &#8220;street name.&#8221; Also consists of 197,374 shares held of record by M-4 Management L.P., or M-4 and 19,303 shares issuable upon the exercise of options held by Mr. Belzer. The general partner of MMT is Millennium Materials II Fund Management Company Ltd., or MMC2. Mr. Belzer is one of four persons that controls MMC2 and, as such, he may be deemed to share beneficial ownership over our shares held by MMT. Mr. Belzer controls the general partner of M-4 and therefore beneficially owns the shares held by M-4. Mr. Belzer&#8217;s address is 6 Koifman Street, Floor 14, Tel Aviv 68012, Israel.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(6)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Consists of 131,146 shares held by a trustee on behalf of Dr. Katz and 331,000 shares issuable upon the exercise of options.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(7)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Consists of (i) 586,238 ordinary shares (including 39,032 restricted shares that become vested as of March 31, 2016 and 38,964 restricted shares that remain subject to vesting conditions) and (ii) 667,967 shares issuable upon the exercise of options that have vested or will become vested within 60 days of February 29, 2016 and remain outstanding. Please see footnotes (5) and (6) above for further information concerning the composition of the shares beneficially owned by our executive officers and directors.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Significant Changes in Ownership of Major Shareholders
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Following our initial public offering on September 26, 2013, Galam Ltd. and its affiliates beneficially owned 6,521,880, or 31.3%, of our issued and outstanding ordinary shares.&#160;&#160;On February 12, 2015, Galam Ltd. filed a Schedule 13G stating that as of December 31, 2014 it beneficially owned 4,623,232, or 20.6%, of our issued and outstanding ordinary shares, as a result of a public offering of our ordinary shares by certain selling shareholders on March 5, 2014.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Following our initial public offering on September 26, 2013, XT Hi-Tech Investments (1992) Ltd. beneficially owned 3,068,704, or 14.7%, of our issued and outstanding ordinary shares.&#160;&#160;Following a public offering of our ordinary shares by certain selling shareholders on March 5, 2014, XT Hi-Tech Investments (1992) Ltd. beneficially owned 1,889,915, or 8.4%, of our issued and outstanding ordinary shares.&#160;&#160;On February 9, 2016, XT Hi-Tech Investments (1992) Ltd. filed a Schedule 13G/A stating that, as of December 31, 2015, it no longer beneficially owned more than 5% of our issued and outstanding ordinary shares.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	On February 14, 2014, Paulson &amp; Co. filed a Schedule 13G stating that it beneficially owned 1,733,030 ordinary shares, or 8.3% of our issued and outstanding ordinary shares.&#160;&#160;On March 10, 2014, Paulson &amp; Co. filed a Schedule 13G/A stating that it beneficially owned 4,177,830, or 19.24%, of our issued and outstanding ordinary shares.&#160;&#160;On February 17, 2015, Paulson &amp; Co. filed a Schedule 13G/A stating that, as of December 31, 2014, it beneficially owned 4,238,275, or 18.8%, of our issued and outstanding ordinary shares.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	On March 10, 2014, VBMF filed a Schedule 13G with the SEC stating that it beneficially owned 1,140,000 ordinary shares, or 5.2% of our issued and outstanding ordinary shares.&#160;&#160;On February 12, 2015, VBMF filed a Schedule 13G/A with the SEC stating that, as of December 31, 2014 it beneficially owned 2,125,000 ordinary shares, which is 9.4% of our issued and outstanding ordinary shares.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Record Holders
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As of February 29, 2016, we had four holders of record of our ordinary shares in the United States including Cede &amp; Co., the nominee of The Depository Trust Company. These shareholders held, in the aggregate, 17,541,158 ordinary shares, representing 77.1% of the outstanding ordinary shares as of February 29, 2016. The number of record holders in the United States is not representative of the number of beneficial holders nor is it representative of where such beneficial holders are resident since many of these ordinary shares were held by brokers or other nominees.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	96
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage103"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	B.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Related Party Transactions
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Investors&#8217; Rights Agreement
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Pursuant to our Amended and Restated Investors&#8217; Rights Agreement (the &#8220;Investors&#8217; Rights Agreement&#8221;), dated as of September 22, 2013, certain of our shareholders hold registration rights as described below.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Demand registration rights
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Subject to the terms of the any lock-up agreements entered into by parties to the Investors&#8217; Rights Agreement, at the request of the holders of a majority of the then -outstanding ordinary shares that are registrable pursuant to the Investors&#8217; Rights Agreement, we must register any or all of these shareholders&#8217; ordinary shares as follows:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="6%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	before we become eligible under applicable securities laws to file a registration statement on Form F-3, we are required to effect up to two such registrations, but only if the minimum anticipated aggregate offering price of the shares to be registered exceeds $5.0 million, and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="6%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	after we become eligible under applicable securities laws to file a registration statement on Form F-3, we are required to effect an unlimited number of registrations, but only (1) if the minimum anticipated aggregate offering price of the shares to be registered exceeds $1.0 million, and (2) up to two within a period of twelve months.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Such registration must also include any additional registrable securities requested to be included in such registration by any other holders of registrable ordinary shares who are party to the Investors&#8217; Rights Agreement or entitled thereunder. In March 2014, we effected one registration of ordinary shares held by shareholders party to our Investors&#8217; Rights Agreement with an offering price exceeding $5.0 million, using a registration statement on Form F-1.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our obligation to effect a registration is subject to certain qualifications and limitations, including (i) our right to postpone a registration during the period that is 60 days (30 days in the case that we use a registration statement on Form F-3) before our good faith estimate of the date of filing of, and ending on the date 180 days (90 days in the case that we use a registration statement on Form F-3) after the effective date of, a registration statement initiated by us; (ii) our right to postpone a registration no more than once in any 12 -month period for a period of up to 90 days in the event of our furnishing a certificate signed by the Chairman of our board of directors that states that in the good faith judgment of our board of directors, it would be materially detrimental to us or our shareholders for such registration statement to either become effective or remain effective, because such action would (a) materially interfere with a significant acquisition, corporate reorganization, or other similar transaction involving us; (b) require premature disclosure of material information that we have a bona fide business purpose for preserving as confidential; or (c) render us unable to comply with requirements under the Securities Act or Exchange Act; and (iii) our right not to effect a registration using a registration statement on Form F-1 if the initiating holders propose to dispose of shares that may be immediately registered pursuant to a previously -requested registration using a statement on Form F- 3.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Piggyback registration rights
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	All of our shareholders that are a party to the Investors&#8217; Rights Agreement have the right to request that we include their registrable securities in certain registration statements that we file in connection with the public offering of our shares. If the public offering that we are effecting is underwritten, the right of any shareholder to include shares in the registration related thereto is conditioned upon the shareholder accepting the terms of the underwriting as agreed between us and the underwriters and then only in such quantity as the underwriters in their sole discretion determine will not jeopardize the success of an offering.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Expenses
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have agreed to pay all expenses incurred in carrying out the above registrations, including the reasonable fees of one counsel chosen by the selling shareholders that are a party to the Investors&#8217; Rights Agreement. However, each shareholder participating in such registration or sale is responsible for its pro rata portion of the customary and standard discounts or commissions payable to any underwriter, as well as transfer taxes owed in connection with the sale of its shares and any individual shareholder or group of shareholders that retains separate advisors is entirely responsible for the fees and expenses related thereto.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	97
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage104"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Agreements and arrangements with, and compensation of, directors and executive officers
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Employment agreements
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have entered into written employment agreements with each of our executive officers. These agreements provide for notice periods of varying duration for termination of the agreement by us or by the relevant executive officer, during which time the executive officer will continue to receive base salary and benefits. These agreements also contain customary provisions regarding noncompetition, confidentiality of information and assignment of inventions. However, the enforceability of the noncompetition provisions may be limited under applicable law. See &#8220;Item 3.D. Key Information &#8212; Risk factors &#8212; Risks relating to our business and industry &#8212; Under applicable employment laws, we may not be able to enforce covenants not to compete&#8221; for a further description of the enforceability of non-competition clauses.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Indemnification agreements
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160; &#160;&#160;&#160;Our articles of association permit us to exculpate, indemnify and insure each of our directors and office holders to the fullest extent permitted by the Israeli Companies Law. We have entered into indemnification agreements with each of our directors and executive officers, undertaking to indemnify them to the fullest extent permitted by Israeli law, including with respect to liabilities resulting from a public offering of our shares, to the extent that these liabilities are not covered by insurance. We have also obtained Directors and Officers insurance for each of our executive officers and directors. For further information, see &#8220;Item 6.C. Directors, Senior Management and Employees &#8212; Board Practices &#8212; Exculpation, insurance and indemnification of directors and officers.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	C.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Interests of experts and counsel
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
</EFX_SECURITY_OWNERS>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_FINANCIAL_DATA>
<A NAME="FIS_FINANCIAL_DATA"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 8: Financial I
<A NAME="ZK1618102_HTM_6">
	nfo
</A>
	rmation
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	A.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Consolidated Financial Statements and Other Financial Information
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Consolidated Financial Statements
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have appended our consolidated Financial Statements at the end of this annual report, starting at page F-2, as part of this annual report.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_LEGAL_PROCEEDINGS>
<A NAME="FIS_LEGAL_PROCEEDINGS"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Legal Proceedings
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; We are party to ongoing litigation in the ordinary course of business and other legal proceedings. For a discussion of these matters, see &#8220;commitments and contingencies&#8221; included in Note 8 to our consolidated Financial Statements included elsewhere in this annual report.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Dividend policy
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have never declared or paid cash or non-cash dividends to our shareholders and we do not intend to pay cash or non-cash dividends in the foreseeable future. We intend to reinvest any earnings in developing and expanding our business. Any future determination relating to our dividend policy will be at the discretion of our board of directors and will depend on a number of factors, including future earnings, our financial condition, operating results, contractual restrictions, capital requirements, business prospects, our strategic goals and plans to expand our business, applicable law and other factors that our board of directors may deem relevant.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	98
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage105"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	See &#8220;Item 3.D. Key Information &#8212; Risk factors &#8212; Risks related to an investment in our ordinary shares &#8212; We have never paid cash or non-cash dividends on our share capital, and we do not anticipate paying any cash or non-cash dividends in the foreseeable future&#8221; for an explanation concerning the payment of dividends under Israeli law.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	B.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Significant Changes
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No significant changes have occurred since December 31, 2015, except as otherwise disclosed in this annual report.
</FONT>
</DIV>
</EFX_LEGAL_PROCEEDINGS>
</EFX_FINANCIAL_DATA>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_LISTING>
<A NAME="FIS_LISTING"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 9: The Offer
<A NAME="ZK1618102_HTM_7">
	and Listing
</A>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_21"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	A.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Offer and Listing Details
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our ordinary shares began trading publicly on the NASDAQ Global Select Market on September 27, 2013 under the symbol &#8220;ENZY.&#8221; The following table sets forth, for the periods indicated, the high and low sales prices of our ordinary shares as reported by the NASDAQ Global Select Market.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Period
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	High
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Low
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Annual
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Year ended December 31, 2015
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10.83
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5.38
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Year ended December 31, 2014
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	30.40
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6.34
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Year ended December 31, 2013
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	35.12
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	14.25
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Quarterly
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	First Quarter 2016 (through February 29, 2016)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10.00
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6.60
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Fourth Quarter 2015
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10.32
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8.00
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Third Quarter 2015
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10.70
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7.17
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Second Quarter 2015
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10.83
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6.85
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	First Quarter 2015
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8.40
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5.38
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Fourth Quarter 2014
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8.75
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6.34
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Third Quarter 2014
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	15.40
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6.62
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Second Quarter 2014
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	22.39
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12.10
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	First Quarter 2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	30.40
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	20.52
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Most Recent Six Months
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; PADDING-LEFT: 0PT; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	February 2016 (through February 29, 2016)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10.00
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6.60
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	January 2016
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10.00
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8.02
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	December 2015
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10.32
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9.25
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	November 2015
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10.19
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8.23
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	October 2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9.67
</FONT>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8.00
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	September 2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10.70
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8.50
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	99
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage106"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The closing sale price of our ordinary shares, as reported by the NASDAQ Global Select Market, on February 29, 2016, was $8.02 per ordinary share.
</FONT>
<BR>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	B.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Plan of Distribution
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	C.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Markets
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	See &#8220;&#8212; Offer and Listing Details&#8221; above.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	D.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Selling Shareholders
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	E.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Dilution
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	F.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Expenses of the Issue
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_LISTING>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_ADDITIONAL_INFORMATION>
<A NAME="FIS_ADDITIONAL_INFORMATION"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 10: Additional Info
<A NAME="ZK1618102_HTM_8">
	rm
</A>
	ation
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	A.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Share Capital
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	B.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Memorandum of Association and Articles of Association
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	General
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As of February 29, 2016, our authorized share capital consists of 100,000,000 ordinary shares, par value NIS 0.01 per share.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	All of our outstanding ordinary shares will be validly issued, fully paid and non-assessable. Our ordinary shares are not redeemable and do not have any preemptive rights.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	100
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage107"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Registration number and purposes of the company
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our registration number with the Israeli Registrar of Companies is 51-260924-9. As set forth in Article 3 of our articles of association, our purpose is to engage in any lawful activity.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Voting rights and conversion
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	All ordinary shares will have identical voting and other rights in all respects.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Transfer of shares
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our fully paid ordinary shares are issued in registered form and may be freely transferred under our articles of association, unless the transfer is restricted or prohibited by another instrument, applicable law or the rules of a stock exchange on which the shares are listed for trade. The ownership or voting of our ordinary shares by non-residents of Israel is not restricted in any way by our articles of association or the laws of the State of Israel, except for ownership by nationals of some countries that are, or have been, in a state of war with Israel.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Election of directors
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our ordinary shares do not have cumulative voting rights for the election of directors. As a result, the holders of a majority of the voting power represented at a shareholders meeting have the power to elect all of our directors, subject to the special approval requirements for external directors described under &#8220;Item 6.C. Directors, Senior Management and Employees &#8212; Board Practices &#8212; External directors.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under our articles of association, our board of directors must consist of not less than five but no more than nine directors, not including two external directors as required by the Israeli Companies Law. Pursuant to our amended articles of association, other than the external directors, for whom special election requirements apply under the Israeli Companies Law, the vote required to appoint a director is a simple majority vote of holders of our voting shares, participating and voting at the relevant meeting. In addition, our directors, other than the external directors, are divided into three classes that are each elected at a general meeting of our shareholders every three years, in a staggered fashion (such that one class is elected each year), and serve on our board of directors until they are removed by a vote of 65% of the voting power of our shareholders at a general or extraordinary meeting of our shareholders or upon the occurrence of certain events, in accordance with the Israeli Companies Law and our articles of association. In addition, our articles of association allow our board of directors to appoint directors to fill vacancies on the board of directors to serve for a term of office equal to the remaining period of the term of office of the directors(s) whose office(s) have been vacated. External directors are elected for an initial term of three years, may be elected for additional terms of three years each under certain circumstances, and may be removed from office pursuant to the terms of the Israeli Companies Law. See &#8220;Item 6.C. Directors, Senior Management and Employees &#8212; Board Practices &#8212; External directors.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Dividend and liquidation rights
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We may declare a dividend to be paid to the holders of our ordinary shares in proportion to their respective shareholdings. Under the Israeli Companies Law, dividend distributions are determined by the board of directors and do not require the approval of the shareholders of a company unless the company&#8217;s articles of association provide otherwise. Our articles of association do not require shareholder approval of a dividend distribution and provide that dividend distributions may be determined by our board of directors.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Pursuant to the Israeli Companies Law, the distribution amount is limited to the greater of retained earnings or earnings generated over the previous two years, according to our then last reviewed or audited financial statements, provided that the date of the financial statements is not more than six months prior to the date of the distribution, or we may distribute dividends that do not meet such criteria only with court approval. In each case, we are only permitted to distribute a dividend if our board of directors and the court, if applicable, determines that there is no reasonable concern that payment of the dividend will prevent us from satisfying our existing and foreseeable obligations as they become due.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	101
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage108"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In the event of our liquidation, after satisfaction of liabilities to creditors, our assets will be distributed to the holders of our ordinary shares in proportion to their shareholdings. This right, as well as the right to receive dividends, may be affected by the grant of preferential dividend or distribution rights to the holders of a class of shares with preferential rights that may be authorized in the future.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Exchange controls
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	There are currently no Israeli currency control restrictions on remittances of dividends on our ordinary shares, proceeds from the sale of the shares or interest or other payments to non-residents of Israel, except for shareholders who are subjects of countries that are, or have been, in a state of war with Israel.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Shareholder meetings
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under Israeli law, we are required to hold an annual general meeting of our shareholders once every calendar year that must be held no later than 15 months after the date of the previous annual general meeting. All meetings other than the annual general meeting of shareholders are referred to in our articles of association as extraordinary general meetings. Our board of directors may call extraordinary general meetings whenever it sees fit, at such time and place, within or outside of Israel, as it may determine. In addition, the Israeli Companies Law provides that our board of directors is required to convene an extraordinary general meeting upon the written request of (i) any two of our directors or one-quarter of the members of our board of directors or (ii) one or more shareholders holding, in the aggregate, either (a) 5% or more of our outstanding issued shares and 1% of our outstanding voting power or (b) 5% or more of our outstanding voting power.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Subject to the provisions of the Israeli Companies Law and the regulations promulgated thereunder, shareholders entitled to participate and vote at general meetings are the shareholders of record on a date to be decided by the board of directors, which may be between four and 40 days prior to the date of the meeting. Furthermore, the Israeli Companies Law requires that resolutions regarding the following matters must be passed at a general meeting of our shareholders:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="6%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="74%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	amendments to our articles of association;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="6%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="74%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	appointment or termination of our auditors;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="6%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="74%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	appointment of external directors;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="6%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="74%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	approval of certain related party transactions;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="6%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="74%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	increases or reductions of our authorized share capital;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="6%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="74%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	a merger; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 72PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="6%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="74%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	the exercise of our board of director&#8217;s powers by a general meeting, if our board of directors is unable to exercise its powers and the exercise of any of its powers is required for our proper management.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Israeli Companies Law and our articles of association require that a notice of any annual general meeting or extraordinary general meeting be provided to shareholders at least 21 days prior to the meeting and if the agenda of the meeting includes the appointment or removal of directors, the approval of transactions with office holders or interested or related parties, or an approval of a merger, notice must be provided at least 35 days prior to the meeting.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	102
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage109"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law and under our articles of association, shareholders are not permitted to take action via written consent in lieu of a meeting.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Voting rights
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Quorum requirements
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Pursuant to our articles of association, holders of our ordinary shares have one vote for each ordinary share held on all matters submitted to a vote before the shareholders at a general meeting. As a foreign private issuer, the quorum required for our general meetings of shareholders consists of at least two shareholders present in person, by proxy or written ballot who hold or represent between them at least 25% of the total outstanding voting rights. A meeting adjourned for lack of a quorum is generally adjourned to the same day in the following week at the same time and place or to a later time or date if so specified in the notice of the meeting. At the reconvened meeting, any two or more shareholders present in person or by proxy shall constitute a lawful quorum.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Vote requirements
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our articles of association provide that all resolutions of our shareholders require a simple majority vote, unless otherwise required by the Israeli Companies Law or by our articles of association. Under the Israeli Companies Law, each of (i) the approval of an extraordinary transaction with a controlling shareholder; (ii) the terms of employment or other engagement of the controlling shareholder of the company or such controlling shareholder&#8217;s relative (even if not extraordinary) requires, the approval described above under &#8220;Item 6.C. Directors, Senior Management and Employees &#8212; Board Practices &#8212; Approval of related party transactions under Israeli law &#8212; Fiduciary duties of directors and executive officers &#8212; Disclosure of personal interests of controlling shareholders and approval of certain transactions&#8221; and (iii) approval of certain compensation-related matters requires the approval described above under &#8220;Item 6.C. Directors, Senior Management and Employees &#8212; Board Practices &#8212;Board Committees&#8212;Compensation Committee and Compensation Policy.&#8221; Under our articles of association, the alteration of the rights, privileges, preferences or obligations of any class of our shares requires a simple majority of the class so affected (or such other percentage of the relevant class that may be set forth in the governing documents relevant to such class), in addition to the ordinary majority vote of all classes of shares voting together as a single class at a shareholder meeting. Our articles of association also require that the removal of any director from office (other than our external directors) or the amendment of the provisions of our articles of association relating to our staggered board requires the vote of 65% of the voting power of our shareholders. Another exception to the simple majority vote requirement is a resolution for the voluntary winding up, or an approval of a scheme of arrangement or reorganization, of the company pursuant to Section 350 of the Israeli Companies Law, which requires the approval of holders of 75% of the voting rights represented at the meeting, in person, by proxy or by voting deed and voting on the resolution.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Acce
</FONT>
	s
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	s to Corporate Records
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law, shareholders are provided access to: minutes of our general meetings; our shareholders register and principal shareholders register, articles of association and financial statements; and any document that we are required by law to file publicly with the Israeli Companies Registrar or the Israel Securities Authority. In addition, shareholders may request to be provided with any document related to an action or transaction requiring shareholder approval under the related party transaction provisions of the Israeli Companies Law. We may deny this request if we believe it has not been made in good faith or if such denial is necessary to protect our interest or protect a trade secret or patent.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Modification of class rights
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Israeli Companies Law and our articles of association, the rights attached to any class of share, such as voting, liquidation and dividend rights, may be amended by adoption of a resolution by the holders of a majority of the shares of that class present at a separate class meeting, or otherwise in accordance with the rights attached to such class of shares, as set forth in our amended articles of association.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Registration rights
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For a discussion of registration rights we have granted to certain of our shareholders, please see &#8220;Item 7.B. Major Shareholders and Related Party Transactions &#8212; Related Party Transactions &#8212; Investors&#8217; rights agreement.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	103
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage110"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Acquisitions under Israeli law
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Full tender offer
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	A person wishing to acquire shares of an Israeli public company and who would as a result hold over 90% of the target company&#8217;s issued and outstanding share capital is required by the Israeli Companies Law to make a tender offer to all of the company&#8217;s shareholders for the purchase of all of the issued and outstanding shares of the company. A person wishing to acquire shares of a public Israeli company and who would as a result hold over 90% of the issued and outstanding share capital of a certain class of shares is required to make a tender offer to all of the shareholders who hold shares of the relevant class for the purchase of all of the issued and outstanding shares of that class. If the shareholders who do not accept the offer hold less than 5% of the issued and outstanding share capital of the company or of the applicable class, and more than half of the shareholders who do not have a personal interest in the offer accept the offer, all of the shares that the acquirer offered to purchase will be transferred to the acquirer by operation of law. However, a tender offer will also be accepted if the shareholders who do not accept the offer hold less than 2% of the issued and outstanding share capital of the company or of the applicable class of shares.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Upon a successful completion of such a full tender offer, any shareholder that was an offeree in such tender offer, whether such shareholder accepted the tender offer or not, may, within six months from the date of acceptance of the tender offer, petition an Israeli court to determine whether the tender offer was for less than fair value and that the fair value should be paid as determined by the court. However, under certain conditions, the offeror may include in the terms of the tender offer that an offeree who accepted the offer will not be entitled to petition the Israeli court as described above.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If (a) the shareholders who did not respond or accept the tender offer hold at least 5% of the issued and outstanding share capital of the company or of the applicable class or the shareholders who accept the offer constitute less than a majority of the offerees that do not have a personal interest in the acceptance of the tender offer, or (b) the shareholders who did not accept the tender offer hold 2% or more of the issued and outstanding share capital of the company (or of the applicable class), the acquirer may not acquire shares of the company that will increase its holdings to more than 90% of the company&#8217;s issued and outstanding share capital or of the applicable class from shareholders who accepted the tender offer.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Special tender offer
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Israeli Companies Law provides that an acquisition of shares of an Israeli public company must be made by means of a special tender offer if as a result of the acquisition the purchaser would become a holder of 25% or more of the voting rights in the company. This requirement does not apply if there is already another holder of at least 25% of the voting rights in the company. Similarly, the Israeli Companies Law provides that an acquisition of shares in a public company must be made by means of a special tender offer if as a result of the acquisition the purchaser would become a holder of more than 45% of the voting rights in the company, if there is no other shareholder of the company who holds more than 45% of the voting rights in the company, subject to certain exceptions.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	A special tender offer must be extended to all shareholders of a company but the offeror is not required to purchase shares representing more than 5% of the voting power attached to the company&#8217;s outstanding shares, regardless of how many shares are tendered by shareholders. A special tender offer may be consummated only if (i) at least 5% of the voting power attached to the company&#8217;s outstanding shares will be acquired by the offeror; and (ii) the number of shares tendered in the offer exceeds the number of shares whose holders objected to the offer (excluding the purchaser, controlling shareholders, holders of 25% or more of the voting rights in the company or any person having a personal interest in the acceptance of the tender offer). If a special tender offer is accepted, then the purchaser or any person or entity controlling it or under common control with the purchaser or such controlling person or entity may not make a subsequent tender offer for the purchase of shares of the target company and may not enter into a merger with the target company for a period of one year from the date of the offer, unless the purchaser or such person or entity undertook to effect such an offer or merger in the initial special tender offer.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Merger
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Israeli Companies Law permits merger transactions if approved by each party&#8217;s board of directors and, unless certain requirements described under the Israeli Companies Law are met, by a majority vote of each party&#8217;s shares, and, in the case of the target company, a majority vote of each class of its shares, voted on the proposed merger at a shareholders meeting.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	104
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage111"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;For purposes of the shareholder vote, unless a court rules otherwise, the merger will not be deemed approved if a majority of the votes of shares represented at the shareholders meeting that are held by parties other than the other party to the merger, or by any person (or group of persons acting in concert) who holds (or hold, as the case may be) 25% or more of the voting rights or the right to appoint 25% or more of the directors of the other party, vote against the merger. If, however, the merger involves a merger with a company&#8217;s own controlling shareholder or if the controlling shareholder has a personal interest in the merger, then the merger is instead subject to the same Special Majority approval that governs all extraordinary transactions with controlling shareholders (as described under &#8220;Item 6.C. Directors, Senior Management and Employees &#8212; Board Practices &#8212; Approval of related party transactions under Israeli law &#8212; Fiduciary duties of directors and executive officers &#8212; Disclosure of personal interests of controlling shareholders and approval of certain transactions&#8221;).
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If the transaction would have been approved by the shareholders of a merging company but for the separate approval of each class or the exclusion of the votes of certain shareholders as provided above, a court may still approve the merger upon the request of holders of at least 25% of the voting rights of a company, if the court holds that the merger is fair and reasonable, taking into account the value of the parties to the merger and the consideration offered to the shareholders of the company.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Upon the request of a creditor of either party to the proposed merger, the court may delay or prevent the merger if it concludes that there exists a reasonable concern that, as a result of the merger, the surviving company will be unable to satisfy the obligations of the merging entities, and may further give instructions to secure the rights of creditors.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition, a merger may not be consummated unless at least 50 days have passed from the date on which a proposal for approval of the merger was filed by each party with the Israeli Registrar of Companies and at least 30 days have passed from the date on which the merger was approved by the shareholders of each party.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Anti-takeover measures under Israeli law
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Israeli Companies Law allows us to create and issue shares having rights different from those attached to our ordinary shares, including shares providing certain preferred rights with respect to voting, distributions or other matters and shares having preemptive rights. Currently, no preferred shares are authorized under our amended articles of association. In the future, if we do authorize, create and issue a specific class of preferred shares, such class of shares, depending on the specific rights that may be attached to it, may have the ability to frustrate or prevent a takeover or otherwise prevent our shareholders from realizing a potential premium over the market value of their ordinary shares. The authorization and designation of a class of preferred shares will require an amendment to our articles of association, which requires the prior approval of the holders of a majority of the voting power attaching to our issued and outstanding shares at a general meeting. The convening of the meeting, the shareholders entitled to participate and the majority vote required to be obtained at such a meeting will be subject to the requirements set forth in the Israeli Companies Law as described above in &#8220;&#8212; Voting rights.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Borrowing powers
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Pursuant to the Israeli Companies Law and our articles of association, our board of directors may exercise all powers and take all actions that are not required under law or under our amended articles of association to be exercised or taken by our shareholders, including the power to borrow money for company purposes.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Changes in capital
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our articles of association enable us to increase or reduce our share capital. Any such changes are subject to the provisions of the Israeli Companies Law and must be approved by a resolution duly passed by our shareholders at a general meeting by voting on such change in the capital. In addition, transactions that have the effect of reducing capital, such as the declaration and payment of dividends in the absence of sufficient retained earnings or profits, require the approval of both our board of directors and an Israeli court.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_22"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	C.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Material Contracts
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN">
	&#160;
</FONT>
	Summaries of the following material contracts and amendments to these contracts are included in this annual report in the places indicated:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 36PT" ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="95%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="38%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; BORDER-LEFT: BLACK 1PX SOLID; BORDER-TOP: BLACK 1PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Material Contract
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="62%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; BORDER-LEFT: BLACK 2PX SOLID; BORDER-TOP: BLACK 1PX SOLID; BORDER-RIGHT: BLACK 1PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Location in This Annual Report
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="38%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; BORDER-LEFT: BLACK 1PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Amended and Restated Investors&#8217; Rights Agreement, dated September 22, 2013, between us and the parties thereto
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="62%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; BORDER-LEFT: BLACK 2PX SOLID; BORDER-RIGHT: BLACK 1PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8220;Item 7.B. Major Shareholders and Related Party Transactions&#8212;Related Party Transaction&#8212;Investors&#8217; Rights Agreement.&#8221;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="38%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; BORDER-LEFT: BLACK 1PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Agreements and arrangements with, and compensation of, directors and executive officers
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="62%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; BORDER-LEFT: BLACK 2PX SOLID; BORDER-RIGHT: BLACK 1PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8220;Item 7.B. Major Shareholders and Related Party Transactions&#8212;Related Party Transaction&#8212;Agreements and arrangements with, and compensation of, directors and executive officers.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="38%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; BORDER-LEFT: BLACK 1PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Shareholders&#8217; Agreement, dated June 14, 2007, between Enzymotec Ltd. and AarhusKarlshamn AB (publ) regarding the joint venture company Advanced Lipids AB
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="62%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; BORDER-LEFT: BLACK 2PX SOLID; BORDER-RIGHT: BLACK 1PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8220;Item 4.B. Information on the Company&#8212;B. Business Overview&#8212;Joint Venture with AAK.&#8221;
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="38%" STYLE="BORDER-BOTTOM: BLACK 1PX SOLID; BORDER-LEFT: BLACK 1PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Agreement, dated September 17, 2009, between us and the Israel Land Administration regarding our facility at the Sagi 2000 Industrial Area, Migdal Ha&#8217;Emeq, Israel and Addendum thereto dated August 14, 2013
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="62%" STYLE="BORDER-BOTTOM: BLACK 1PX SOLID; BORDER-LEFT: BLACK 2PX SOLID; BORDER-RIGHT: BLACK 1PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8220;Item 4.D. Information on the Company&#8212;D. Property, Plants and Equipment.&#8221;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	105
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage112"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	D.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Exchange Controls
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 1998, Israeli currency control regulations were liberalized significantly, so that Israeli residents generally may freely deal in foreign currency and foreign assets, and non-residents may freely deal in Israeli currency and Israeli assets. There are currently no Israeli currency control restrictions on remittances of dividends on the ordinary shares or the proceeds from the sale of the shares provided that all taxes were paid or withheld; however, legislation remains in effect pursuant to which currency controls can be imposed by administrative action at any time.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Non-residents of Israel may freely hold and trade our securities. Neither our articles of association nor the laws of the State of Israel restrict in any way the ownership or voting of ordinary shares by non-residents, except that such restrictions may exist with respect to citizens of countries which are in a state of war with Israel. Israeli residents are allowed to purchase our ordinary shares.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	E.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Taxation
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following description is not intended to constitute a complete analysis of all tax consequences relating to the acquisition, ownership and disposition of our ordinary shares. You should consult your own tax advisor concerning the tax consequences of your particular situation, as well as any tax consequences that may arise under the laws of any state, local, foreign or other taxing jurisdiction.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Israeli tax considerations and government programs
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following is a brief summary of the material Israeli tax laws applicable to us, and certain Israeli Government programs that benefit us. This section also contains a discussion of material Israeli tax consequences concerning the ownership and disposition of our ordinary shares. This summary does not discuss all the aspects of Israeli tax law that may be relevant to a particular investor in light of his or her personal investment circumstances or to some types of investors subject to special treatment under Israeli law. Examples of such investors include residents of Israel or traders in securities who are subject to special tax regimes not covered in this discussion. Because parts of this discussion are based on new tax legislation that has not yet been subject to judicial or administrative interpretation, we cannot assure you that the appropriate tax authorities or the courts will accept the views expressed in this discussion. The discussion below is subject to change, including due to amendments under Israeli law or changes to the applicable judicial or administrative interpretations of Israeli law, which change could affect the tax consequences described below.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	106
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage113"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	General corporate tax structure in Israel
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Israeli companies are generally subject to corporate tax on their taxable income.&#160;&#160;As of 2016, the corporate tax rate is 25% (in 2014 and 2015 the corporate tax rate was 26.5%. However, the effective tax rate payable by a company that derives income from an Approved Enterprise, a Benefited Enterprise or a Preferred Enterprise (as discussed below) may be considerably less. Capital gains derived by an Israeli company are generally subject to tax at the prevailing corporate tax rate.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
	Starting in the year ended December 31, 2014, the Company elected to compute its taxable income in accordance with Income Tax Regulations (Rules for Accounting for Foreign Investors Companies and Certain Partnerships and Setting their Taxable Income), 1986. Accordingly, the taxable income or loss is calculated in dollars. Applying these regulations reduces the effect of dollar-NIS exchange rate on the Company&#8217;s Israeli taxable income.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Law for the Encouragement of Industry (Taxes), 5729-1969
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Law for the Encouragement of Industry (Taxes), 5729-1969, generally referred to as the Industry Encouragement Law, provides several tax benefits for &#8220;Industrial Companies.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Industry Encouragement Law defines an &#8220;Industrial Company&#8221; as a company resident in Israel, which was incorporated in Israel and of which 90% or more of its income in any tax year, other than income from certain government loans, is derived from an &#8220;Industrial Enterprise&#8221; owned by it and located in Israel. An &#8220;Industrial Enterprise&#8221; is defined as an enterprise whose principal activity in a given tax year is industrial production.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following tax benefits, among others, are available to Industrial Companies:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	deduction of the cost of purchased know-how and patents and rights to use a patent and know-how which are used for the development or promotion&#160;&#160;of the Industrial Enterprise, over an eight-year period commencing in the year in which such rights were first exercised;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	under limited conditions, an election to file consolidated tax returns with related Israeli Industrial Companies controlled by it; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	expenses related to a public offering are deductible in equal amounts over three years.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Eligibility for benefits under the Industry Encouragement Law is not subject to receipt of prior approval from any governmental authority.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We currently qualify as an Industrial Company within the meaning of the Industry Encouragement Law.&#160;&#160;There can be no assurance that we will continue to qualify as an Industrial Company or that the benefits described above will be available in the future.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Law for the Encouragement of Capital Investments, 5719-1959
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Law for the Encouragement of Capital Investments, 5719-1959, generally referred to as the Investment Law, provides certain incentives for capital investments in production facilities (or other eligible assets) by &#8220;Industrial Enterprises&#8221; (as defined under the Investment Law).
</FONT>
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	107
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage114"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Investment Law was significantly amended effective April 1, 2005, or the 2005 Amendment, and further amended as of January 1, 2011, or the 2011 Amendment. Pursuant to the 2005 Amendment, tax benefits granted in accordance with the provisions of the Investment Law prior to its revision by the 2005 Amendment remain in force but any benefits granted subsequently are subject to the provisions of the 2005 Amendment. Similarly, the 2011 Amendment introduced new benefits to replace those granted in accordance with the provisions of the Investment Law in effect prior to the 2011 Amendment. However, companies entitled to benefits under the Investment Law as in effect prior to January 1, 2011 were entitled to choose to continue to enjoy such benefits, provided that certain conditions are met, or elect instead, irrevocably, to forego such benefits and have the benefits of the 2011 Amendment apply. We have examined the possible effect, if any, of these provisions of the 2011 Amendment on our financial statements and have decided, at this time, not to opt to apply the new benefits under the 2011 Amendment.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Tax benefits prior to the 2005 Amendment
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	An investment program that is implemented in accordance with the provisions of the Investment Law prior to the 2005 Amendment, referred to as an &#8220;Approved Enterprise,&#8221; is entitled to certain benefits. A company that wished to receive benefits as an Approved Enterprise must have received approval from the Investment Center of the Israeli Ministry of Economy and Industry, or the Investment Center. Each certificate of approval for an Approved Enterprise relates to a specific investment program, delineated both by the financial scope of the investment, including source of funds, and by the physical characteristics of the facility or the asset.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In general, an Approved Enterprise is entitled to receive a grant from the Government of Israel or an alternative package of tax benefits, known as the alternative benefits track. Under the alternative benefits track, a company&#8217;s undistributed income derived from an Approved Enterprise will be exempt from corporate tax for a period of between two and ten years from the first year of taxable income, depending on the geographic location within Israel of the Approved Enterprise, and a reduced corporate tax rate of between 10% to 25% for the remainder of the benefits period, depending on the level of foreign investment in the company in each year, as detailed below. The benefits commence on the date in which that taxable income is first earned. If a company has more than one Approved Enterprise program or if only a portion of its capital investments are approved, its effective tax rate is the result of a weighted combination of the applicable rates. The tax benefits available under any certificate of approval relate only to taxable income attributable to the specific specific program and are contingent upon meeting the criteria set out in the certificate of approval. Income derived from activity that is not integral to the activity of the Approved Enterprise will not enjoy tax benefits. The entitlement to the above benefits is subject to fulfillment of certain conditions, according to the law and related regulations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition, a company that has an Approved Enterprise program is eligible for further tax benefits if it qualifies as a Foreign Investors&#8217; Company (&#8220;FIC&#8221;), which is a company with a level of foreign investment, as defined in the Investment Law, of more than 25%. The level of foreign investment is measured as the percentage of rights in the company (in terms of shares, rights to profits, voting and appointment of directors), and of combined share and loan capital, that are owned, directly or indirectly, by persons who are not residents of Israel. The determination as to whether a company qualifies as an FIC is made on an annual basis.&#160;&#160;An FIC that has an Approved Enterprise program will be eligible for an extension of the period during which it is entitled to tax benefits under its Approved Enterprise status (so that the benefits period may be up to ten years) and for further tax benefits if the level of foreign investment is 49% or more. If a company that has an Approved Enterprise program is a wholly owned subsidiary of another company, then the percentage of foreign investments is determined based on the percentage of foreign investment in the parent company.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The corporate tax rates and related levels of foreign investments with respect to an FIC that has an Approved Enterprise program are set forth in the following table:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_23"></A>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="85%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Percentage of non-Israeli ownership
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Corporate
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Tax Rate
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Over 25% but less than 49%
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 12PT">
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	25
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	49% or more but less than 74%
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 12PT">
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	20
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	74% or more but less than 90%
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 12PT">
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	15
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	90% or more
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 12PT">
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	108
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage115"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If a company elects the alternative benefits track and distributes a dividend out of income derived by its Approved Enterprise during the tax exemption period it will be subject to corporate tax in respect of the amount of the distributed dividend (grossed-up to reflect the pre-tax income that it would have had to earn in order to distribute the dividend) at the corporate tax rate which would have been applicable if such income had not been tax-exempted under the alternative benefits track. This rate generally ranges from 10% to 25%, depending on the level of foreign investment in the company in each year, as explained above. In addition, dividends paid out of income attributed to an Approved Enterprise (or out of dividends received from a company whose income is attributed to an Approved Enterprise) are generally subject to withholding tax at source at the rate of 15% or such lower rate as may be provided in an applicable tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate). The 15% tax rate is limited to dividends and distributions out of income derived during the benefits period and actually paid at any time up to twelve years thereafter. After this period, the withholding tax is applied at a rate of up to 30%, or at the lower rate under an applicable tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate). In the case of an FIC, the twelve year limitation on reduced withholding tax on dividends does not apply.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Investment Law also provides that an Approved Enterprise is entitled to accelerated depreciation on its property and equipment that are included in an Approved Enterprise program during the first five years in which the equipment is used. This benefit is an incentive granted by the Israeli government regardless of whether the alternative benefits program is elected.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The benefits available to an Approved Enterprise are subject to the continued fulfillment of conditions stipulated in the Investment Law and its regulations and the criteria in the specific certificate of approval, as described above. If a company does not meet these conditions, it would be required to refund the amount of tax benefits, as adjusted by the Israeli consumer price index, and interest, or other monetary penalty.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We currently have Approved Enterprise programs under the Investment Law, which, we believe, entitle us to certain tax benefits. The tax benefit period for these programs has not yet commenced. We have elected the alternative benefits program which provides for the waiver of grants in return for tax exemptions. Accordingly, taxable income from our Approved Enterprise programs (once generated) will be tax exempt for a period of ten years commencing with the year we will first earn such taxable income.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Tax benefits subsequent to the 2005 Amendment
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The 2005 Amendment applies to new investment programs commencing after 2004, but does not apply to investment programs approved prior to April 1, 2005. The 2005 Amendment provides that terms and benefits included in any certificate of approval that was granted before the 2005 Amendment became effective (April 1, 2005) will remain subject to the provisions of the Investment Law as in effect on the date of such approval. Pursuant to the 2005 Amendment, the Investment Center will continue to grant Approved Enterprise status to qualifying investments. The 2005 Amendment, however, limits the scope of enterprises that may be approved by the Investment Center by setting criteria for the approval of a facility as an Approved Enterprise.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	An enterprise that qualifies under the new provisions is referred to as a &#8220;Benefited Enterprise,&#8221; rather than &#8220;Approved Enterprise&#8221;. The 2005 Amendment provides that a certificate of approval from the Investment Center will only be necessary for receiving cash grants. As a result, it was no longer necessary for a company to obtain the advance approval of the Investment Center in order to receive the tax benefits previously available under the alternative benefits track. Rather, a company may claim the tax benefits offered by the Investment Law directly in its tax returns, provided that its facilities meet the criteria for tax benefits set forth in the 2005 Amendment.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Tax benefits are available under the 2005 Amendment to production facilities (or other eligible facilities) which are generally required to derive more than 25% of their business income from export to specific markets with a population of at least 14 million in 2012 (such export criteria will further be increased in the future by 1.4% per annum). In order to receive the tax benefits, the 2005 Amendment states that a company must make an investment which meets certain conditions set forth in the amendment for tax benefits, including exceeding a minimum investment amount specified in the Investment Law. Such investment entitles a company to &#8220;Benefited Enterprise&#8221; status with respect to the investment, and may be made over a period of no more than three years from the end of the year in which the company chose to have the tax benefits apply to its Benefited Enterprise. Where a company requests to have the tax benefits apply to an expansion of existing facilities, only the expansion will be considered to be a Benefited Enterprise and the company&#8217;s effective tax rate will be the weighted average of the applicable rates. In such case, the minimum investment required in order to qualify as a Benefited Enterprise must exceed a certain percentage of the value of the company&#8217;s production assets before the expansion.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	109
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage116"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The extent of the tax benefits available under the 2005 Amendment to qualifying income of a Benefited Enterprise depends on, among other things, the geographic location in Israel of the Benefited Enterprise. The location will also determine the period for which tax benefits are available. Such tax benefits include an exemption from corporate tax on undistributed income generated by the Benefited Enterprise for a period of between two to ten years, depending on the geographic location of the Benefited Enterprise in Israel, and a reduced corporate tax rate of between 10% to 25% for the remainder of the benefits period, depending on the level of foreign investment in the company in each year, as explained above. The benefits period is limited to 12 or 14 years from the year the company first chose to have the tax benefits apply, depending on the location of the company.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;A company qualifying for tax benefits under the 2005 Amendment which pays a dividend out of income derived by its Benefited Enterprise during the tax exemption period will be subject to corporate tax in respect of the amount of the dividend distributed (grossed-up to reflect the pre-tax income that it would have had to earn in order to distribute the dividend) at the corporate tax rate which would have otherwise been applicable. Dividends paid out of income attributed to a Benefited Enterprise are generally subject to withholding tax at source at the rate of 15% or such lower rate as may be provided in an applicable tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate). The reduced rate of 15% is limited to dividends and distributions out of income attributed to a Benefited Enterprise during the benefits period and actually paid at any time up to 12 years thereafter except with respect to an FIC, in which case the 12-year limit does not apply.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The benefits available to a Benefited Enterprise are subject to the continued fulfillment of conditions stipulated in the Investment Law and its regulations. If a company does not meet these conditions, it would be required to refund the amount of tax benefits, as adjusted by the Israeli consumer price index, and interest, or other monetary penalties.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We currently have Benefited Enterprise programs under the Investments Law, which, we believe, entitle us to certain tax benefits. The tax benefit period for these programs has not yet commenced but is expected to end in 2022. During the benefits period, the majority of the taxable income from our Benefited Enterprise programs (once generated) will be tax exempt for a period of ten years commencing with the year we will first earn taxable income relating to such enterprises, subject to the 12 or 14 year limitation described above.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Tax benefits under the 2011 Amendment
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The 2011 Amendment canceled the availability of the benefits granted to companies in accordance with the provisions of the Investment Law prior to 2011 and, instead, introduced new benefits for income generated by a &#8220;Preferred Company&#8221; through its &#8220;Preferred Enterprise&#8221; (as such terms are defined in the Investment Law) as of January 1, 2011. The definition of a Preferred Company includes a company incorporated in Israel that is not wholly-owned by a governmental entity, and that has, among other things, Preferred Enterprise status and is controlled and managed from Israel. Pursuant to the 2011 Amendment, a Preferred Company is entitled to a reduced corporate tax rate of 15% with respect to its preferred income derived by its Preferred Enterprise in 2011 and 2012, unless the Preferred Enterprise is located in a specified development zone, in which case the rate is 10%. Such corporate tax rates were reduced from 15% and 10%, respectively, to 12.5% and 7%, respectively, in 2013.&#160;&#160;Such corporate tax rates were increased to 16% and 9%, respectively, in 2014 and thereafter. Our facilities are located in a specified development zone.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Dividends paid out of income attributed to a Preferred Enterprise are generally subject to withholding tax at source at the rate of 20% or such lower rate as may be provided in an applicable tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate). However, if such dividends are paid to an Israeli company, no tax is required to be withheld (although, if such dividends are subsequently distributed to individuals or a non-Israeli company, withholding tax at a rate of 20% or such lower rate as may be provided in an applicable tax treaty will apply).
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	110
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage117"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The 2011 Amendment also provided transitional provisions to address companies already enjoying existing tax benefits under the Investment Law. These transitional provisions provide, among other things, that unless an irrevocable request is made to apply the provisions of the Investment Law as amended in 2011 with respect to income to be derived as of January 1, 2011: (i) the terms and benefits included in any certificate of approval that was granted to an Approved Enterprise which chose to receive grants before the 2011 Amendment became effective will remain subject to the provisions of the Investment Law as in effect on the date of such approval, and subject to certain other conditions; (ii) terms and benefits included in any certificate of approval that was granted to an Approved Enterprise which had participated in an alternative benefits track before the 2011 Amendment became effective will remain subject to the provisions of the Investment Law as in effect on the date of such approval, provided that certain conditions are met; and (iii) a Benefited Enterprise can elect to continue to benefit from the benefits provided to it before the 2011 Amendment came into effect, provided that certain conditions are met.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The termination or substantial reduction of any of the benefits available under the Investment Law could materially increase our tax liabilities.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have examined the possible effect, if any, of the provisions of the 2011 Amendment on our financial statements and have decided, at this time, not to apply the new benefits under the 2011 Amendment.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Taxation of our shareholders
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Capital Gains Taxes Applicable to Non-Israeli Resident Shareholders
</FONT>
	. A non-Israeli resident who derives capital gains from the sale of shares in an Israeli resident company that were purchased after the company was listed for trading on a stock exchange outside of Israel will be exempt from Israeli tax so long as the shares were not held through a permanent establishment that the non-resident maintains in Israel and that such shareholders are not subject to the Israeli Income Tax Law (Inflationary Adjustments) 5745-1985. However, non-Israeli corporations will not be entitled to the foregoing exemption if Israeli residents: (i) have a controlling interest of 25% or more in such non-Israeli corporation or (ii) are the beneficiaries of, or are entitled to, 25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly. Such exemption is not applicable to a person whose gains from selling or otherwise disposing of the shares are deemed to be business income.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Additionally, a sale of securities by a non-Israeli resident may be exempt from Israeli capital gains tax under the provisions of an applicable tax treaty. For example, under the United States-Israel Tax Treaty, the disposition of shares by a shareholder who (i) is a U.S. resident (for purposes of the treaty); (ii) holds the shares as a capital asset; and (iii) is entitled to claim the benefits afforded to such person by the treaty, is generally exempt from Israeli capital gains tax. Such exemption will not apply if: (i) the capital gain arising from the disposition can be attributed to a permanent establishment of the shareholder is maintained in Israel; (ii) the shareholder holds, directly or indirectly, shares representing 10% or more of the voting capital during any part of the 12-month period preceding such sale, exchange or disposition, subject to certain conditions; or (iii) such U.S. resident is an individual and was present in Israel for a period or periods of 183 days or more in the aggrgate during the relevant taxable year. In such case, the sale, exchange or disposition of our ordinary shares would be subject to Israeli tax, to the extent applicable; however, under the United States-Israel Tax Treaty, a U.S. resident would be permitted to claim a credit for such taxes against the U.S. federal income tax imposed with respect to such sale, exchange or disposition, subject to the limitations under U.S. law applicable to foreign tax credits. The United States-Israel Tax Treaty does not relate to U.S. state or local taxes.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In some instances where our shareholders may be liable for Israeli tax on the sale of their ordinary shares, the payment of the consideration may be subject to the withholding of Israeli tax at source. Shareholders may be required to demonstrate that they are exempt from tax on their capital gains in order to avoid withholding at source at the time of sale. Specifically, in transactions involving a sale of all of the shares of an Israeli resident company, in the form of a merger or otherwise, the Israel Tax Authority may require from shareholders who are not liable for Israeli tax to sign declarations in forms specified by this authority or obtain a specific exemption from the Israel Tax Authority to confirm their status as non-Israeli resident, and, in the absence of such declarations or exemptions, may require the purchaser of the shares to withhold taxes at source.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Taxation of Non-Israeli Shareholders on Receipt of Dividends
</FONT>
	.&#160;&#160;Non-Israeli residents (whether individuals or corporations) are generally subject to Israeli income tax on the receipt of dividends paid on our ordinary shares at the rate of 25% or 30% (if&#160;&#160;the dividend recipient is a &#8220;substantial shareholder&#8221; at the time of receiving the dividend or on any time during the preceding twelve months).&#160;&#160;or 15% if the dividend is distributed from income attributed to an Approved Enterprise or Benefited Enterprise (and 20% with respect to Preferred Enterprise). A &#8220;substantial shareholder&#8221; is generally a person who alone or together with such person&#8217;s relative or another person who collaborates with such person on a permanent basis, holds, directly or indirectly, at least 10% of any of the &#8220;means of control&#8221; of the corporation. &#8220;Means of control&#8221; generally include the right to vote, receive profits, nominate a director or an executive officer, receive assets upon liquidation, or order someone who holds any of the aforesaid rights how to act, regardless of the source of such right. Such dividends are generally subject to Israeli withholding tax at a rate of 25% so long as the shares are registered with a nominee company (whether the recipient is a substantial shareholder or not) and 15% if the dividend is distributed from income attributed to an Approved Enterprise or a Benefited Enterprise (and 20% if the dividend is distributed from income attributed to a Preferred Enterprise), unless a reduced rate is provided under an applicable tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate).Under the United States-Israel Tax Treaty, the maximum rate of tax withheld at source in Israel on dividends paid to a holder of our ordinary shares who is a U.S. resident (for purposes of the United States-Israel Tax Treaty) is 25%. However, generally, the maximum rate of withholding tax on dividends, not generated by an Approved Enterprise or Benefited Enterprise, that are paid to a U.S. corporation holding at least 10% or more of our outstanding voting capital from the start of the tax year preceding the distribution of the dividend through (and including) the distribution of the dividend, is 12.5%, provided that no more than 25% of our gross income for such preceding year consists of certain types of dividends and interest. Notwithstanding the foregoing, a distribution of dividends to non-Israeli residents is subject to withholding tax at source at a rate of 15% if the dividend is distributed from income attributed to an Approved Enterprise or a Benefited Enterprise for such U.S. corporation shareholder, provided that the condition related to our gross income for the previous year (as set forth in the previous sentence) is met. We cannot assure you that in the event we declare a dividend we will designate the income out of which the dividend is paid in a manner that will reduce shareholders&#8217; tax liability.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	111
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage118"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If the dividend is attributable partly to income derived from an Approved Enterprise, Benefited Enterprise or Preferred Enterprise, and partly to other sources of income, the withholding rate will be a blended rate reflecting the relative portions of the two types of income. U.S. residents who are subject to Israeli withholding tax on a dividend may be entitled to a credit or deduction for Untied States federal income tax purposes in the amount of the taxes withheld, subject to detailed rules contained in U.S. tax legislation.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	A non-Israeli resident who receives dividends from which tax was withheld is generally exempt from the obligation to file tax returns in Israel with respect to such income, provided that (i) such income was not generated from business conducted in Israel by the taxpayer, and (ii) the taxpayer has no other taxable sources of income in Israel with respect to which a tax return is required to be filed.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Excess Tax
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Individuals who are subject to tax in Israel are also subject to an additional tax at a rate of 2% on annual income exceeding NIS 810,720 for 2015, which amount is linked to the annual change in the Israeli consumer price index, including, but not limited to, dividends, interest and capital gain.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Estate and gift tax
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Israeli law presently does not impose estate or gift taxes.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. federal income tax consequences
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following is a description of the material U.S. federal income tax consequences relating to the acquisition, ownership and disposition of our ordinary shares. This description addresses only the U.S. federal income tax consequences to holders that are initial purchasers of our ordinary shares and that will hold such ordinary shares as capital assets. This description does not address tax considerations applicable to holders that may be subject to special tax rules, including, without limitation:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	banks, financial institutions or insurance companies;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	real estate investment trusts, regulated investment companies or grantor trusts;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	dealers or traders in securities, commodities or currencies;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	112
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage119"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	tax exempt entities or organizations, including an &#8220;individual retirement account&#8221; or &#8220;Roth IRA&#8221; as defined in Section 408 or 408A of the Code (as defined below), respectively;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	certain former citizens or long-term residents of the United States;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	persons that received our shares as compensation for the performance of services;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	persons that will hold our shares as part of a &#8220;hedging,&#8221; &#8220;integrated&#8221; or &#8220;conversion&#8221; transaction or as a position in a &#8220;straddle&#8221; for U.S. federal income tax purposes;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	partnerships (including entities classified as partnerships for U.S. federal income tax purposes) or other pass-through entities, or holders that will hold our shares through such an entity;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	S corporations;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	holders that acquire ordinary shares as a result of holding or owning our preferred shares;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	U.S. Holders (as defined below) whose &#8220;functional currency&#8221; is not the U.S. Dollar; or
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	holders that own directly, indirectly or through attribution 10% or more of the voting power or value of our shares.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Moreover, this description does not address the U.S. federal estate, gift, or alternative minimum tax consequences, or any U.S. state, local or non-U.S. tax consequences of the acquisition, ownership and disposition of our ordinary shares.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	This description is based on the U.S. Internal Revenue Code of 1986, as amended, or the Code, existing, proposed and temporary U.S. Treasury Regulations promulgated thereunder and administrative and judicial interpretations thereof, in each case as in effect and available on the date hereof. All the foregoing is subject to change, which change could apply retroactively and could affect the tax consequences described below. There can be no assurances that the U.S. Internal Revenue Service, or IRS, will not take a different position concerning the tax consequences of the acquisition, ownership and disposition of our ordinary shares or that such a position would not be sustained. Holders should consult their own tax advisors concerning the U.S. federal, state, local and foreign tax consequences of acquiring, owning and disposing of our ordinary shares in their particular circumstances.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For purposes of this description, the term &#8220;U.S. Holder&#8221; means a beneficial owner of our ordinary shares that, for U.S. federal income tax purposes, is (i) a citizen or resident of the United States; (ii) a corporation (or entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof, or the District of Columbia; (iii) an estate the income of which is subject to U.S. federal income tax regardless of its source; or (iv) a trust (x) with respect to which a court within the United States is able to exercise primary supervision over its administration and one or more U.S. persons have the authority to control all of its substantial decisions or (y) that has elected to be treated as a domestic trust for U.S. federal income tax purposes.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	A &#8220;Non-U.S. Holder&#8221; is a beneficial owner of our ordinary shares that is neither a U.S. Holder nor a partnership (or other entity treated as a partnership for U.S. federal income tax purposes).
</FONT>
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	113
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage120"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If a partnership (or any other entity treated as a partnership for U.S. federal income tax purposes) holds our ordinary shares, the U.S. federal income tax consequences relating to an investment in our ordinary shares will depend in part upon the status of the partner and the activities of the partnership. Such a partner or partnership should consult its tax advisor regarding the U.S. federal income tax consequences of acquiring, owning and disposing of our ordinary shares in its particular circumstances.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Unless otherwise indicated, this discussion assumes that the Company is not, and will not become, a &#8220;passive foreign investment company, or a PFIC, for U.S. federal income tax purposes. See &#8220;&#8212; Passive foreign investment company consequences&#8221; below.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Persons considering an investment in our ordinary shares should consult their own tax advisors as to the particular tax consequences applicable to them relating to the acquisition, ownership and disposition of our ordinary shares, including the applicability of U.S. federal, state and local tax laws and non-U.S. tax laws.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Distributions
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If you are a U.S. Holder, the gross amount of any distribution made to you with respect to our ordinary shares before reduction for any Israeli taxes withheld therefrom, other than certain distributions, if any, of our ordinary shares distributed pro rata to all our shareholders, generally will be includible in your income as dividend income to the extent such distribution is paid out of our current or accumulated earnings and profits as determined under U.S. federal income tax principles. We do not expect to maintain calculations of our earnings and profits under U.S. federal income tax principles. Therefore, U.S. Holders should expect that the entire amount of any distribution generally will be reported as dividend income. Non-corporate U.S. Holders may qualify for the lower rates of taxation with respect to dividends on ordinary shares applicable to long-term capital gains (i.e., gains from the sale of capital assets held for more than one year), provided that certain conditions are met, including certain holding period requirements and the absence of certain risk reduction transactions. However, such dividends will not be eligible for the dividends received deduction generally allowed to corporate U.S. Holders. To the extent that the amount of any distribution by us exceeds our current and accumulated earnings and profits as determined under U.S. federal income tax principles, it will be treated first as a tax-free return of your adjusted tax basis in our ordinary shares and thereafter as either long-term or short-term capital gain depending upon whether the U.S. Holder has held our ordinary shares for more than one year as of the time such distribution is received.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If you are a U.S. Holder, dividends paid to you with respect to our ordinary shares will be foreign source income, which may be relevant in calculating your foreign tax credit limitation. Subject to certain conditions and limitations, Israeli tax withheld on dividends may be deducted from your taxable income or credited against your U.S. federal income tax liability. The limitation on foreign taxes eligible for credit is calculated separately with respect to specific classes of income. For this purpose, dividends that we distribute generally should constitute &#8220;passive category income,&#8221; or, in the case of certain U.S. Holders, &#8220;general category income.&#8221; A foreign tax credit for foreign taxes imposed on distributions may be denied if you do not satisfy certain minimum holding period requirements. The rules relating to the determination of the foreign tax credit are complex, and you should consult your tax advisor to determine whether and to what extent you will be entitled to this credit.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The amount of a distribution paid to a U.S. Holder in a foreign currency will be the dollar value of the foreign currency calculated by reference to the spot exchange rate on the day the U.S. Holder receives the distribution, regardless of whether the foreign currency is converted into dollars at that time. Any foreign currency gain or loss a U.S. Holder realizes on a subsequent conversion of foreign currency into dollars will be U.S. source ordinary income or loss. If dividends received in foreign currency are converted into dollars on the day they are received, a U.S. Holder generally should not be required to recognize foreign currency gain or loss in respect of the dividend.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Subject to the discussion below under &#8220;&#8212;Backup Withholding Tax and Information Reporting Requirements,&#8221; if you are a Non-U.S. Holder, you generally will not be subject to U.S. federal income (or withholding) tax on dividends received by you on your ordinary shares, unless you conduct a trade or business in the United States and such income is effectively connected with that trade or business (or, if required by an applicable income tax treaty, the dividends are attributable to a permanent establishment or fixed base that such holder maintains in the United States).
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Sale, exchange or other disposition of our ordinary shares
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Subject to the discussion below under &#8220;&#8212; Passive foreign investment company consequences,&#8221; if you are a U.S. Holder, you generally will recognize gain or loss on the sale, exchange or other disposition of our ordinary shares equal to the difference between the amount realized on such sale, exchange or other disposition and your adjusted tax basis in our ordinary shares, and such gain or loss will be capital gain or loss. The adjusted tax basis in an ordinary share generally will be equal to the cost of such ordinary share. If you are a non-corporate U.S. Holder, capital gain from the sale, exchange or other disposition of ordinary shares is generally eligible for a preferential rate of taxation applicable to capital gains, if your holding period determined at the time of such sale, exchange or other disposition for such ordinary shares exceeds one year (i.e., such gain is long-term capital gain). The deductibility of capital losses for U.S. federal income tax purposes is subject to limitations under the Code. Any such gain or loss that a U.S. Holder recognizes generally will be treated as U.S. source income or loss for foreign tax credit limitation purposes.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	114
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage121"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For a cash basis taxpayer, units of foreign currency paid or received are translated into dollars at the spot rate on the settlement date of the purchase or sale. In that case, no foreign currency exchange gain or loss will result from currency fluctuations between the trade date and the settlement date of such a purchase or sale. An accrual basis taxpayer, however, may elect the same treatment required of cash basis taxpayers with respect to purchases and sales of our ordinary shares that are traded on an established securities market, provided the election is applied consistently from year to year. Such election may not be changed without the consent of the IRS. For an accrual basis taxpayer who does not make such election, units of foreign currency paid or received are translated into dollars at the spot rate on the trade date of the purchase or sale. Such an accrual basis taxpayer may recognize exchange gain or loss based on currency fluctuations between the trade date and the settlement date. Any foreign currency gain or loss a U.S. Holder realizes will be U.S. source ordinary income or loss.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The determination of whether our ordinary shares are traded on an established securities market is not entirely clear under current U.S. federal income tax law.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Subject to the discussion below under &#8220;Backup Withholding Tax and Information Reporting Requirements,&#8221; if you are a Non-U.S. Holder, you generally will not be subject to U.S. federal income or withholding tax on any gain realized on the sale or exchange of such ordinary shares unless:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	such gain is effectively connected with your conduct of a trade or business in the United States (or, if required by an applicable income tax treaty, the gain is attributable to a permanent establishment or fixed base that you maintain in the United States); or
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	you are an individual and have been present in the United States for 183 days or more in the taxable year of such sale or exchange and certain other conditions are met.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Passive foreign investment company consequences
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If we were to be classified as a PFIC in any taxable year, a U.S. Holder would be subject to special rules generally intended to reduce or eliminate any benefits from the deferral of U.S. federal income tax that a U.S. Holder could derive from investing in a non-U.S. company that does not distribute all of its earnings on a current basis.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	A non-U.S. corporation will be classified as a PFIC for U.S. federal income tax purposes in any taxable year in which, after applying certain look-through rules with respect to the income and assets of subsidiaries, either (i) at least 75% of its gross income is &#8220;passive income&#8221; or (ii) at least 50% of the average quarterly value of its total gross assets (which would generally be measured by fair market value of the assets, and for which purpose the total value of our assets may be determined in part by the market value of our ordinary shares, which is subject to change) is attributable to assets that produce &#8220;passive income&#8221; or are held for the production of passive income.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Passive income for this purpose generally includes dividends, interest, royalties, rents, gains from commodities and securities transactions, the excess of gains over losses from the disposition of assets which produce passive income, and includes amounts derived by reason of the temporary investment of funds raised in offerings of our ordinary shares. If a non-U.S. corporation owns at least 25% by value of the stock of another corporation, the non-U.S. corporation is treated for purposes of the PFIC tests as owning its proportionate share of the assets of the other corporation and as receiving directly its proportionate share of the other corporation&#8217;s income. If we are classified as a PFIC in any year with respect to which a U.S. Holder owns our ordinary shares, we will continue to be treated as a PFIC with respect to such U.S. Holder in all succeeding years during which the U.S. Holder owns our ordinary shares, regardless of whether we continue to meet the tests described above.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	115
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage122"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Based on the composition of our income and the composition and estimated fair market values of our assets, we do not believe that we were a PFIC for the taxable year ended December 31, 2015 and based on our future projections, we do not expect to be a PFIC for the taxable year ending December 31, 2016. There can be no assurance that we will not be considered a PFIC for any taxable year. PFIC status is determined as of the end of the taxable year and depends on a number of factors, including the value of a corporation&#8217;s assets and the amount and type of its gross income. Furthermore, because the value of our gross assets is likely to be determined in large part by reference to our market capitalization, a decline in the value of our ordinary shares may result in our becoming a PFIC. Even though we have determined that we were not a PFIC for the year ended December 31, 2015, there can be no assurance that the IRS will agree with our conclusion.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If we were a PFIC, and you are a U.S. Holder, then unless you make one of the elections described below, a special tax regime will apply to both (a) any &#8220;excess distribution&#8221; by us to you (generally, your ratable portion of distributions in any year which are greater than 125% of the average annual distribution received by you in the shorter of the three preceding years or your holding period for our ordinary shares) and (b) any gain realized on the sale or other disposition of the ordinary shares. Under this regime, any excess distribution and realized gain will be treated as ordinary income and will be subject to tax as if (a) the excess distribution or gain had been realized ratably over your holding period, (b) the amount deemed realized in each year had been subject to tax in each year of that holding period at the highest marginal rate for such year (other than income allocated to the current period or any taxable period before we became a PFIC, which would be subject to tax at the U.S. Holder&#8217;s regular ordinary income rate for the current year and would not be subject to the interest charge discussed below), and (c) the interest charge generally applicable to underpayments of tax had been imposed on the taxes deemed to have been payable in those years. In addition, dividend distributions made to you will not qualify for the lower rates of taxation applicable to long-term capital gains discussed above under &#8220;&#8212;Distributions.&#8221;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Certain elections exist that may alleviate some of the adverse consequences of PFIC status and would result in an alternative treatment (such as mark-to-market treatment) of our ordinary shares. If a U.S. Holder makes the mark-to-market election, the U.S. Holder generally will recognize as ordinary income any excess of the fair market value of the ordinary shares at the end of each taxable year over their adjusted tax basis, and will recognize an ordinary loss in respect of any excess of the adjusted tax basis of the ordinary shares over their fair market value at the end of the taxable year (but only to the extent of the net amount of income previously included as a result of the mark-to-market election). If a U.S. Holder makes the election, the U.S. Holder&#8217;s tax basis in the ordinary shares will be adjusted to reflect these income or loss amounts. Any gain recognized on the sale or other disposition of ordinary shares in a year when we are a PFIC will be treated as ordinary income and any loss will be treated as an ordinary loss (but only to the extent of the net amount of income previously included as a result of the mark-to-market election). The mark-to-market election is available only if we are a PFIC and our ordinary shares are &#8220;regularly traded&#8221; on a &#8220;qualified exchange.&#8221; Our ordinary shares will be treated as &#8220;regularly traded&#8221; in any calendar year in which more than a de minimis quantity of the ordinary shares are traded on a qualified exchange on at least 15 days during each calendar quarter. The NASDAQ Global Select Market is a qualified exchange for this purpose and, consequently, if the ordinary shares are regularly traded, the mark-to-market election will be available to a U.S. Holder.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We do not intend to provide the information necessary for U.S. Holders to make qualified electing fund elections if we are classified as a PFIC. U.S. Holders should consult their tax advisors to determine whether any of these elections would be available and if so, what the consequences of the alternative treatments would be in their particular circumstances.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If we are determined to be a PFIC, the general tax treatment for U.S. Holders described in this section would apply to indirect distributions and gains deemed to be realized by U.S. Holders in respect of any of our subsidiaries that also may be determined to be PFICs.
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	If a U.S. Holder owns ordinary shares during any year in which we are a PFIC and the U.S. Holder recognizes gain on a disposition of our ordinary shares or receives distributions with respect to our ordinary shares, the U.S. Holder generally will be required to file an IRS Form 8621 (Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund) with respect to the company, generally with the U.S. Holder&#8217;s federal income tax return for that year. If our company were a PFIC for a given taxable year, then you should consult your tax advisor concerning your annual filing requirements
</FONT>
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	116
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage123"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	The U.S. federal income tax rules relating to PFICs are complex. Prospective U.S. investors are urged to consult their own tax advisors with respect to the acquisition, ownership and disposition of our ordinary shares, the consequences to them of an investment in a PFIC, any elections available with respect to our ordinary shares and the IRS information reporting obligations with respect to the acquisition, ownership and disposition of our ordinary shares.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Medicare tax
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Certain U.S. Holders that are individuals, estates or trusts are subject to a 3.8% tax on all or a portion of their &#8220;net investment income,&#8221; which may include all or a portion of their dividend income and net gains from the disposition of ordinary shares. Each U.S. Holder that is an individual, estate or trust is urged to consult its tax advisors regarding the applicability of the Medicare tax to its income and gains in respect of its investment in our ordinary shares.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Certain reporting requirements with respect to payments to foreign corporations
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	U.S. Holders paying more than U.S. $100,000 for our ordinary shares generally will be required to file IRS Form 926 reporting the payment for our ordinary shares to any foreign corporation. Substantial penalties may be imposed upon a U.S. Holder that fails to comply. Each U.S. Holder should consult its own tax advisor as to the possible obligation to file IRS Form 926.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Backup withholding tax and information reporting requirements
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	U.S. backup withholding tax and information reporting requirements may apply to certain payments to certain holders of stock. Information reporting generally will apply to payments of dividends on, and to proceeds from the sale or redemption of, our ordinary shares made within the United States, or by a U.S. payor or U.S. middleman, to a holder of our ordinary shares, other than an exempt recipient (including a payee that is not a U.S. person that provides an appropriate certification and certain other persons). A payor will be required to withhold backup withholding tax from any payments of dividends on, or the proceeds from the sale or redemption of, ordinary shares within the United States, or by a U.S. payor or U.S. middleman, to a holder, other than an exempt recipient, if such holder fails to furnish its correct taxpayer identification number or otherwise fails to comply with, or establish an exemption from, such backup withholding tax requirements. Any amounts withheld under the backup withholding rules will be allowed as a credit against the beneficial owner&#8217;s U.S. federal income tax liability, if any, and any excess amounts withheld under the backup withholding rules may be refunded, provided that the required information is timely furnished to the IRS.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Foreign asset reporting
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Certain U.S. Holders who are individuals are required to report information relating to an interest in our ordinary shares, subject to certain exceptions (including an exception for shares held in accounts maintained by financial institutions) by filing IRS Form 8938 (Statement of Specified Foreign Financial Assets) with their federal income tax return. U.S. Holders are urged to consult their tax advisors regarding their information reporting obligations, if any, with respect to their ownership and disposition of our ordinary shares.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	THE DISCUSSION ABOVE IS A GENERAL SUMMARY. IT DOES NOT COVER ALL TAX MATTERS THAT MAY BE OF IMPORTANCE TO A PROSPECTIVE INVESTOR. EACH PROSPECTIVE INVESTOR IS URGED TO CONSULT ITS OWN TAX ADVISOR ABOUT THE TAX CONSEQUENCES TO IT OF AN INVESTMENT IN ORDINARY SHARES IN LIGHT OF THE INVESTOR&#8217;S OWN CIRCUMSTANCES.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	F.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Dividends and Paying Agents
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	G.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Statement by Experts
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	117
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage124"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	H.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Documents on Display
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We are currently subject to the information and periodic reporting requirements of the Exchange Act applicable to foreign private issuers and fulfill the obligations of those requirements by filing reports with the SEC. We file periodic reports and other information with the SEC through its electronic data gathering, analysis and retrieval (EDGAR) system.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As a foreign private issuer, we are exempt from the rules under the Exchange Act relating to the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as domestic companies whose securities are registered under the Exchange Act.&#160;&#160;However, we are required to file with the SEC, within 120 days after the end of each subsequent fiscal year, an annual report on Form 20-F containing financial statements which will be examined and reported on, with an opinion expressed, by an independent public accounting firm. We also furnish to the SEC reports on Form 6-K containing quarterly unaudited financial information.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our securities filings, including this annual report and the exhibits thereto, are available for inspection and copying at the public reference room of the SEC located at Room 1580, 100 F Street, N.E., Washington, D.C. 20549. Additionally, you may obtain copies of the documents at prescribed rates by writing to the Public Reference Section of the SEC at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. The SEC maintains a website at http://www.sec.gov from which certain filings may be accessed. Our filings with the SEC are also available to the public through this website at http://www.sec.gov.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As permitted under NASDAQ Rule 5250(d)(1)(c), we post our annual reports filed with the SEC on our website at http://ir.enzymotec.com
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	.
</FONT>
	We will furnish hard copies of such reports to our shareholders free of charge upon written request. The information contained on our website is not part of this or any other report filed with or furnished to the SEC.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	I.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="95%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Subsidiary Information
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_ADDITIONAL_INFORMATION>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<EFX_MARKET_RISK>
<A NAME="FIS_MARKET_RISK"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 11: Quantitative and Quali
<A NAME="ZK1618102_HTM_9">
	tativ
</A>
	e Disclosures About Market Risk
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Quantitative and qualitative disclosure about market risk
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Market risk is the risk of loss related to changes in market prices, including interest rates and foreign exchange rates, of financial instruments that may adversely impact our consolidated financial position, results of operations or cash flows.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Foreign currency exchange risk.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The U.S. dollar, or the dollar&#160;is our functional and reporting currency, with net revenues denominated in dollars accounting for 73% and 74% of our net revenues in 2014 and 2015. While we incur expenses primarily in dollars, a significant portion of expenses are denominated in shekels, accounting for 38% and 41% of our expenses in 2014 and 2015, respectively. We also have expenses, although to a much lesser extent, in other non- dollar currencies, in particular the euro. This exposes us to risk associated with exchange rate fluctuations vis-&#224;-vis the dollar. Furthermore, we anticipate that a material portion of our expenses, principally of salaries and related personnel expenses, will continue to be denominated in shekels.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	To the extent the dollar weakens against the shekel, we will experience a negative impact on our profit margins. A devaluation of the shekel in relation to the dollar has the effect of reducing the dollar amount of our expenses that are payable in shekels, unless those expenses or payables are linked to the dollar. Conversely, any increase in the value of the shekel in relation to the dollar has the effect of increasing the dollar value of our unlinked shekel expenses, which would have a negative impact on our profit margins. In 2014, the value of the shekel depreciated in relation to the dollar by approximately 12.0%, the effect of which was offset by a negative inflation of Israel, at a rate of approximately 0.2%. In 2015, the value of the shekel depreciated in relation to the dollar by approximately 0.3%, the effect of which was offset by a negative inflation of Israel, at a rate of approximately 1.0%.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	118
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage125"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In Europe, our net revenues are received primarily in euros, accounting for approximately 27% and 21% of our total net revenues in 2014 and 2015, respectively, and such net revenues exceed our expenses incurred in euros. Accordingly, if the euro appreciates relative to the dollar, the dollar value of our sales is positively impacted, as was the case in 2013, when the euro appreciated by 4.5% in relation to the dollar. However, if the euro depreciates relative to the dollar, the dollar value of our sales is negatively impacted, as was the case in 2014 and 2015, when the euro depreciated by 11.8% and 10.4%, respectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Because exchange rates between the dollar and the shekel (as well as between the dollar and other currencies) fluctuate continuously, such fluctuations have an impact on our results of operations and period-to-period comparisons of our results. The effects of foreign currency re-measurements are reported in our consolidated statements of operations. We engage in currency hedging activities in order to reduce some of this currency exposure. These measures, however, may not adequately protect us from material adverse effects due to the impact of foreign currency fluctuations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following table presents information about the changes in the exchange rates of the shekel against the dollar and changes in the exchange rates of the euro against the dollar:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Change&#160;in&#160;Average&#160;Exchange&#160;Rate
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<A NAME="FIS_UNIDENTIFIED_TABLE_24"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Period
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Shekel&#160;against&#160;the
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	dollar&#160;(%)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Euro&#160;against&#160;the
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	dollar&#160;(%)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(0.9
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(0.2
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8.6
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(16.3
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)&#160;
</FONT>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The net effect of risks stemming from currency exchange rate fluctuations on our operating results can be quantified as follows:
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	An increase of 10% in the value of the shekel relative to the dollar in the year ended December 31, 2015 would have resulted in a net decrease in the dollar reporting value of our operating income of $1.8 million, due to the adverse impact on our operating margins that we would experience as a result of such an increase, while a 10% decrease in value of the shekel relative to the dollar in the year ended December 31, 2015 would have caused a net increase in the dollar reporting value of our operating income of $1.8 million for 2015, due to the favorable effect on our operating margins that would result from such devaluation of the shekel.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8226;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	An increase of 10% in the value of the euro relative to the dollar in 2015 would have resulted in a net increase in the dollar reporting value of our operating income of $0.9 million, due to the favorable effect on our operating margins that we would experience as a result of such an increase, while a decrease of 10% in the value of the euro relative to the dollar in 2015 would have resulted in a net decrease in the dollar reporting value of our operating income of $0.9 million for 2015, due to the adverse impact on our operating margins that would result from such devaluation of the euro.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We will continue to monitor exposure to currency fluctuations. Instruments that may be used to hedge future risks may include foreign currency forward and swap contracts. These instruments may be used to selectively manage risks, but there can be no assurance that we will be fully protected against material foreign currency fluctuations. See Note 12 to our consolidated Financial Statements contained elsewhere in this annual report for additional information regarding foreign exchange risk management.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	119
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage126"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Inflation-related risks
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We do not believe that the rate of inflation in Israel has had a material impact on our business to date. However, our costs in Israel will increase if inflation in Israel exceeds the devaluation of the shekel against the dollar or if the timing of such devaluation lags behind inflation in Israel.
</FONT>
</DIV>
</EFX_MARKET_RISK>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_OTHER_SECURITIES>
<A NAME="FIS_OTHER_SECURITIES"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 12: Description of Securities Ot
<A NAME="ZK1618102_HTM_10">
	her
</A>
	Than Equity Securities
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
<BR>
</DIV>
</EFX_OTHER_SECURITIES>
</EFX_PART_I>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<EFX_PART_II>
<A NAME="FIS_PART_II"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	PART II
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_DEFAULTS>
<A NAME="FIS_DEFAULTS"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 13: Defaults, Dividend Arrearages and Delinquencies
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	None.
</FONT>
</DIV>
</EFX_DEFAULTS>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_MATERIAL_MODIFICATIONS>
<A NAME="FIS_MATERIAL_MODIFICATIONS"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 14: Material Modifications to the Rights of Security Holders and Use of Proceeds
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Initial Public Offering
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Our initial public offering closed on October 2, 2013. We issued a total of 5,073,800 ordinary shares with aggregate proceeds of $71.0 million (including the option to purchase additional shares) at a price per share of $14.00. Under the terms of the offering, we incurred aggregate underwriting discounts of $5.0 million (including the option to purchase additional shares), resulting in net proceeds of $66.1 million. We also incurred expenses of $3.2 million in connection with the offering.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	From the effective date of the registration statement and until December 31, 2015, we used approximately $11 million of the net proceeds for the purchase of property, plant and equipment and intangible assets, $1 million of the net proceeds to pay bonuses to certain of our employees, including some of our executive officers, $10 million for funding our increased working capital and approximately $4 million of the net proceeds to pay the remaining balance of an existing long-term credit facility, including acceleration fees.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We may use a portion of the balance of the net proceeds to meet our anticipated increased working capital requirements and for other general corporate purposes. We may also use a portion of our net proceeds to fund the construction of the additional manufacturing facility. We may use also a portion of our net proceeds for exploring opportunities to accelerate growth in our core business through acquisitions of complementary businesses or technologies. We do not currently have specific plans or commitments with respect to the balance of net proceeds from the initial offering, and, accordingly, are unable to quantify the allocation of such proceeds among the various potential uses. Our management has significant flexibility in applying the net proceeds of the initial public offering.
</FONT>
</DIV>
</EFX_MATERIAL_MODIFICATIONS>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_CONTROL_AND_PROCEDURES>
<A NAME="FIS_CONTROL_AND_PROCEDURES"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 15: Controls and Procedures
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	Disclosure Controls and Procedures
</FONT>
	. Our management, including our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2015. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of December 31, 2015, our disclosure controls and procedures were effective such that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	Management&#8217;s Annual Report on Internal Control Over Financial Reporting
</FONT>
	.&#160;&#160;Our management, under the supervision of our Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Internal control over financial reporting is a process designed by, or under the supervision of, the company&#8217;s principal executive and principal financial officers and effected by the company&#8217;s board of directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE;" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	120
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage127"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE;" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE;" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;Our management, including our Chief Executive Officer and Chief Financial Officer, assessed the effectiveness of our internal control over financial reporting as of December 31, 2015. In making such assessment, our management used the criteria established in Internal Control&#8212;Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on such assessment, management has concluded that, as of December 31, 2015, our internal control over financial reporting&#160;was effective to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external reporting purposes in accordance with generally accepted accounting principles.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	Attestation report of the registered public accounting firm
</FONT>
	. This annual report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting because the Jumpstart Our Business Startups Act provides an exemption from such requirement as we qualify as an emerging growth company.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	Changes in Internal Control Over Financial Reporting
</FONT>
	. During the period covered by this report, no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) have occurred that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 16: R
<A NAME="ZK1618102_HTM_11">
	es
</A>
	erved
</FONT>
</DIV>
</EFX_CONTROL_AND_PROCEDURES>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_AUDIT_COMMITTEE_EXPERT>
<A NAME="FIS_AUDIT_COMMITTEE_EXPERT"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 16A: Audit Committee Financial Expert
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;All members of our audit committee meet the requirements for financial literacy under the applicable rules and regulations of the SEC and the NASDAQ rules. Our board of directors has determined that Joseph Tenne is an audit committee financial expert as defined by the SEC rules and has the requisite financial experience as defined by the NASDAQ rules. In addition, Mr. Tenne is independent as such term is defined in Rule 10A-3(b)(1) under the Exchange Act and under the listing standards of NASDAQ.
</FONT>
</DIV>
</EFX_AUDIT_COMMITTEE_EXPERT>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_CODE_OF_ETHICS>
<A NAME="FIS_CODE_OF_ETHICS"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 16B: Code of Ethics
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have adopted a Code of Business Conduct and Ethics applicable to all of our directors and employees, including our Chief Executive Officer, Chief Financial Officer, controller or principal accounting officer, or other persons performing similar functions, which is a &#8220;code of ethics&#8221; as defined in this Item 16B of Form 20-F promulgated by the SEC. The full text of the Code of Business Conduct and Ethics is posted on our website at http://ir.enzymotec.com
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	.
</FONT>
	Information contained on, or that can be accessed through, our website does not constitute a part of this annual report and is not incorporated by reference herein. If we make any amendment to the Code of Business Conduct and Ethics or grant any waivers, including any implicit waiver, from a provision of said code, we will disclose the nature and basis of such amendment or waiver on a Form 6-K or on our website to the extent required by the rules and regulations of the SEC, including the instructions to Item 16B of Form 20-F. We granted no waivers under our Code of Business Ethics and Conduct in 2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	121
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage128"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_CODE_OF_ETHICS>
<EFX_ACCOUNTANT_FEES>
<A NAME="FIS_ACCOUNTANT_FEES"></A>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 16C: Principal Accountant Fees and Services
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_25"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Fees paid to the Auditors
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;The following table sets forth, for each of the years indicated, the fees billed by our independent registered public accounting firm, Kesselman &amp; Kesselman (a member firm of Pricewaterhouse Coopers International Limited)(PwC Israel).
</FONT>
</DIV>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="50%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="60%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="36%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December, 31
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="60%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="16%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="16%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="60%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="36%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(in thousands of dollars)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="60%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Audit fees
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="14%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	210
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="14%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	165
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="60%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Audit-related fees
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="14%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8213;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="14%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8213;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="60%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Tax fees
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="14%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	37
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="14%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	24
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="60%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	All other fees
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="14%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8213;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="14%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8213;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="60%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="14%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	247
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="14%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	189
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
	&#160;
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160; &#160;&#160;Audit fees for the years ended December 31, 2014 and 2015 were for professional services rendered for the audit of our annual consolidated financial statements as of December 31, 2014 and 2015, review of consolidated quarterly financial statements, statutory audits of Enzymotec and its subsidiaries, issuance of comfort letters, consents and assistance with review of documents filed with the SEC (including our registration statement on Form F-1 related to a follow-on offering in 2014).
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160; &#160;&#160;&#160;Tax fees for the years ended December 31, 2014 and 2015 were for services related to tax compliance, including tax returns and claims for refund, and tax planning and tax advice, including assistance with tax audits and appeals, and assistance with respect to requests for rulings from tax authorities.
</FONT>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Audit Committee&#8217;s Pre-Approval Policies and Procedures
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;Our audit committee provides assistance to our board of directors in fulfilling its legal and fiduciary obligations in matters involving our accounting, auditing, financial reporting, internal control and legal compliance functions by pre-approving the services performed by our independent accountants and reviewing their reports regarding our accounting practices. Our audit committee also oversees the audit efforts of our independent accountants and takes those actions that it deems necessary to satisfy itself that the accountants are independent of management.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160; &#160;&#160;Our audit committee is responsible for the oversight of its independent auditors&#8217; work. The audit committee&#8217;s policy is to pre-approve all audit and non-audit services provided by PwC and other members of PricewaterhouseCoopers International Limited. These services may include audit services, audit-related services, tax services and other services, as further described above. The audit committee sets forth the basis for its pre-approval in detail, listing the particular services or categories of services which are pre-approved, and setting forth a specific budget for such services. Additional services may be pre-approved by the audit committee on an individual basis. Once services have been pre-approved, PwC and management then report to the audit committee on a periodic basis regarding the extent of services actually provided in accordance with the applicable pre-approval and the fees for the services performed. Such fees for 2014 and 2015 were pre-approved by the audit committee in accordance with these procedures.
</FONT>
</DIV>
</EFX_ACCOUNTANT_FEES>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_EXEMPTIONS_FROM_LISTING>
<A NAME="FIS_EXEMPTIONS_FROM_LISTING"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 16D: Exemptions from the
<A NAME="ZK1618102_HTM_12">
	Listing
</A>
	Standards for Audit Committees
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
</EFX_EXEMPTIONS_FROM_LISTING>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_PURCHASES_OF_EQUITY>
<A NAME="FIS_PURCHASES_OF_EQUITY"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 16E: Purchase of Equity Securities by the Company and Affiliated Purchasers
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Not applicable.
</FONT>
</DIV>
</EFX_PURCHASES_OF_EQUITY>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_CHANGE_IN_ACCOUNTANT>
<A NAME="FIS_CHANGE_IN_ACCOUNTANT"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 16F: Change in Registrant&#8217;s Certifying Accountant
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	None.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	122
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage129"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_CHANGE_IN_ACCOUNTANT>
<EFX_CORPORATE_GOVERNANCE>
<A NAME="FIS_CORPORATE_GOVERNANCE"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 16G: Corporate
<A NAME="ZK1618102_HTM_13">
	Gov
</A>
	ernance
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As a foreign private issuer, we are permitted to, and do, follow certain home country corporate governance practices instead of those otherwise required under the NASDAQ rules for domestic U.S. issuers. For instance, we follow home country practice in Israel with regard to the quorum requirement for shareholder meetings. As permitted under the Israeli Companies Law, our articles of association provide that the quorum for any meeting of shareholders shall be the presence of at least two shareholders present in person, by proxy or by a voting instrument, who hold at least 25% of the voting power of our shares instead of 33 1/3% of the issued share capital requirement. We may in the future elect to follow home country practices in Israel with regard to other matters, including the formation of compensation, nominating and corporate governance committees, separate executive sessions of independent directors and non-management directors and the requirement to obtain shareholder approval for certain dilutive events (such as for the establishment or amendment of certain equity-based compensation plans, issuances that will result in a change of control of the company, certain transactions other than a public offering involving issuances of a 20% or more interest in the company and certain acquisitions of the stock or assets of another company). Our home country governance practices as opposed to the requirements that would otherwise apply to a domestic issuer listed on the NASDAQ Global Select Market may provide less protection to you than what is accorded to investors under the NASDAQ requirements applicable to domestic issuers.
</FONT>
</DIV>
</EFX_CORPORATE_GOVERNANCE>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_MINE_SAFETY_DISCLOSURE>
<A NAME="FIS_MINE_SAFETY_DISCLOSURE"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 16H: Mine Safety Disclosures
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;Not applicable.
</FONT>
</DIV>
</EFX_MINE_SAFETY_DISCLOSURE>
</EFX_PART_II>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<EFX_PART_III>
<A NAME="FIS_PART_III"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	PART III
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<EFX_FINANCIAL_STATEMENTS>
<A NAME="FIS_FINANCIAL_STATEMENTS"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 17: Financial Statements
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;Not applicable.
</FONT>
</DIV>
</EFX_FINANCIAL_STATEMENTS>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_FINANCIAL_STATEMENTS>
<A NAME="FIS_FINANCIAL_STATEMENTS_2"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 18: Financial Statements
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	&#160;
</FONT>
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;We have appended our consolidated Financial Statements at the end of this annual report, starting at page F-2, as part of this annual report.
</FONT>
</DIV>
</EFX_FINANCIAL_STATEMENTS>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_EXHIBITS>
<A NAME="FIS_EXHIBITS"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ITEM 19: Exhibits
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 9PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;See exhibit index incorporated herein by reference.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	123
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage130"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_EXHIBITS>
</EFX_PART_III>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<EFX_SIGNATURES>
<A NAME="FIS_SIGNATURES"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	SIGNATURES
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 36PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="50%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="TOP" WIDTH="38%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Enzymotec Ltd.
</FONT>
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="50%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="35%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="50%" STYLE="BORDER-BOTTOM: #FFFFFF SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="3%" STYLE="BORDER-BOTTOM: #FFFFFF SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	By:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" NOWRAP VALIGN="TOP" WIDTH="35%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	/s/&#160;Ariel Katz
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%" STYLE="BORDER-BOTTOM: #FFFFFF SOLID">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="50%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" NOWRAP VALIGN="BOTTOM" WIDTH="35%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Dr. Ariel Katz
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="50%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	President and Chief Executive Officer
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="50%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="35%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	Dated: March 3, 2016
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	124
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage131"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ANNUAL REPORT ON FORM 20-F
</FONT>
<BR>
</DIV>
</EFX_SIGNATURES>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<EFX_EXHIBIT_INDEX>
<A NAME="FIS_EXHIBIT_INDEX"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	INDEX OF EXHIBITS
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_26"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="2" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Exhibit no.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Description of exhibit
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Amended and Restated Articles of Association of the Registrant
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(3)
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Amended and Restated Investors&#8217; Rights Agreement, dated September 22, 2013, by and among the Registrant and the other parties thereto
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(3)
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Agreement between the Israel Land Administration and Registrant, dated September 17, 2009 relating to Registrant&#8217;s facility at the Sagi 2000 Industrial Area, Migdal Ha&#8217;Emeq, Israel and Addendum thereto dated August 14, 2013
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	&#8734;(2)
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4.2
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Shareholders&#8217; Agreement between AarhusKarlshamn AB (publ) and Enzymotec Ltd. regarding the joint venture company Advanced Lipids AB dated June 14, 2007
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	&#8224;(1)
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4.4
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Enzymotec Ltd. Employee Share Option Plan (1999)
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(4)
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4.5
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Enzymotec Ltd. 2003 Israeli Share Option Plan, as amended as of April 17, 2013
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(4)
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4.6
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2012 U.S. Addendum to 2003 Israeli Share Option Plan
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(4)
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4.7
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Enzymotec Ltd. 2013 Omnibus Equity Incentive Plan
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(2)
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4.8
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Form of indemnification agreement by and between Enzymotec Ltd. and each of its directors and executive officers&#160;&#160;
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(4)
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4.9
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Enzymotec Ltd. 2014 Compensation Policy
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(5)
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	List of subsidiaries of Enzymotec Ltd.
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Certification of Principal Executive Officer required by Rule 13a-14(a) and Rule 15d-14(a) (Section 302 Certifications)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12.2
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Certification of Principal Financial Officer required by Rule 13a-14(a) and Rule 15d-14(a) (Section 302 Certifications)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Certification of Principal Executive Officer and Principal Financial Officer required by Rule 13a-14(b) and Rule 15d-14(b) (Section 906 Certifications), furnished herewith
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	15.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Consent of Kesselman &amp; Kesselman, a member firm of PricewaterhouseCoopers International Limited, an independent registered public accounting firm
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	101.INS
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	XBRL Instance Document
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	101.SCH
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	XBRL Taxonomy Extension Schema Document
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	101.CAL
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	XBRL Taxonomy Extension Calculation Linkbase Document
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	101.DEF
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	XBRL Taxonomy Definition Linkbase Document
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	101.LAB
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	XBRL Taxonomy Extension Label Linkbase Document
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	101.PRE
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	XBRL Taxonomy Extension Presentation Linkbase Document
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	____________
</FONT>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8734;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	English summary of original Hebrew document.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	125
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage132"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; PADDING-LEFT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8224;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="96%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Portions of this exhibit have been omitted and a complete copy of the agreement has been provided separately to the Securities and Exchange Commission (the &#8220;SEC&#8221;) pursuant to a confidential treatment request
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	under Rule 406 of the Securities Act of 1933, as amended.
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;(1)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Previously filed with the SEC on August 22, 2013 pursuant to a registration statement on Form F-1 (File No. 333-190781) and incorporated by reference herein.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;(2)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Previously filed with the SEC on September 16, 2013 pursuant to a pre-effective amendment to a registration statement on Form F-1 (File No. 333-190781) and incorporated by reference herein.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;(3)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Previously filed with the SEC on September 24, 2013 pursuant to a pre-effective amendment to a registration statement on Form F-1 (File No. 333-190781) and incorporated by reference herein.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;(4)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Previously filed with the SEC on September 27, 2013 pursuant to a post-effective amendment to a registration statement on Form F-1 (File No. 333-190781) and incorporated by reference herein.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;(5)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Previously furnished to the SEC on May 30, 2014 as part of Exhibit 99.1 to a current report on Form 6-K and incorporated by reference herein.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	126
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage133"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<A NAME="ZK1618102_HTM_TICF">
<!--EFPLACEHOLDER-->
</A>
	INDEX TO FINANCIAL STATEMENTS
</FONT>
</DIV>
<DIV>
<DIV>
	&#160;
</DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="63%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="6%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Page
</FONT>
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="63%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Report of independent registered public accounting firm
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F-2
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="63%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Consolidated balance sheets as of December 31, 2014 and 2015
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F-3
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="63%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Consolidated statements of income for the years ended December 31, 2013, 2014 and 2015
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F-5
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="63%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Statements of equity for the years ended December 31, 2013, 2014 and 2015
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F-6
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="63%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Consolidated statements of cash flows for the years ended December 31, 2013, 2014 and 2015
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F-7
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="63%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Notes to consolidated financial statements
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="6%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F-8
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage134"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</DIV>
<DIV ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2015 ANNUAL REPORT
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage135"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</DIV>
<DIV ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2015 ANNUAL REPORT
</FONT>
</DIV>
<DIV ALIGN="CENTER">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	TABLE OF CONTENTS
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="65%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="8%" STYLE="TEXT-ALIGN: CENTER">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Page
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="65%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<A HREF="#ZK1618102_HTM_F1">
	REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F-2
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="65%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	CONSOLIDATED FINANCIAL STATEMENTS:
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="8%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="65%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 14.2PT">
</FONT>
<A HREF="#ZK1618102_HTM_F2">
	Balance sheets
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F-3-F-4
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="65%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 14.2PT">
</FONT>
<A HREF="#ZK1618102_HTM_F3">
	Statements of operations and comprehensive income
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F-5
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="65%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 14.2PT">
</FONT>
<A HREF="#ZK1618102_HTM_F4">
	Statements of changes in shareholders' equity
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F-6
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="65%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 14.2PT">
</FONT>
<A HREF="#ZK1618102_HTM_F5">
	Statements of cash flows
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F-7
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="65%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 14.2PT">
</FONT>
<A HREF="#ZK1618102_HTM_F6">
	Notes to consolidated financial statements
</A>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="8%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F-8-F-36
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage136"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_EXHIBIT_INDEX>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/03/0001178913-16-004598_PWC.JPG" ALT="">
</DIV>
<EFX_AUDITORS_OPINION>
<A NAME="FIS_AUDITORS_OPINION"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<A NAME="ZK1618102_HTM_F1">
	REPORT
</A>
	OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	To the Shareholders of
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We have audited the accompanying consolidated balance sheets of Enzymotec Ltd. (the "Company") and its subsidiaries as of December 31, 2015 and 2014 and the related consolidated statements of operations and comprehensive income, changes in shareholders' equity and cash flows for each of the three years in the period ended December 31, 2015. These financial statements are the responsibility of the Company&#8217;s Board of Directors and management. Our responsibility is to express an opinion on these financial statements based on our audits.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by the Company&#8217;s Board of Directors and management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company and its subsidiaries at December 31, 2015 and 2014 and the consolidated results of their operations and comprehensive income and their cash flows for each of the three years in the period ended December 31, 2015 in conformity with accounting principles generally accepted in the United States of America.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="50%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Tel-Aviv, Israel
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="50%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; TEXT-DECORATION: UNDERLINE">
	/s/
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Kesselman &amp; Kesselman
</FONT>
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="50%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	March 3
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN">
	, 2016
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="50%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Kesselman &amp; Kesselman
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="50%">
	&#160;
</TD>
<TD VALIGN="TOP" WIDTH="50%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Certified Public Accountants (Isr.)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="50%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="50%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	A member firm of PricewaterhouseCoopers International Limited
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV>
	&#160;
</DIV>
<DIV ALIGN="CENTER">
<TABLE BGCOLOR="WHITE" CELLPADDING="3" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD WIDTH="100%" STYLE="TEXT-ALIGN: LEFT; BORDER-LEFT: BLACK 1PX DOTTED; BORDER-TOP: BLACK 1PX DOTTED">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Kesselman &amp; Kesselman, Trade Tower, 25 Hamered Street, Tel-Aviv 6812508, Israel,
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD WIDTH="100%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	P.O Box 50005 Tel-Aviv 6150001&#160;&#160;Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage137"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<A NAME="ZK1618102_HTM_F2">
	ENZYMOTEC
</A>
	LTD.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	CONSOLIDATED BALANCE SHEETS
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	December 31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	A&#160;&#160;s&#160;&#160;s&#160;&#160;e&#160;&#160;t&#160;&#160;s
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</EFX_AUDITORS_OPINION>
<EFX_BALANCE_SHEET>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<A NAME="FIS_BALANCE_SHEET"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	CURRENT ASSETS:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 14.2PT">
</FONT>
	Cash and cash equivalents
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,987
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,315
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160; Short-term bank deposits
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	17,042
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	19,970
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160; &#160;Marketable securities
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,009
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,943
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 14.2PT">
</FONT>
	Accounts receivable:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 28.35PT">
</FONT>
	Trade
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	14,956
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,433
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 28.35PT">
</FONT>
	Other
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,358
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,110
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 14.2PT">
</FONT>
	Inventories
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,815
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,572
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	TOTAL&#160;&#160;CURRENT ASSETS
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	84,167
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	70,343
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NON-CURRENT ASSETS:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 14.2PT">
</FONT>
	Investment in equity investee
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,499
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,152
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;Marketable securities
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	31,360
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	35,287
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160; Funds in respect of retirement benefits obligation
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,076
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	994
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 14.2PT">
</FONT>
	Intangibles, long-term deposits and other
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,116
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,200
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	PROPERTY, PLANT AND EQUIPMENT:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cost
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	40,796
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	38,237
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	L e s s - accumulated depreciation and amortization
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,088
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8,963
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	29,708
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	29,274
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 9PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	TOTAL&#160;&#160;ASSETS
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	148,926
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	138,250
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</EFX_BALANCE_SHEET>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 3
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage138"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	CONSOLIDATED BALANCE SHEETS
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	December 31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Liabilities and shareholders' equity
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<EFX_BALANCE_SHEET>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<A NAME="FIS_BALANCE_SHEET_2"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	CURRENT LIABILITIES
</FONT>
	-
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 14.2PT">
</FONT>
	accounts payable and accruals:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 28.35PT">
</FONT>
	Trade
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,529
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,259
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 28.35PT">
</FONT>
	Other
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,427
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,569
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	TOTAL&#160;&#160;CURRENT LIABILITIES
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,956
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8,828
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	LONG TERM LIABILITY -
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 14.2PT">
</FONT>
	retirement benefits obligation
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,253
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,150
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	COMMITMENTS AND CONTINGENCIES
</FONT>
	(Note 8)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	TOTAL&#160;&#160;LIABILITIES
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12,209
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9,978
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	SHAREHOLDERS' EQUITY:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Ordinary shares
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	58
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	57
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Additional paid-in capital
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	124,243
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	122,075
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Accumulated other comprehensive loss
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(471
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(64
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Retained earnings
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12,887
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,204
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	TOTAL SHAREHOLDERS' EQUITY
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	136,717
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	128,272
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	148,926
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	138,250
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</EFX_BALANCE_SHEET>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	The accompanying notes are an integral part of the consolidated financial statements.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 4
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage139"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<EFX_INCOME_STATEMENT>
<A NAME="FIS_INCOME_STATEMENT"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<A NAME="ZK1618102_HTM_F3">
	ENZYMOTEC
</A>
	LTD.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December 31
</FONT>
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 8.8PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(except per share data)
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NET REVENUES
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	50,391
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,103
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	64,975
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	COST OF REVENUES
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(19,635
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(18,316
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(32,110
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	GROSS PROFIT
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	30,756
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	28,787
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32,865
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	OPERATING EXPENSES:
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Research and development &#8211; net
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(6,149
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(5,986
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(5,947
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Selling and marketing
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(11,425
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(8,034
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(6,725
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	General and administrative
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(7,008
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(7,475
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(8,434
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	TOTAL&#160;&#160;OPERATING EXPENSES
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(24,582
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(21,495
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(21,106
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	OPERATING INCOME
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,174
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,292
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,759
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	FINANCIAL INCOME (EXPENSES)
</FONT>
	-
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
	net
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	471
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	499
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(531
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	INCOME BEFORE TAXES ON INCOME
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,645
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,791
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,228
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	TAXES ON INCOME
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(407
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(406
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(324
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	SHARE IN PROFITS OF EQUITY INVESTEES
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	445
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	453
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	491
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NET INCOME
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,683
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,838
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,395
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	OTHER COMPREHENSIVE INCOME (LOSS):
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Unrealized loss on marketable securities
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(159
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(125
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Currency translation adjustments on equity investees
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(98
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(202
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Changes in unrealized gains (losses) in respect of derivative
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	instruments designated for cash flow hedge
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(150
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	328
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	171
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	TOTAL&#160;&#160;COMPREHENSIVE INCOME
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,276
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,839
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,577
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	EARNINGS PER SHARE:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Basic
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.30
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.36
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.66
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Diluted
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.29
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.34
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.53
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</EFX_INCOME_STATEMENT>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	WEIGHTED AVERAGE NUMBER OF ORDINARY
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	SHARES USED IN COMPUTATION OF EARNINGS
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	PER SHARE:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Basic
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	22,506,955
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,902,057
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,544,387
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Diluted
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	23,282,865
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	23,210,573
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9,286,456
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 1.95PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	The accompanying notes are an integral part of the consolidated financial statements.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 1.95PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 5
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage140"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<EFX_STOCKHOLDERS_EQUITY>
<A NAME="FIS_STOCKHOLDERS_EQUITY"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<A NAME="ZK1618102_HTM_F4">
	ENZYMOTEC
</A>
	LTD.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="20%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Ordinary shares
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Preferred shares
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Ordinary shares
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Preferred shares
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Additional
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	paid-in
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	capital
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Accumulated
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	other comprehensive income (loss)
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Retained
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;earnings (accumulated deficit)
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Total
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="20%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="18%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 9PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Number of shares
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="22" VALIGN="BOTTOM" WIDTH="58%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	BALANCE AT DECEMBER 31, 2012
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,996,624
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	170,928
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
	&#160;
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,449
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(247
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(13,029
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	34,181
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	CHANGES IN THE YEAR ENDED
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;&#160;&#160; DECEMBER 31, 2013:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Comprehensive income
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	182
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,395
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,577
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Exercise of options by employees
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,940
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Issuance of B2 preferred shares and warrants, net of issuance costs&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18,856
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,850
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,850
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160; Exercise of warrants
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,663
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,340
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,340
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Conversion of preferred shares to ordinary shares and bonus share distribution
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,290,396
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(195,447
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	33
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(*
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(33
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Issuance of ordinary shares in an&#160;&#160;initial public offering, net of issuance costs
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,073,800
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	14
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	62,824
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	62,838
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Issuance of restricted shares
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	156,060
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Share-based compensation expense
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,109
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,109
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	BALANCE AT DECEMBER 31, 2013
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,564,820
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	55
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	119,547
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(65
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1,634
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	117,903
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</EFX_STOCKHOLDERS_EQUITY>
<EFX_UNIDENTIFIED_TABLE>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<A NAME="FIS_UNIDENTIFIED_TABLE_27"></A>
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	CHANGES IN THE YEAR ENDED
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;&#160; DECEMBER 31, 2014:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Comprehensive income
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,838
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,839
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Exercise of options by employees
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	908,169
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,754
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,756
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Issuance of restricted shares
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9,520
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Share issuance costs
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(78
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(78
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Share-based compensation
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	852
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	852
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	BALANCE AT DECEMBER 31, 2014
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	22,482,509
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	57
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	122,075
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(64
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,204
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	128,272
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
<EFX_UNIDENTIFIED_TABLE>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<A NAME="FIS_UNIDENTIFIED_TABLE_28"></A>
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	CHANGES IN THE YEAR ENDED
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;&#160; DECEMBER 31, 2015:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Comprehensive income (loss)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(407
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,683
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,276
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Exercise of options by employees
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	175,482
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	535
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	536
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Issuance of restricted shares
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	60,344
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Share-based compensation
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,633
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,633
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="20%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	BALANCE AT DECEMBER 31, 2015
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	22,718,335
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	58
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	124,243
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(471
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12,887
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	136,717
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 1.95PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	* Represents an amount of less than $1,000.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 1.95PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 1.95PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	The accompanying notes are an integral part of the consolidated financial statements.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 1.95PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 1.95PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 6
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage141"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 1.95PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<A NAME="ZK1618102_HTM_F5">
	ENZYMOTEC
</A>
	LTD.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	CONSOLIDATED STATEMENTS OF CASH FLOWS
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December 31
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<EFX_CASH_FLOW>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<A NAME="FIS_CASH_FLOW"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	CASH FLOWS FROM OPERATING ACTIVITIES:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Net Income
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,683
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,838
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,395
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160; Adjustments required to reflect cash flows from operations:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160; Depreciation and amortization
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,327
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,308
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,551
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160; Share in profits of equity investee
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(445
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(453
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(491
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160; Share-based compensation expense
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,633
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	852
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,109
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160; Loss (gain) on sale of property, plant and equipment
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	37
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(3
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160; Change in inventories
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(243
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(9,629
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2,584
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160; Change in accounts receivable
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(881
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,304
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(6,965
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160; Change in accounts payable and accruals
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,300
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(3,868
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,052
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160; Change in other non-current assets
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(304
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(141
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	49
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160; Change in retirement benefits obligation
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	91
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(246
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	277
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160; Net&#160;cash provided by operating activities
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,198
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,965
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,390
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	CASH FLOWS FROM INVESTING ACTIVITIES:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Purchase of property, plant and equipment and intangible assets
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2,869
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(6,361
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(4,885
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Change in bank deposits, net
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,995
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(20,009
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;Investment in marketable securities
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(9,428
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(42,499
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
	&#160;
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;Investment in equity investee
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(92
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;Proceeds from sale of marketable securities
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9,299
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,285
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Proceeds from sale of property, plant and equipment
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Change in funds in respect of retirement benefits obligation
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(70
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	118
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(156
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Net cash used in investing activities
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(62
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(63,558
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(5,025
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	CASH FLOWS FROM FINANCING ACTIVITIES:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 9PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Change in short-term loans
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1,000
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 9PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Repayment of long-term bank loan
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(4,200
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(700
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 9PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Proceeds from exercise of options by employees
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	536
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,756
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 9PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Proceeds from exercise of warrants
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,340
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Share issuance costs
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(78
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Proceeds from initial public offering, net of issuance costs
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	of $8.2 million
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	62,838
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 9PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Proceeds from issuance of equity and warrants
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,850
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 9PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net cash provided by (used in) financing activities
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	536
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2,522
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	69,336
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,672
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(64,115
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	71,701
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	BALANCE OF CASH AND CASH EQUIVALENTS
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	AT BEGINNING OF YEAR
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,315
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	74,430
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,729
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	BALANCE OF CASH AND CASH EQUIVALENTS
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	AT END OF YEAR
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,987
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,315
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	74,430
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" COLSPAN="12" VALIGN="BOTTOM">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Interest paid
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#8212;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	187
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	385
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 9PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Income taxes paid, net of refunds
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	268
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	691
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	161
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</EFX_CASH_FLOW>
</TABLE>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Supplementary information on financing and investing activities not involving cash flows
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	At December 31, 2015, 2014 and 2013, trade payables include $450,000 $622,000 and $ 632,000, respectively, in respect of acquisition of property, plant and equipment. These balances will be given recognition in these statements upon payment.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 1.95PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	The accompanying notes are an integral part of the consolidated financial statements.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 7
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage142"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<A NAME="ZK1618102_HTM_F6">
	ENZYMOTEC
</A>
	LTD.
</FONT>
</FONT>
</DIV>
<EFX_NOTES_TO_FINANCIAL_STATEMENT>
<A NAME="FIS_NOTES_TO_FINANCIAL_STATEMENT"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in United States of America ("U.S. GAAP"). The significant accounting policies were applied on a consistent basis, as follows:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	a.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	General
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Enzymotec Ltd. (the "Company"), an Israeli company, which, together with its subsidiaries, develops, manufactures, markets and sells innovative bio-functional lipid ingredients, as well as final products, based on sophisticated proprietary processes and technologies.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company's sales are made to companies that market dietary supplements, to distributors related to those companies, to nutrition companies that provide balanced nutrition to babies and to pharmaceutical companies that market the products as treating diseases by providing the body with optimal amounts of substances which are natural to the body. In the VAYA Pharma segment, the majority of the products are sold directly to customers in the U.S. through wholesalers. Outside the U.S., sales are made through leading pharmaceutical companies. As to sales by geographic locations and major customers, see Note 5.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In June 2007, the Company entered into a joint collaboration agreement with a Swedish vegetable oil company (the "Partner" or "AAK") for the manufacture, marketing and sale of products to the infant food industry and established Advance Lipids AB, a Swedish company jointly owned by both parties in equal proportions ("Advanced Lipids") for this purpose, see also Note 4.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	b.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Use of estimates in preparation of financial statements
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results may differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to contingencies and derivatives.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	c.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Functional currency
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The U.S. dollar ("dollar") is the currency of the primary economic environment in which the operations of the Company are conducted.&#160;&#160;The majority of the Company's sales are denominated in dollars; the majority of the Company&#8217;s expenses are incurred in dollars; and the majority of the Company&#8217;s financing has been provided in dollars.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Transactions and balances originally denominated in dollars are presented at their original amounts.&#160;&#160;Balances in non-dollar currencies are translated into dollars using historical and current exchange rates for non-monetary and monetary balances, respectively.&#160;&#160;For non-dollar transactions and other items in the consolidated statements of operations and comprehensive income (indicated below), the following exchange rates are used: (i) for transactions - exchange rates at transaction dates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation and amortization, etc.) - historical exchange rates.&#160;&#160;Currency transaction gains and losses are recorded in financial income or expenses, as appropriate.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The functional currency of the Company's equity investee, Advanced Lipids, is the Swedish Krona, which is the currency of the primary economic environment in which the operations of Advanced Lipids are conducted.&#160;&#160;Currency translation adjustments are presented within other comprehensive income (loss).
</FONT>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 8
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage143"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	d
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN">
	.
</FONT>
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Principles of consolidation
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.&#160;&#160;Intercompany balances and transactions have been fully eliminated. Profits from intercompany sales have also been eliminated.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN">
	e.
</FONT>
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Investment in equity investees
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company&#8217;s investment in equity investees, which is a less-than-majority-owned entity in which the Company exercises significant influence over operating and financial policies, is accounted for using the equity method of accounting. Under the equity method, original investments are recorded at cost and adjusted by the Company&#8217;s share of undistributed profits or losses of such company. The Company&#8217;s profits from equity investees have been reflected as "share in profits of equity investee" in the consolidated statements of operations and comprehensive income.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;&#160;
</FONT>
<BR>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN">
	f.
</FONT>
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Cash equivalents
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company considers all highly liquid investments, which include short-term bank deposits (up to three months from date of deposit) that are not restricted as to withdrawal or use, to be cash equivalents.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	g.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Inventories
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Inventories include raw materials and finished products and are valued at the lower of cost or market.&#160;&#160;The inventories are determined as follows:
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD ALIGN="RIGHT" STYLE="WIDTH: 99PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
</TD>
<TD ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	Raw materials and supplies - on the "first-in, first-out" basis;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	Products in process and finished products: the raw and packaging materials on the "first-in, first-out" basis; the capitalized production cost &#8211; on an average basis over the production period.
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	h.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Investment in securities
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Investment in securities consists of debt securities classified as available-for-sale and recorded at fair value. The fair value of quoted securities is based on current market value.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Unrealized gains (losses) of available-for-sale securities, net of taxes, are reflected in other comprehensive income. Unrealized losses considered to be temporary are reflected in other comprehensive income; unrealized losses that are considered to be other-than-temporary are charged to income as an impairment charge. Realized gains and losses for debt securities are included in financial income (expenses) - net.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company considers available evidence in evaluating potential impairments of its investments, including the duration and extent to which fair value is less than cost. For debt securities, an other-than-temporary impairment has occurred if the Company does not expect to recover the entire amortized cost basis of the debt security. If the Company does not intend to sell the impaired debt security, and it is not more likely than not it will be required to sell the debt security before the recovery of its amortized cost basis, the amount of the other-than-temporary impairment are charged to income included in financial income (expenses) - net, is limited to the portion attributed to credit loss. The remaining portion of the other-than-temporary impairment related to other factors is recognized in other comprehensive income.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 9
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage144"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
<BR>
</DIV>
<DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES
</FONT>
	(continued):
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	i.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Intangible assets
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Intangible assets represent licenses to sell in certain territories (see also Note 8e (1)) and are shown at historical cost. Licenses have a finite useful life and are carried at cost, net of accumulated amortization. Amortization is calculated using the straight-line method over the estimated useful life of the license.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	j.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Property, plant and equipment
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	These assets are stated at cost, net of accumulated depreciation and amortization. The assets are depreciated by the straight-line method on the basis of their estimated useful lives.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Annual rates of depreciation are as follows:
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_29"></A>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="85%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="88%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE">
	%
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%">
	&#160;
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="10%" STYLE="TEXT-ALIGN: RIGHT">
	&#160;
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Computers and software
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="10%" STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	33
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Buildings
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="10%" STYLE="TEXT-ALIGN: CENTER">
	2
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Vehicles
</FONT>
</FONT>
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="10%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	15
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="88%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Manufacturing equipment
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="10%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7-10
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="88%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Laboratory equipment
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="10%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7-20
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="88%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="10%" STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(Mainly 15%)
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="88%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Furniture and office equipment
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="10%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6-15
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
	&#160;
</TD>
<TD>
	Leasehold improvements are amortized by the straight-line method over the term of the lease, which is shorter than the estimated useful life of the improvements.
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	k.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Impairment of long-lived assets
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company tests long-lived assets (including intangible assets) for impairment whenever events or circumstances present an indication of impairment. If the sum of expected future cash flows (undiscounted and without interest charges) of the assets is less than the carrying amount of such assets, an impairment loss would be recognized. The assets would be written down to their estimated fair values, calculated based on the present value of expected future cash flows (discounted cash flows), or some other fair value measure.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For the years ended December 31, 2015, 2014 and 2013, the Company did not recognize an impairment loss in respect of its long-lived assets.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	l.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Revenue recognition
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company recognizes revenue from sales of its products to customers, including distributors, when persuasive evidence of sales arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is reasonably assured. See also Note 4 for timing of revenue recognition related to the Company's joint collaboration agreement.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company provides a right of return to its U.S. distributors upon expiry of the medical food products sold in the VAYA Pharma segment. Accordingly, the Company records a reserve for estimated sales returns based on historical experience as well as specific factors, such as levels of inventory in the distribution channel, product dating and expiration. Returns to date have been inconsequential. Revenues from product sales are also recorded net of cash discounts and distribution fees, which can be reasonably estimated.
</FONT>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	m.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Research and development expenses
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Research and development expenses are charged to income as incurred. Participation from government departments and from research foundations for development of approved projects is recognized as a reduction of expense as the related costs are incurred. The main components of the research and development expenses are salaries and related expenses, laboratory, clinical research and regulatory related expenses.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 10
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage145"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
<BR>
</DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	n.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Contingencies
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Certain conditions may exist as of the balance sheet date, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. Management assesses such contingent liabilities, if any, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, management evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Management applies the guidance in Accounting Standards Codification ("ASC") 450-20-25 when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability is recorded as accrued expenses in the Company&#8217;s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material are disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantees are disclosed.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	o.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Income taxes
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Deferred income taxes are determined by the asset and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the tax rates expected to be in effect at the time when these differences reverse. Valuation allowances in respect of the deferred tax assets are provided when it is more likely than not that all or a portion of the deferred income tax assets will not be realized. See Note&#160;10g for additional information regarding deferred taxes.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company assesses its valuation allowance considering different indicators, including profitability of the different entities in the different tax jurisdictions, the ability to utilize the deferred tax assets in subsequent years, etc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Upon the distribution of dividends from the tax-exempt income of an "Approved Enterprise" or "Benefitted Enterprise" (see also Note 10a (3)), the amount distributed is subject to tax at the rate that would have been applicable had the Company not been exempted from payment thereof. The Company intends to permanently reinvest the amounts of tax exempt income and it does not intend to distribute such dividends. Therefore, no deferred income taxes have been provided in respect of such tax-exempt income.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company may incur an additional tax liability in the event of an inter-company dividend distribution from foreign subsidiaries; no additional deferred income taxes have been provided, since it is the Company&#8217;s policy not to distribute dividends in the foreseeable future that may result in additional tax liability.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Taxes that would apply in the event of disposal of investments in foreign subsidiaries have not been taken into account in computing deferred income taxes, as it is the Company&#8217;s intent and ability to hold these investments.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Tax benefits recognized in the consolidated financial statements are those that management deems at least more likely than not to be sustained, based on technical merits.&#160;&#160;The amount of benefits recorded for these tax benefits is measured as the largest benefit management deems more likely than not to be sustained.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 11
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage146"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
<BR>
</DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	p.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Share-based compensation
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company accounts for employees and directors share-based compensation awards classified as equity awards using the grant-date fair value method.&#160;&#160;The fair value of share-based compensation transactions is recognized as an expense over the requisite service period, net of estimated forfeitures.&#160;&#160;The Company estimates forfeitures based on historical experience and anticipated future conditions. Performance-based awards are expensed over the requisite service period when the achievement of performance criteria is probable.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company elected to recognize compensation cost for an award with only service conditions that has a graded vesting schedule using the straight-line method based on the multiple-option award approach.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	When options are granted as consideration for services provided by consultants and other non-employees, the grant is accounted for based on the fair value of the consideration received or the fair value of the options issued, whichever is more reliably measurable. The fair value of the options granted is measured on a final basis at the end of the related service period and is recognized over the related service period using the straight-line method.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	q.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Shipping and handling costs
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Shipping and handling costs on sales are classified as a component of cost of revenues.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	r.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Advertising
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Costs related to advertising and promotion of products, are charged to selling and marketing expense as incurred.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	s.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Earnings per share
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Basic earnings per share are computed by dividing net income applicable to ordinary shareholders by the weighted average number of shares of the Company's ordinary shares outstanding for each period.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Diluted earnings per share are calculated by dividing net income applicable to ordinary shareholders by the fully-diluted weighted-average number of ordinary shares outstanding during each period.&#160;&#160;Potentially dilutive shares are comprised of: (i) incremental ordinary shares issuable upon the exercise of share options, restricted shares or warrants, using the treasury stock method; and (ii) shares issuable upon conversion of preferred shares using the &#8220;if-converted&#8221; method. For the Company's performance-vested share awards, their contingent features result in an assessment for any potentially dilutive common stock by using the end of the reporting period as if it were the end of the contingency period for all awards granted.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Basic and diluted earnings per share are presented in conformity with the two-class method for participating securities for the period prior to their conversion upon the Company's initial public offering in October 2013 when all preferred shares were converted into ordinary shares. Under this method the earnings per share for each class of shares (ordinary shares and preferred shares) are calculated assuming 100% of the Company&#8217;s earnings are distributed as dividends to each class of shares based on their contractual rights.
</FONT>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 12
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage147"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
<BR>
</DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	t.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Derivatives
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company purchases foreign exchange derivative financial instruments (mainly forward exchange contracts, and written and purchased currency options). The transactions are designed to hedge the Company&#8217;s currency exposure.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Derivatives that do not qualify for hedge accounting are recognized in the balance sheet at their fair value, with changes in the fair value recognized as a component of &#8220;financial income (expenses) - net&#8221; in the consolidated statements of operations and comprehensive income.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Changes in the fair value of derivatives that are highly effective and designated as cash flow hedges are reported as a component of other comprehensive income or loss and reclassified into earnings in the same line-item associated with the forecasted transaction and in the same periods during which the hedged transaction impacts earnings.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For derivatives that do not qualify for hedge accounting, the cash flows associated with these derivatives are reflected as cash flows from operating activities in the consolidated statements of cash flows.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For derivatives that qualify for hedge accounting, the cash flows associated with these derivatives are reported in the consolidated statements of cash flows consistently with the classification of cash flows from the underlying hedged items that these derivatives are hedging.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.65PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	u.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Fair value measurement
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company measures fair value and discloses fair value measurements for financial assets and liabilities. Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The fair value of the financial instruments included in the working capital of the Company is usually identical or close to their carrying value. The fair value of bank borrowing also approximates the carrying value since it bears interest at rates close to the prevailing market rates.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The three levels of inputs that may be used to measure fair value are as follows:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Level 1 - Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Level 2 - Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Level 3 - Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and considers counterparty credit risk in its assessment of fair value.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 13
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage148"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES
</FONT>
	(continued):
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.7PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	v.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Concentration of credit risks, trade receivables and suppliers
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents, bank deposits, marketable securities and trade receivables.&#160;&#160;The Company deposits cash and cash equivalents with highly rated financial institutions, mainly Israeli and U.S. banks. Deposits in U.S. banks are federally insured up to $250,000 per account.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company has not experienced any credit losses in these accounts and does not believe it is exposed to any significant credit risk on these instruments. The Company performs ongoing credit evaluations to estimate the need for maintaining reserves for potential credit losses. An allowance for doubtful accounts is recognized on a specific basis with respect to those amounts that the Company has determined to be doubtful of collection. Following are the changes in the allowance for doubtful accounts for the years ended December 31, 2015 and 2014. There was no change in the year ended December 31, 2013.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_30"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December&#160;31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Balance at beginning of year
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	245
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Charged to cost and expenses
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	245
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Released from doubtful accounts
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(245
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Balance at end of year
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	245
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV>
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.7PT">
	&#160;
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	At December 31, 2015, two customers accounted for more than 10% of gross accounts receivable with balances of $1,929,000 and $1,658,000. At December 31, 2014, one customer accounted for more than 10% of gross accounts receivable with a balance of $2,930,000.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company is dependent on third parties to supply krill meal, an essential raw material for the production of krill oil, which accounted for 35.3%, 40.6% and 53.8% of total net revenues in the years ended December 31, 2015, 2014 and 2013, respectively. The Company currently purchases krill meal from a limited number of suppliers. Though growing, there is only a limited number of vessels capable of producing krill meal onboard. In 2014, the Company also purchased frozen krill, which, while more expensive to process into krill meal onshore compared to krill from vessels that process krill meal onboard, is more readily obtainable. The Company also signed a toll processing agreement in 2014 with a toll processor for processing the frozen krill into krill meal. The Company intends to meet its krill meal needs in the future by sourcing krill meal both from vessels that process krill meal onboard and suppliers of frozen krill. However, if the Company, for any reason, is no longer able to obtain the krill meal from a supplier on terms reasonable to it, or at all, this would have a material adverse effect on its results of operations and financial condition.
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 14
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage149"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
<DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES
</FONT>
	(continued):
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 49.7PT">
	&#160;
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	w.
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Recently issued accounting pronouncements
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In January 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update (ASU) 2016-01 which addresses certain aspects of recognition, measurement, presentation and disclosure of financial instruments. A financial instrument is defined as cash, evidence of ownership interest in a company or other entity, or a contract that both: (i)&#160;imposes on one entity a contractual obligation either to deliver cash or another financial instrument to a second entity or to exchange other financial instruments on potentially unfavorable terms with the second entity and (ii)&#160;conveys to that second entity a contractual right either to receive cash or another financial instruments from the first entity or to exchange other financial instruments on potentially favorable terms with the first entity. This pronouncement is effective for financial statements issued for annual periods beginning after December&#160;15, 2017 (January 1, 2018 for the Company) and interim periods within those annual periods with earlier application permitted as of the beginning of the fiscal year of adoption. The Company is currently evaluating the potential effect of the guidance on its consolidated financial statements.
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In July 2015, the FASB issued guidance on current accounting for inventory measurement. The new guidance requires entities to measure inventory at the lower of cost or net realizable value. Net realizable value is defined by the guidance as the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The guidance is effective for the interim and annual periods beginning on or after December 15, 2016 (January 1, 2017 for the Company)&#160;&#160;(early adoption is permitted). The Company is currently evaluating the potential effect of the guidance on its consolidated financial statements.
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In May 2014, the FASB issued guidance on revenue from contracts with customers that will supersede most current revenue recognition guidance, including industry-specific guidance. The underlying principle is that an entity will recognize revenue upon the transfer of goods or services to customers in an amount that the entity expects to be entitled to in exchange for those goods or services. The guidance provides a five-step analysis of transactions to determine when and how revenue is recognized. Other major provisions include capitalization of certain contract costs, consideration of the time value of money in the transaction price, and allowing estimates of variable consideration to be recognized before contingencies are resolved in certain circumstances. The guidance also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from an entity&#8217;s contracts with customers. The guidance is effective for the interim and annual periods beginning on or after December 15, 2017 (January 1, 2018 for the Company) (early adoption is permitted for the interim and annual periods beginning on or after December 15, 2016, January 1, 2017 for the Company). The guidance permits the use of either a retrospective or cumulative effect transition method. The Company is currently evaluating the impact of the amended guidance on its consolidated financial statements.
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 15
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage150"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 2 - INITIAL PUBLIC OFFERING ("IPO") AND SECONDERY OFFERING
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	On October 2, 2013, the Company closed its IPO in the United States with respect to the sale of 5,073,800 ordinary shares.&#160;&#160;In connection with the IPO, the Company&#8217;s ordinary shares were listed on the NASDAQ Global Select Market. The IPO price was $14 per share. After deducting the underwriting discount and the offering expenses, the net proceeds to the Company from the offering amounted to $62,838,000. The number of shares offered included the underwriters&#8217; option to purchase an additional 661,800 ordinary shares at the IPO price that was exercised in full prior to closing.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Upon the closing of the IPO, all warrants issued to the Company's former preferred shareholders were exercised for preferred shares, which subsequently converted together with all other outstanding preferred shares into ordinary shares. The following table details the number of ordinary shares outstanding following the closing of the IPO as of October 2, 2013:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_31"></A>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="88%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Number of shares
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="88%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Ordinary shares outstanding at September 30, 2013
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,167,304
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Ordinary shares issued following the conversion of the preferred shares outstanding
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12,905,312
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Ordinary shares issued following the exercise of preferred share warrants and subsequent conversion
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	385,084
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Ordinary shares issued in the IPO (including the underwriters&#8217; option to purchase additional shares)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,073,800
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="88%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total ordinary shares outstanding at October 2, 2013
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,531,500
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV ALIGN="RIGHT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In connection with the closing of the IPO and in accordance with their original terms, the vesting period for certain options was accelerated such that options to purchase 262,888 ordinary shares
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	vested and became exercisable upon the closing of the IPO and options to purchase 224,740 ordinary shares vested and became exercisable after one year from the closing of the IPO. Additionally, restricted shares, whose vesting was also subject to the occurrence of a change in control event (i.e. closing of an IPO) will vest according to their vesting schedule, see also Note 9d.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 446PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition, following the closing of the IPO, the Company's Board of Directors approved a grant of 9,520 fully vested restricted shares to the Company's then-current Vice Chairman of the Board of Directors, see also Note 9d.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 446PT">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Accordingly, the Company recorded $0.9 million of share-based compensation expense in the fourth quarter of 2013 in respect of vested options and restricted shares.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 446PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition, the Company recorded $1.0 million of expense in respect of IPO-related bonuses to certain employees. Such bonuses were partly subject to the closing of the IPO ($0.5 million) and partly subject to the Company's market capitalization exceeding an agreed upon level for at least 30 trading days within 24 months following its IPO ($0.5 million). As all conditions were met, the Company recorded the expense in the fourth quarter of 2013.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 446PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	On March 5, 2014, the Company closed a registered public offering by certain selling shareholders of 5,403,685 ordinary shares at $28.00 per share, which included 704,828 shares purchased pursuant to the full exercise of the underwriters' option to purchase additional shares. The Company did not receive any proceeds from the sale of these shares. The Company recognized in the statement of operations and comprehensive income $0.4 million expenses in respect of such offering.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 16
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage151"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_32"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 3 - PROPERTY, PLANT AND EQUIPMENT
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Composition of property and equipment grouped by major classifications is as follows:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	December 31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -1.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Manufacturing equipment
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	23,613
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	19,488
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -1.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Buildings
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,605
</FONT>
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,472
</FONT>
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -1.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Laboratory equipment
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,613
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,536
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -1.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Land*
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	951
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	951
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -1.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Furniture, office equipment and computers
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,837
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,272
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -1.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Leasehold improvements
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	161
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	161
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -1.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Vehicles
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	16
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	27
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -1.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Advances on account of acquisition of machinery and equipment
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,330
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	40,796
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	38,237
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -1.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Less: accumulated depreciation and amortization
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,088
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8,963
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	29,708
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	29,274
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*&#160;&#160;&#160;&#160;&#160;Land includes long-term leasehold rights in Israel with useful lives of 98 years.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 90PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Depreciation and amortization expense totaled $2,215,000, $1,941,000 and $1,551,000 for the years ended December 31, 2015, 2014 and 2013, respectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 4 - JOINT COLLABORATION AGREEMENT
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As described in Note 1, the Company has entered into a joint collaboration agreement with a Swedish vegetable oil company. The joint collaboration agreement's initial term ends on December&#160;31, 2016. Thereafter the agreement will be automatically extended for consecutive periods of three years, unless terminated by a notice of either party at least 12 months prior to its expiration. As neither party gave termination notice by December 31, 2015, the agreement was automatically extended through December 31, 2019. Under the joint collaboration agreement and two related supply agreements entered into between the parties, the activities of the joint operations are allocated as follows:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company has the responsibility for production of the enzyme, research and development, marketing and business development activities. The Partner has responsibility for the supply chain (purchase and procurement of raw materials, managing stock, delivery and collection).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Advanced Lipids operates as a low risk distributor of the joint collaboration. The Company recognizes revenues from its sales of enzymes to the Partner only upon sale of InFat (as described below in Note 5a) by Advanced Lipids to its customers.&#160;&#160;As described in Note 1e, the Company accounts for its investment in Advanced Lipids using the equity method of accounting and recognizes its 50% proportionate share of the profit or loss of Advanced Lipids. For the years ended December 31, 2015, 2014 and 2013, sales of enzymes by the Company to the Partner amounted to $13,950,000, $13,280,000 and $16,666,000, respectively. At December 31, 2015 and 2014, the receivable balance was $3,706,000 and $2,321,000, respectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 17
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage152"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 4 - JOINT COLLABORATION AGREEMENT
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In May 2014, AAK submitted a request for arbitration against the Company seeking a declaration that the Company breached the confidentiality provisions of the agreement by disclosing confidential information of the joint venture in its registration statement for its IPO, as well as a declaration regarding the correct interpretation of certain provisions of the joint venture agreement. The Company submitted its answer to AAK&#8217;s arbitration request rejecting AAK's allegations and including also a counter claim, in which the company is seeking monetary damages from AAK due to various breaches of the joint venture agreement by AAK. The arbitration hearing took place in June 2015. On
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
	February 2, 2016, the Arbitrators rendered their decision, rejecting, in their entirety, AAK's requests for declaratory relief in connection with alleged breaches by the Company of the joint venture agreement's non-disclosure obligations.&#160;&#160;Additionally, the Arbitrators found that, as the Company maintained,&#160;&#160;the joint venture agreement should be interpreted such that the only exit the parties have from the agreement is via a buy-sell process which must end in one party buying out the other and not, as AAK had claimed, simply through the expiration of the joint venture agreement.&#160;&#160;With respect to the Company's counterclaims, the Arbitrator denied all relief requested by the Company.
</FONT>
</FONT>
</DIV>
<BR>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 5 - SEGMENT INFORMATION:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	a.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Segment information:
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Chief Executive Officer ("CEO") is the Company&#8217;s chief operating decision-maker ("CODM"). Management has determined that there are two operating segments, based on the Company's organizational structure, its business activities and information reviewed by the CODM for the purposes of allocating resources and assessing performance.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Nutrition.
</FONT>
	&#160;&#160;This segment develops and manufactures lipid compositions and bioactive ingredients as ingredients for infant formula and dietary supplements, which are tailored to the special needs of the nutrition industry.&#160;&#160;These ingredients include InFat, a proprietary, clinically-proven infant formula fat ingredient that mimics human breast milk fat to facilitate healthy infant development and premium phospholipids-based bioactive ingredients for nutritional supplements.&#160;&#160;The best-selling product is krill oil, which provides the anti-aging benefits of Omega-3 fatty acids.&#160;&#160;Other products are targeted at improving brain health and providing benefits in memory, learning abilities and concentration.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Nutrition Segment includes the results of Advanced Lipids and other activities performed at the Company level.&#160;&#160;For accounting purposes, the results of Advanced Lipids are recorded using the equity method of accounting.&#160;&#160;For management purposes, the results of Advanced Lipids are analyzed based on proportionate consolidation, which represents the Company's share (50%) of the gross results of Advanced Lipids.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	VAYA Pharma
</FONT>
	.&#160;&#160;This segment develops, manufactures and sells branded lipid-based medical foods for the dietary management of medical disorders and common diseases.&#160;&#160;This is a research-based, specialty pharmaceutical segment, which currently offers medical foods products for the cardiovascular and neurological markets.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The CODM assesses the performance based on a measure of "Adjusted EBITDA" (earnings before financial expenses, tax, depreciation and amortization and excluding share-based compensation expenses and other unusual income or expenses).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The measure of assets has not been disclosed for each segment as it is not regularly provided to the CODM.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 18
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage153"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_33"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 5 - SEGMENT INFORMATION
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 2.55PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Segment data for the year ended December 31, 2015 is as follows:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Nutrition
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	VAYA
</FONT>
	Pharma
</FONT>
</DIV>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Total
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Elimination**
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Consolidated
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="18" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues from external customers
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	54,163
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8,471
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	62,634
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(12,243
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	50,391
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cost of revenues*
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	29,686
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,506
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	31,192
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(11,665
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	19,527
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit*
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	24,477
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,965
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	31,442
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(578
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	30,864
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating expenses*
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12,704
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,356
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	23,060
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(3
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	23,057
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Depreciation and amortization
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,127
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	200
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,327
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Adjusted EBITDA
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,900
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(3,191
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Share-based compensation expense
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,633
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating Income
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,174
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial income - net
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	471
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Income before taxes on income
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,645
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Including depreciation and amortization but excluding share based compensation expense.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	**&#160;&#160;&#160;Representing the change from proportionate consolidation to the equity method of accounting.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 2.55PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Segment data for the year ended December 31, 2014 is as follows:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 2.55PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_34"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Nutrition
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	VAYA
</FONT>
	&#160;Pharma
</FONT>
</DIV>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Total
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Elimination***
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Consolidated
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="18" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues from external customers
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	55,815
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,641
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	61,456
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(14,353
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,103
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cost of revenues*
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	30,605
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,435
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32,040
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(13,775
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18,265
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit*
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	25,210
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,206
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	29,416
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(578
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	28,838
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating expenses**
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,347
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,957
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	20,304
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(3
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	20,301
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Depreciation and amortization
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,112
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	196
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,308
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Adjusted EBITDA
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,975
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2,555
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Secondary offering expenses
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	393
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Share-based compensation expense
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	852
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating Income
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,292
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial expenses - net
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	499
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Income before taxes on income
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,791
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD ALIGN="RIGHT" STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Including depreciation and amortization but excluding share based compensation expense.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD ALIGN="RIGHT" STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	**
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Including depreciation and amortization, but excluding share-based compensation and Secondary offering expenses.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD ALIGN="RIGHT" STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	***&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Representing the change from proportionate consolidation to the equity method of accounting.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 19
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage154"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_35"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 5 - SEGMENT INFORMATION
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 2.55PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Segment data for the year ended December 31, 2013 is as follows:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Nutrition
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	VAYA
</FONT>
	Pharma
</FONT>
</DIV>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Total
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Elimination***
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Consolidated
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="18" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues from external customers
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	76,167
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,444
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	80,611
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(15,636
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	64,975
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cost of revenues*
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	45,804
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,255
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,059
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(14,981
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32,078
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Gross profit*
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	30,363
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,189
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	33,552
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(655
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32,897
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating expenses**
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,009
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,020
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	19,029
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	19,029
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Depreciation and amortization
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,415
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	136
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,551
</FONT>
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Adjusted EBITDA
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	18,769
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2,695
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Share-based compensation expense
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,109
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	IPO related bonus
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,000
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Operating income
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,759
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial expenses - net
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(531
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="40%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Income before taxes on income
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,228
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV>
	&#160;
</DIV>
<DIV>
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="TEXT-ALIGN: LEFT; WIDTH: 27PT">
<DIV STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Including depreciation and amortization but excluding share based compensation expense.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD ALIGN="RIGHT" STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	**
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Including depreciation and amortization but excluding share based compensation expense and IPO related&#160;bonus.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD ALIGN="RIGHT" STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	***&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Representing the change from proportionate consolidation to the equity method of accounting.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	b.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Entity wide information:
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 67.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1)
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues by geographic location were as follows:
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_36"></A>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December 31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	North America
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	29,635
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	25,810
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	35,458
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Europe
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,071
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,395
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,382
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Australia
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,188
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,388
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,811
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Asia
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,173
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,019
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,735
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Israel
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,324
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,491
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	589
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Total revenues
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	50,391
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,103
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	64,975
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.899PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2)
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Substantially all of the Company's long lived assets are located in Israel.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" ID="LIST" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</TABLE>
</DIV>
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.899PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3)
</FONT>
</DIV>
</TD>
<TD>
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Revenues from sales of four products, which exceed 10% of total revenues, are as follows:
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_37"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December 31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 7.1PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Krill oil (Nutrition Segment)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	17,776
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	19,131
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	34,926
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 7.1PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Enzymes for the production of InFat (Nutrition Segment), see Note 4
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,950
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,280
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	16,666
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 7.1PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Vayarin (VAYA Pharma Segment)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,395
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,203
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,096
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 7.1PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Sharp PS (Nutrition Segment)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,884
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,505
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,248
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 20
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage155"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_38"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 5 - SEGMENT INFORMATION
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.899PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4)
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net revenues from single customers out of the Nutrition Segment that exceed 10% of total net revenues in the relevant year:
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December 31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 7.1PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Customer A
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	998
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,958
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,692
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 7.1PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Customer B
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,318
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,471
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9,833
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 7.1PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Customer C
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,528
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,173
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,476
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_39"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 6 - INVENTORIES:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	December 31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -1.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Raw materials and supplies
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12,927
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12,240
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -1.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In-process inventories
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,379
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,644
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -1.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Finished goods
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,509
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,688
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,815
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,572
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 7 - EMPLOYEE RIGHTS UPON RETIREMENT
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company is required to make severance payments with respect to its Israeli employees upon dismissal of an employee or upon termination of employment in certain circumstances.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In accordance with the current employment agreements with most of its Israeli employees, the Company makes regular deposits with certain insurance companies for accounts controlled by each applicable employee in order to secure the employee&#8217;s retirement benefit obligation. The Company is fully relieved from any severance pay liability with respect to each such employee after it makes the payments on behalf of the employee. The liability accrued in respect of these employees and the
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	amounts funded, as of the respective agreement dates, are not reflected in the Company&#8217;s consolidated balance sheets, as the amounts funded are not under the control and management of the Company and the pension or severance pay risks have been irrevocably transferred to the applicable insurance companies (the &#8220;Contribution Plan&#8221;).
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	With regard to the employees without a Contribution Plan, the liability is funded in part by the purchase of insurance policies or by the establishment of pension funds with dedicated deposits in the funds. These policies are the Company's assets. The severance payment liability to the employees (based upon length of service and the latest monthly salary&#160;- one month&#8217;s salary for each year of employment) is recorded on the Company's balance sheets under &#8220;retirement benefits obligation&#8221;. The liability is recorded as if it was payable at each balance sheet date on an undiscounted basis. In the years ended December&#160;31, 2015, 2014 and 2013, the Company deposited $114,000, $147,000 and $156,000, respectively, with insurance companies and pension funds in connection with its severance payment obligations.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 446PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The amounts of severance payment expenses were $449,000, $392,000 and $506,000 for the years ended December&#160;31, 2015, 2014 and 2013, respectively, of which $314,000, $312,000 and $230,000 in the years ended December 31, 2015,&#160;2014 and 2013, respectively, were in respect of the Contribution Plan and funded accordingly.&#160;&#160;Gains (losses) on the amounts funded in insurance companies and pension funds, in respect of retirement benefit obligation totaled $12,000,
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	($78,000) and $154,000 for the years ended December&#160;31, 2015, 2014 and 2013, respectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 446PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company expects to contribute approximately $480,000 in the year ending December&#160;31, 2016 to insurance companies in connection with its severance liabilities for its operations for that year, $360,000 of which will be contributed to a Contribution Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 21
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage156"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 8 - COMMITMENTS AND CONTINGENCIES:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	a.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Operating leases
</FONT>
</FONT>
</DIV>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	As of December 31, 2015, minimum future rentals under operating leases of office space, machinery and equipment and vehicles for periods in excess of one year amounted to $1,620,000 and were to be paid as follows: 2016 - $802,000; 2017 - $434,000; 2018 - $274,000; 2019 &#8211; $110,000. The lease expenses in each of the years ended December 31, 2015, 2014 and 2013 were $902,000, $868,000 and $452,000, respectively.
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	b.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Marketing and distribution agreements
</FONT>
</DIV>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	The Company has entered into marketing and distribution agreements with commercial entities with respect to its products.&#160;&#160;Under the terms of the agreements, the distributors have received rights to distribute the products in a defined territory and for various periods.
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
</DIV>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	c.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Toll manufacturing agreement
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company has entered into a 10-year toll manufacturing agreement with respect to one of its products. Under the terms of the agreement, the Company has committed for minimum purchasing through the term of the agreement. The Company can terminate the agreement with a 90-day notice, subject to payment of termination payment which is based on a fixed amount of up to $500,000 reduced by actual purchasing before termination.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	d.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Royalties:
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1)
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company is committed to pay royalties to the Office of the Chief Scientist of the Israeli Ministry of Economy and Industry (the "Chief Scientist"); the royalties are computed based on the Company's net revenues arising from know-how in the research and development in which the Chief Scientist participated by way of grants.&#160;&#160;Under the terms of the Company&#8217;s funding from the Chief Scientist, royalties of 3%-5% are payable on sales of products developed from a project so funded, up to 100% of the amount of the grant received by the Company (dollar linked with the addition of annual interest at LIBOR rate). At the time the grants were received, successful development of the related projects was not assured.&#160;&#160;In the case of failure of a project that was partly financed by royalty-bearing Government grants, the Company is not obligated to pay any such royalties to the Israeli Government. At December&#160;31, 2015, the maximum royalty amount payable (including interest) by the Company is approximately $3.2 million.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2)
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 2001, the Company and a third party (the U.S. Partner) entered into an agreement for the development, manufacture and supply of a new product.&#160;&#160;The development of this product was funded by BIRD &#8211; Israel-U.S. Binational Industrial Research and Development Foundation (the "BIRD Foundation"). The Company is committed to pay royalties to the BIRD Foundation which are computed based on the Company's net revenues from sale of products in the development of which the BIRD Foundation participated.
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The U.S. Partner has terminated the research project and the BIRD Foundation gave its consent to the termination as above. Therefore, the Company is not expected to derive any revenues from the said research; however, in case such revenues shall arise to the Company, the maximum royalty amount payable by the Company is $ 370,000 as of December 31, 2015.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3)
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Royalty expenses for the years ended December 31, 2015, 2014 and 2013 were recorded in cost of revenues and amounted to $194,000, $115,000 and $101,000, respectively.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 22
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage157"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 8 - COMMITMENTS AND CONTINGENCIES
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	e.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Litigation:
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1)
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company was a party to a number of actions initiated by Neptune Technologies &amp; Bioressources Inc., ("Neptune"), in which Neptune claimed that the Company's krill oil products infringed certain of its patents, namely U.S. Patent Nos. 8,030,348, 8,278,351 and 8,383,675, ( the "348 patent", the "351 patent" and the "675 patent", respectively).
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Additionally, in April 2013, the Company received a notice of an investigation by the United States International Trade Commission, ("ITC"), regarding complaints filed before the ITC by Neptune and its subsidiary, Acasi Pharma Inc., stating that our alleged patent infringement violated the Tariff Act of 1930.
</FONT>
</DIV>
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	On April 27, 2014, the Company signed a settlement agreement with Neptune (the "Settlement Agreement"). Pursuant to the Settlement Agreement, the Neptune patent litigations were dismissed with prejudice on May 2, 2014 and the ITC action was terminated on June 12, 2014. Under the Settlement Agreement, the Company received a&#160;worldwide non-exclusive license to the entire "348 patent family" for as long as any patent in that family exists, for all of the Company's relevant current products and future anticipated products under development in consideration of a one-time upfront payment to Neptune. This payment was recorded as intangible asset, which is being amortized over the life of the "348 patent family".&#160;&#160;Any further payments to Neptune depend upon the outcome of (1) Inter Partes Review (&#8220;IPR&#8221;) proceedings in the U.S. Patent Office (&#8220;USPTO&#8221;) of certain agreed claims of the "351 Patent" and (2) a potential Australian post-grant reexamination of certain agreed claims of Neptune&#8217;s Australian Patent AU2002322233.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	With respect to the "351 patent", in March 2014, the USPTO issued a decision instituting an IPR of the agreed claims of the "351 patent" filed by Aker BioMarine AS (&#8220;Aker&#8221;), concluding that there is reasonable likelihood that Aker will prevail in demonstrating unpatentability of those claims.&#160;&#160;On July 9, 2014, the USPTO issued a decision instituting the Company&#8217;s IPR of the agreed claims of the "351 patent" and granted the Company&#8217;s motion to join the Company&#8217;s IPR with Aker&#8217;s IPR.&#160;&#160;&#160;&#160;On March 23, 2015, the USPTO issued a decision finding 26 of the 28 Agreed Claims unpatentable.&#160; On April 22, 2015, Aker and the Company filed a petition for hearing with the USPTO with respect to the two remaining claims. The rehearing request was denied on July 8, 2015.&#160;&#160;The Company has appealed the March 23, 2015 USPTO decision to the U.S. Court of Appeals for the Federal Circuit. Management believes it is more likely than not that the USPTO decision of patentability with respect to those two claims will be reversed on appeal.&#160;&#160;Accordingly, at this stage, management does not believe that it is probable that the Company will incur a loss and therefore, the Company has not included any provision in its financial statements for these claims.
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 23
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage158"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<BR>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 8 - COMMITMENTS AND CONTINGENCIES
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
	&#160;
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The "351 patent" is also the subject of an ex parte reexamination, which has been stayed pending the outcome of Aker&#8217;s 351 IPR.&#160;&#160;Prior to the reexamination being stayed, the Patent Office rejected all claims of the "351 patent" in a January 2, 2014 office action.&#160;&#160;That action is not final and Neptune will have an opportunity to respond once the stay is lifted.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the terms of the Settlement Agreement, the Company submitted its post-grant reexamination to the Australian Patent Office ("APO") on December 12, 2014.&#160;&#160;On January 28, 2015, the APO issued a reexamination report, finding that all the agree claims lack novelty. Following a second reexamination report for which the Company requested further reexamination, the APO issued a re-examination report on September 4, 2015 finding in favor of Neptune. On November 9, 2015, the Company filed a further reexamination request. Management believes it is more likely than not that the APO decision of patentability with respect to those agreed claims will be reversed on reexamination.&#160;&#160;Accordingly, at this stage, management does not believe that it is probable that the Company will incur a loss and therefore, the Company has not recorded any provision in its financial statements for these claims.
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2)
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	On September 5, 2014 and September 30, 2014, two stockholders filed class action complaints in the United States District Court for the District of New Jersey purportedly on behalf of all persons who acquired the Company's securities in its IPO or between September 27, 2013 and August 4, 2014.&#160;&#160;The lawsuits named as defendants the Company, its directors, certain of its officers and the underwriters of its IPO and assert claims under the United States federal securities laws.&#160;&#160;On February 11, 2015, the Court consolidated the cases as In re Enzymotec Ltd. Securities Litigation, Master File No. 14-CV-05556 and appointed a lead plaintiff.&#160;&#160;The lead plaintiff filed an amended complaint on May 18, 2015 asserting essentially the same claims as the claims asserted in the initial class action complaints.&#160;&#160;The amended complaint, however, does not name the underwriters of the IPO as defendants as the underwriters and lead plaintiff entered into a tolling agreement.&#160;&#160;The Company filed a motion to dismiss on July 17, 2015, lead plaintiffs filed an opposition to the motion on September 15, 2015 and the Company filed a reply on October 30, 2015. The Court dismissed the claims related to the Company's krill oil business but did not dismiss the claims related to the infant formula business in China. The Company answered the amended complaint on February 19, 2016. Management believes that an estimate of the likelihood that the Company might incur financial loss as a result of this litigation, as required by ASC 450-20-50-4, "Contingencies", cannot be made at this time, given the early stage of these lawsuits. Accordingly, the Company has not included any provision in its consolidated financial statements for this claim. However, management believes that the lawsuits are without merit and intends to defend itself vigorously. Under the underwriting agreement, the Company is obligated to provide indemnification to the underwriters in connection with legal proceedings, as defined in the agreement. However, as discussed above, the underwriters are no longer named defendants.
</FONT>
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	f.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As to indemnification provided to several customers and distributors and underwriters in connection with legal proceedings, see e(1) and e(2) above.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
	&#160;
</DIV>
<DIV>
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 24
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage159"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<BR>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 9 - SHAREHOLDERS' EQUITY:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	a.
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Share capital:
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	On September 2, 2013, the Company's shareholders approved an increase in its authorized share capital to an aggregate of NIS 1 million divided into 100 million ordinary shares. On September 12, 2013, the Company effected a bonus share distribution under which: (i) 67 bonus shares were issued for each share outstanding prior to such distribution; and (ii) the conversion rate for each preferred share, option and warrant was adjusted to reflect such bonus share distribution.
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1)
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Ordinary shares
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The ordinary shares confer upon their holders voting rights and the right to participate in shareholders' meetings (the holders of shares of NIS 0.01 par values are entitled to one vote per share), the right to receive profits and the right to share in excess assets upon liquidation of the Company.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2)
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Preferred shares
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Until the closing of the IPO (see Note 2), the A, B, B1 and B2 preferred shares conferred upon their holders voting rights similar to the ordinary shares and the right to participate in dividends in priority to holders of ordinary shares. In addition, the holders of preferred shares had additional preferential rights including liquidation, conversion and other rights as defined. Upon the closing of the IPO, all outstanding preferred shares were converted into ordinary shares and accordingly the former preferred shareholders are no longer entitled to such preferential rights.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3)
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Share Purchase Agreement ("SPA")
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In September 2011, the Company signed an SPA with certain of its shareholders. Following this SPA and certain amendments signed by the Company, certain shareholders invested in the Company, during the years 2011 through 2013, a total of $12.5 million in exchange for Series B2 Preferred shares NIS 0.01 par value and at a price per share equal to $5.34.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In addition, the Company issued to each of the investors warrants to purchase additional Series B2 Preferred shares amounting to 20% of the number of Series B2 Preferred shares purchased by them as part of the investment round.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Upon the closing of the IPO (see Note 2), all warrants issued to the Company's former preferred shareholders were exercised for preferred shares on a cashless and non-cashless basis, in consideration of $1.3 million, with respect to the non-cashless exercise only.&#160;&#160;The underlying preferred shares subsequently converted into ordinary shares.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	b.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Option plans
</FONT>
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In 2001, 2003 and 2013 the Company's Board of Directors approved option plans for employees, directors and service providers (the "Plans").&#160;&#160;Through December 31, 2015, the Company granted as part of the Plans 4,838,924 options, 165,580 restricted shares and 445,147 restricted share units (see d. below) to employees, directors and service providers. Each option is exercisable into one ordinary share of NIS 0.01 par value.&#160;&#160;On December 31, 2015, 132,476 shares were available for issuance upon grants of options or restricted shares or restricted share units under the Plans.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	From the effective date of grant options generally vest over a 4-year period 25% each year. In addition, at December 31, 2015, there are 62,782 outstanding options, which are also subject to performance conditions that were not met as of December 31, 2015. Immediately upon exercise, the ordinary shares issued will have the same rights as all other ordinary shares.&#160;&#160;In general, any option not exercised within 10 years from the grant date or within three months from the termination of employment will expire, unless extended by the Board of Directors.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 25
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage160"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 9 - SHAREHOLDERS' EQUITY
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Plans with respect to Israeli employees are intended to be governed by the terms stipulated by Section 102 of the Israeli Income Tax Ordinance. In accordance with the capital gain track chosen by the Company and pursuant to the terms thereof, the Company is not allowed to claim, as an expense for tax purposes, the amounts credited to employees as a benefit, including amounts recorded as salary benefits in the Company&#8217;s accounts, in respect of options granted to employees under the Plan - with the exception of the work-income benefit component, if any, determined on the grant date. Options granted to employees from other countries are subject to similar terms with certain changes required for local regulations.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The fair value of options granted during the years ended December 31, 2015, 2014 and 2013 was $2.75, $3.57 and $2.02, respectively.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The fair value of each option granted is estimated on the date of grant using the binomial option-pricing model, with the following assumptions:
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_40"></A>
<DIV STYLE="MARGIN-LEFT: 72PT" ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="91%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December 31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -9PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Dividend yield
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -9PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Expected volatility&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	64
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	71
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	67
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -9PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Risk-free interest rate
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2.07
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2.44
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1.8
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -9PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Contractual&#160;&#160;term
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10 years
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10 years
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10 years
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -9PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Early exercise multiple
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	178%-203
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	178%-203
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	215% -246
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The expected volatility is based on the historical volatility of comparable companies.&#160;&#160;The risk-free interest rate assumption is derived from the interest curve for U.S. government bonds for periods corresponding to the life term of the option on the grant date. The early exercise multiple was based on data of comparable companies.
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<BR>
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The total unrecognized compensation cost of options granted to employees, directors and service providers (not including compensation cost in respect of restricted shares, see d. below) at December&#160;31, 2015 is $1,677,000 which is expected to be recognized over a period of 3 years.
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<BR>
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	A summary of share option plans (excluding restricted shares information, see d. below), and related information, under all of the Company's equity incentive plans for the years ended December&#160;31, 2015, 2014 and 2013 are as follows:
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<BR>
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Options granted to employees, directors and service providers:
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_41"></A>
<DIV STYLE="MARGIN-LEFT: 72PT" ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="91%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="22" VALIGN="BOTTOM" WIDTH="70%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December 31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Number of shares upon exercise
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Weighted average exercise price*
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Number of shares upon exercise
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Weighted average exercise price*
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Number of shares upon exercise
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Weighted average exercise price*
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="28%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Outstanding at the beginning of the year
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,587,612
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6.64
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,967,784
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2.51
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,866,940
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2.13
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%">
<DIV STYLE="TEXT-INDENT: -9PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;Granted
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	347,563
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7.38
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	554,433
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13.76
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	174,420
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6.02
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%">
<DIV STYLE="TEXT-INDENT: -9PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;Exercised
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(175,482
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3.04
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(908,169
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1.94
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(47,940
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.15
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -9PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;Forfeited
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(87,009
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	12.55
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(26,436
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9.73
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(25,636
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3.12
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="28%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Outstanding at the end of the year
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,672,684
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6.87
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,587,612
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6.64
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,967,784
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2.51
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="28%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Exercisable at the end of the year
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	987,568
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4.22
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,039,011
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2.87
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,747,532
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2.29
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	* In dollars per share.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 26
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage161"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_NOTES_TO_FINANCIAL_STATEMENT>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<EFX_OPTIONS_AGGREGATE>
<A NAME="FIS_OPTIONS_AGGREGATE"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 9 - SHAREHOLDERS' EQUITY
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following table summarizes information concerning outstanding and exercisable options as of December 31, 2015:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 72PT" ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="91%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Options outstanding
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Options exercisable
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Shares
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Shares upon
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Aggregate
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	upon
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Aggregate
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	exercise of
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Weighted
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	intrinsic
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	exercise of
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Weighted
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	intrinsic
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	options
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	average
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	value
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	options
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	average
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	value
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	outstanding
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	remaining
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(U.S.
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	outstanding
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	remaining
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	(U.S.
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Exercise
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	at end of
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	contractual
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	dollars in
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	at end of
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	contractual
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	dollars in
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	prices *
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	year
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	life
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	thousands)
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	year
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	life
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	thousands)
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.0001
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,600
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1.79
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	467
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,600
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1.79
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	467
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1.47
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	193,800
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2.62
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,614
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	193,800
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2.62
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,614
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3.12
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	528,946
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4.91
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,533
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	528,946
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4.91
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,533
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5.34
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	89,778
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7.26
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	400
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	89,778
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7.26
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	400
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6.97
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	185,820
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9.03
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	526
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7.84
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	140,162
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9.01
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	275
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8.35
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,750
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9.58
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13.76
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	469,228
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8.62
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	120,644
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	8.62
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	14
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	13,600
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7.76
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,800
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7.76
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	-
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,672,684
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6.56
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,821
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	987,568
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5.00
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,014
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_OPTIONS_AGGREGATE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	* In dollars per share
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	The aggregate intrinsic value in the above table represents the total pre-tax intrinsic value, based on the Company's closing share price of $9.80 on December 31, 2015, less the exercise price. This represents the potential amount receivable by the option holders had all option holders exercised their options as of such date.
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 45PT">
	&#160;
</TD>
<TD ALIGN="RIGHT" STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	c.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Restricted shares and restricted share units
</FONT>
</FONT>
<DIV STYLE="MARGIN-LEFT: 36PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In August 2013, the Company's Board of Directors approved a grant of 156,060 restricted shares to the current Chairman of the Board of Directors.&#160;&#160;The restricted shares are subject to vesting over four years commencing on March 31, 2013 and to other vesting milestones as follows: (i) the vesting of 104,040 restricted shares is subject to the occurrence of a change of control event, as defined; and (ii) the vesting of 52,020 restricted shares is subject to: (a) the occurrence of a change of control event, as defined and (b) the achievement of a market cap milestone, as defined. Following the closing of the IPO, the change in control event occurred and accordingly, the 104,040 restricted shares will vest according to their vesting schedule. In addition, the market cap milestone was met after year-end and the 52,020 restricted shares will vest according to their vesting schedule.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The fair value of restricted shares is estimated based on the market value of the Company's stock on the date of grant. The Company recorded an expense of $412,000, $412,000 and $377,000 for the years ended December 31 2015, 2014 and 2013, respectively in respect of such restricted shares. The total unrecognized compensation expense in respect of such restricted shares at December&#160;31, 2015 is $514,000, which is expected to be recognized over a period of 1.25 years.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In November 2013, in connection with the closing of the IPO, the Company's Board of Directors approved a grant of 9,520 fully vested restricted shares to the previous Vice Chairman of the Board of Directors.&#160;&#160;The Company recorded an expense of $294,000 in the fourth quarter of 2013 in respect of such restricted shares.&#160;&#160;Such shares were issued in January 2014.
</FONT>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 27
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage162"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 9 - SHAREHOLDERS' EQUITY
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
	&#160;
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In August 2014, the Company's Board of Directors approved a grant of 277,249 restricted share units to the Company's employees. The restricted share units are subject to vesting over four years commencing on August 15, 2014. The fair value of these restricted share units is estimated based on the market value of the Company's stock on the date of award. The Company recorded an expense of $397,000 and $170,000 for the years ended December 31, 2015 and 2014, respectively in respect of such restricted share units.
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
	The total unrecognized compensation expense in respect of such restricted shares units at December&#160;31, 2015 is $1,042,000, which is expected to be recognized over a period of 2.6 years.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In January and February 2015, the Company granted 160,398 restricted share units to the Company's employees of which 129,007 are subject to vesting over four years commencing on January 1, 2015 and 31,391 are also subject to performance conditions that were not met as of December 31, 2015. The fair value of the 129,007 restricted share units is estimated based on the market value of the Company's stock on the date of award. The Company recorded an expense of $153,000 in the year ended December 31, 2015 in respect of such restricted share units.
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
	The total unrecognized compensation expense in respect of such restricted shares units at December&#160;31, 2015 is $482,000, which is expected to be recognized over a period of 3 years.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In February and July 2015, the Company granted 7,500 restricted share units to two of its directors. The restricted share units will vest upon the Company's annual meeting of shareholders in 2016. The fair value of these restricted share units is estimated based on the market value of the Company's stock on the date of award. The Company recorded an expense of $24,000 in the year ended December 31, 2015 in respect of such restricted share units.
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
	The total unrecognized compensation expense in respect of such restricted shares units at December&#160;31, 2015 is $21,000, which is expected to be recognized in 2016.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	A summary of restricted share units' information for the year ended December&#160;31, 2015:
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_42"></A>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="88%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Number of
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	restricted
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	share units
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	upon exercise
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="88%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Outstanding at the beginning of the year
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	269,231
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="88%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;Granted
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	167,898
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%">
<DIV STYLE="TEXT-INDENT: -9PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;Vested
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(60,344
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -9PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;Forfeited
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(43,511
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="88%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Outstanding at the end of the year
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	333,274
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 28
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage163"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 9 - SHAREHOLDERS' EQUITY
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	d.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Share based compensation expense
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following table illustrates the effect of share-based compensation (including restricted shares and restricted share units information) expense on the consolidated statement of operations and comprehensive income:
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_43"></A>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December&#160;31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2013
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cost of revenues
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	108
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	51
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Research and development expenses -net
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	255
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	103
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	56
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Selling and marketing expenses
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	362
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	146
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	77
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	General and administrative expenses
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	908
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	552
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	944
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,633
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	852
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,109
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	e.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Accumulated other comprehensive loss:
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_44"></A>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	December&#160;31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2013
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Unrealized loss on marketable securities*
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(284
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(125
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Currency translation adjustment
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(275
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(177
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	25
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Unrealized gain (loss) from cash flow hedge**
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	88
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	238
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(90
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(471
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(64
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(65
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 72PT">
	&#160;
</TD>
<TD ALIGN="RIGHT" STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	*
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In the year ended December 31, 2015, an amount of $108,000 in respect of unrealized loss from marketable securities was reclassified from accumulated other comprehensive income into financial expenses.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 72PT">
	&#160;
</TD>
<TD ALIGN="RIGHT" STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	**
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In the year ended December 31, 2014, amounts of $60,000 and $470,000 in respect of unrealized gain (loss) from cash flow hedge were reclassified from accumulated other comprehensive income into financial income and revenues, respectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In the year ended December 31, 2015, an amount of $939,000 in respect of unrealized gain from cash flow hedge was reclassified from accumulated other comprehensive income into revenues.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 29
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage164"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 10 - TAXES ON INCOME:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	a.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	The Company
</FONT>
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	The Company is taxed according to Israeli tax laws:
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1)
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Measurement of results for tax purposes
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As explained in Note 1c, the dollar is the functional currency of the Company, and the Company's consolidated financial statements are presented in dollars. The difference between the changes in the Israeli shekel ("NIS") and the exchange rate of the dollar, both on an annual and a cumulative basis causes a difference between taxable income and income reflected in these consolidated financial statements.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	ASC 740-10-25, "Income Taxes", prohibits the recognition of deferred tax liabilities or assets that arise from differences between the financial reporting and tax bases of assets and liabilities that are premeasured from the local currency into dollars using historical exchange rates, and that result from changes in exchange rates or indexing for tax purposes. Consequently, the abovementioned differences were not reflected in the computation of deferred tax assets and liabilities.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Starting in the year ended December 31, 2014, the Company elected to compute its taxable income in accordance with Income Tax Regulations (Rules for Accounting for Foreign Investors Companies and Certain Partnerships and Setting their Taxable Income), 1986. Accordingly, the taxable income or loss is calculated in dollars. Applying these regulations reduces the effect of dollar-NIS exchange rate on the Company&#8217;s Israeli taxable income.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2)
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Tax rates
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The income of the Company (other than income from "Approved Enterprise" or "Benefited Enterprise", see 3. below) is taxed at the regular corporate tax rate. On December 6, 2011, the "Tax Burden Distribution Law" Legislation Amendments (2011) was published. Under this law, the corporate tax rate was set at 25% as from 2012 and thereafter.&#160;&#160;On August 5, 2013, the Law for Change of National Priorities (Legislative Amendments for Achieving the Budgetary Goals for 2013-2014), 2013 was published. Under this law, the corporate tax rate was raised to 26.5% beginning in 2014 and thereafter.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In January 2016, the Amendment of the Income Tax Ordinance (No. 216), 2016, was published and set the reduction of the corporate tax, starting in 2016 and thereafter, from 26.5% to 25%.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 30
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage165"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 10 - TAXES ON INCOME
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN">
	3)
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Tax benefits under the Law for the Encouragement of Capital Investments, 1959 (the "Investment Law")
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under the Investment Law, including Amendment No. 60 to the Investment Law that was published in April 2005, by virtue of the Approved Enterprise or Benefited Enterprise status granted to certain of its production facilities the Company is entitled to various tax benefits.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The main benefit arising from such status is the reduction in tax rates on income derived from an Approved Enterprise. Income derived from Approved or Benefited Enterprises is tax exempt for a period of up to ten years period of benefits. The period of tax benefits, as described above, is subject to limitations of the earlier of 12 years from the commencement of production, or 14 years from the date of approval. As of December 31, 2015, the period of benefits has not yet commenced.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In the event of distribution of cash dividends from income which was tax exempt as above, the amount distributed will be subject to the tax rate it was exempted from.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company is entitled to claim accelerated depreciation in respect of equipment used by the Approved or Benefited Enterprises during five tax years.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Entitlement to the above benefits is conditioned upon the Company fulfilling the conditions stipulated by the Investment Law and regulations published thereunder, and in the certificate of approval for the specific investments in Approved Enterprises. In the event of failure to comply with these conditions, the benefits may be canceled and the Company may be required to refund the amount of the benefits, in whole or in part, with the addition of linkage differences to the Israeli consumer price index and interest.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4)
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Amendment of the Investment Law
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Under an amendment 68 to the Investment Law (&#8220;Amendment 68&#8221;), a uniform corporate tax rate will apply to all qualifying industrial income of such company
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(&#8220;Industrial Company&#8221;), as opposed to the previous law&#8217;s incentives, which were limited to income from Approved Enterprises during their benefits period. Under the law, when the election is made, the uniform tax rate (for 2014 and on) will be 9% in areas in Israel designated as Development Zone A.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The benefits are granted to companies that qualify under criteria set forth in the Investment Law; for the most part, those criteria are similar to the criteria that have existed in the Investment Law prior to its amendment and the benefit period is unlimited in time. Under the transitional provisions of the Investment Law, a company is allowed to continue to enjoy the tax benefits available under the Investment Law prior to its amendment until the end of the period of benefits, as defined in the Investment Law. In each year during the period of benefits of its Approved or Benefitted Enterprises, the Company will be able to opt for application of the Amendment, thereby making available to itself the tax rates as above. The Company's election to apply the Amendment is irrevocable.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As of December 31, 2015, the Company decided not to adopt the application of Amendment 68.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 70.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5)
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Losses for tax purposes, carried forward to future years
</FONT>
</DIV>
<DIV ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Carryforward tax losses of the Company at December 31, 2015, approximated $5 million and can be carried forward without expiration.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 31
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage166"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	NOTE 10 - TAXES ON INCOME
</FONT>
	(continued):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	b.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Non-Israeli Subsidiaries
</FONT>
</FONT>
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	Subsidiaries that are incorporated outside of Israel are assessed for tax under the tax laws in their countries of residence. The principal tax rates (Federal and State) applicable to the subsidiaries incorporated in the U.S. is approximately 40%.
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	c.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Tax assessments
</FONT>
</FONT>
</FONT>
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	The Company and its subsidiaries have not been assessed since incorporation. In accordance with the Israeli Income Tax Ordinance, tax assessments of the Company through tax year 2010 are considered final.
</FONT>
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	d.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Income before income taxes is composed of the following:
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_45"></A>
<DIV>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December&#160;31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars In thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Israel
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,742
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,138
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,414
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Non-Israeli subsidiaries
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	903
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	653
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	814
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,645
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,791
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,228
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV>
	&#160;
</DIV>
<DIV ALIGN="CENTER">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP" BGCOLOR="WHITE">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	e.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Taxes on income
</FONT>
	-
<FONT STYLE="FONT-WEIGHT: NORMAL">
	current
</FONT>
	-
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	non-Israeli subsidiaries
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	407
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	406
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	324
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	f.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Uncertain tax positions
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	As of December 31, 2015 and 2014, the Company had not accrued a provision for uncertain tax positions.
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
	&#160;
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	g.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Deferred income taxes
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	Deferred taxes are computed using the tax rates expected to be in effect when those differences reverse.&#160;&#160;Since the Company is entitled to a tax exemption for a period of ten years, the tax rate used in computation of deferred taxes on its carry forward losses and timing differences is zero.
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 41PT">
	&#160;
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	h.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Reconciliation of theoretical tax expense to actual tax expense:
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_46"></A>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December&#160;31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2013
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Income&#160;&#160;before taxes on income
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,645
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,791
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,228
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Theoretical tax expenses (benefit) at the statutory rate (2013 &#8211; 25%; 2014 and 2015-26.5%)
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,761
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,065
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,807
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Increase (decrease) in taxes on income due to:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Computation of deferred taxes at a rate, which is different than statutory rate
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1,194
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1,314
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2,033
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Difference between income reported for tax purposes and income for financial reporting purposes &#8211; mainly dollar &#8211; NIS differences
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(738
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(675
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(754
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Non-deductible expenses- mainly share-based compensation expense
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	452
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	256
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	183
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Different effective tax rates applicable to the subsidiaries
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	126
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	74
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	121
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	407
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	406
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	324
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 32
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage167"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_47"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: -2.85PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
</DIV>
<DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 11 - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION:
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="92%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	December&#160;31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	a.
</FONT>
	&#160;&#160;&#160;&#160;&#160;
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Accounts receivable
</FONT>
	- other:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: -45PT; DISPLAY: BLOCK; MARGIN-LEFT: 54PT; MARGIN-RIGHT: -6PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160; &#160; Advance to supplier
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	71
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	128
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Institutions
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,291
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,126
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Chief Scientist
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	54
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	65
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Fair value of derivatives
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	423
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	905
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Prepaid expenses and sundry
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	519
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	886
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,358
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,110
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	b.&#160;&#160;&#160;&#160;
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Accounts payable and accruals
</FONT>
	- other:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -6PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Employees and payroll related institutions
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,541
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	727
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -6PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Provision for vacation and recreation pay
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	468
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	402
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -6PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Royalties payable
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	106
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	93
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -6PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Fair value of derivatives
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	45
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	217
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: -6PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Accrued expenses and sundry
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,267
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2,130
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,427
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,569
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="92%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December&#160;31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	c.
</FONT>
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Research and development expenses -
</FONT>
	net
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	:
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total expenses
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,275
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,131
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,144
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less - participation and grants
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	126
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	145
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	197
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,149
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,986
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	5,947
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	d.
</FONT>
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<FONT STYLE="DISPLAY: INLINE; FONT-WEIGHT: BOLD">
	Financial income (expenses) -
</FONT>
	net:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest expenses and other bank charges
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(152
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(139
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(595
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest income
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	601
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	332
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	50
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Foreign exchange gain (losses) &#8211; net
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(311
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	276
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(82
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Gain in respect of derivatives &#8211; net
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	333
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	30
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	96
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	471
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	499
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(531
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_48"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 12 - FAIR VALUE MEASUREMENT
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 54PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Financial items carried at fair value as of December 31, 2015 and 2014 are classified in the tables below in one of the three categories described in Note 1r:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	December 31, 2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Level 1
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Level 2
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cash and cash equivalents -
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	cash deposits
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,987
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: -36PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 14.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Marketable securities -&#160;
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	debt securities
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	37,369
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Derivatives:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Forward contracts and currency options (current liabilities) designated as hedging instruments
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(42
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Currency options (current liabilities)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(3
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Forward contracts and currency options (current assets) designated as hedging instruments
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	417
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Currency options (current assets)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	59,356
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	378
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 33
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage168"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_49"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
<BR>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 12 - FAIR VALUE MEASUREMENT
</FONT>
<FONT STYLE="FONT-WEIGHT: NORMAL">
	(continued):
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	December 31, 2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Level 1
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Level 2
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Cash and cash equivalents -
</FONT>
	cash deposits
</FONT>
</DIV>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	10,315
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: -36PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 14.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Marketable securities -&#160;
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	debt securities
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	37,230
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Derivatives:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 1.65PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Interest rate swap (liabilities)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(19
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Forward contracts and currency options (current liabilities) designated as hedging instruments
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(39
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Currency options (current liabilities)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(159
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Forward contracts and currency options (current assets) designated as hedging instruments
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	807
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Currency options (current assets)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	98
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="76%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	47,545
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	688
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 81PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 81PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Foreign exchange risk management
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 81PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Company enters into forward exchange contracts in non-functional currencies and purchases and writes non-functional currency options in order to hedge the currency exposure on identifiable balance sheet items. In addition, the Company takes steps to reduce exposure by using &#8220;natural&#8221; hedging. The currency hedged items are usually denominated in NIS. The writing of options is part of a comprehensive currency hedging strategy. These transactions are for periods of less than one year. The counterparties to the derivatives is comprised of major banks and, in view of the current financial environment, the Company is monitoring the associated inherent credit risks. The above transactions do not qualify for hedge accounting.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 81PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In December 2015 and 2014, the Company entered into forward exchange contracts in respect of forecasted sales transactions at a notional amount of &#8364;8.5 million and &#8364;7.6 million, respectively (approximately $9.2 million at December 31, 2015).
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 81PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 81PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Such transactions were entered into to reduce the exposure from sales denominated in euros. These transactions qualify for cash flow hedge accounting.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 81PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	In August 2015 the Company entered into collar deal contracts in respect of forecasted
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	operating expenses at a notional amount of NIS 33 million (approximately $8.7 million at December 31, 2015).
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 10PT">
	Such transactions were entered into to reduce the exposure from expenses denominated in NIS. These transactions qualify for cash flow hedge accounting.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 34
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage169"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
<BR>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 13 - MARKETABLE SECURITIES:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 53.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	a.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Available-for-sale securities
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 81PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 81PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Available-for-sale securities are comprised of debt securities.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 81PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	As of December 31, 2015 and 2014 the fair value, amortized cost and gross unrealized holding gains and losses of such securities are as follows:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_50"></A>
<DIV>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="52%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Fair value
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Amortized
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	cost
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Unrealized
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	holding
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	gains
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Unrealized
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	holding
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	losses
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="52%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="14" VALIGN="BOTTOM" WIDTH="46%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="52%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="52%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	December 31, 2015
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	37,369
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	37,653
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	69
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	353
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="52%" STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	December 31, 2014
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	37,230
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	37,355
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	32
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	157
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 81PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Investments in marketable securities are classified based on the remaining period until maturity.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 53.9PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 27PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	b.
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Contractual maturities
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 81PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The contractual maturities of debt securities at December 31, 2015 are as follows:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_51"></A>
<DIV>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="88%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 1.65PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2016
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,009
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2017
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	16,734
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%">
<DIV STYLE="TEXT-INDENT: -27PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: -5.4PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2018
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3,462
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="88%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 1.65PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;2019 and thereafter
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,164
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="88%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	37,369
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 14 - RELATED PARTIES:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="92%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December&#160;31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	U.S. dollars in thousands
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Directors' fees
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	375
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	246
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	143
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 54PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	At December 31, 2015, there were 168,754 options outstanding with an average exercise price of $4.64 that were granted to directors. At December 31, 2015, 135,166 out of these options were exercisable. As to restricted shares and restricted share units granted to the directors, see Note 9c.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	F - 35
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="3">
</DIV>
</DIV>
<A NAME="eolPage170"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 8PT">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_52"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	ENZYMOTEC LTD.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: NORMAL">
	NOTES TO FINANCIAL STATEMENTS
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	NOTE 15 - EARNINGS PER SHARE
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 54PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The following table sets forth the computation of basic and diluted earnings per share for the years indicated (in thousands, except per share amounts):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Year ended December&#160;31
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	2013
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -63PT; DISPLAY: BLOCK; MARGIN-LEFT: 63PT; MARGIN-RIGHT: -8.2PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Basic earnings per share:
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -9PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 14.2PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Net income
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,683
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,838
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	11,395
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 14.2PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Amount allocated to participating preferred shareholders
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(6,439
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	)
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Net income applicable to ordinary shareholders &#8211;basic
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,683
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,838
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,956
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 1.7PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Weighted average ordinary shares outstanding
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	22,506,955
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,902,057
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,544,387
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -9PT; DISPLAY: BLOCK; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 14.2PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Basic earnings per share
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.30
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.36
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.66
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="64%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Diluted earnings per share:
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="88%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 1.7PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Net income applicable to ordinary shareholders &#8211; diluted
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	6,683
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,838
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4,956
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 1.7PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Weighted average number of shares used in the computation of basic earnings per share
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	22,506,955
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	21,902,057
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	7,544,387
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%">
<DIV STYLE="TEXT-INDENT: -54PT; DISPLAY: BLOCK; MARGIN-LEFT: 54PT; MARGIN-RIGHT: 1.7PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160;&#160;Add -
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 1.7PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	additional shares from the assumed exercise of employee options, restricted shares and restricted share units vesting
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	775,910
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,308,516
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1,742,069
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -18PT; DISPLAY: BLOCK; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 1.7PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Weighted average number of shares used in the computation of diluted earnings per share
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	23,282,865
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	23,210,573
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	9,286,456
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="64%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="TEXT-INDENT: -54PT; DISPLAY: BLOCK; MARGIN-LEFT: 54PT; MARGIN-RIGHT: 1.7PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;&#160;&#160; Diluted earnings per share
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.29
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.34
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE; TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	0.53
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 4PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 54PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For the year ended December 31, 2015, 881,733 options, 77,996 restricted shares and 31,391 restricted share units to employees and directors were excluded from the calculation of the diluted earnings per share for the year since their effect was anti-dilutive or certain performance conditions were not satisfied at the end of the year.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 446PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 54PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For the year ended December 31, 2014, 552,001 options to employees were excluded from the calculation of the diluted earnings per share for the year since their effect was anti-dilutive.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 446PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 54PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	For the year ended December 31, 2013, 13,600 options to employees,&#160;&#160;52,020 restricted shares and all preferred shares (12,905,312) were excluded from the calculation of the diluted earnings per share for the year since their effect was anti-dilutive or certain performance conditions were not satisfied at the end of the year.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<BR>
	F - 36
</DIV>
<DIV>
<HR STYLE="MARGIN-TOP: -5PX; COLOR: #000000" NOSHADE SIZE="1">
<HR STYLE="MARGIN-TOP: -13PX; COLOR: #000000" NOSHADE SIZE="4">
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</EFX_FORM>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage171"></A>
<A NAME="EXHIBIT_8-1_HTM"></A>
<EFX_EXHIBIT_8>
<A NAME="FIS_EXHIBIT_8"></A>
<DIV>
<HR STYLE="MARGIN-TOP: -5PX; COLOR: #000000" NOSHADE SIZE="4">
<HR STYLE="MARGIN-TOP: -10PX; COLOR: #000000" NOSHADE SIZE="1">
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_53"></A>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	EXHIBIT 8.1
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	SUBSIDIARIES OF ENZYMOTEC LTD.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="52%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Name of Subsidiary
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Jurisdiction of Organization
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	Ownership Interest
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="52%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="30%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="10%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="52%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Enzymotec USA, Inc.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Delaware
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	100
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="52%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	VAYA Pharma, Inc.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Delaware
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	100
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="52%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Enzymotec Australia Pty&#160;&#160;LTD.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Australia
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	100
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="52%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Enzymotec Singapore PTE Ltd.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Singapore
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	100
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="52%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	VAYA Pharma Pte Ltd.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Singapore
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	80
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="52%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Advanced Lipids AB
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Sweden
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	50
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="52%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Advanced Omega A/S
<FONT STYLE="DISPLAY: INLINE; FONT-SIZE: 70%; VERTICAL-ALIGN: TEXT-TOP">
	(1)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="2%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Denmark
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	50
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	%
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV>
	&#160;
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 18PT">
<DIV>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="TEXT-INDENT: 0PT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1)
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In final stages of liquidation.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<HR STYLE="MARGIN-TOP: -5PX; COLOR: #000000" NOSHADE SIZE="1">
<HR STYLE="MARGIN-TOP: -13PX; COLOR: #000000" NOSHADE SIZE="4">
</DIV>
</EFX_EXHIBIT_8>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage172"></A>
<A NAME="EXHIBIT_12-1_HTM"></A>
<EFX_EXHIBIT_12>
<A NAME="FIS_EXHIBIT_12"></A>
<DIV>
<HR STYLE="MARGIN-TOP: -5PX; COLOR: #000000" NOSHADE SIZE="4">
<HR STYLE="MARGIN-TOP: -10PX; COLOR: #000000" NOSHADE SIZE="1">
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	EXHIBIT 12.1
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	EXCHANGE ACT RULE 13A-14(A)/15D-14(A)
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	AS ADOPTED PURSUANT TO SECTION 302
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	OF THE SARBANES-OXLEY ACT OF 2002
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	I, Ariel Katz, certify that:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1. I have reviewed this annual report on Form 20-F of Enzymotec Ltd.;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4. The company&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(c) Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(d) Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting; and
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;5. The company&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information; and
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Date: March 3, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	/s/ Ariel Katz
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Dr. Ariel Katz
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	President and Chief Executive Officer
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(Principal Executive Officer)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="22%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<HR STYLE="MARGIN-TOP: -5PX; COLOR: #000000" NOSHADE SIZE="1">
<HR STYLE="MARGIN-TOP: -13PX; COLOR: #000000" NOSHADE SIZE="4">
</DIV>
</EFX_EXHIBIT_12>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage173"></A>
<A NAME="EXHIBIT_12-2_HTM"></A>
<EFX_EXHIBIT_12>
<A NAME="FIS_EXHIBIT_12_2"></A>
<DIV>
<HR STYLE="MARGIN-TOP: -5PX; COLOR: #000000" NOSHADE SIZE="4">
<HR STYLE="MARGIN-TOP: -10PX; COLOR: #000000" NOSHADE SIZE="1">
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	EXHIBIT 12.2
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	EXCHANGE ACT RULE 13A-14(A)/15D-14(A)
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	AS ADOPTED PURSUANT TO SECTION 302
</FONT>
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	OF THE SARBANES-OXLEY ACT OF 2002
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	I, Oren Bryan, certify that:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	1. I have reviewed this annual report on Form 20-F of Enzymotec Ltd.;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	4. The company&#8217;s other certifying officer
</FONT>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<BR>
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(c) Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(d) Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting; and
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;5. The company&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions):
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information; and
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK">
<BR>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Date: March 3, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	/s/ Oren Bryan
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Oren Bryan
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Vice President and Chief Financial Officer
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(Principal Financial Officer)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<HR STYLE="MARGIN-TOP: -5PX; COLOR: #000000" NOSHADE SIZE="1">
<HR STYLE="MARGIN-TOP: -13PX; COLOR: #000000" NOSHADE SIZE="4">
</DIV>
</EFX_EXHIBIT_12>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage174"></A>
<A NAME="EXHIBIT_13-1_HTM"></A>
<EFX_EXHIBIT_13>
<A NAME="FIS_EXHIBIT_13"></A>
<DIV>
<HR STYLE="MARGIN-TOP: -5PX; COLOR: #000000" NOSHADE SIZE="4">
<HR STYLE="MARGIN-TOP: -10PX; COLOR: #000000" NOSHADE SIZE="1">
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	EXHIBIT 13.1
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
<BR>
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	AND PRINCIPAL FINANCIAL OFFICER
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	&#160;PURSUANT TO
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	18 U.S.C. SECTION 1350
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	AS ADOPTED PURSUANT TO SECTION 906
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
	OF THE SARBANES-OXLEY ACT OF 2002
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	In connection with the Annual Report of Enzymotec Ltd. (the &#8220;
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	Company
</FONT>
	&#8221;) on Form 20-F for the period ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	Report
</FONT>
	&#8221;), I, Ariel Katz, and I, Oren Bryan, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(1)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(2)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="79%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	/s/ Ariel Katz
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Dr. Ariel Katz
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	President and Chief Executive Officer
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(Principal Executive Officer)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Date: March 3, 2016
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	/s/ Oren Bryan
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Oren Bryan
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Vice President and Chief Financial Officer
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	(Principal Financial Officer)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="22%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Date: March 3, 2016
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="78%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<HR STYLE="MARGIN-TOP: -5PX; COLOR: #000000" NOSHADE SIZE="1">
<HR STYLE="MARGIN-TOP: -13PX; COLOR: #000000" NOSHADE SIZE="4">
</DIV>
</EFX_EXHIBIT_13>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage175"></A>
<A NAME="EXHIBIT_15-1_HTM"></A>
<EFX_EXHIBIT_15>
<A NAME="FIS_EXHIBIT_15"></A>
<DIV>
<HR STYLE="MARGIN-TOP: -5PX; COLOR: #000000" NOSHADE SIZE="4">
<HR STYLE="MARGIN-TOP: -10PX; COLOR: #000000" NOSHADE SIZE="1">
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="RIGHT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-WEIGHT: BOLD">
<FONT STYLE="DISPLAY: INLINE; TEXT-DECORATION: UNDERLINE">
	EXHIBIT 15.1
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/03/0001178913-16-004598_PWC.JPG" ALT="">
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="CENTER">
	&#160;
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-193118 and 333-202839) of Enzymotec Ltd. of our report dated March 3, 2016, relating to the consolidated financial statements of Enzymotec Ltd., which appears in this Form 20-F.
</FONT>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="30%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Tel-Aviv, Israel
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="55%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	/s/ Kesselman &amp; Kesselman
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="30%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	March 3, 2016
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="55%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Kesselman &amp; Kesselman
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="30%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="55%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	Certified Public Accountants (lsr.)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="30%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="55%">
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
<FONT STYLE="DISPLAY: INLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT">
	A member firm of PricewaterhouseCoopers International Limited
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-INDENT: 0PT; DISPLAY: BLOCK; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV>
<HR STYLE="MARGIN-TOP: -5PX; COLOR: #000000" NOSHADE SIZE="1">
<HR STYLE="MARGIN-TOP: -13PX; COLOR: #000000" NOSHADE SIZE="4">
</DIV>
</EFX_EXHIBIT_15>

<!-- FOOTER LOGO -->
</BODY>
</HTML>
